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Abstract 
The c-Jun N-terminal Kinases 1-3 (JNK1-3) are mitogen activated protein kinases (MAPK) 
involved in the non-canonical Wnt / planar cell polarity (PCP) signalling pathway. In mouse 
models and human patients, mutations in the PCP pathway have been associated with 
congenital heart malformation; however investigating the function of Jnk using null mice has 
been difficult because of genetic redundancy and embryonic death that occurs in Jnk1/Jnk2 
compound mutants. Both human and mouse JNK1 orthologs have four known transcripts 
which differ in sequence at two locations. Although evidence has been published to show 
that these transcripts have differential downstream binding affinities, no transcript-specific 
functions have been suggested. 
Zebrafish possess two jnk1 paralogs on chromosomes 12 (jnk1b) and 13 (jnk1a) that arose 
from the teleost genome duplication event. The aim of this thesis was to identify the jnk1 
transcripts that arose from the zebrafish jnk1 genes and compare them to what is seen in 
human JNK1. Furthermore I aimed to knock-down zebrafish jnk1 translation during 
development using morpholino oligonucleotides (MOs) and assess the phenotypes caused. 
Considering the involvement of PCP in cardiac development, I hypothesised that jnk1 would 
be required for cardiac morphogenesis, and that some subfunctionalization would exist 
between zebrafish jnk1a and jnk1b paralogs which would explain the retention of both 
duplicated genes. 
I was able to clone four different transcripts from each of the jnk1 paralogs, and these 
transcripts closely resembled mouse and human orthologs. Semi-quantitative RT-PCR 
demonstrated that these transcripts had differential expression levels during development 
and in adult tissues. When knocked down, jnk1a and jnk1b morphants were viable (to 
72hpf) but displayed multiple developmental defects that were paralog-specific. The 
jnk1a morphants displayed retinal layer underdevelopment, structural immaturity of the 
heart and uncoupling of the jog-loop cardiac morphogenetic movements. In contrast 
the jnk1b morphants displayed a high frequency of reversed cardiac situs with a milder 
overall heart phenotype, in addition to curled body axis formation and failure to form the 
somitic horizontal myoseptum. Dual knockdown resulted in a combination of paralog-
specific defects, as well as developmental delay and a failure for the heart tube to loop. 
These results demonstrated that the human and zebrafish JNK1 genes are highly conserved 
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and suggested that following genome duplication the zebrafish jnk1 paralogs have 
undergone subfunctionalization. The jnk1a gene appears to have organ specific roles and in 
particular is required for heart growth whereas the jnk1b gene appears to be important for 
somatic left-right signalling and therefore heart looping and jogging. 
This work expands on what is known about the two jnk1 paralogs and strengthens their 
validity as a model of human JNK1. Establishment of a zebrafish knockdown model provides 
a powerful tool for the investigation of jnk1 in an organism that has many advantages for 
developmental biology research. The demonstration that several organs require jnk1 during 
development will allow for future work to investigate the exact role of this gene during 
organogenesis, and the involvement in left-right axis patterning strengthens the evidence 
that JNK acts in the PCP pathway. 
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The c-Jun N-terminal Kinase (JNK) family genes have been shown to function in both the 
mitogen activated protein kinase (MAPK) and planar cell polarity (PCP) signalling pathways. 
Through these two pathways the JNK proteins mediate the appropriate tissue-specific 
responses to both intracellular and extracellular stimuli, and have been implicated with 
many different cellular processes and disease progressions. However, the understanding of 
JNK signalling has been hampered by the quantity and diversity of upstream signals, 
moderating co-factors, and downstream targets which have been identified. A further 
complexity to understanding the role of each JNK gene individually is the existence of 
genetic redundancy that has been shown between the different mouse Jnk genes - loss of a 
single Jnk isoform does not cause any overt physical phenotypic changes (Kuan et al., 1999). 
The aim of this thesis was therefore to characterise the two zebrafish jnk1 genes (jnk1a and 
jnk1b), compare them to the human gene, and examine their expression pattern during 
development and between different tissues. Furthermore a jnk1 morpholino 
oligonucleotide method was developed, and phenotypic analysis was performed in order to 
explore the functions of the two jnk1 genes during zebrafish embryogenesis. It is hoped that 
this research will expand upon what is currently known about the jnk1 genes and offer an 
amenable system for the study of jnk1 function during development. 
 
1.1 LEFT-RIGHT PATTERNING 
Externally the human body appears symmetrical across the left-right axis, however 
internally many of the organs are located on one side, or are left-right asymmetrical (Figure 
1A). This asymmetry is most apparent amongst the visceral organs where the heart, 
stomach, spleen and pancreas are predominantly left sided, whereas the liver and gall 
bladder are right sided. Furthermore the left side of the heart is far thicker whereas the 
lungs possess two right and three left-sided lobes. The normal asymmetrical arrangement of 
the body is known as situs solitus, and is a feature common to all of the bilateria (organisms 
with one axis of symmetry), which include all major phyla of animals except for the sponges 
and Hydra (Blum et al., 2014). 
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The mechanisms by which situs solitus is established have been well studied between 
several species, and many key pathways are found to be universally used. When left-right 
patterning is disrupted the result is a heterogeneous spectrum of disorders ranging from 
complete reversal or “mirror image” of organ situs (situs inversus totalis) (Figure 1B), 
discordance between the situs of different organs (heterotaxy) (Figure 1C) or isomerism of 
organs (Figure 1D) such as right atrial isomerism, bilateral trilobed lungs, or polysplenia (Lin 
et al., 2000, Kaulitz et al., 2004, Hashmi et al., 1998, Yokoyama et al., 1993, Bartram et al., 
2005). The incidence of abnormal situs in humans is estimated at about 1:10,000 (Lin et al., 
2000) and is thought to account for 1-3% of congenital heart defects (Bartram et al., 2008, 
Sutherland and Ware, 2009). 
Figure 1 The body plan of all bilateria display asymmetry of the internal 
organs. 
A) Internally the human visceral organs display asymmetrical shape or 
placement with respect to the anterior-posterior axis.  The normal arrangement 
of organs is known as situs solitus. B) Complete reversal of normal situs is situs 
inversus totalis. C) Heterotaxy is when there exists a discordance of organ situs 
(e.g. normal heart and reversed liver  situs). D) Isomerism of an organ is where 
both sides are symmetrical (mirrored) and display either left -sided or right-
sided isomerism (e.g. bilateral trilobed lungs).  
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Congenital heart defects (CHDs), represent one of the most common human congenital 
disorders, having an incidence of between 6 and 19 per 1000 live births (Hoffman and 
Kaplan, 2002). These defects include conditions as diverse as hypoplastic left heart, double 
outlet right ventricle, atrial or ventricular septal defects, bicuspid aortic valve and patent 
ductus arteriosus. A link between organ situs and heart defects has long been described 
(Ferencz, 1964, Icardo and Sanchez de Vega, 1991, Merklin and Varano, 1963), however 
more recently it has been suggested that a vast number of complex CHDs may arise from 
subtle laterality defects that result in improper formation of the developing organ 
(Ramsdell, 2005, Francis et al., 2012). Due to the prevalence and severity of defects caused 
by defects of organ situs, it is important to understand the genetic pathways involved in 
proper left-right patterning. 
 
1.1.1 Early Symmetry Breaking 
The origin of embryonic asymmetry has long been contested, and still remains unclear (for 
review see (Vandenberg and Levin, 2010)). Despite much of the left-right patterning 
research being focused upon the function of motile cilia during post-gastrula stages of 
development (see section 1.1.2) the first break in symmetry has been shown to occur much 
earlier in several species. Since the issue was first contemplated it has been suggested that 
the left-right axis is patterned by default once the other two body axes (anterior-posterior, 
dorsal-ventral axes)  are established (Brown and Wolpert, 1990). Indeed pre-gastrula stage 
left-right asymmetries have been shown to exist in Xenopus, chick and zebrafish (Adams et 
al., 2006, Aw et al., 2010, Fukumoto et al., 2005, Levin et al., 2002, Morokuma et al., 2008, 
Vandenberg et al., 2013) although the mechanisms by which this asymmetry is established 
are not well understood. 
In Xenopus and chicken it has been shown that during the first few cell cleavages there is a 
left-sided depolarisation of the embryo mediated by several ATP-dependent ion channels. 
Inhibition of these ion channels (H+/K+-ATPase, H+-V-ATPase, KCNQ1 and KCNE1 K+ 
channels) results in disruption of normal organ situs independent of the other embryonic 
axes (Adams et al., 2006, Levin et al., 2002, Morokuma et al., 2008). It has also been shown 
that inhibition of H+/K+-ATPases in zebrafish between 0-10 hours post fertilisation can 
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randomise organ situs via retinoic acid signalling (Kawakami et al., 2005)  Although most of 
the channels found to play a role in early left-right symmetry breaking are asymmetrically 
distributed in the blastomere, possibly under the control of Rab GTPases (Vandenberg et al., 
2013, Aw et al., 2010), K+-ATPase channels are symmetrically distributed but also lead to 
situs defects when inhibited.     
Early symmetry breaking has also been described in the chick where depolarisation is 
observable at primitive streak stages and this is also dependent upon ion channel function 
(Levin et al., 2002). This bioelectrical gradient controls the distribution of maternally 
inherited serotonin in both chick and Xenopus long before organ asymmetry is observed. 
Inhibition of serotonin during development, particularly in the right ventral blastomere of 
Xenopus causes heterotaxia of the visceral organs later during development (Fukumoto et 
al., 2005). 
Despite the recent accumulation of evidence there still remains no evidence in mouse that 
there exists left-right asymmetry in the embryo earlier than appearance of the node, 
therefore the idea of early embryonic asymmetry is still widely viewed as a species-specific 
phenomenon. 
 
1.1.2 Left-Right Symmetry in the Lateral Plate Mesoderm 
Although few papers have examined the earliest breaks of left-right patterning during 
development, there is a wealth of evidence generated concerning left-right asymmetry 
breaking during somitic stages of development. The majority of this work has been 
performed in mouse and therefore so will much of the literature discussed here. Where 
evidence from other animal models is available it will be stated. One of the most important 
discoveries in understanding the somitic transmission of left-right signals through the 
embryo was defining the function of the node. 
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1.1.2.1 The Node 
The node is a transient vesicle present during somitogenesis of the mouse (Sulik et al., 
1994), frog (Schweickert et al., 2007) and zebrafish (Essner et al., 2005b), although in the 
latter it is known as Kupffer’s vesicle. The vesicle is filled with extraembryonic fluid and 
small cilia project from the cells on the ventral surface into the node (Nonaka et al., 1998, 
Okada et al., 1999). Motile cilia within this population rotate in a clockwise manner to 
generate a right-to-left fluid flow known as the nodal flow (Figure 2A+B). This nodal flow has 
been studied thoroughly in mouse and zebrafish and is critical for correct laterality of both 
the visceral organs and certain structures of the brain (Essner et al., 2005b); disturbance of 
normal cilia length (Nonaka et al., 1998, Lopes et al., 2010), cilia motility (Essner et al., 
2005b, Kramer-Zucker et al., 2005), or fluid flow directly (Nonaka et al., 2002) may disturb 
normal organ situs (Figure 2C). The mechanism by which fluid flow translates to organ situs 
is contested, however shortly after node formation several key genes in left-right 
determination establish an asymmetric expression pattern through the left lateral plate 
mesoderm (Long et al., 2003b). There are two alternative (non-mutually exclusive) 
hypotheses about how nodal flow translates to asymmetric gene expression.  
The first theory of symmetry breaking in the node states that the TGFβ-related protein 
NODAL is itself physically shuttled to the embryonic left by nodal flow, or that nodal 
vesicular particles (containing Sonic Hedgehog and Retinoic acid) are shuttled which 
upregulate NODAL expression (Figure 2D) (Nonaka et al., 1998, Tanaka et al., 2005). As a 
secreted cytokine, a small imbalance of Nodal may be caused on the left side by nodal 
function which will be amplified since nodal is capable of increasing its own expression 
(Saijoh et al., 2000).  
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The opposing theory postulates that there exist sensory cilia within the node that react to 
the mechanical forces of nodal flow, and increase intracellular calcium on the left side 
(Figure 2D) (Tabin and Vogan, 2003). It has been shown comprehensively in mouse that 
there are two distinct populations of cilia within the node, a central motile population which 
require the left-right dynein (Lrd) to generate nodal flow, and a peripheral immotile 
population (McGrath et al., 2003). Both cilia populations contain the calcium channel 
protein polycystin-2 which is also found on the mechanosensory renal cilia that increase 
Figure 2 Leftward nodal flow is critical of embryonic left-right patterning. 
A) The node contains posterior-facing motile cilia that beat and produce a net leftward 
fluid flow (taken from (Hirokawa et al., 2006)). B) Net leftward flow (blue) is dependent 
upon polarised cilia postitioning (red). C) Disruption of cilia orientation creates 
turbulent nodal flow without net leftward movement. D) Two theories exist to e xplain 
the role of nodal fluid flow. The determinant model suggests that some molecular 
determinant is shuttled to the left side of the embryo by nodal flow, establishing a gene 
expression asymmetry. The mechanical model suggests that physical fluid flow is sensed 
by mechanosensory cilia at the edge of the node which influences downstream left -
determination (taken from (Shiratori and Hamada, 2006)). 
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intracellular calcium in this environment in response to flow (Nauli et al., 2003). 
Furthermore left-sided asymmetrical calcium signalling has been reported in the node of 
mouse (McGrath et al., 2003) and zebrafish (Francescatto et al., 2010), and mutations of 
polycystin-2 cause loss of nodal signalling resulting in heterotaxy (Pennekamp et al., 2002, 
Bisgrove et al., 2005, Obara et al., 2006). Both theories therefore have supportive 
experimental evidence and neither has definitively been shown to be the dominant 
mechanism of symmetry breaking in the LPM. However, as stated above these two 
mechanisms are not mutually exclusive and could cooperate in order to establish left 
sidedness in the embryo. Regardless of the mechanism by which left-right patterning is 
established within the lateral plate mesoderm, the eventual readout is left-sided Nodal 
expression.  
Further evidence for the importance of the node in left-right patterning has come from a 
subset of genetic conditions that affect cilia formation or function. Primary ciliary dyskinesia 
is an autosomal recessive disorder that is characterised by immotile primary cilia of the 
respiratory tract and sperm cells (Afzelius, 1976). Over 30 genes have been identified in this 
disorder, which encode components of the primary cilia or genes involved in the assembly 
of cilia (Leigh, 2015). Approximately half of the patients that present with primary ciliary 
dyskinesia also display organ laterality defects that are thought to be caused by incorrect 
function of nodal cilia. 
 
1.1.2.2 Molecular Patterning of the Lateral Plate Mesoderm 
Although earlier breaks of left-right patterning have been described, the node is responsible 
for transmitting left-right aysymmetry through the lateral plate mesoderm by establishing 
asymmetrical gene expression. NODAL is one of the most critical determinants of “leftness” 
for patterning of the left-right axis in mouse (Collignon et al., 1996), frog (Lowe et al., 1996), 
chick, and zebrafish (Ahmad et al., 2004). Nodal is initially expressed symmetrically in peri-
nodal cells around the node before it becomes restricted to the left LPM (Figure 3) 
(Collignon et al., 1996). Once an imbalance is present on the left, Nodal may upregulate its 
own expression via binding to a Nodal-responsive transcriptional enhancer (Saijoh et al., 
2000, Yashiro et al., 2000) which allows for very rapid amplification of Nodal on the left. In 
order to self regulate, Nodal upregulates the expression of two of its antagonists, the TGFβ-
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related cytokines Lefty1 and Lefty 2. These proteins, in zebrafish at least, diffuse more 
quickly than nodal (Muller et al., 2012) and antagonise Nodal action by competing for 
receptor binding (Varlet et al., 1997, Cheng et al., 2004, Meno et al., 1999). Although the 
expression of Lefty2 somewhat overlaps that of Nodal (Long et al., 2003b), Lefty1 expression 
is restricted to the midline and is postulated to play a role in the chemical midline barrier 
(Figure 3). Both NODAL and LEFTY function has been shown to be critical for normal organ 
situs in mouse (Lowe et al., 1996, Meno et al., 1999, Meno et al., 1998), zebrafish (Ahmad et 
al., 2004, Long et al., 2003a, Long et al., 2003b, Meno et al., 1999), and Xenopus (Osada et 
al., 2000, Cheng et al., 2000, Toyoizumi et al., 2005).  
Numerous other genes are also critical for left-right patterning of the embryo including 
embryonic growth/differentiation factor 1 (GDF1). In mouse, Gdf1 is bilaterally expressed 
around the node at the same time as Nodal, and knockout Gdf1 mice fail to establish left-
sided nodal expression (Rankin et al., 2000, Wall et al., 2000). Gdf1 may be considered a 
cofactor of Nodal since the two form heterodimers which greatly increases the activity and 
range of Nodal (Shiratori and Hamada, 2014, Tanaka et al., 2007). Although Gdf1 appears to 
perform a role in left-right determination in human (Karkera et al., 2007), to date no 
zebrafish ortholog has been reported. 
Right-sided antagonism is also critical for normal organ situs around the time when NODAL 
is expressed. Cerl2 (Dand5) pre-empts Nodal expression, and is predominantly right-sided 
around the node (Figure 3). Cerl2 antagonises Nodal function and null mouse mutants 
present with bilateral or right sided Nodal expression (Marques et al., 2004). The zebrafish 
homolog charon is initially bilateral, but switches to right-sided by the 8-10 somite stage 
(Lopes et al., 2010). Charon binds directly to southpaw (zebrafish nodal) and disruption of 
this gene results in organ situs defects (Hashimoto et al., 2004). The interplay of both 
agonists and antagonists of vertebrate NODAL are thought to set up a gradient so that 
expression of NODAL becomes restricted to the left lateral plate mesoderm (Matsui and 
Bessho, 2012, Shiratori and Hamada, 2014). 
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Despite being a left-determinant, the temporal expression of Nodal is fairly short, between 
2 to 10 somites in the mouse (Lowe et al., 1996), but at its peak includes the entirety of the 
left lateral plate mesoderm. However Nodal activity, in combination with Cited2, 
upregulates the expression of Pitx2, a bicoid-type homeobox gene, in the left lateral plate 
mesoderm (Bamforth et al., 2004). Pitx2 expression can be detected as late as E10.5 in 
mouse (Yoshioka et al., 1998) and is thought to be responsible for transmission of leftness 
to the organs such as the lungs and heart. Indeed Pitx2 is expressed in the left side of the 
cardiac crescent (heart progenitor population) as well as the left side of the developing 
organ itself (Campione et al., 2001).  Aberrant expression of Pitx2 results in organs situs 
defects to the heart, lungs, and gut (Kitamura et al., 1999, Lu et al., 1999, Campione et al., 
1999). 
 
Figure 3 Left-right patterning of the lateral plate mesoderm requires 
several key TGFβ-related cytokines.  
Schematic representation of the expression patterns displayed by mouse 
Nodal, Cerl2, Lefty1 and Lefty2 during L-R patterning. Cerl2 is expressed 
predominantly on the left of the node, before expression of Nodal, and 
antagonises it. Nodal is initially bilaterally expressed at the node but 
becomes predominantly left-sided over a few hours. Lefty2 is a Nodal 
antagonist whose expression is upregulated by Nodal. Much of the 
expression pattern of Lefty2 overlaps Nodal. Lefty1 forms part of the 
molecular midline barrier and is predominantly expressed in the notochord 
and floor plate. Figure modified from (Saijoh et al., 2014). 
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1.1.3 The Role of the Midline Barrier 
Although NODAL diffuses through the lateral plate mesoderm, it is restricted to the left side 
of the embryo by the function of the midline barrier. The midline barrier is proposed to have 
both a physical and molecular component which separates the embryo left and right and 
prevents NODAL propagation. The physical midline barrier is thought to be composed of 
midline structures such as the notochord and floor plate. In Xenopus, surgical removal of 
the notochord and adjacent tissue resulted in a randomisation of cardiac loop direction 
(Danos and Yost, 1996). Furthermore, zebrafish mutants such as no tail (Brachyury) and 
floading head (Xnot) which are known to have defects in the these midline structures 
(Schulte-Merker et al., 1994, Halpern et al., 1993) also display visceral organ laterality 
defects (Danos and Yost, 1996). The molecular barrier is composed of the NODAL inhibitor 
LEFTY1 in mouse (Meno et al., 1998), zebrafish (Meno et al., 1999, Bisgrove et al., 1999) and 
Xenopus (Cheng et al., 2000), which is restricted to the notochord, floor plate, and adjacent 
left axial mesoderm. This antagonist prevents diffusion of NODAL across the midline and 
loss results in bilateral NODAL expression (Meno et al., 1998). Although LEFTY1 represents a 
critical component of the midline barrier, its expression does not span the whole of the 
embryonic midline, and cannot act in anterior regions such as the brain where NODAL 
signalling is known to act (Long et al., 2003a, Long et al., 2003b). Instead other midline 
barrier genes have been hypothesised to be expressed in regions where LEFTY1 is not, and 
recently two of these antagonists were discovered in zebrafish. lefty2 and an unidentified 
BMP member were shown to be expressed in the midline and  extend the barrier anteriorly 
and posteriorly (Lenhart et al., 2011); whether these genes truly act as midline barriers 
remains to be seen. 
 
1.1.4 Organ Response to Left-Right Patterning 
With the loss of NODAL and LEFTY expression before development of the visceral organs, it 
is thought that the NODAL target PITX2 confers leftness during organogenesis (Campione et 
al., 2001, Logan et al., 1998). This role of PITX2 has been shown conclusively in the heart 
where PITX2 is required for looping and formation of the left atrium (Franco et al., 2014). In 
Xenopus, heart laterality can be disturbed by right-sided injection of pitx2, and similar situs 
disturbance is observed in the chicken with pitx2 knockdown (Campione et al., 1999, Linask 
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et al., 2002). However, a loss of Pitx2 in the mouse does not result in looping defects 
suggesting that some genetic redundancy may exist in this model (Lin et al., 1999, Kitamura 
et al., 1999). Instead Pitx2 deficient mice display body wall closure defects and more 
interestingly right atrial and right pulmonary isomerism, suggestive that Pitx2 signals 
leftness in the atrium at least (Kitamura et al., 1999). Pitx2 does show expression within the 
cardiac progenitors, and in the left side of the primitive heart tube consistent with this 
theory. Furthermore, overexpression of Pitx2 has been shown to upregulate Islet1 and 
Mef2c which are early lineage markers of cardiomyocyte fate (Lozano-Velasco et al., 2011). 
 
1.2 THE PLANAR CELL POLARITY PATHWAY 
In addition to the apical / basal polarity, many tissues also display a polarity within the plane 
of a tissue (Karner et al., 2006b). This tissue or planar cell polarity (PCP) is critical for correct 
tissue development and function and has been linked to cytoskeletal rearrangement, cell 
migration, oriented cell division, cell fate specification and cilia formation (Winter et al., 
2001, Kilian et al., 2003, Saburi et al., 2008, Yang et al., 2002, Kim et al., 2010). In 
vertebrates the PCP pathway has been shown to respond to the Frizzled ligands Wnt5a and 
Wnt11 without action of β-catenin, and is therefore also known as the non-canonical wnt 
pathway. Critically, the PCP pathway has also been comprehensively linked to left-right 
patterning of the lateral plate mesoderm during vertebrate development. 
 
1.2.1 The Molecular Genetics of the PCP Pathway 
The PCP pathway controls cell polarity within a tissue by establishing a proximal-distal 
asymmetry within the cell in response to global cues (Karner et al., 2006a). The ultimate 
readout of PCP signalling is the rearrangement of the actin cytoskeleton. The exact 
mechanism by which PCP signalling rearranges the cytoskeleton has not been fully 
elucidated, however, the most complete theory suggests that there are three layers of 
signalling which progress linearly to lead to cytoskeletal changes: the upstream “global” 
cues, the core PCP members and the downstream, tissue specific effectors (for review see 
(Simons and Mlodzik, 2008)). Although the PCP pathway has been shown to be well 
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conserved between species, much of the research has been conducted in Drosophila so this 
will be discussed first.  
 
1.2.1.1 Planar Cell Polarity in Drosophila 
The most upstream level of polarity determination in Drosophila involves the atypical 
cadherins daschsous (ds) and fat (ft) (Yang et al., 2002). These proteins are able to form 
heterodimers at the cell surface in one of two orientations between cells at cell-cell 
boundaries (Matakatsu and Blair, 2004). The Golgi transmembrane protein four-jointed (fj) 
acts upon these ds-ft heterodimers and phosphorylates both proteins. The result of this 
modification is to bias the assembly of the dimers in one orientation over the other because 
the ability of ft to bind ds increases while the ability of ds to bind ft is weakened (Figure 4A) 
(Axelrod, 2009, Zeidler et al., 1999, Brittle et al., 2010, Simon et al., 2010, Strutt et al., 2004). 
This mechanism is thought to pattern a global tissue orientation because Drosophila displays 
opposing transcriptional gradients of fj and ds in polarised tissues (Yang et al., 2002). Once 
heterodimer orientation is established it has been hypothesised that these proteins may 
stabilise the asymmetric localisation of the core PCP proteins. When members of the 
upstream module are mutated the result is retention of cellular core protein polarity, but a 
loss of global polarity across the tissue as a whole (Yang et al., 2002, Zeidler et al., 1999). 
The core PCP proteins in Drosophila are frizzled (fz), dishevelled (dsh), flamingo / starry 
night (fmi / stan), strabismus / van gogh (stbm / vang), prickle (pk) and diego (dgo), and 
each of these have been shown to have at least one mammalian ortholog (Simons and 
Mlodzik, 2008). These core PCP proteins co-localise asymmetrically at adherens junctions to 
the proximal or distal poles of the cell. The G-protein coupled receptor protein frizzled 
localises to the distal cell membrane and putatively forms a complex with the ankyrin repeat 
protein diego and cytoplasmic dishevelled (Theisen et al., 1994). At the proximal pole the 
four-pass transmembrane protein strabismus complexes with cytoplasmic prickle (Figure 
4A). The final core PCP protein is the protocadherin-like protein starry night which localises 
to both proximal and distal poles (Gao and Chen, 2010). Once formed, these asymmetrical 
complexes are able to transmit polarity to neighbouring cells in a cell non-autonomous 
manner (Vinson and Adler, 1987, Taylor et al., 1998, Gubb and Garciabellido, 1982). This 
interaction with surrounding cells is thought to occur between the transmembrane proteins 
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strabismus, frizzled and flamingo (Strutt and Strutt, 2009, Wu and Mlodzik, 2008) and 
interactions between these transmembrane proteins ensures polarity of neighbouring cells 
coincide.   
The downstream module of PCP signalling is composed of tissue-specific effectors that 
modify cellular morphology to ensure proper function (Karner et al., 2006a). This 
downstream module is the least well understood aspect of the PCP pathway but the genes 
involved are responsible for regulating the morphological changes appropriate to the tissue. 
In Drosophila it has been shown that the small GTPases Rac and Rho are downstream of the 
core proteins, and may be involved in mediating the tissue specific response to PCP 
signalling (Fanto et al., 2000, Strutt et al., 1997). Despite the classical hypothesis that each 
layer of the PCP pathway is affected by the layer above in the cascade, it has been shown 
that the upstream module may bypass the core proteins in certain tissues (Casal et al., 
2006). In these situations the loss of core PCP proteins can be mitigated by overexpression 
of ft or ds, and polarisation of the tissue is rescued. 
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1.2.1.2 The Vertebrate PCP Pathway 
Although many of the Drosophila PCP components are shared there are additional levels of 
complexity found within vertebrates. Firstly, the degree to which the Ft/Ds/Fj pathway 
patterns global polarity cues appears to be less pronounced in vertebrates than it is in flies. 
Although knockdown of mouse Fat1, Fat4, or Dchs1 cause PCP-related phenotypes such as 
defects in the renal glomeruli, cystic kidney disease, shortening of the inner ear cilia and 
wider neural tube, the polarity disruption is modest (Ciani et al., 2003, Saburi et al., 2008, 
Mao et al., 2011). A more potent global cue for vertebrate polarity comes from the wingless 
(WNT) family glycoproteins, WNT5a and WNT11. In zebrafish and Xenopus the wnt5a and 
Figure 4 Schematic representation of the PCP pathway proteins in (A) 
Drosophila and (B) vertebrates.  
A) The PCP pathway is composed of three discrete modules. The upstream module 
establishes global polarity via heterodimer formation of Ft and Ds. The interaction of 
Fj ensures that correct orientation of the dimer is achieved. Global cues mediate the 
asymmetrical localisation of the core proteins to the proxiaml and distal sides of the 
cell. This core module acts in a cell non-autonomous manner to ensure uniform 
polarity throughout the tissue. The core module then acts through tissue specific 
effectors to ensure an appropriate tissue response. In addition the global module may 
be able to bypass the core module and moderate tissue specific effectors directly. 
Taken from (Axelrod, 2009) B) In vertebrates the core proteins have also been shown 
to localise  asymmetrically between the proximal and distal membrane however this is 
though to occur in response to activation by the non -canonical WNT proteins Wnt5a 
and Wnt11. The core module then activates the small GTPases RhoA and Rac which 
themselves activate the kinases ROCK and JNK. Appropriate tissue responses are 
achieved through the phosphorylation of downstream targets, leading to changes in 
cell morphology. Taken from (Henderson and Chaudhry, 2011)  
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wnt11 proteins have been shown to increase jnk activity through binding to frizzled, 
however critically there is no effect on β-catenin levels (which demonstrates that it is not 
acting through the canonical wnt pathway)  (Kilian et al., 2003, Yamanaka et al., 2002, 
Garriock et al., 2005). Loss of these non-canonical wnts results in pronounced shortening of 
the anterior-posterior body axis (Heisenberg et al., 2000, Yamanaka et al., 2002, Kilian et al., 
2003) via the disruption of convergent extension cell movements during gastrulation. 
Convergent extension (CE) movements involve the intercalation of cells in order to extend 
the anterior-posterior axis and have been shown to be regulated by the PCP pathway (Tada 
and Smith, 2000, Djiane et al., 2000, Gong et al., 2004). In mouse it has been shown that 
Wnt5a binds to Frizzled but does not act through the canonical Wnt pathway (Oishi et al., 
2003). A loss of Wnt5a function leads to loss of tissue polarisation in the inner ear, 
convergent extension-like defects and incomplete neural tube closure defects (Qian et al., 
2007), all phenotypes linked with PCP. Despite evidence in vertebrates, no convincing 
evidence of a wnt (wingless) contribution is seen in Drosophila PCP. 
The core PCP module is particularly well conserved in vertebrates and asymmetric 
localisation to the cell membrane is observed. At the proximal side the complex of Celsr 
(mouse fmi), Prickle, and Vangl2 (mouse strb) is formed while at the distal side the Celsr, 
Frizzled, Dishevelled and Deigo complex forms (Figure 4B). The core proteins activate the 
downstream GTPases Rho and Rac, which themselves activate the protein kinases c-Jun N-
terminal Kinase and Rho Kinase (Habas et al., 2003, Djiane et al., 2000, Goto and Keller, 
2002, Curtin et al., 2003, Montcouquiol et al., 2003). The tissue-specific affects of the PCP 
pathway are thought to be orchestrated by these two kinases via cytoskeletal reorganisation 
and gene transcription.  
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1.2.2 PCP Signalling is Crucial for Normal Development 
1.2.2.1 PCP Involvement in Ciliated Tissue 
One of the most well studied examples of PCP can be seen in the epidermal tissue of the 
Drosophila melanogaster wing where each cell of the monolayer projects a single trichome 
(small hair). These hairs project in a distal direction, parallel to their neighbours, and 
disruption to tissue polarity results in randomised positioning of the trichomes (Gubb and 
Garciabellido, 1982).  
Similar tissues in vertebrate species have also been described including the apparatus for 
transduction of sound – the organ of Corti – and the node (section 1.1.2.1). In the 
mammalian inner ear, stereocilia project from the apical cell surface and form v-shaped 
arrays with a single kinocilia at the apex (Kimura et al., 1964). It is critical to the function of 
these stereocilia that they point in the same direction as disruption of this uniformity results 
in defective hearing. The uniform polarisation of these cilia is under the control of the PCP 
pathway and several mutants of the PCP pathway such as Vangl2, Celsr1, Frizzled, and Dsh 
have randomisation of stereocilia orientation (Curtin et al., 2003, Wang et al., 2006b, Davies 
et al., 2005, Montcouquiol et al., 2003, Yu et al., 2010). The cells of the node are also ciliated 
and these cilia are vital for creating the nodal flow that propagates left-right patterning 
through the lateral plate mesoderm. Loss of several zebrafish PCP members have been 
shown to cause either a failure for Kupffer’s Vesicle (node) to form, improper cilia 
formation, or misaligned polarity of the cilia (for review see (Matsui and Bessho, 2012)). 
Loss of core PCP genes such as vangl2, pickle and frizzled, as well as the downstream kinase 
rock2b cause defects of Kupffer’s Vesicle and associated left-right patterning defects (Oishi 
et al., 2006, Wang et al., 2011, Oteiza et al., 2010, Borovina et al., 2010). 
 
1.2.2.2 Convergent Extension and Neural Tube Closure 
The role of PCP signalling is much more diverse than simply the correct alignment of hairs 
within the body, and disruption of PCP members has been shown to affect many 
developmental processes including cell migration, polarised cell division and convergent 
extension movements. Convergent extension movements during development have been 
thoroughly studied in the zebrafish and Xenopus models thanks to their external 
INTRODUCTION 
18 
 
development (for review see (Tada and Heisenberg, 2012)). During early and mid-gastrula 
stages, the mesendoermal cells undergo collective migration as a sheet, as well as 
intercalation of the cells which results in extension of the anterior-posterior axis and 
narrowing of the medio-lateral axis. This process requires considerable cellular cohesion and 
polarisation of the cells in the direction of movement which has been shown to require PCP 
signalling (Carreira-Barbosa et al., 2009, Choi and Han, 2002).  
In the zebrafish a loss of the non-canonical wnts, pk, vangl2, and jnk2 have been shown to 
cause convergent extension defects resulting in short and fat embryos (Heisenberg et al., 
2000, Seo et al., 2010, Kilian et al., 2003, Veeman et al., 2003, Jessen et al., 2002, Carreira-
Barbosa et al., 2009). In Xenopus convergent extension defects are also observed in PCP 
mutants and are often associated with neural fold closure defects (Goto and Keller, 2002, 
Wallingford and Harland, 2002), a process which involves elevation of the neural fold, 
migration of the epithelial and mesenchymal cell sheets and fusion at the embryonic midline 
(Sadler, 1998). The failure to close the neural tube due to PCP pathway disruption is 
conserved in the mouse (including in Jnk1-/- Jnk2-/- mice), and also human VANGL2 
mutations have been described with presentation of neural tube defects (Curtin et al., 2003, 
Wang et al., 2006b, Lei et al., 2010, Hamblet et al., 2002, Kuan et al., 1999). Although 
neurulation does not occur in Drosophila, a similar process of dorsal closure does occur. 
Dorsal closure also requires convergence of two cell sheets at the midline which fuse, in a 
process which resembles that of neural tube closure. In Drosophila, PCP mutants such as of 
the frizzled and basket (jnk) orthologs display a failure of dorsal closure and it has been 
suggested that the mechanisms by which these two processes occur are shared between 
species (RiesgoEscovar et al., 1996). 
 
1.2.2.3 Participation of PCP in Heart Organogenesis 
Planar cell polarity signalling has been shown to be critical during development of several 
vertebrate organs (for reviews see (Karner et al., 2006a, Wu et al., 2011, Papakrivopoulou et 
al., 2014), however, one of the most well-studied examples is the heart. During early 
development of the heart, two cardiac progenitor fields are located in the left and right 
lateral plate mesoderm, and fuse together at the embryonic midline.  In zebrafish, loss of 
function of the PCP member diversin (diego ortholog) and dishevelled result in failure of the 
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cardiac progenitors to migrate and a cardia bifida phenotype (Moeller et al., 2006, Matsui et 
al., 2005). Although less prevalent (~10%) cardia bifida defects are also observed in a wnt11-
R knockdown Xenopus model (Garriock et al., 2005). These results highlight the importance 
of PCP in cell migration during formation of the early heart. 
As discussed in section 1.1 the left-right patterning of the lateral plate mesoderm is 
responsible for symmetry breaking of the developing visceral organs. The PCP pathway is 
instrumental in normal development of the embryonic node, ensuring that NODAL 
expression is restricted to the embryonic left. Loss of several different PCP members have 
been shown to cause aberrant left-right patterning, such as in the zebrafish where a loss of 
PCP kinase rock2b results in between 30-40% of embryos displaying incorrect organ situs. In 
Xenopus also, a loss of wnt11b results in ~50% of embryos with absent pitx2 expression – a 
key determinant in heart asymmetry (see section 1.1.4). In the mouse Inversin (core PCP 
cofactor) null there is presentation of cardiac situs defects, although in this model system 
there is a propensity for situs inversus totalus (mirror image) of the visceral organs 
(Yokoyama et al., 1993). Other mouse mutants such as the loss-of-function Vangl2 and Dvl2 
mutants present with heart defects including double outlet right ventricle (Henderson et al., 
2001, Hamblet et al., 2002) – a defect which may result from subtle left-right patterning 
defects (Ramsdell, 2005). However, in these models it is also notable that they possess 
severe outflow tract and ventricular septal defects which may indicate defects in cell 
migration to the developing heart (in addition or instead of a L-R defect). The link between 
PCP and left-right patterning is convincing, however there are many PCP mutants which do 
not have organ situs defects which still need to be explained. To date no link between loss 
of JNK and left-right patterning defects have been published in vertebrates. 
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1.3 THE MAP KINASE CASCADES 
The mitogen-activated protein kinases (MAP kinases, MAPKs) are a superfamily of serine / 
threonine (ser/thr) protein kinases that are well conserved in eukaryotes (Krens et al., 
2006a, Widmann et al., 1999). These MAPKs act through distinct signalling cascades in order 
to mediate the cellular response to diverse intracellular and extracellular signals including 
cytokines, mitogens, hormones, growth factors, UV radiation, heat shock and endoplasmic 
reticular stress. The ultimate outcome of MAPK activation also spans a vast diversity of 
cellular processes such as proliferation, differentiation, apoptosis, cytoskeletal 
rearrangement and migration (Goetze et al., 1999, MagiGalluzzi et al., 1997, Gururajan et 
al., 2005, Derijard et al., 1994, Park et al., 2005, Jono et al., 2003, Nguyen and Shiozaki, 
1999, Crean et al., 2002, Yosimichi et al., 2001, Xu et al., 2008). The functional scope and 
diversity of the MAPK cascades has implicated them in both embryonic development and 
disease progression, although elucidating the exact role of each MAPK component has 
proven complex. 
In mammals the MAPKs may be split into four families: extracellular signal-related kinase 
1/2 (ERK1/2), p38, c-Jun N-terminal kinase (JNK) and ERK5. Broadly speaking the ERK1/2 
cascade has roles in regulating cell proliferation and differentiation, whereas JNK and p38 
mediate apoptosis in response to cellular stress, and ERK5 has roles in both proliferation 
and stress responses. However, some functional overlap exists between these MAPK 
cascades, for example JNK activation may promote proliferation of hepatocytes and the 
ERK1/2 cascade has been shown to regulate apoptosis in response to cellular stress (Bacus 
et al., 2001, Schwabe et al., 2003). Clearly the MAPK cascades do not function in isolation 
but cooperate as a complete system, perhaps to ensure that the signalling is robust. Indeed, 
genetic redundancy is observed within the MAPK system as mouse models are able to 
compensate for loss of Jnk1, Jnk2, Erk1, p38β, p38γ or p38δ with only very mild or no 
discernible phenotype observed (Kuan et al., 1999, Pages et al., 1999, Beardmore et al., 
2005, Sabio et al., 2005). Conversely compound Jnk1+/- Jnk2-/- are embryonic lethal.  
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The MAPK cascades are generally considered to consist of five protein tiers although only 
the three core tiers are indispensible in every scenario (Figure 5) (Keshet and Seger, 2010). 
The core MAPK cascades are structured so that the MAPK protein lies downstream of, and 
may be phosphorylated by, a MAPKK (MEK/MKK), which is itself phosphorylated by a 
MAPKKK (MAP3K). At each level of the cascade two sites (either serine or tyrosine and 
threonine) must be phosphorylated within the activation domain in order to activate the 
enzyme. The MEK and MAP3K proteins usually favour one cascade, for example JNK is 
activated by MKK4 and MKK7 (Fleming et al., 2000) which are themselves activated by 
MAP3Ks such as TAK and ASK. However, crosstalk between cascades has been shown 
Figure 5 Schematic representation of the MAPK cell signaling pathway.  
The mammalian MAPK pathway is split between four cascades: ERK5, p38, JNK, 
ERK1/2. The core tiers are composed of a MAP3K which phosphorylates a 
MAPKK (MEK), which phosphorylates the MAPK of each cascade. Cellular 
responses may be evoked directly by activation of cytoplasmic or nuclear 
targets, or through another tier of kinases – the MAPKAPKs. In some situations 
the core MAPK pathway may respond to cellular stress or morphogens directly, 
or via small G proteins and protein adapters, which transmit the signal through 
MAP4Ks. The MAPK pathway has been linked to numerous cellular processes 
including proliferation, apoptosis and differentiation. Figure modified from 
(Keshet and Seger, 2010). 
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between MKK4/7 (predominantly JNK MKKs) and p38 MAPK (Dashti et al., 2001, Derijard et 
al., 1995) and several MAP3Ks activate both p38 and JNK cascades (Keshet and Seger, 2010).  
Upstream of the core cascade there are a further subset of kinases (MAP4K) which are 
activated by small GTPases or adapter proteins under the control of cellular stress or 
mitogens (Figure 5). Downstream of the core cascade there are a further subtype of kinases 
known as the MAP kinase-activated protein kinases (MAPKAPKs). In total there are about 70 
genes which code for members of the MAPK system, and with the inclusion of each splice-
variant that these genes encode for that brings the value to almost 200 pathway 
components (Keshet and Seger, 2010). 
Once activated the MAPK proteins may act within the cytosol, or translocate to the nucleus 
and phosphorylate downstream targets. ERK1/2 has at least 160 substrates whereas 52 
substrates have been described for JNK and similarly high numbers are expected for the 
other MAPKs (Bogoyevitch and Kobe, 2006a, Keshet and Seger, 2010). Considering the high 
number of substrates that lie downstream of the MAPK pathway ensuring that the correct 
cellular response is achieved requires tight regulation. Several methods of regulation have 
been proposed which including protein phosphatases, subcellular localisation, differential 
function of each splice-variant and interactions with other signalling pathways (Keshet and 
Seger, 2010, Raman et al., 2007, Karlsson et al., 2006). The reality is probably a contribution 
from each of these levels of regulation in order to invoke the correct response for each 
circumstance. 
The MAPK cascades have also been implicated in disease progression, and although a full 
review of pathogenicity of this pathway is beyond the scope of this thesis it is interesting to 
note the link between the MAPKs and cell cycle progression. JNK and p38 control cell cycle 
progression through mediation of cyclin-dependent kinase and p53 (Ambrosino and 
Nebreda, 2001, Thornton and Rincon, 2009, Das et al., 2007, Fuchs et al., 1998) and both 
have been implicated in human cancers such as hepatocellular carcinoma and lung cancer 
(Wagner and Nebreda, 2009, Taylor et al., 2013, Huynh et al., 2003). Furthermore JNK 
activity has been shown to initiate apoptosis of cardiomyocytes during ischemic heart 
disease, and may be a therapeutic target for diseases such as atherosclerosis and cardiac 
infarction (Wei et al., 2011, He et al., 1999).  
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1.4 C-JUN N-TERMINAL KINASE 1 
The JNK genes are components of both the MAPK and PCP pathways although their role in 
PCP signaling is poorly understood. Originally identified as an oncogene when stimulated by 
ultraviolet (UV) exposure (Hibi et al., 1993), JNK phosphorylates many downstream targets 
including c-Jun (a component of the activator protein 1 complex), p53 and C-Myc (critical for 
cell apoptosis and proliferation respectively) and paxillin (microtubule-associated protein 2 
that helps regulate cell architecture) (Bjorkblom et al., 2005, Huang et al., 2003a, 
Bogoyevitch and Kobe, 2006b, Pulverer et al., 1991). 
 
1.4.1 The Mammalian JNK Genes 
The mammalian JNK family consists of three different genes: JNK1, JNK2 and JNK3, and 
between them they produce at least ten different transcripts which arise from differential 
exon splicing (Figure 6). The splice-variants differ by their length at the 3’ end (producing 
46kDa or 54kDa proteins) and the inclusion of one of two different exons that contribute to 
the kinase domain. It has been shown that these different splice-variants have different 
affinities to downstream transcription factors (Gupta et al., 1996). Each JNK member 
contains a protein kinase domain which allows for phosphorylation of downstream targets, 
as well as both an adenosine triphosphate (ATP) binding site, and threonine/tyrosine (TPY) 
phosphorylation domain which is responsible for activating the molecule (Uniprot: P45983).  
The three different JNK genes have also been shown to have different expression patterns in 
mouse, with Jnk1 and Jnk2 being ubiquitously expressed whilst Jnk3 is primarily restricted to 
the central nervous system (CNS) (Kuan et al., 1999). There is also evidence to suggest that 
the three genes may have genetic redundancy as single Jnk1 or Jnk2 knockout mice are 
viable, as are compound Jnk1 + Jnk3 and Jnk2 + Jnk3 nulls. However, compound Jnk1 + Jnk2 
null mice die before E12.5 displaying reduced forebrain apoptosis and hindbrain 
exencephaly, representing a failure to close the neural tube. These data demonstrates that 
the JNK proteins are critical for early development but are capable of compensating for the 
loss of one isoform. 
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1.4.2 The Zebrafish Genes Appear to Correlate with Human JNK1 
As has been discussed above, the MAPK genes have been shown to be well conserved 
between species, including the JNK1 gene (Krens et al., 2006a, Widmann et al., 1999). As is 
expected, the similarities are greater in species that diverged most recently, and zebrafish 
show very good consistency with human JNK1. Human JNK1 is found on chromosome 10 
and codes for at least four different splice-variants (Gupta et al., 1996). These four variants 
differ in two locations, in the middle of the gene where one of two exons is included in the 
variant, and at the 3’ end where alternative splice-acceptor site usage creates a short 
(1152bp) or a long (1281bp) variant. Interestingly it has been found that in mouse the 
middle exon usage alters the binding affinity of the variants to the downstream 
Figure 6 The splice-variants of human JNK.  
Schematic representation of the three human JNK genes and their ten different 
transcripts: 4 JNK1, 4 JNK2, and 2 JNK3 splice-variants. Each gene has 11 
subdomains that contribute to the N-terminal or C-terminal lobe of the tertiary 
structure. The general structure of each variant is well conserved between 
genes and they differ in the inclusion of either exon 7 or exon 8 and in a C -
terminal splicing event which determines overall length. The aster isks donate 
the location of the Tyr/Thr phosphorylation sites that regulate JNK activity. 
Values on the far right show the amino acid sequence identity of each gene 
compared to either JNK1α1 or JNK1α2. Modified from (Barr and Bogoyevitch, 
2001). 
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transcription factors Atf2, Elk-1 and Jun (Gupta et al., 1996). The four transcripts code for 
proteins that are either 46kDa or 54kDa in weight. Despite experimental evidence for only 
four JNK1 transcripts, the ENSEMBL Genebuild pipeline has predicted sixteen possible splice-
variants that may arise from the human JNK1 gene (www.ensembl.org ENSG00000107643).  
Zebrafish possess two orthologs of human JNK1 which are thought to have arisen from the 
teleost genome duplication event. Evidence for this duplication has been shown via 
assessment of the genes surrounding jnk1a and jnk1b, and analysis shows four genes 
surrounding the jnk1 genes have also been duplicated (see Figure 9, modified from 
Unpublished data, Tania Papoutsi PhD Thesis). These putative paralogs (duplicate genes that 
have arisen from a species-specific genome duplication event) are known as jnk1a and jnk1b 
and are found on chromosome 13 and 12 respectively. ENSEMBL annotations predict that 
jnk1a possesses five splice-variants whereas jnk1b possesses four variants. Despite this 
duplication of the jnk1 genes there appears to be a lot of similarity between the zebrafish 
and human homologs. Two of the zebrafish jnk1a homologs are 1284bps in length and code 
for proteins of 54kDa in size. Furthermore these two variants differ only by the alternate use 
of a middle exon, identical to what is observed in the human α2 and β2 (see Figure 6). The 
zebrafish jnk1b paralog also produces two variants which show similarity to what is seen in 
human JNK1. Two of the jnk1b paralogs are predicted to be 1152bp and 1284bp in length 
and code for proteins that are 46kDa and 54kDa in size respectively (www.ensembl.com 
ENSDARG00000031888 and ENSDARG00000009870). These data suggest that the two 
zebrafish genes each possess one-half of the splice-variants known to exist in human JNK1, 
and may therefore have shared the function of the JNK1 gene between these two paralogs. 
 
1.4.3 The Role of the JNK Genes during Development 
The single Drosophila homologue of JNK is known as basket (Bsk) and loss-of-function 
mutations within basket have been shown to cause dorsal closure defects during 
development (RiesgoEscovar et al., 1996). Incomplete dorsal closure causes mis-localisation 
of the internal organs as a secondary defect, however the role of Bsk in organ development 
can be examined via altering the function of puckered - a Bsk phosphatase. Puckered loss of 
function and puckered overexpression were found to cause left-right laterality defects in the 
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developing gut. The Drosophila anterior-midgut breaks symmetry at stage 15 by leftward 
tilting before rotating anterioposteriorly at stage 16. Over a third of puckered loss-of-
function mutants displayed anterior-midgut laterality inversion, which is rescued by Bsk 
dominant-negative overexpression. Furthermore overexpression of puckered under the hs-
GAL4 promoter also results in anterior-midgut laterality defects, suggesting that a 
regimented dose of Bsk is required for correct organ laterality (Taniguchi et al., 2007). 
In vertebrates, JNK has been shown to be vital for convergent extension (CE) movement, a 
process known to require PCP signalling. Wnt5a is a non-canonical Wnt that activates PCP 
signalling and increases the activity of JNK in vivo (Kilian et al., 2003). The inhibition of 
Xenopus wnt5a causes convergent extension defects in xenopus by acting through the 
MKK7/JNK pathway (Yamanaka et al., 2002). The JNK gene responsible for CE moderation 
has been further narrowed down in zebrafish by the use of morpholino oligonucleotides 
(MO). It was shown that knockdown of jnk2 results in CE defects during development 
whereas this defect is not seen in jnk1 knockdown (Seo et al., 2010). Interestingly in 
Xenopus it has been shown that jnk1 overexpression is capable of rescuing CE defects 
caused by dominant negative (XENLA) rhoA overexpression (Kim and Han, 2005). However, 
this result does not necessarily contradict the zebrafish data as a jnk2 rescue was not 
attempted, nor did they examine whether inhibition of jnk1 by itself could cause convergent 
extension defects. This leaves open the possibility that overexpression of one form may 
compensate for the loss-of-function of another isoform via genetic redundancy. 
The role of the jnk proteins during development have also been investigated in the zebrafish 
by the use of the pan-jnk inhibitor SP600125 (Bennett et al., 2001). Incubation of developing 
embryos in 5μM SP600125 between 0-30hpf caused oedema, failure of the swim bladder to 
inflate, reduced body length and bent tail and trunk defects. Furthermore, embryos were 
shown to have disorganisation of brain structure, underdeveloped retinal layers, multiple or 
ectopic lens development, and underdeveloped jaw formation (Valesio et al., 2013). Dosing 
of the embryos between 18-24hpf or 22-28hpf caused milder defects, although oedema and 
failure of the swim bladder to inflate was still observed. Later work confirmed the 
occurrence of oedema, body length reduction and underdifferentiated retinal layers when 
SP600125 was used at 1.4μM between 0-72hpf (Xiao et al., 2013). In addition this report 
showed that this treatment also resulted in undifferentiation of the gonadal cells in jnk 
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inhibited embryos, and cranial bone deficiencies when embryos were dosed with 0.8μM 
after 72hpf; at the 1.4μM dose there was almost 100% mortality. Interestingly the Xiao et al. 
(2013) paper also attempted to knockdown jnk1 specifically with an siRNA approach, 
however, at this 300ng dose there was approximately 90% mortality observed before 24hpf. 
Those embryos which survived longer than 24hpf were shown to harbour yolk 
abnormalities, developmental delay and curling of the body axis, although the validity of 
these data is questionable considering the percentage death that was observed. Those 
phenotypes that have been described may be due to a general failure of development, and 
stress-linked signalling rather than directly due to jnk1 knockdown. 
As described previously the compound knockout of Jnk1 and Jnk2 in mice is lethal due to the 
failure to close the neural tube. Loss of a single Jnk gene was initially reported to have no 
phenotypic effect as mice were viable and phenotypically normal, suggesting that genetic 
redundancy may exist between the genes (Kuan et al., 1999). However, further investigation 
revealed that single Jnk knockouts do display differences to controls, although these defects 
are relatively mild compared to what is described in other model organisms. One of the 
major roles for Jnk signalling that has been discovered in the mouse is in the immune 
response. Jnk1 and Jnk2 null mice have been shown to be immunodeficient (Constant et al., 
2000) and these Jnk isoforms are critical for T-cell maturation (for review see (Huang et al., 
2009)). Furthermore single Jnk 1, 2 and 3 null mice show different explorative behaviour 
when presented with behavioural tests (Reinecke et al., 2013) suggestive of roles for JNK in 
the CNS. Jnk3, whose expression is primarily restricted to the brain, has been shown to have 
a role in controlling processes in neuronal tissue such as axonal branching (Yang et al., 2012) 
and retinal cell death (Fernandes et al., 2012). However, Jnk1 and Jnk2 have also been 
shown to have roles in the CNS, highlighting the fact that Jnk3 does not exclusively control 
processes in the brain (Kuan et al., 1999). 
Despite the severe mouse defect observed in compound Jnk1 and Jnk2 knockouts, no 
convergent extension or heart defects were described. Interestingly, knockout of c-Jun (one 
of JNKs major downstream effectors) is lethal due to the heart defect persistent truncus 
arteriosus. Furthermore, conditional knockout of Jun restricted to the second heart field 
lineage causes a plethora of CHDs (Zhang et al., 2013) including some which have been 
hypothesised as being caused by situs ambiguous i.e. septal defect, double outlet right 
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ventricle, and aortic arch defect. It is therefore unclear why compound Jnk1 and Jnk2 
knockouts would not display heart defects, especially considering the laterality defect 
observed in Drosophila. It is possible that other Jun activators may be more important in 
regulating heart development, or that they are able to compensate when JNK signalling is 
quashed. Taken together these results suggest that the JNK genes do indeed have a role in 
normal development, although there appears to be little consistency between the results of 
different model organisms. I believe that this inconsistency comes from the relative lack of 
experimental evidence that has been acquired on the role of JNK in development, and 
indeed a lot more work is required to fully elucidate the exact roles of these genes.  
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1.5 ZEBRAFISH AS A MODEL ORGANISM OF DEVELOPMENT 
1.5.1 Advantages of Zebrafish as a Model Organism 
Zebrafish were established as a model organism in the 1970s by George Streisinger at the 
University of Oregon (Nüsslein-Volhard and Dahm, 2002). His first publication in 1981 
detailed how to create homozygous, diploid clones (Streisinger et al., 1981). Since then the 
zebrafish has become an established model organism for genetics, development, 
pharmacology and toxicology research (Chen and Ekker, 2004, Glickman and Yelon, 2002, 
Hill et al., 2005, Lieschke, 2001, Morris and Fadool, 2005, Parng et al., 2002, Vogel and 
Weinstein, 2000). Zebrafish possess many advantages which make them favourable for the 
study of vertebrate development; they are small, robust and have high fecundity which 
allows for a single breeding pair to spawn several hundred eggs every week. Although the 
generation turnover of four months is not significantly quicker than other vertebrate 
models, the less complex organs of the embryo have developed before 5 days post 
fertilisation (Kimmel et al., 1995).  
Zebrafish embryos are able to survive quite significant insult during development allowing 
for genetic and pharmacological modification that would not be possible in the mouse. For 
example, lack of a functional cardiac system is survivable up until 5 days post fertilisation 
due to diffusion of oxygen from the media (Pelster and Burggren, 1996). Furthermore 
developing embryos require only basic media and temperatures of between 25-33oC, 
making them amenable to high throughput techniques (Nüsslein-Volhard and Dahm, 2002, 
Kimmel et al., 1995). The external fertilisation, relatively large embryo size and transparency 
of embryos up until 24hpf all allow for very high resolution microscopy of live samples. 
Pigment production can be prevented beyond this stage by the addition of 1-phenyl 2-
thiourea (PTU) into the media ensuring transparency for the duration of the treatment 
(Karlsson et al., 2001). As a result many live imaging techniques are permissive when using 
zebrafish that can track real-time changes during development or under treatment 
conditions (Ko et al., 2011, McLean and Fetcho, 2008, Miura and Yelon, 2011). 
One of the greatest benefits for zebrafish biologists is that the whole genome has been 
mapped to a high standard, annotated and is maintained by the European Molecular Biology 
Laboratory (EMBL). The zebrafish genome (completed in 2009) contains >26,000 genes 
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found on 25 chromosome pairs (www.ensembl.org) (Flicek et al., 2014). In addition to the 
genetic sequence, the ENSEMBL project also provides intron/exon annotation, single 
nucleotide polymorphism data and prediction of alternative splice-variants. Furthermore 
several reverse genetic approaches have superseded the N-ethyl-N-nitrosourea mutagenesis 
techniques of the past, allowing for directed manipulation of target genes. Morpholino 
oligonucleotides (MOs) are a popular antisense technology that enable up to 85% of target 
mRNA to be knocked down. Injected before the 8-cell stage, MOs do not require large time-
scales to generate stable, germline mutants, and provide high specificity to the gene of 
interest (Summerton and Weller, 1997b). Recently the clustered regularly interspaces short 
palindromic repeats (CRISPR) / Cas system has been introduced which is an RNA directed 
genome-editing system capable of causing double stranded breaks which may result in 
insertion-deletion mutations following nonhomologous end joining repair (Cong et al., 2013, 
Mali et al., 2013). The efficiency of this system to generate heritable mutations is being 
reported as being between 86-100% making it a powerful tool for the generation of mutant 
lines (Hwang et al., 2013a, Hruscha et al., 2013, Sung et al., 2014). These genetic techniques 
are therefore allowing for greater ability to study gene function in the zebrafish. 
 
1.5.2 Limitations of Zebrafish as a Model Organism 
One of the greatest strengths of the zebrafish model is the wealth of genomic information 
that is freely available from EMBL. However, zebrafish, being a teleost, underwent a 
genome duplication event following their divergence from mammals. The result is that 
many orthologs of human and mouse genes possess two copies in zebrafish (Taylor et al., 
2001), known as paralogs. Where both copies have persisted, this abrogates the 
evolutionary pressure to conserve function of both copies and therefore there is potential 
for these paralogs to have partial or novel function not observed within other organisms 
(Force et al., 1999). Due to the higher probability of deleterious over gain of function 
mutations, it is believed that where both copies have persisted, there could be some 
subfunctionalization meaning that both copies are required to fulfil the complete function 
of the ancestral gene (Taylor and Raes, 2004). Jnk1 is one gene that has maintained both 
duplicated copies and therefore care is necessary when extrapolating results back to 
human.  
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When using zebrafish as a model of human development there are obviously significant 
anatomical and physiological differences which do not permit the zebrafish to model 
humans in every circumstance. Although typically a lot of the core processes are conserved 
between distant species, certain aspects cannot be modelled. For example, the zebrafish 
neural tube forms via secondary neurulation (formation of a solid neural rod which later 
forms a central lumen) compared to by primary neurulation in mammals. Furthermore, the 
zebrafish heart has only two chambers, and lack separate systemic and respiratory systems. 
As such it is not possible to study septation of the chambers or outflow tract in this model. 
Despite these differences a great amount of developmental processes are conserved 
between zebrafish and mammals and they certainly have an important role in 
understanding the complexity of development. 
 
1.5.3 Normal Zebrafish Development 
1.5.3.1 The Zygote to Blastula Stage 
Zebrafish oocytes are externally fertilised and thus normal development has been well 
characterised in the literature (Kimmel et al., 1995). When fertilised, the zygote is made up 
of a large vegetal portion (yolk), and smaller animal portion (first cell) (Figure 7A). The yolk 
persists to provide nutrition for the developing embryo until feeding begins at around 
120hpf. Before the first cleavage the cytoplasm of the first cell increases in size. Due to the 
transparency of the zyogote it is possible to see the cytoskeletal bridges projecting from the 
cell into the vegetal layer. These cytoplasmic bridges shuttle maternal proteins and mRNA 
into the cell and provide a means of delivery for morpholino oligonucleotides (MOs) 
(Shestopalov and Chen, 2010). The first cell cleavage occurs after approximately 40 minutes 
following fertilisation and each subsequent cleavage-stage division takes 15 minutes. These 
early cleavages happen synchronously, but are incomplete up to the 8-cell stage, as the cells 
do not become fully separated from one another and share cytoplasm (Figure 7B). This 
ensures that any administered MO will enter every cell of the embryo if injected up to the 
eight-cell stage (Nasevicius and Ekker, 2000). 
Each subsequent cleavage is complete, fully separating each cell from its neighbour, 
although all cells remain in contact with the surface of the yolk until the 32-cell cycle. The 
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blastula stage of the zebrafish embryo is considered to be between the 128-cell stage until 
the start of gastrulation (2 ¼ - 5 ¼ hpf at 28.5oc). During the early blastula stage cell divisions 
stop occurring synchronously and cells enter a mid-blastula transition where the G1 and G2 
stages are introduced to the cell cycle, at the 10th cell cleavage in zebrafish. Also at the 10th 
division maternal-to-zygotic transition occurs when zygotic mRNA is first transcribed (Aanes 
et al., 2011), and the yolk syncytial layer (YSL) develops (Figure 8), a feature unique to the 
teleosts. The marginal cells which lie immediately adjacent to the yolk release their 
cytoplasm and nuclei into the adjacent yolk to form a ring of about 20 nuclei. The YSL cells 
continue to divide for 3 cycles and at later stages are critical for directing cell movements. 
The YSL cells give rise to the dorsal forerunner cells during gastrulation, and these cells later 
form Kupffer’s vesicle (the node).  
Epiboly in the zebrafish begins at around 4 2/3 hpf, and is the process whereby the animal 
hemisphere thins and expands to form an epidermal layer that will eventually surround the 
yolk completely. During epiboly the embryo’s deep cells spread out radially, and intercalate 
with more superficial cells to produce a blastoderm of roughly even thickness; at the same 
time the yolk domes upwards underneath the advancing cells. Two populations of yolk 
synsytical layer cells arise during epiboly: the first remains between the yolk and animal 
hemispheres and is termed the internal YSL (I-YSL). Meanwhile the second population 
advances ahead of the spreading blastoderm and is termed the external YSL (E-YSL) / dorsal 
forerunner cells (DFCs) (Oteiza et al., 2008). The migration of the deep cells towards the 
vegetal hemisphere is dependent upon the E-YSL cells, and separation of these two cell 
types results in failure of the blastoderm to migrate. 
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1.5.3.2 Gastrulation and Convergent Extension 
Gastrulation commences with the involution of the blastoderm which occurs at around 50% 
epiboly in zebrafish (5 1/3 hpf at 28.5oc) (Figure 7D). Gastrulation occurs despite the absence 
of a blastopore (as in the case of amphibians) and instead occurs around the entire margin 
of the advancing blastoderm, leading to a thick ring known as the germ ring. This involution 
produces two different cell layers known as the epiblast (superficially) and the hypoblast 
(internally). The cells that remain in the epiblast once gastrulation is complete become the 
definitive ectoderm, whereas the hyoblastic cells contribute to mesodermal and 
endodermal lineages. During the initiation of involution epiboly pauses, but resumes about 
1 ½ hours after the start of gastrulation. Gastrulation is typically considered as complete 
once 100% epiboly is reached, however, gastrulation-like cell movements are reported to 
continue after this time (Kimmel et al., 1995). 
Shortly after involution commences there is a dorsal convergence of cells from all regions of 
the blastoderm. Cellular convergence occurs within both tissue layers and results in the 
formation of a thickened structure known as the shield (Figure 7E). The shield is critical for 
patterning the dorsal axis of the embryo and is equivalent to the organiser in Xenopus. 
Convergence and extension also occurs anteriorly from the shield along the dorsal midline, 
marking the embryonic axis. This convergent extension (CE) in combination with orientated 
cell division extends the embryonic axis under the control of the planar cell polarity (PCP) 
pathway (Gong et al., 2004). By the midpoint of gastrulation the dorsal epiblast thickens 
along the dorsal midline and gives rise to the chordamesoderm, a precursor of the 
notochord. This thickening at the anterior pole of the embryo reveals the future position of 
the head. At around 80% epiboly the DFCs converge into an “oval-cluster” near the vegetal 
pole as a precursor to Kupffer’s vesicle formation (Oteiza et al., 2008). In the posterior of the 
embryo a clear separation can be detected between the axial hypoblast and the flanking 
paraxial hypoblast. The paraxial hypoblast forms much of the somites during segmentation 
which will form the vertebrae and skeletal muscle of the trunk. At 100% epiboly a swelling 
appears at the posterior of the embryonic axis, signifying the region of the tail bud. Also at 
this time the dorsal forerunner cells begin to become organised and a lumen appears in the 
primitive Kupffer’s vesicle (Figure 8) (Oteiza et al., 2008). The distance between head and 
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tail bud, as well as the tail buds lifting away from the yolk can be used to stage the embryo 
during the next developmental stage (Figure 7F). 
 
1.5.3.3  Segmentation Stage 
When gastrulation is complete the yolk sac is totally enveloped by blastoderm and the 
embryo has a clear animal axis which wraps around it. Soon afterwards the somites begin to 
“bud” in bilateral pairs from the preaxial mesoderm in an anterior to posterior direction at a 
rate of two per hour (three per hour for the first six somites) (Figure 7G). During this 
segmentation the somites are initially separated by the formation of somitic furrows and 
then the surrounding tissue becomes epithelialized. Convergent extension cell migration 
and proliferation causes the embryonic axis to elongate, and the head and tail of the 
embryo grow closer to one another. Lumen growth of Kupffer’s vesicle in the tail bud 
increases by around 12-fold between the 1 and 4 somite stage, and ciliogenesis occurs 
(Oteiza et al., 2008). At around the 4 somite stage the neural keel forms, in an anterior to 
posterior direction via secondary neurulation, and cavitation later forms the lumen of the 
mature neural tube. The optic primordia can also be seen budding from the presumptive 
brain shortly after this stage. By the eight somite stage the early pronephros is apparent 
which forms the renal system. Constriction of the yolk adjacent to the developing tail causes 
a “kidney-bean” appearance of the yolk sac. This yolk constriction later goes on to form the 
yolk extension which is a cylindrical projection of the main yolk sac that runs parallel to the 
trunk (Kimmel et al., 1995).  
Over the next few hours of development the brain rudiment forms ten swellings known as 
neuromeres. The anterior three neuromeres produce the diencephalon, telencephalon and 
mesencephalon of the brain while the remaining seven become rhombomeres.  Also around 
this time the olfactory and otic placodes form from thickened ectoderm at the level of the 
neural keel which will give rise to the olfactory and auditory organs. In the trunk the older 
somites have begun to take on a chevron shaped appearance. At 19hpf (20 somite stage) 
the trunk of the embryo finally begins to straighten out away from the central yolk sac, 
however the head does not straighten out until much later in development. Most of the 
somites are chevron shaped and the first contractions appear as the muscle is innervated. 
The otic placode hollows out into the otic vesicle and two otoliths (sensory components of 
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gravity and movement) form within each vesicle. The brain ventricles also begin to inflate, 
independent of the circulatory system. The last timepoint at which the somites might 
reliably be used to stage the embryos is at 22hpf (26 somite stage) (Figure 7H) as the last 
somites form more slowly and vary between 30-34 pairs (Kimmel et al., 1995). At this stage 
the heart precursors have migrated and fused on the midline and begin to form the linear 
heart tube (Glickman and Yelon, 2002). The first heartbeat can be seen by around 24hpf 
(Figure 7I). 
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Figure 7 Zebrafish developmental series.  
Schematic representation of normal zebrafish development at 28.5 oC at (A) 1-cell 
stage, (B) 8-cell stage the latest timpoint when cytoplasm is shared between all cells, 
(C) 256-cell stage, (D) 50% Epiboly half way through gastrulation, (E) Shield stage – 
the shield (arrowhead) is homologous to the amphibian organiser, ( F) tail-bud stage 
elongation of the anterior-posterior axis and formation of the hatching gland rudiment 
(arrowhead), (G) 6-somite stage displaying the eye primodrdium and kupffer’s vesicle 
(anterior and posterior arrowheads respectively), (H) 26 -somite stage the latest that 
somite number can accurately measure developmental stage, (I) 25hpf the heart 
(arrowhead) can be seen beating on the midline, (J) 48hpf heart looking complete and 
embryo is now pigmented, (K) 72hpf jaw developed and embryos begin to hat ch from 
chorion (Adapted from (Kimmel et al., 1995)). 
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1.5.3.4 Heart Development 
The developmental processes that lead to zebrafish heart formation are fairly well 
conserved with those of mammals, but the zebrafish heart represents a more simplified 
structure with only two contractile chambers. The cardiac progenitor cells differentiate from 
the anterior lateral plate mesoderm and form two bilateral cardiac primordia either side of 
the midline by 16hpf (Yelon et al., 1999). The first heart field cells express the transcription 
factor tbx2-5 whereas the putative second heart field express mef2cb and latent TGF-β 
binding protein 3 (Lazic and Scott, 2011, Zhou et al., 2011, Chen and Fishman, 1996). An 
initial phase of migration brings cardiomyocytes to the embryonic midline where they fuse 
in a posterior to anterior manner to form the cardiac cone at around 19hpf (Yelon et al., 
1999). Elongation of the cone establishes the linear heart tube which is composed of a 
single layer of cardiomyocytes surrounding a single layer of endocardiumon the embryonic 
midline (Peal et al., 2011).  These early phase cardiomyocytes (Figure 8) contribute to the 
future ventricle and inner curvature of the atrium (de Pater et al., 2009). Between 19 and 
26hpf there is addition of cardiomyocytes to the venous end of the heart tube contributing 
to the outer curvature of the atrium from the presumptive second heart field. Later second 
phase cardiomyocyte migration also adds to the venous pole between 34-48hpf (de Pater et 
al., 2009).  
Almost as soon as the linear heart tube forms the heartbeat can be seen as a peristaltic 
contraction in a caudal to rostral wave (Yelon et al., 1999). Between 24 and 28hpf this heart 
tube breaks symmetry from the embryonic midline and the caudal heart rotates over to the 
left side of the embryo in a process known as heart jogging (Figure 8) (Chin et al., 2000). This 
process is generally thought of as specific to the teleosts, however a leftward caudal heart 
tube movement has been reported in the mouse heart prior to looping which may be 
homologous (Biben and Harvey, 1997). Zebrafish cardiac jogging establishes the heart in its 
mature position with the majority on the left side of the body and precedes looping. 
Looping of the zebrafish heart involves bending of the linear heart tube at the 
atrioventricular canal, moving the ventricle to a more posterior position with respect to the 
arium (Chin et al., 2000). Consistent with the mammalian system, looping of the heart tube 
acts to orientate the chambers relatively to one another in the conformation of the adult 
organ. By the time that heart looping has occurred (~36hpf) the heart contraction has 
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changed to a sequential atrial / ventricular beat (Glickman and Yelon, 2002) enabling easy 
identification of the two chambers. 
Although the heart beat and circulation of blood occurs early in zebrafish heart 
development, the formation of the valve does not occur until after heart looping. The 
earliest events in zebrafish valve formation are cell morphology changes in the endocardium 
and myocardium between 36-40hpf (Beis et al., 2005, Chi et al., 2008). These cell changes 
coincide with increasing concentration of cardiac jelly at the atrioventricular canal, causing a 
constriction between the two chambers, and forming the presumptive endocardial cushions 
(Peal et al., 2011, Walsh and Stainier, 2001). Cardiac jelly is an extracellular matrix which 
resides between endocardial and myocardial cell layers and contains collagen, 
proteoglycans and hyaluronic acid (Little and Rongish, 1995). By 55hpf the primitive valve 
has begun to form and consists of about 20 endothelial cells which continue to develop until 
28 days post fertilisation (Peal et al., 2011, Beis et al., 2005). 
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1.5.3.5 Somite Development 
During development, all vertebrate species display a stage where segmentation occurs 
through the trunk along the anterior-posterior (AP) axis. This segmentation occurs within 
the preaxial mesoderm to form discrete bilateral pairs of somites (Stickney et al., 2000). 
Somites form adjacent to the axial mesoderm (tissue which contributes to the notochord 
and neural tube) and is reliant upon signalling from this tissue for correct somite formation. 
In zebrafish the segmentation period occurs between ~10 and 24hpf (Figure 8) with somites 
“budding” sequentially in an anterior to posterior manner at a rate of approximately 2 
somites per hour (Kimmel, 1995). Epithelialisation at the borders of the somites results in 
Figure 8 Zebrafish Developmental Timeline 
Schematic depicting major developmental events during zebrafish development 
between 0 and 72hpf. Zebrafish development has been grouped into stages by 
(Kimmel et al., 1995) dependent upon major developmental events (blue boxes), and 
at 28.5oC these events show strict temporal regulation. Above is represented major 
developmental events in development of the heart, Kupffer’s Vesicle and the E ye, 
that are important in this thesis, as well as the time at which they occur. LHT=linear 
heart tube. YSL=yolk syncytical layer differentiation and migration. DFC=dorsal 
forrunner cell (node progenitors) migration. KV=Kupffer’s Vesicle formation and 
duration. 
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segmentation by the somitic furrows, a process which is strictly regulated by a molecular 
oscillator known as the segmentation clock (for review see (Holley and Takeda, 2002, 
Pourquie, 2003)).  
The embryonic somite is composed of three compartments – dermatome, myotome, and 
sclerotome that give rise to the dermis, skeletal muscle and axial skeleton respectively (Rida 
et al., 2004). The myotome of the anamniotes such as the zebrafish is much larger than that 
of the higher vertebrates, due primarily to the increased support afforded by the 
surrounding water (Scaal and Wiegreffe, 2006). This myotome goes on to form slow muscle 
fibres (SMFs) which develop exclusively at the superficial surface of the somite and the fast 
muscle fibres (FMFs) which develop in the remainder of the myotome (Chong et al., 2009). 
Slow muscle fibres differentiate from an axial mesoderm lineage adjacent to the notochord 
and are patterned by sonic hedgehog signalling (Barresi et al., 2000, Blagden et al., 1997). 
These SMFs then migrate to the outer edge of the somite until they surround the FMFs. A 
thin layer of these SMFs runs through the somite in the coronal plane, separating the 
somites into dorsal and ventral hemispheres. This population of cells composed of pioneer 
slow muscle cells is known as the horizontal myoseptum and contributes to the chevron 
shape of the somites; in the absence of SMFs the somites take on a u-shaped appearance 
(van Eeden et al., 1996). Interestingly, the number of slow-muscle cells is dependent upon 
convergent extension movements that bring the putative SMF cells into contact with the 
notochord. Failure of CE results in fewer cells being driven down the SMF fate, and cause 
reduced numbers of these cell types and can result in failure to establish the horizontal 
myoseptum (van Eeden et al., 1996, Yin and Solnica-Krezel, 2007). 
 
1.5.3.6 Eye Development 
The bilateral optic vesicles develop from the forebrain around 12hpf and invaginate to form 
the optic cup between 16hpf and 22hpf (Kimmel et al., 1995, Fadool and Dowling, 2008, Li 
et al., 2000). The inner layers continue to proliferate to form the 1 glial and 6 neural cell 
types that make up the retina. The cornea and lens develop from the overlying ectoderm at 
around 16-18hpf (Zhao et al., 2006) and lens detachment is achieved by apoptosis of the 
surrounding cells. The first differentiation of retinal cells (ganglion cells) occurs at around 
32hpf and these form part of the inner most layer of the eye. The last cells to differentiate 
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(bipolar cells) do so after 60hpf (Figure 8), and the first responses to visual cues occurs after 
almost three days (Easter and Nicola, 1996). Pigmentation of the retinal pigmented 
epithelium can be detected by light microscopy by 42hpf and the different retinal 
laminations are achieved by 48hpf (Kimmel et al., 1995, Fadool and Dowling, 2008) As in 
mammals the retinal lamina are composed of three nuclear layers – the photoreceptor, 
outer nuclear and ganglion layer – that contain the retinal cells, with the two intermediate 
layers – inner and outer plexiform layers – containing the cellular processes. 
 
1.5.1 The Current jnk1 Genetic Model 
1.5.1.1 The Nomenclature Usage of Zebrafish jnk1 
The scientific literature has gone through several different naming iterations for the JNK 
family genes since they were first identified (Hibi et al., 1993). In human the contemporary 
naming convention for the three different genes is MAPK8 (JNK1), MAPK9 (JNK2) and 
MAPK10 (JNK3). However, for this body of work I will refer to the genes as JNK1, JNK2, and 
JNK3 to ensure that there is a clear distinction between the JNK genes and the wider 
mitogen-activated protein kinase (MAPK) family to which they belong. Zebrafish possess 
four orthologous JNK genes: jnk2, jnk3 and two jnk1 genes. The two orthologs of human 
JNK1 are thought to have arisen from the teleost genome duplication event (Taylor et al., 
2001). If these two genes have indeed resulted from a duplication event then the standard 
naming convention would be jnk1a and jnk1b (www.zfin.org). Evidence to support the two 
zebrafish jnk1 genes being paralogs (duplicate genes that have arisen from a species-specific 
genome duplication event) was found by a previous student in our lab (Unpublished data – 
Papoutsi, 2011 PhD Thesis). This data shows that four genes that flank the jnk1a gene are 
duplicated in the same flanking position around the jnk1b gene (Figure 9). Comparatively 
jnk2 contains only one, and jnk3 contains two duplicated genes in the surrounding region of 
the chromosome. 
In this thesis standard naming conventions for human and mouse nomenclature is observed, 
including the use of italics and capitals for gene symbols and protein products i.e. (HUMAN) 
JNK1 and JNK1, (MOUSE) Jnk1 and JNK1. Zebrafish standard nomenclature is an all lower 
case and italicised gene symbol with the protein name having a single capital without italics 
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i.e. jnk1 and Jnk1. Where other species are mentioned the gene name is prefixed by the 
common species abbreviation in parentheses (http://www.uniprot.org/docs/speclist). The 
only exception to this is for Drosophila melanogaster which has a single JNK ortholog known 
by its locus name “basket” (bsk) 
(http://flybase.org/static_pages/docs/nomenclature/nomenclature3.html#11.1.).  
 
 
 
 
 
 
 
 
 
  
Figure 9 Similarities in the Chromosomal Regions Surrounding the Four 
jnk1 Genes Suggests that jnk1a and jnk1b may have Arisen from a 
Duplication Event.  
Modified from Papoutsi, 2011 PhD Thesis. Examination of the flanking regions 
of the four zebrafish jnk1 genes reveals that several genes are duplicated 
between the different chromosomes. Four of the genes flanking jnk1a possess 
duplicates that flank jnk1b, whereas there are only one and two duplicated 
genes that flank the jnk2 and jnk3 genes respectively. This high similarity 
between the surrounding regions of jnk1a and jnk1b suggest that they are more 
closely related to one another than to the other jnk genes, and is consistent 
with two genes that have arisen through a genome duplication event.Genes are 
represented as coloured boxes where there also exists a duplicate gene on 
another chromosome. Black boxes are genes that are not duplicated.  
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Species Gene Symbol AKA 
Protein 
Symbol 
Human JNK1 SAPK1 / MAP8 JNK1 
Mouse Jnk1 Sapk1 / Mapk8 JNK1 
Zebrafish jnk1a mapk8a Jnk1 
Zebrafish jnk1b mapk8b Jnk1 
  
Xenopus 
Laevis (XENLA) jnk1   (XENLA) Jnk1 
Chicken (CHICK) jnk1   (CHICK) Jnk1 
Drosophila bsk   Bsk 
 
 
 
 
 
1.5.2  The Current jnk1 Genetic Model in Zebrafish 
 
 
1.5.2.1  Gene Structure and Splice-Variants 
The Zebrafish Genome Project includes two putative orthologs of human JNK1 in the current 
build (Zv9 release 77), which is accessible via the ENSEMBL website 
(http://www.ensembl.org/Danio_rerio/Info/Index).  The database provides comprehensive 
data on these two protein coding genes: jnk1a (ENSDARG00000031888) and jnk1b 
(ENSDARG00000009870), including the complete gene sequence, exon and intron 
annotation and a prediction of different splice-variants that arise. These data provided a 
strong foundation of knowledge that helped in the design of experimental reagents such as 
primers in later experiments. These gene annotations were automated by the ENSEMBL 
genebuild pipeline – a collection of different gene annotation pipelines. The genebuild 
pipeline aligns species-specific protein sequences to the compiled genome sequence where 
possible, or uses a closely related species where proteomic sequence is sparse. From these 
alignments the software is able to identify genic regions and predict intron-exon 
boundaries. In addition, cDNA and expressed sequence tag (EST) sequences are aligned to 
the genomic sequence and is able to strengthen evidence of gene structure, as well as 
identify 5’ and 3’ untranslated regions in some instances (www.ENSEMBL.org). 
Table 1 Naming conventions for the JNK family homologues.   
Human, mouse and zebrafish standard naming conventions are conserved when 
referring to gene names and protein products. Where other species are 
referenced they are prefixed by their common species abbreviation in 
parenthesis, as described on (http://www.uniprot.org/docs/speclist). The single 
Drosophila JNK is referred to by its locus name “basket”.  
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The gene jnk1a is 20,288 basepairs (bp) long and found on the antisense strand of zebrafish 
chromosome 13 (Figure 10A). In total the gene possesses thirteen exons, of which twelve 
are predicted to contribute to the coding sequence (CDS), whereas exon 1 provides 
upstream untranslated region (UTR) only. Exon 7 and exon 8 of this gene are of identical 
length (72bp) (Figure 10C) and are predicted to be used alternatively to produce different 
mRNA transcripts (Figure 12A cf. “-001” and “-002”). This integration of alternative exons 
into the middle of the sequence is common to human JNK1, where the exon switch has 
been shown to alter transcription factor binding (Gupta et al., 1996). However, this has not 
been investigated in zebrafish. The final exon of zebrafish jnk1a is 865bps in length although 
most of this sequence is predicted to contribute to the 3’ UTR with only 146bp contributing 
to the protein coding sequence (Figure 12).  
  
Figure 10 Schematic representation of the zebrafish jnk1a and jnk1b gene 
structure  
A) jnk1a is found on the reverse strand of chromosome 13 and consists of thirteen 
exons B) jnk1b is found on the reverse strand of chromosome 12 and consists of 12 
exons. The size of the exons are representative of nucleotide number. C) Table 
displaying the total nucleotide length of each gene (introns and exons) and the 
length of each exon individually. Figure based upon gene  information taken from 
the ENSEMBL website. 
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The gene jnk1b is 18,169bp in length and is found on the antisense strand of chromosome 
12 (Figure 10B). jnk1b consists of twelve exons, of which eleven contribute to the CDS, with 
exon 1 contributing only 5’ UTR, and a majority of the final exon providing 3’ UTR (Figure 
12B). Since jnk1b possesses only 12 exons, it appears that one exon has been lost since the 
divergence from a common ancestor with humans: human JNK1 and zebrafish jnk1a have 13 
exons but jnk1b has retained only 12. When a sequence alignment is run against jnk1a and 
jnk1b we see that the exon which has been lost is exon 7 - one of the two “middle exons” 
which are alternatively spliced into the transcripts of jnk1a. The exonic sequence which has 
been retained in the jnk1b gene shows greater sequence identity to jnk1a exon 8 suggesting 
that the exon which has been lost is homologous to jnk1a exon 7 (Figure 11). This absence 
also explains why jnk1b is not predicted to have splice-variants which differ in the 
alternative splicing in the middle of the gene. Despite being homologous to exon 8, jnk1b 
exon 7 is much longer (253bp) than the 72bp of the jnk1a exon (Figure 10C); although 
interesting only 72bps of this long exon contribute to the CDS of two of the predicted splice-
variants (Figure 12B). The other two variants are predicted to use a greater proportion of 
this longer middle exon which is a feature that is not observed in humans, and may 
therefore be unique to zebrafish. 
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Figure 11 jnk1b Exon 7 is Homologous to jnk1a Exon 8.  
A) An alignment of the ENSEMBL provided exonic sequence for jnk1b exon 7 against 
jnk1a exons 7 and 8. The alignment shows that exon 7 of jnk1b shares greater 
sequence identity with exon 8 of jnk1a, particularly in the region between basepairs 
26 and 54 (|--|). B) This greater sequence identity can be quantified by examining the 
percentage sequence identity. These data also reveal that jnk1b exon 7 is more 
similar to jnk1a exon 8 than exon 7. 
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A comparison of exon length between the two zebrafish paralogs revealed that seven of the 
exons are of identical length, suggesting that these exons may be homologous to one 
another (Figure 10C). This conservation of length of so many exons is also complimentary 
with the idea that these two genes resulted due to a duplication event. Furthermore, as 
discussed above, although the middle exon of jnk1b is 253bp long compared to the 72bp of 
jnk1a, this long exon only contributes 72bp to the CDS of several exons and may therefore 
be homologous to exon 8 of jnk1a. 
The different splice-variants of jnk1a and jnk1b that appear on the ENSEMBL website have 
been automatically generated by the predictive ENSEMBL pipeline. The jnk1a gene is 
predicted to give rise to five different splice-variants that differ in exon usage and length 
(Figure 12A); three of these variants are greater than 1,500bp in length whereas two are 
smaller than 800bp. The three longest variants of jnk1a have the greatest amount of 
evidence supporting their existence. One of these splice-variants, jnk1a-001, has been 
shown to exists experimentally (Seo et al., 2010), and is listed on NCBI (NM_001110389). 
Additionally, jnk1a-201 is identical in the sequence of the CDS to variant jnk1a-001; the only 
differences between these two variants exists in the 5’ UTR region where the -001 variant 
possesses more sequence upstream of the transcriptional start site (Figure 12A). If both of 
these variants do exist then they would code for identical proteins, but could be subject to 
different post-transcriptional regulation as has been shown to occur for certain genes 
involved in embryonic development or those that are receptive to levels of iron (Klausner et 
al., 1993, van der Velden and Thomas, 1999). The third long splice-variant predicted to arise 
from the jnk1a gene is variant -002. This variant has a long 5’ UTR the same as variant -001 
but also has a very long 3’ UTR. Within the CDS the only difference that exists between 
jnk1a-002 and the other two long variants is the alternative splicing of exon 7 into the 
transcript, replacing exon 8 (Figure 12A). As has been discussed earlier, this process of 
alternatively splicing a middle exon into the transcript has been described in human JNK1 
where it also involves two exons that are 72bp long (Gupta et al., 1996). This similarity 
between what is observed in humans and what is predicted to occur in zebrafish therefore 
provides some circumstantial evidence to support the existence of both -001 and -002 
transcripts; however sequencing of different zebrafish transcripts is required for 
confirmation. 
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Although evidence can be found for the existence of the long jnk1a splice-variants, no 
published research supports the existence of the two predicted short variants. Variant 
jnk1a-004 is the shortest variant predicted at only 421bp and represents an incomplete 
transcript (Figure 12). ENSEMBL lists variant -004 as “CDS 3’ incomplete” because it has 
arisen from an incomplete clone during the genome sequencing, and is subsequently 
missing sequence at the 3’ end. The real transcript may therefore be much longer than what 
is shown here. Variant jnk1a-003 is 746bp in length but is not predicted to be protein coding 
(Figure 12). This transcript is also predicted to retain some exonic sequence (N.B. not shown 
in Figure 4).  
The gene jnk1b is predicted to give rise to four different splice variants which differ in length 
from each other. jnk1b-001 is 2,059bp long, including a large 3’ UTR region, and is translated 
into a 384 amino acid protein (Figure 12B). This splice-variant has been shown to exist 
experimentally (Krens et al., 2006b) and is listed on NCBI (NM_131721), as well as having a 
human ortholog. jnk1b-002 is a shorter DNA sequence of 1,287bp but is not predicted to 
have any 5’ or 3’ UTR and is translated into a 428 amino acid protein. The longer open 
reading frame (ORF) of variant -002 results from a “skipping” of 5bp at the start of the final 
exon (Figure 12B arrow) but no experimental evidence for this zebrafish transcript have yet 
been published. However, there has been a human ortholog described (N.B. ortholog is 427 
amino acids in length) which shows the same skipping of 5bp at the start of the final exon. 
This splicing event represents the presence of an alternative splice-acceptor site within the 
final exon which allows for a short and long variant to be transcribed (Gupta et al., 1996). 
There is therefore circumstantial evidence to suggest that this variant does exist in 
zebrafish. 
 Both of the remaining predicted variants (jnk1b-003 and -201) start identically to variant 
jnk1a-001 but use a larger amount of exon 7. As described earlier, exon 7 of jnk1b is 253bp 
long – much longer than the 72bp of exon 7 and 8 in jnk1a. Variants jnk1b-003 and -201 are 
predicted to transcribe larger regions of this exon before reaching a STOP codon within this 
exon. Interestingly the -201 variant is also predicted to skip 4bp within the middle of exon 7 
(Figure 12B arrow) in a splicing event reminiscent of what is seen in variant -002. However, 
no published evidence of these variants or known orthologs exist. 
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Figure 12 Predicted Model of Zebrafish jnk1 Transcription.  
Schematic representation of the ENSEMBL predicted jnk1 transcripts where length is representative of basepair length. The 
exons of each gene are numbered and alternate exons are represented in light and dark shades. Where regions of UTR are 
predicted these are coloured in white. A) Top line is a model of the jnk1a gene exonic sequence displaying all thirteen exons . 
Below shows the five different splice-variants predicted to arise,  each is accompanied by their numerical code designated on 
the ENSEMBL site. B) The top line shows a model of the jnk1b gene exonic sequence with all twelve exons. Below the four 
predicted splice-variants are shown with ENSEMBL designated codes. The arrows  () depict where bases are skipped in the 
two 3’ splicing events. Both result in a frame -shift and longer open reading frame. All information for this schematic has 
been taken from ENSEMBL Zv9 release 77 (jnk1a [ENSDARG00000031888], jnk1b [ENSDARG00000009 870]). 
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1.5.3  The Expression Pattern of jnk1 
The expression pattern of a gene shows when the gene is being actively expressed in the 
cell, and can be informative about function. Unfortunately, there is little known about the 
expression pattern of zebrafish jnk1, and even less about differences in expression between 
splice-variants. To gain some insight into zebrafish expression I therefore examined the 
limited literature as well as what was known about orthologs of jnk1. 
 
1.5.3.1 Expression of Homologous jnk1 Genes 
Very few papers deal with the topic of JNK1 expression, however those that exist broadly 
agree that the gene is ubiquitously expressed during development: mouse (Kuan et al., 
1999), Xenopus (Yamanaka et al., 2002), and in adult tissue: human (Derijard et al., 1994). A 
majority of the focus of JNK1 expression has been centred on the brain in mouse (Sabapathy 
et al., 1999) and the skeletal muscle of Xenopus during somitogenesis (Yamanaka et al., 
2002) however there is no consistency between species of a single organ or developmental 
process that is most reliant on jnk1 function. 
 
1.5.3.2  jnk1 Expression in the Zebrafish 
In Krens et al. (2006) it was shown by wholemount in situ hybridisation that zebrafish pan-
jnk1b expression (all splice-variants) is primarily restricted to the brain and gut at 24 and 
48hpf (Krens et al., 2006b). This result was unexpected because it differs from what is 
observed in mouse and frog where expression was shown to be ubiquitous during 
development. The Krens et al. paper also utilised reverse transcription PCR (RT-PCR) to 
measure mRNA abundance during development, and showed that pan-jnk1b has weak 
maternal inheritance but is expressed strongly thereafter up to about 18hpf (Krens et al., 
2006b). Expression of jnk1b later in development falls to low levels, although by adulthood 
the abundance is once again high (adult tissue type not stated). Since different tissue types 
were not examined during the developmental time series it is not clear whether these RT-
PCR results support the in situ findings, although it does suggest that this gene may be 
important during early development. Within our own lab in situ hybridisation analysis of 
pan-jnk1b (using a newly generated riboprobe) showed ubiquitous expression within the 
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embryo at 24hpf but a more restricted pattern by 36hpf- anteriorly in the embryo, and with 
very clear staining in the heart, gut and head (Unpublished data – Papoutsi, 2011 PhD 
Thesis). These results do not match exactly what was shown by Krens et al. or what has 
been shown to occur in other species. These data highlight some uncertainty in the 
expression of jnk1b during zebrafish development. 
More recently an in-depth examination of jnk1b expression patterns was conducted by Xiao 
et al. (2013) where both immunoblotting and RT-PCR were utilised in order to determine 
jnk1b expression over development and in adult zebrafish tissues (Xiao et al., 2013). This 
paper showed that expression of jnk1b mRNA is very variable during the course of 
development, particularly between 5 ¼ hours post fertilisation (hpf) and 10hpf where 
expression drops about three-fold, and also between 11 2/3 hpf – 16hpf where there is an 
~six-fold increase.  Conversely the western blots appeared to show that protein levels of 
Jnk1 (the antibody bound to both the Jnk1a and Jnk1b proteins) start low due to maternal 
inheritance, but increase steadily during early development and reach a moderate and 
stable level by brain differentiation stages (<24hpf). These protein levels (although they 
represent the combined abundance of protein from both genes) did not replicate the 
variability of the mRNA levels. This discrepancy between results may be caused by the 
methodology of the two experiments, since the western blot measured protein from both 
paralogs of jnk1, whereas the RT-PCR measured only the contribution of jnk1b. However it 
does seem unlikely that the protein contribution of jnk1a would be able to compensate for 
the sharp rises and falls that were shown in the jnk1b transcript level, and therefore retain a 
steady protein band on the blot. I believe that this discrepancy therefore highlights the 
importance of considering the role of both jnk1 paralogs within my own analyses. The Xiao 
paper also examined the expression of pan-Jnk1 within different adult tissues by western 
blot. The results suggest that expression is high in heart, muscle, liver and ovary with low 
levels in kidney and negligible levels in the testis (Xiao et al., 2013). Interestingly the blots 
resolved only one band for Jnk1 protein despite multiple different sized products being 
predicted by the ENSEMBL pipeline. Since the authors do not state what antibody was used, 
it is difficult to know why this may be the case, but it could be binding to only certain splice-
variants, and not to others. 
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The published work on the expression pattern of the zebrafish jnk1 paralogs is incomplete 
and contradictory. I have aimed to address this problem in this Thesis and improve the 
knowledge of expression of jnk1 in the zebrafish.   
 
1.5.4 The Functional Domains of the jnk1 Protein 
Although no information specifically about zebrafish Jnk1 protein functional domains exist, 
there is far more research on the human and murine forms of the protein. Analysis of the 
human and mouse JNK1 proteins on UniProt (http://www.uniprot.org HUMAN - P45983, 
MOUSE - Q91Y86) reveals that there are several functional domains within the amino acid 
sequence. The main functional domain is a protein kinase domain that spans over 250 
amino acid residues and is shared amongst all of the JNK genes. Within this protein kinase 
domain is an ATP binding domain that exists at position 55 and is necessary to 
phosphorylate downstream targets. The second important motif is the threonine / tyrosine 
(Thr/Tyr) phosphorylation site at position 183-185. This phosphorylation site is the main 
regulator of JNK1 activity and when both of these residues are phosphorylated the protein 
becomes active. Interestingly the middle exons (exons 7 and 8), which are used alternately 
for different splice-variants in both human and mouse JNK1, is present within the protein 
kinase domain, suggesting that it could have a role in regulating the activity of this MAP 
kinase. 
 
 
 
 
 
 
 
Figure 13 Schematic Representation of the Human JNK1 Functional 
Protein Domains.  
JNK1 contains a large protein kinase domain (solid red) which spans exons 
2-10. Within this domain is the ATP binding domain (arrow) and a Thr/Tyr 
phosphorylation motif (white). The middle exon of JNK1 contributes to the 
protein kinase domain (*), and lies close to the phosphorylation domain. 
Figure based upon human JNK1 structure from UniProt site (P45983).  
INTRODUCTION 
53 
 
Overall, the amount of information that is known about the structure and function of the 
zebrafish jnk1 genes and their products is limited. In order to gain some insight into these 
genes it was therefore necessary to utilise what is known about orthologous genes and use 
this as a basis of what might occur in the zebrafish. Indeed there are some similarities 
shown between human JNK1 and the two zebrafish paralogs i.e. jnk1a variants show 
alternative middle exon splicing, and different length jnk1b variants arise from an in-frame 
3’ splicing event. However, a far better knowledge of the zebrafish jnk1 genes was required 
in order to develop a targeted morpholino. The first priority of this project was therefore to 
expand upon what is known about zebrafish jnk1 and its transcripts. 
 
1.6 SUMMARY 
In this thesis the zebrafish jnk1 genes were investigated and the role of each of these genes 
was examined during development through the use of morpholino oligonucleotides. This 
introduction has introduced the topics that are important in understanding the project, 
including what is currently known about the role of the JNK genes and the developmental 
processes which the PCP and MAPK signalling pathways are thought to contribute to. Firstly 
the concept of left-right organ asymmetry and the mechanisms of symmetry breaking were 
introduced in the context of humans and model organisms. Second the PCP pathway was 
discussed and the link that has been shown between this signalling pathway and left-right 
signalling in the lateral plate mesoderm. Then the MAPK pathway was considered and the 
developmental processes which are known to be controlled through this signalling cascade. 
Following this the JNK1 gene was discussed in greater detail, highlighting what we know 
about the splice-variants created from this gene in man and zebrafish, and what role this 
gene is thought to have during normal embryogenesis. Finally the zebrafish was discussed as 
a model organism for developmental research, highlighting the advantages and limitations 
of using this model, and detailing normal embryogenesis for this species. 
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1.6.1 Aim of the Thesis 
The aim of this thesis was to expand upon what was known about the zebrafish jnk1 genes 
(jnk1a and jnk1b) particularly examining the different splice-variants that arise from the two 
genes. The automated annotation of the ENSEMBL pipeline predicted that the two genes 
each possess two splice-variants which are putatively orthologs of variants shown to arise in 
human JNK1, and confirmation that these variants have been shared between the two 
genes which arise from a duplication may suggest a sharing of gene function 
(subfunctionalization). Once the splice-variants of the jnk1 genes had been identified I 
aimed to characterise the different expression of these transcripts as a way to identify if 
they had functional roles in different tissue-types or at different times during development. 
The second major aim of this thesis was to develop a jnk1 morphant knockdown in the 
zebrafish in order to determine which developmental processes and which organs required 
the jnk1 genes for normal development. Once doses suitable for experimentation were 
determined I aimed to look at specific organ development, with a particular emphasis on 
the heart, to determine what changes were affected in embryos with knockdown of the jnk1 
genes. It was also hypothesised that the jnk1 genes may act through the PCP pathway to 
control left-right patterning in the embryo, as has been shown for rock2b (Wang et al., 
2011), and therefore organ situs was also examined. 
 Investigate the existence of different transcripts that arise from the jnk1a and jnk1b 
genes and determine their expression pattern between different tissue and over 
development. 
 Develop a jnk1a and jnk1b morpholino knockdown and characterise the gross 
phenotypic consequences of loss of these genes. 
 Determine whether situs defects arise in the visceral organs of jnk1 morphants. 
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2.1 BIOINFORMATICS 
2.1.1 Databases Used 
Predicted as well as experimentally validated gene and protein sequences were obtained 
from freely-accessible online databases. The majority of the zebrafish genomic data was 
obtained from the automatically annotated ENSEMBL Zv9 assembly release 70 
(www.ensembl.org).  This source provided gene sequences for jnk1a and jnk1b, intron and 
exon structure, and predicted splice variants for both genes. Where possible these splice-
variants were validated with experimentally generated CDS data uploaded to the NCBI 
nucleotide database (http://www.ncbi.nlm.nih.gov/nucleotide). This resource contains a 
few uploaded zebrafish jnk1 sequences that have been characterised in journal publications. 
All of the protein sequences used were taken from the UniProt protein sequence database 
(http://www.uniprot.org), apart from three exceptions. Protein alignments of the zebrafish 
jnk1 sequences were generated from translating the sequencing data obtained within this 
project. Finally the 3D rendering of human JNK1, and the contributing sequence, was 
obtained from the RCSB Protein Data Bank (http://www.rcsb.org/pdb/home/home.do). A 
list of all the sequences used and their accession numbers is listed below in Table 2. 
Gene / Protein 
Name Species 
DNA / 
Protein Source Accession Number 
jnk1a D. rerio DNA ENSEMBL ENSDARG00000031888 
jnk1a D. rerio DNA NCBI NM_001110389 
jnk1b D. rerio DNA ENSEMBL ENSDARG00000009870 
jnk1b D. rerio DNA NCBI NM_131721 
  
jnk1 C. elegans protein UniProt Q8WQG9 
jnk1 D. melanogaster protein UniProt P92208 
jnk1 X. laevis protein UniProt Q8QHK8 
jnk1 Chicken protein UniProt E1C1H4 
Jnk1 Mouse protein UniProt Q91Y86 
JNK1 Human protein UniProt P45983 
JNK1 Human protein PDB 2XRW_A 
Table 2 Sources of gene and protein sequencing data plus accession 
numbers. 
 
 
MATERIALS AND METHODS 
57 
 
2.1.2 Gene Structure Figures 
The sequencing data and genomic annotation of zebrafish jnk1 were downloaded from the 
ENSEMBL database in order to create schematic representation of the genes and their 
transcripts. The intron-exon structure of each gene was generated in powerpoint by 
producing boxes that were of sizes relative to the length of the exonic sequence. These 
representations of the exons were then distributed at a distance apart that was an 
estimation of intronic distance, but was not to scale. Lines were used to represent the 
intronic sequence. The transcript variant figure was also designed in powerpoint. The 
intronic sequeces were excluded and only exonic sequence was represented (without 
spaces). The transcript sequences were then downloaded from the ENSEMBL database and 
aligned in order to determine which exon, and how much, each transcript used. The exon 
usage of each transcript was then represented graphically by boxes of a size relative to 
sequence length. Lines were used to donate where parts or whole exons were skipped in 
the transcript. 
 
2.1.3 DNA / Protein Alignment 
DNA and Protein alignments were performed using ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2) and Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo) websites. These programs also generate a score 
for sequence identity which was used to compare similarity between species. The alignment 
.text files were inputted into BoxShade 
(http://www.ch.embnet.org/software/BOX_form.html) in order to achieve the shaded 
figures included in this thesis. Where appropriate annotations were made to the shaded 
files to indicate exon number, functional protein domains etc. 
To graphically represent the sequence identity between jnk1a and jnk1b at the nucleotide 
and protein level the sequences were aligned in Clustal Omega and inputted into JalView 
2.8.1 (Waterhouse et al., 2009). The shading of the alignment was changed to “percentage 
identity” and the individual nucleotide/amino acid letters were hidden. For nucleotide 
alignment the standard blue colour was used, but this was changed to red for the protein 
alignment. An image file was generated from the alignment and transformed in Adobe 
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Photoshop® to compress the alignment of several hundred bases / amino acids so that it 
would fit onto an A4 page. In the final alignment the coloured regions are sequences with 
conserved sequence identity and gaps are regions that do not have the same sequence. 
 
2.1.4 Functional Domain Identification 
The functional domain annotation of human JNK is accessible from UniProt (P45983). 
Alignment of human and zebrafish JNK1 genes revealed that sequence identity was high, 
and the kinase domain, ATP binding domain, Thr/Tyr phosphorylation sites were all 
conserved between the two species (Figure ). Running the two zebrafish genes through 
protein domain prediction software InterProScan 
(http://www.ebi.ac.uk/Tools/pfa/iprscan5/) confirmed that these domains were conserved 
but did not identify any other functional domains. 
 
2.1.5 Protein Secondary Structure 
Secondary structure of the jnk1 genes was predicted and compared by use of the JalView 
2.8.1 tool JNet Secondary Structure Prediction (Waterhouse et al., 2009). This tool predicted 
areas of helix and sheet in the sequence and produced a graphical representation. The 
graphical representation of secondary structure was used in Figure 19 to estimate how well 
secondary structure is conserved between jnk1a exon 7 and 8 and jnk1b exon 7 and 8. 
 
2.1.6 Protein Tertiary Structure 
The X-ray crysalographic tertiary structure of human JNK1 (2XRW_A) was downloaded from 
the Protein Database (http://www.rcsb.org/pdb/home/home.do) and opened in the 
freeware program Cn3D 4.3.1 for identification of which 3D structures the “middle exons” 
contributed to and for generation of 3D image files (downloaded from 
http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml).  
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2.1.7 Tissue-Specific Expression Analysis of JNK1 in Zebrafish, Mouse and 
Human 
Gene expression data for human and mouse JNK1 genes were obtained from the EBI 
Expression Atlas (https://www.ebi.ac.uk/gxa) by searching for MAPK8 and Mapk8 
respectively. In total six adult human and six adult mouse studies were returned and 
analysed for this study (Table 3). The studies where expression was measured in less than 
five different tissues were excluded from the analysis to reduce outlying results from 
skewing the analysis; this meant that two mouse studies were excluded at this point. 
Expression results from each tissue were then taken and upper and lower quartile values 
were calculated over all measurements. Any tissues where expression was less than the 
lower quartile (Q1) was considered low gene expression and any value higher than the 
upper quartile (Q3) was considered high gene expression. Use of quartiles was used for this 
test to again prevent skew of the data since it does not assume normal distribution of the 
dataset. 
Mouse Studies Used Human Studies Used 
Tissues - 49 FANTOM5 project - adult Tissues - 68 FANTOM5 project - adult 
Tissues - 9 in 3 strains - CD1 mus strain * Tissues - 53 GTEx 
Tissues - 9 in 3 strains - DBA/2J * Tissues - 32 Uhlen's Lab 
Tissues - 6 Tissues - Illumina Body Map 
Tissues - Mammalian Kaessmann Tissues - Mammalian Kaessmann 
Tissues - Vertebrates Proteomics - Tissues - Human Proteome Map - adult 
Table 3 List of Gene Expression Studies used to Determine Tissue -Specific 
Expression of the mouse Jnk1 and Human JNK1 Genes.  
To determine the tissue-specific expression of mouse Jnk1 and human JNK1 
genes all expression studies from the EBI Expression Atlas 
(https://www.ebi.ac.uk/gxa) to include these genes in adult tissue were 
analysed – twelve studies in total. An “*” identifies a study that was later 
discounted from analysis due to expression abundance b eing stated for too few 
tissues which would have introduced errors of data skew into the analysis.  
 
Once all six human and four mouse studies were analysed and low, medium or high 
expression was determined in each tissue of each experiment, the results were refined to 
include only tissues that had been analysed in the zebrafish RT-PCR: heart, skeletal muscle, 
testis, liver and brain. A consensus expression amount was then reached for each of the five 
tissues for human and for mouse. This consensus was made by comparing the value in each 
experiment; where ≥75% of values were the same (e.g. low) then this value was used as 
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consensus (i.e. low). Where <75% of values were the same then the different values were 
listed (e.g. low/med). This method was therefore able to provide a qualitative estimate of 
gene expression in different tissues that could be compared to the qualitative densitometry 
results generated by RT-PCR of zebrafish tissue. 
 
2.1.8 In silico Primer Characteristics and Specificity 
Primers were generated manually using sequence alignments to identify regions of poor 
conservation between the four zebrafish jnk1 genes. Several candidate primers were 
generated and the characteristics (melting temperature, GC content, dimerisation and 
secondary structure probability) were predicted by use of the primer design tool from 
Sigma-Aldrich® (http://www.sigmaaldrich.com/united-kingdom.html). Once suitable 
primers were chosen they were run through the Primer-BLAST software  
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) to determine whether they were 
predicted to amplify any unintended targets. Although it was predicted that the primers 
may amplify unintended targets between 30-380bp long, no other bands were detected in 
RT-PCRs except the ~500bp jnk1 amplicons. 
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2.2 MOLECULAR BIOLOGY TECHNIQUES 
2.2.1 Commonly Used Molecular Biology Reagents 
Tris-acetate-EDTA (TAE) Buffer: 
0.04M Tris-Acetate 
0.001M EDTA 
 
Tris buffered saline (TBS) / TBS-Tween (TBS-T): 
50mM Tris-Hcl 
150mM NaCl 
Adjust pH to 7.5 with 1M HCl 
Top up to 1L with ddH2O 
Add 0.1% Tween 20 for TBS-T 
 
Phosphate buffered saline (PBS): 
Made by dissolving 10 PBS tablets (Oxoid) into 1L ddH2O 
137mM NaCl 
2.7mM KCl 
10mM Na2HPO4 
1.8mM KH2PO4 
 
Diethylpyrocarbonate (DEPC) Water (DEPC-H2O): 
1ml DEPC (Sigma-Aldrich®) in 1L ddH2O, 
Leave at room temp in fume hood overnight, 
Autoclave before use. 
 
4% Paraformaldehyde (PFA): 
40g PFA in 800ml PBS, 
Dissolve at 60oC and add 1ml 1M NaOH, 
Top-up to 1L with PBS and aliquot. 
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2.2.2 List of DNA Primers 
Several primers were used in this study, and are listed below. All primers were obtained 
from Sigma-Aldrich®. 
Gene / Binding 
Site 
Forward Primer Sequence Reverse Primer Sequence 
Full-length jnk1a 
AGAGAGGGATCCATGAACAAA
AATAAGCGAGAG 
TAGTAGCTCGAGTCATCTGCAGCAG
CTCAG 
Full-length jnk1b 
AGAGAGGGATCCATGAACAGG
AATAAGCGCGAG 
AGAGAGTCTAGATCATCTGCAGCAG
TGCAGCGC 
pGEM-T Easy T7 
site / SP6 site 
TAATACGACTCACTATAGGG CTATAGTGTCACCTAAATAGCTTGGC 
jnk1a exon 7 TTTGGCAGAAATGGTCCGTC (short / long reverse primer) 
jnk1a exon 8 
GAGGTAGTGTATTATTTCCGGG
TTC 
(short / long reverse primer) 
jnk1a short (Exon 7 / 8 forward primer) CTGCTGCACCTGTGCTAGG 
jnk1a long (Exon 7 / 8 forward primer) TTGATCACTGCTGCACCTAGG 
jnk1b exon 7 TAACGTGGATATTTGGGCTGTT (short / long reverse primer) 
jnk1b exon 8 
GCTAACGTTGATGTCTGGTCTA
TTG 
(short / long reverse primer) 
jnk1b short (Exon 7 / 8 forward primer) TGCTGCACCTGTGCTAGC 
jnk1b long (Exon 7 / 8 forward primer) GCTCACTGCTGCACCTAGC 
elfa1 CTTCTCAGGCTGACTGTGC CCGCTAGCATTACCCTCC 
Table 4 List of Primer Sequences 
 
2.2.3 Standard Tissue Homogenisation Procedure 
Tissue homogenisation for RNA extraction and western blotting was performed by passing 
the material through a gradient of needles with increasing gauges. Depending upon the 
biological material required, RNA or protein, the tissue was added to half the total volume 
of TRIzol® or laemmli buffer respectively on ice in a fume hood. Homogenisation was 
achieved by sucking the tissue up and down through a 19G needle and 1ml syringe for 30 
seconds. This process was repeated using the same syringe with a 21G and 23G needle. The 
remaining TRIzol® or laemmli buffer was added (up to a final volume of 1ml TRIzol® or 400µl 
laemmli) and the tissue was homogenised for a further 1 minute using a 23G needle. 
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Homogenised tissue was used immediately for downstream methods to minimise 
degradation of the reagent. 
 
2.2.4 Standard RNA Extraction Method 
Total RNA extraction was performed using TRIzol® reagent (Ambion) in 1.5ml eppendorf 
tubes in accordance with the manufacturer’s instruction. Briefly, the tissue of 40 embryos 
was homogenised in 1ml of TRIzol (see 2.2.1) and incubated at room temperature for 5 
minutes. To the TRIzol® 0.2ml chloroform was added, the tube was vortexed and then 
incubated for a further 3 minutes. Phase separation was achieved at 12,000 x g for 15 
minutes at 4oC, and the aqueous phase was removed by pipette. In a fresh eppendorf the 
aqueous phase was added to 0.5ml isopropanol and incubated on ice for 30 minutes, before 
RNA precipitation was achieved by centrifuging a second time. The supernatant was 
removed to leave the RNA pellet, and one wash in 75% ethanol was performed followed by 
centrifugation at 7,500 x g for 5 minutes to collect the pellet. The wash was removed and 
the pellet was air dried for 5 minutes. The RNA pellet was resuspended in 50μl of DEPC-H2O 
and quantification was performed by NanoDrop™ spectrophotometry (see 2.2.5).  
RNA clean-up was performed by addition of 110μl lithium chloride / EDTA solution, and 
incubation at -80oC for 48 hours. The RNA was then precipitated by centrifugation at 12,000 
x g for 20 minutes at 4oC before the pellet was washed in 1ml 75% ethanol by inversion of 
the tube. The pellet was collected as before and air dried for 5 minutes before RNA was 
quantified by NanoDrop ™ spectrophotometry.  
 
2.2.5 Quantification of RNA/DNA 
RNA and DNA yields were quantified by the NanoDrop™ 8000 spectrophotometer. Values of 
absorbance at 260nm were used to quantify the RNA/DNA abundance per sample, and 
260/280 and 260/230 values were used as an indicator for contamination with co-purified 
agents. 
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2.2.6 cDNA Generation (Random Hexamers) 
For the purpose of RT-PCR analysis, cDNA was generated with random hexamer primers 
using the High-Capacity cDNA Reverse Transcription kit (Applied Biosciences). Briefly the 
RNA was diluted down to 0.2μg/μl in a 10μl volume and stored on ice until used. The kit 
reagents were thawed and a master mix was made for as many reactions that were required 
as follows: 
Reagent Volume per Reaction 
10x Buffer 2.0 
25x dNTPs 0.8 
10x Random Hexamer Primers 2.0 
Multiscribe Transcriptase 1.0 
dH2O 4.2 
Total Volume 10.0 
 
Once vortexed, the master mix was aliquoted out to 0.2ml PCR tubes and all 10μl of dilute 
RNA were added to each reaction. The cDNA reactions were performed in a thermocyler 
under the conditions in following conditions: 
 
Time (min) Temperature (oC) 
10 25 
120 37 
5 85 
Pause 4 
 
2.2.7 Gel Extraction and PCR Product Clean-up 
PCR products were cleaned-up with or without gel electrophoresis and gel extraction by use 
of the Wizard® SV Gel and PCR Clean-Up System (Promega). Where gel extraction was 
required the DNA was visualised in the agarose gel by the UV transluminator, and bands 
were excised with a clean scalpel blade. The gel was then weighed and dissolved in an equal 
amount (volume:weight) of Membrane Binding Solution at 65oC with frequent vortexing. 
PCR products that did not require gel extraction were added to an equal volume of 
Membrane Binding Buffer, and then the two methods were identical. 
MATERIALS AND METHODS 
65 
 
The melted gel or PCR product was added to an SV Minicolumn and allowed to bind at 1 
minute at room temperature, before centrifuging at 16,000 x g for 1 minute. Flowthrough 
was discarded and 700μl of Wash Solution was added before centrifuging for 1 minute. This 
step was repeated but 500μl of wash buffer was used this second time, and the tube was 
centrifuged for 5 minutes. The SV minicolumn was transferred to a 1.5ml eppendorf tube 
and 50μl of DEPC-H2O was added directly to the membrane. The column was incubated at 
room temperature for 1 minute before the DNA was collected in the eppendorf by 
centrifuging for 1 minute. 
 
2.2.8 Full-length jnk1 Variant Sub-Cloning 
The sub-cloning of full-length jnk1 transcripts was performed to both gain accurate 
sequences of the jnk1 genes in the AB zebrafish strain, and to prove the existence of 
different splice-variants. The variants with the most published evidence for their existence 
were targeted for cloning through the use of primers designed to bind at the beginning and 
end of the sequence. The two jnk1a variants targeted were jnk1a-001 and -002, whereas 
the two jnk1b variants were jnk1b-001 and -002 (See Figure 12). In both instances only a 
single primer pair was required to pull out both transcripts. 
 
2.2.8.1 Full-Length Transcript Primer Design 
In order to pull out the targeted full-length transcripts of jnk1a and jnk1b only two primer 
pairs were required. In the case of jnk1a where both variants are of equal size (but differ in 
the middle) it is obvious that primers at both ends will be capable of pulling out both 
variants. The targeted variants only differ in their use of either exon 7 or exon 8 in the 
middle of the sequence, therefore both variants will be amplified by the primers. However, 
in the case of jnk1b where two different sized products are predicted it is not so obvious 
why only one primer set is necessary. The two targeted jnk1b variants (-001 and -002) have 
the same start site, however the STOP codon of variant -001 is 132bp further upstream. The 
reverse jnk1b primer was therefore designed to bind at the STOP codon of the longest 
variant (-002), allowing for this whole sequence to be amplified. In the case of the shorter 
variant (-001) the primer was predicted to bind within the 3’ UTR sequence (See Figure 
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14, Appendix Figure 57) allowing for the whole CDS plus some 3’UTR to be amplified. The 
result of the PCR is therefore that the full CDS of both variants is successfully amplified, but 
a small amount of 3’ UTR is also amplified in the jnk1b-001 variant. 
In order to design the full-length primers there were several challenges that had to 
considered. Firstly the primers were designed against sequence obtained from the Tübingen 
zebrafish strain. This ENSEMBL sequence was the only available sequence that detailed 
alternative splice-variants so there was no other alternative to using this sequence. 
However I was aware, that the primers may not have been 100% complimentary to their 
target within the AB strain. Secondly, the desire to obtain full-length sequences that could 
be transcribed to mRNA and injected into the embryo without further modifications meant 
that primer sites were restricted to the start and end of the coding sequence; these regions 
are fairly well conserved between the two paralogs so there was a risk that primers may 
amplify both paralogs. The sequence identity between the primers and their unintended 
target is between 81-89% (Figure 14). However, since clonal colonies were created, and 
each insert was fully sequenced, some cross-reactivity of the primers could be tolerated. 
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2.2.8.2 cDNA Generation (Oligo dT Primers) 
Template cDNA for the full-length transcript PCR was obtained from 40 AB zebrafish at 
72hpf. This tissue was homogenised and RNA was extracted via standard methodologies. 
Full-length cDNA transcripts were generated via the use of olgo dT primers in a reverse 
transcription reaction using the SuperScript™ III kit (Life Technologies). Briefly, the reagents 
were thawed and into a 0.2ml PCR tube was added 1μl 10mM dNTPs, 1μl dT primers, 5μg 
total RNA, and DEPC-H2O to top up to 12μl total volume. These reagents were mixed and 
incubated at 65oC for 5 minutes, before being chilled on ice for 2 minutes. A master mix 
containing 4μl 1st strand buffer, 4μl 0.1M DTT and 1μl DEPC-H2O per reaction was made and 
6μl of this solution was added to each RT reaction. The PCR tubes were then incubated at 
Figure 14 Explanation of the Full-Length jnk1 Primers.  
A) Schematic representation of the four jnk1 transcripts that were targeted by this 
sub-cloning method as well as where the primers were designed to bind (arrows). 
The predicted amplicons are the full length sequence, plus a small amount of 3’ UTR 
in the case of jnk1b-001. B) Table of the percentage complimentarity of the primers 
to their target gene, as well as to the unintended paralog. The primers share 
between 81-89% sequence identity to the unintended paralog. C) Schematic of the 
various features designed within the forward primer of jnk1a. Each primer contains 
all three of these features.  
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42oC for 2 minutes before 1μl SuperScript III reverse transcriptase was added, and the 
reactions were allowed to progress at 42oC for 1 hour. The reaction was finally terminated 
at 70oc for 15 minutes and the PCR products were purified by the Wizard SV Gel and PCR 
Clean-Up System (2.2.7). 
 
2.2.8.3 Full-length Transcript PCR 
Full-length jnk1 splice-variants were amplified by reverse-transcription PCR prior to sub-
cloning using the primers discussed in section 2.2.8.1. Reactions were performed using 
Phusion (NEB®) high-fidelity polymerase such that each reaction was set-up as below: 
Reagent Final Concentration 
5x Phusion Buffer 1x 
dNTPs 0.2mM of each dNTP 
Forward Primer 0.5mM 
Reverse Primer 0.5mM 
cDNA 50ng 
Phusion polymerase 1 unit 
DEPC-H2O Top up to 20μl 
 
Time (second)  Temp (oC) 
     30      98 
      10      98 
      20      72  x30 
      40      72 
    120      72 
Pause        4 
 
Following the PCR reaction the product was purified via PCP Clean-Up System column 
(2.2.7). 
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2.2.8.4 A-tailing of PCR Products 
Poly-A tails were added to full-length transcripts in order to perform T-cloning into pGEM-T 
Easy (Promega) vector. The products generated by PCRs using full-length primers were 
cleaned-up via SV Wizard columns (section 2.2.7) to remove the 3’ exonuclease activity of 
the high-fidelity polymerase. To this cleaned-up DNA (dissolved in 50μl) was added 5.5μl of 
5x GoTaq® buffer, dATP to a final concentration of 0.2M, and 1μl of GoTaq® DNA 
polymerase (Promega®). The reaction was run at 72oC for 10 minutes and then a further SV 
Wizard clean-up set was performed. 
 
2.2.8.5 T-Clone Ligation 
Ligation of the full-length transcripts into pGEM-T Easy (Promega) was performed at 4oC 
overnight as per the manufacturer’s guidelines. Briefly, the reagents were thawed and 
vortexed before the experimental, one positive and one negative control reaction was set 
up in 0.2ml PCR tubes as below: 
Reagent Experimental Positive Control Negative Control 
Rapid Ligation Buffer 5μl 5μl 5μl 
pGEM-T Easy® Plasmid 1μl 1μl 1μl 
PCR Product 3μl - - 
Control Insert - 2μl - 
T4 DNA Ligase 1μl 1μl 1μl 
DEPC-H2O - 1μl 3μl 
 
Reactions were incubated at 4oC overnight before bacterial transformations. For difficult 
ligations it was necessary to titre the quantities of plasmid and insert such that three 
reactions were performed per PCR reaction- 3:1, 1:1 and 1:3 vector to insert. A plasmid map 
for the resulting cloning products is shown in Figure 15.  
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Figure 15 Plasmid map of the final jnk1 transcript-containing cloning 
vector. 
Schematic representation of the pGEM-T Easy (Promega®) cloning vector 
following the ligation of a zebrafish jnk1 splice -variant. Schematic shows the 
physical location and basepair start and end of the jnk1 variant insert, SP6 
promoter, T7 promoter, M13 forward primer site, M13 reverse primer site, F1 
origin of replication, ampicillin resistence gene (AmpR), ampicillin promoter, 
colicin E1 origin of replication, LacZ alpha gene, and LacZ origin of replication 
site. Plasmid map created with SerialCloner 2.6.1 freeware 
(http://serialbasics.free.fr). 
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2.2.8.6 Bacterial Transformation 
To amplify transcripts and for production of clonal colonies DH5α cells (Invitrogen™) were 
transformed with the plasmid vectors. Subcloning efficiency, competent DH5α cells were 
thawed on ice and 5μl of the ligation was added to 25μl of cells. Following a 30 minute 
incubation on ice, the cells were heat-shocked at 42oC for 30 seconds and then returned to 
ice. The cells were topped up to 1ml with pre-warmed LB broth and incubated at 37oC for 
one hour while being shaken. From these starter colonies 100μl was plated onto LB-agar 
plates with 100μg/ml ampicillin at dilutions of 0.1x, 1x and 10x starter culture. Plates were 
grown for 12-16 hours at 37oC. 
LB Medium: 
10g bacto tryptone, 
2.5g bacto yeast extract 
5g NaCl 
500ml ddH2O 
 
LB Agar: 
10g bacto tryptone, 
2.5g bacto yeast extract, 
5g NaCl, 
7.5g bacto agar, 
500ml ddH2O 
Agar and medium autoclaved before use. 
 
 
2.2.8.7 Colony PCR 
Colony PCRs were performed in order to determine whether inserts of an appropriate size 
had been ligated into the plasmid vectors. A p200 tip was used to pick single colonies from 
an agar/ampicillin plate and then transfer it to both a stab-plate, and 0.2ml PCR tube. Each 
PCR tube corresponded to a single colony on the stab-plate which was then incubated at 
37oC until colonies were visible. Standard Taq polymerase reactions were set up as in 
section 2.2.11.4 and primers against the SP6 and T7 sites (Table 4) in the pGEM-T Easy 
(promega) multiple cloning site were used. The amplification time and number of cycles 
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used were high to ensure amplification of the ~1.2Kb amplicon that was expected with full-
length jnk1 transcripts: 
Time (second)  Temp (oC) 
     120      95 
      30      95 
      30      64  x35 
      90      72 
    300      72 
Pause        4 
 
The PCR product was run through a 1% agarose gel to determine whether the insert was the 
correct size. A sample of these colonies were then selected for isolation and sequencing. 
 
2.2.8.8 Isolation of Plasmid DNA 
Selected colonies were picked with a p200 pipette tip and grown in LB/ampicillin liquid 
culture for 12-16 hours at 37oC under shaking at 225rpm. Plasmid DNA was isolated from 
bacterial cells by use of the QIAprep® Miniprep kit (QIAGEN) as per the manufacturer’s 
instruction. Briefly, the liquid colonies were centrifuged at 6,000 x g for 15 minutes at 4oC to 
pellet the cells and the supernatant was decanted. The pellet was resuspended in 0.25ml P1 
buffer and transferred to a 1.5ml eppendorf tube. To the tube was added 0.25ml P2 buffer 
and the tubes were inverted to mix before the reaction was terminated by addition of 
0.35ml N3 and mixed thoroughly. 
The lysis solution was centrifuged at 18,000 x g for 10 minutes and then the supernatant 
was decanted into a QIAprep spin column and centrifuged for 1 minute. The flowthrough 
was discarded and 0.5ml PB buffer was added before centrifuging for a further minute. The 
flowthrough was discarded and the column was washed with 0.75ml PE buffer before 
centrifuging for 1 minute. The remaining buffer was removed with another 1 minute of 
centrifugation before the column was transferred to a fresh 1.5ml eppendorf tube, 50μl of 
DEPC-H2O was added and the column was centrifuged for 1 minute to collect the DNA. 
Plasmid DNA abundance was qualified via NanoDrop Spectrophotometry (see 2.2.5). 
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2.2.9 Gel Electrophoresis 
Agarose gel electrophoresis was performed in order to resolve and visualise different sized 
DNA bands during the project. In general 2% (weight/volume) agarose gels were used, 
however for full-length transcripts a 1% agarose gel was preferred. The necessary amount of 
agarose was dissolved in TAE solution and heated in a microwave until all the agarose had 
dissolved. After some cooling one drop of ethidium bromide (Sigma-Aldrich ®) was added, 
and the agarose was poured into the mould and allowed to solidify before use. Gel 
electrophoresis was performed with the gel submerged in TAE for 25 minutes under a 
constant 125V or until the bands of interest had been successfully resolved.  
 
2.2.10 Sequencing 
Purified plasmids were sent for forward and reverse Sanger sequencing to GATC Biotech 
(https://www.gatc-biotech.com/en/index.html). SP6 and T7 primers within the plasmid 
multiple cloning site were used for this purpose. 
 
2.2.11 Splice-Variant Specific jnk1 RT-PCRs 
Following the identification of eight different jnk1 splice-variants arising from two genes it 
was decided to investigate the differential expression of these variants. Considering the 
large regions of conservation between variants of the same gene, and lesser but still 
considerable conservation of sequence between variants of different genes, the design, 
optimisation and validation of this experiment was complex. Despite this, primers were 
designed that do successfully target only a single splice-variant and were shown to be 
specific. 
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2.2.11.1 Forward Primer Design 
In order to design four forward primers capable of binding to only one of the four middle 
exons specifically I began by performing a sequence alignment of these exons (Figure 16B). 
Sequence alignment showed that there are very few regions completely unique to each 
exon (Figure 16B white). Where there was divergence between exon 7 and 8 of one paralog, 
the change was often mirrored in the other paralog. Similarly, where differences were seen 
between exon 7 of jnk1a and jnk1b, these changes were often mirrored in exon 8 of the 
same paralog (Figure 16B grey). The conservation of the four sequences made it difficult to 
find primer targets that were sufficiently unique as to be specific to each splice variant. The 
forward primers that were finally chosen had the highest number of mismatches between 
both the variants arising from the same paralog, but using the opposite exon, and those 
variants arising from the opposite paralog, but using the same exon (Table 5). Where 
multiple possible sites existed with the same number of mismatches, those primers that had 
the lowest amount of secondary structure and which were not predicted to dimerise were 
chosen preferentially. All but one of the primers contained 5 or more mismatches to the 
unintended targets and none were predicted with strong secondary structure. 
 
 
 
 
 
 
 
 
 
  
Table 5 Sequences and Characteristics of the Splice-Variant Specific jnk1 Primers.  
The splice-variant primers were designed to be unique to one splice variant only 
with as high a number as possible mismatches with the other transcripts. Other 
factors were also considered including the number of base pairs which directly 
affects the melting temperature of the primers (Tm). Primers with low levels of 
secondary structure as well as those that were not predicted to dimerise were 
chosen preferentially when multiple choices were available.  
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2.2.11.2 Reverse Primer Design 
The splice-variant specific reverse primers were designed to target the two different 3’ 
splice acceptor sites of the jnk1 paralogs. The two splice-acceptors lie just 5bp apart from 
one another so the ~20bp primers were able to completely overlap this site. I designed the 
reverse primers to take advantage of the fact that successful amplification by the 
transcription complex is most susceptible to mismatches at the 3’ end of the primer (Kwok 
et al., 1990).  By designing the 3’ end overlapping the splice-acceptor sites there are at least 
5pb different between the short form and long form (Table 5). However, as was shown in 
Figure 19 the region around the two splice acceptor sites is conserved between jnk1a and 
jnk1b; the only differences in sequencing occurring upstream or downstream of this region. 
Therefore there were very few mismatches (between one and three) between each primer 
and the corresponding splice-variant of the opposite paralog (Table 5). The reverse primers 
are therefore unlikely to be paralog specific; however they will be specific to either the short 
or long variant. It is therefore necessary that the forward primers are paralog specific to 
ensure that, as a pair, the primers are capable of amplifying only one splice-variant each. 
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Figure 16 Design of Splice-Variant Specific Primers.  
A) Schematic representation of where the splice -variant specific primers have 
been designed to bind. Coloured boxes represent the exons where binding takes 
place and the white boxes representing the 3’ UTR. The remaining exons are not 
shown. The forward primers were designed to bind within exon 7 or overlapping 
the exon 6 / exon 7 boundary. The reverse primers were designed within exon 13 
overlapping the two alternative splice acceptor sites. In the long form this is 
represented by a gap at the start of exon 13. B) Sequence alignments of the 
middle exons from jnk1a and jnk1b showing where the primers bind. Nucleotides 
conserved between all four exons are highlighted black and mismatches are 
white. Regions where half the variants have one nucleotide and half the variants 
have another nucleotide are shaded grey. Primer binding site shown by the red 
boxes. C) Sequence alignment of exon 12 and exon 13 of jnk1a and jnk1b 
showing sequence conservation. The primer binding sites are shown by red 
boxes. 
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2.2.11.3 Temperature Gradient RT-PCR 
In order to determine the highest annealing temperature that remained unrestrictive for 
amplification of the splice-variant specific RT-PCRs, the reaction was gauged over a 
temperature gradient. A total of eight master mixes were made up (as in section 2.2.11.4) 
for each jnk1 splice-variant including in the mix the primer pairs. The template cDNA used 
was an equal mixture of cDNA from each of the nine developmental stages that were 
analysed in this project. One positive control for the jnk1a and one for the jnk1b variants 
was included which was the same master mix but with a plasmid DNA template containing 
the jnk1 variant. Distilled water was used to replace the cDNA content for a negative 
control. The PCRs were conducted under the same temperature and time conditions as the 
colony PCRs (section 2.2.8.7) except that for the annealing temperature step, the 
thermocycler plate was set up over a temperature gradient. Each PCR reaction within a set 
had an annealing temperature 2oC higher than the last between 62oC and 70oC. Following 
gel electrophoresis the bands were examined to determine the optimal temperature to use 
for future PCRs that would be specific but still allowed amplification. The optimal 
temperature values are listed in section 2.2.11.4. 
 
2.2.11.4 Testing RT-PCR Specificity (Plasmids) 
The specificity of the splice-specific jnk1 primers were trialled against plasmid DNA to 
ensure that the primers could amplify only one splice-variant of jnk1. The plasmid DNA was 
clonal and contained only a single jnk1 variant, therefore only one primer pair should 
amplify from each template DNA. To test this theory master eight mixes of 4.5 reactions 
each were made up containing all the reagents listed in section 2.2.12 except for the DNA. 
Each of the eight mixes contained a primer set targeted to one of the eight different jnk1 
variants. Each of the jnk1 master mixes were aliquotted into a 0.2ml PCR plate and a 1μl of 
plasmid DNA was added to each reaction to make the final volume up to 20μl. The table 
below represents the template and primer pair grid that was constructed in the PCR plate, 
only reactions where template and primers match was there expected to be any 
amplification: 
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Primer Pair Used 
  
jnk1a_7;short jnk1a_7;long jnk1a_8;short jnk1a_8;long 
Template 
DNA 
jnk1a_7;short match - - - 
jnk1a_7;long - match - - 
jnk1a_8;short - - match - 
jnk1a_8;long - - - match 
  
Primer Pair Used 
  
jnk1b_7;short jnk1b_7;long jnk1b_8;short jnk1b_8;long 
Template 
DNA 
jnk1b_7;short match - - - 
jnk1b_7;long - match - - 
jnk1b_8;short - - match - 
jnk1b_8;long - - - match 
 
The PCRs were run under standard temperatures (see section 2.2.11) and PCR conditions 
(see section 2.2.12) and gel electrophoresis was performed to determine whether 
amplification had been successful. 
 
2.2.12 Developmental and Tissue-Specific RT- PCR 
Developmental and tissue-specific RT-PCRs were both conducted under optimised 
conditions using Taq polymerase and the relevant splice-variant specific primers (Table 4). 
The template cDNA was generated from animals 4 months of age via sacrifice and dissection 
of the required tissues (section 2.3.8). RNA extraction and cDNA generation was then 
performed by standard methodology. 
The tissue-specific RT-PCRs were conducted by producing a standard master mix where each 
reactions contained: 
Reagent Final Concentration 
GoTaq® Flexi Buffer 1x 
MgCl2 1.5mM 
dNTPs (10mM) 0.2mM each dNTP 
Forward Primer (10mM) 0.5μM 
Reverse Primer (10mM) 0.5μM 
cDNA 50ng 
Hot-Start GoTaq® Polymerase 1.25 units 
DEPC-H2O Top up to 20μl 
 
MATERIALS AND METHODS 
79 
 
The RT-PCRs were run in a thermocycler under standard conditions, although the number of 
cycles was dependent upon the splice-variant: 
 
Time (second)  Temp (oC) 
     120      95 
      30      95 
      30       X  x Y 
      30      72 
    300      72 
Pause        4 
 
 
Splice- Variant Annealing Temperature 
(X) oC 
Number of RT-PCR Cycles (Y) 
jnk1a_7;short 64 35 
jnk1a_7;long 64 31 
jnk1a_8;short 64 33 
jnk1a_8;long 64 31 
jnk1b_7;short 67 35 
jnk1b_7;long 67 35 
jnk1b_8;short 67 35 
jnk1b_8;long 67 35 
elfa1 62 21 
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2.2.13 Pan-jnk Western Blotting 
Western blot analysis on morphant tissue was conducted using a polyclonal pan-JNK 
antibody (Cell Signalling: #9252) and gapdh loading control (abcam®: ab9485). The protocol 
used was based upon the detailed protocol published by Abcam® 
(http://www.abcam.com/index.html?pageconfig=resource&rid=11375). The tissue was 
collected from 100 embryos at 48hpf for three conditions: uninjected controls, 4ng jnk1a 
and 4ng jnk1b morpholino. Embryos were batch dechorionated (section 2.3.4) and deyolked 
to reduce background binding as in Link et al.  (Link et al., 2006). Briefly the embryos were 
washed three times in ice-cold deyolking buffer and transferred to a fresh 1.5ml ependorff 
tube. A cOmplete Mini protease inhibitor (Roche) was dissolved into 5ml of deyolking 
buffer, and then 1ml of this solution was added to each tube. The embryos were passed up 
and down a p200 pipette tip thirty times to disrupt the yolk sac followed by 5 minutes of 
shaking at 1100rpm to emulsify the yolk. The tubes were centrifuged at 4oC for 30 seconds 
at 1,900rpm to pellet the embryos and the supernatant was discarded. 
Following deyolking, 200µl of laemmli buffer (half the total volume) was added to each tube 
and the tissue was homogenised through a needle gradient of 19G, 21G and 23G (section 
2.2.3) before 200µl more laemmli buffer was added. The samples were boiled for 5 minutes 
at 95oC and 20µl of each was loaded into a 10% Mini-PROTEIN® gel (Bio-Rad) along with 
10µl PageRuler Plus Prestained protein ladder (Thermo Fisher Scientific). Electrophoresis 
was performed at 80V for 20 minutes and 125V for 1.5 hours before Semi-dry transfer to a 
PVDF membrane was achieved by using the Tran-Blot® SD system (Bio-Rad) at 15V for 45 
minutes.  
Following successful transfer the membrane was cut in two with a clean scalpel at the 
40kDa band. The membrane with low (≤40kDa) molecular weight proteins was used for a 
loading control and blocked in 5% milk / TBS-T, whereas the high molecular weight 
membrane was blocked in 5% BSA / TBS-T for 2 hours in a falcon tube while being rolled. 
The membranes were exposed to antibody (low weight with 1:20,000 anti-gapdh, high 
weight with 1:5,000 anti-jnk) overnight at 4oC while being rolled. The following day both 
membranes were washed thoroughly in TBS-T before horseradish peroxidase conjugated 
swine anti-rabbit secondary antibodies (Dako® P0399) were applied (low weight with 
1:20,000, high weight with 1:5,000) and incubated at room temperature for 2 hours. 
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Once membranes were thoroughly washed with TBS-T 4x 10 minutes the SuperSignal 
Chemiluminescent solution (ThermoScientific) was applied and photographic film was used 
to detect luminescence. Film was developed using a film processor (Konica Minolta) scanned 
on a flatbed scanner, and densitometry was performed on each lane individually to 
determine relative protein abundance. The gapdh loading band was compared between 
samples to generate a normalisation value, and this was used to normalise the jnk protein 
bands. Components of all of the western blot specific solutions are listed below: 
 
Deyolking Buffer: 
55mM NaCl, 
1.8mMKCl, 
1.25mM NaHCO3 
 
Laemmli Buffer: 
4% SDS, 
10% 2-mercaptoethanol, 
20% glycerol, 
0.004% bromophenol blue, 
0.125M Tris HCL 
pH to 6.8 
 
Running Buffer: 
  25mM Tris Base, 
0.19M Glycine, 
 0.1% SDS, 
Dissolved in 1 litre dH2O 
 
Transfer Buffer: 
48mM Tris Base, 
39mM Glycine, 
20% Methanol 
Dissolve in 0.8 litre dH2O 
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2.2.14 Myc-tagged Western Blott 
Sample generation for the myc-tagged mRNA western blots was carried out via 
microinjections (section 2.3.5.2) although there were multiple injections required per 
sample. Large clutches of embryos were selected immediately after being spawned and 120 
embryos were taken and injected with jnk1a morpholino. These morphants were then split 
between three dishes and injected with either 400pg jnk1a-myc mRNA, 400pg jnk1b-myc 
mRNA, or no mRNA. This process was repeated with jnk1b morpholino and then the 
standard Gene-Tools® CMO resulting in a total of nine sample conditions. Morpholino 
microinjection was carried out by me whereas mRNA injection was performed by Dr. Simon 
Ramsbottom. The sharing of microinjections reduced the required time for the injections 
and meant that all nine conditions could be generated within the same clutch of eggs before 
the eight-cell stage. Embryos were then allowed to develop under normal conditions until 
48hpf before tissue was processed by standard methods (see sections 2.2.3 and 2.2.13).  
The anti-myc western blot was then carried out by Dr. Simon Ramsbottom. Briefly the nine 
samples were loaded into a 10% Mini-PROTEIN® gel (Bio-Rad) such that 1 protein 
abundance per well equated to 1 embryo per lane. The electrophoresis was performed for 
20 min at 80V followed by 1.5 hours at 125V in running buffer solution. Semi-dry transfer of 
protein to PVDF membrane was achieved at 15V for 45 min with the Trans-Blot® SD system 
(Bio-Rad). The membrane was blocked in milk for one hour and then cut in two at 45kDa 
allowing for the top and bottom of the membrane to be probed separately. The top of the 
membrane was probed with anti-MYC (abcam®: ab1326) whereas the bottom of the 
membrane was probed with 1:20,000 anti-GAPDH antibody (abcam®: ab9485) overnight at 
4oC. The following day the horseradish peroxidase conjugated swine anti-rabbit (Dako® 
P0399) secondary antibody was incubated with the membranes at room temperature for 2 
hours. Following thorough washing steps the membrane was treated with SuperSignal 
Chemiluminescent solution (ThermoScientific) and exposed to photographic film. The 
resulting photographic images were scanned on a flatbed scanner to be included in this 
thesis. 
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2.2.15 In Situ Hybridisation 
In situ probes were generated from plasmid templates of the zebrafish myl7 (cmlc2) (Yelon 
et al., 1999) and foxa3 (Odenthal and Nusslein-Volhard, 1998) genes by RNA polymerase 
using the DIG RNA Labeling Kit (Roche Diagnostics). RNA transcription of the templates was 
performed with labelling using digoxigenin-UTP by setting up of the reactions as below: 
10μl 5x transcription buffer (Roche Diagnostics) 
2.5μl 10x dig NTP mix 
5μl 100mM Dithiothreitol 
2μl RNase inhibitor 
3μl  T7 RNA polymerase 
0.5μg template DNA 
Top up to 50μl with DEPC-H2O 
The reaction was run at 37oC for 2 hours in a thermocycler and then 2μl of the reaction was 
run through a 1.5% agarose gel to check that the reaction had worked. The template DNA 
was destroyed by adding 1μl of DNase I to the reaction and incubating at 37oC before 
cleaning up with an ammonium acetate RNA precipitation. The probe was redissolved in 
DEPC-H2O and the concentration was quantified by Nanodrop® spectrophotometry (2.2.5).  
Wholemount in situ hybridisation was performed on embryos at 48hpf with cmlc2 and foxa3 
RNA probes that are expressed in cardiomyocytes and pan-endodermal tissue respectively. 
Fixed embryos were equilibrated into phosphate buffered saline (PBS) with 0.1% tween 20 
and then washed in PBS-T four times for 5 minutes each. The embryos were permeablised 
with a 10 minute treatment in 10μg/ml proteinase K and the reaction was stopped by two 
quick PBT washes and then a 30 minute refixation step in 4% paraformaldehyde at room 
temperature. The embryos were thoroughly washed in PBS-T to remove all PFA 5 times for 5 
minutes. Embryos were transferred to warm (65oC) hybridisation mix (HM) for 10 minutes 
before they were transferred to HM plus (HM+) which contained heparin and tDNA. After 2 
hours at 65oC the HM+ was replaced with fresh HM+ containing the 2μl each of the RNA 
probes, and hybridisation was performed overnight. 
The following day the embryos were washed twice for ten minutes in HM and then 
progressed through a gradient of 75%, 50%, 25%, 0% HM / 2x saline sodium citrate (SSC) 
buffer. Two longer washes of 30 minutes were then performed for 30 minutes in 0.2x SSC. 
The embryos were passed through into Tris buffered saline (TBS) with 0.1% tween 20 at 
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room temperature by 75%, 50%, 25%, 0% 0.2x SSC / TBS-T  gradient before being blocked in 
2% Roche block (Roche Diagnostics), 20% heat-treated lamb serum (Life Technologies®) at 
room temperature for 2 hours. The antibody incubation was performed overnight at 4oC 
using 1:5000 Anti-Digoxigenin-AP, Fab fragments (Roche Diagnostics) in blocking solution. 
The embryos were thoroughly washed in TBS-T over two days before they were developed. 
Development was performed using alkaline phosphatase buffer for 90 minutes at room 
temperature before washing thoroughly in PBS and then dehydration into 100% methanol. 
 
Hybridisation Mix: 
50% formamide 
5x SSC 
0.1% Tween 20 
Adjust pH to 6.0 with citric acid 
Dissolve in ddH2O 
 
Add 50μg/ml Heparin and 500μg/ml tRNA for HM+ 
 
20x SSC: 
3M NaCl 
0.3M Trisodium citrate 
Adjust pH to 7.0 with 1M HCl 
Dissolve in ddH2O 
 
Blocking Solution: 
10% Roche® Blocking solution 
20% heat-treated lamb serum 
70% TBS-T 
 
Alkaline phosphatase buffer: 
100mM Tris-HCl 
50mM MgCl2 
100mM NaCl 
0.1% Tween 20 
Dissolve in ddH2O 
 
  
MATERIALS AND METHODS 
85 
 
2.2.16 Densitometry 
Densitometry of DNA and protein bands was performed digitally on uploaded image files in 
the freeware program FIJI (http://fiji.sc/Fiji) by the methodology described here 
(http://lukemiller.org/index.php/2010/11/analyzing-gels-and-western-blots-with-image-j/). 
PCR gel images were saved as .tif files directly whereas western blot photographic films 
were scanned at 300 dpi resolution on a flatbed scanner (Epsom) and saved as .tif. The files 
were opened with FIJI and boxes were drawn around each band individually. The “Gels” 
tools were used to plot the intensity of each band and then the area under the peaks was 
quantified with the “wand” tool. Once quantified the band intensities could be compared 
statistically. 
 
2.2.17 Statistics 
All statistics were performed in the SPSS (Statistics Package for the Social Sciences) suite 
(IBM) and appropriate tests were chosen by use of the flowchart in the statistical guidebook 
by Ennos (2006) (Ennos, 2006). Due to comparisons between multiple groups it was most 
commonly appropriate for the use of one-way ANOVA tests which compare the variance 
within groups with that between groups. Where significant differences were detected the 2-
sided Dunnett post-hoc test was performed in order to determine which groups were 
significantly different. Significance was indicated on the graphs in this thesis by asterisks 
such that * is p<0.05, ** is p<0.01 and *** is p<0.001.  
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2.3 ZEBRAFISH HUSBANDRY, MORPHANT GENERATION AND 
SECTIONING 
2.3.1 Commonly Used Zebrafish Technique Reagents 
E3 Medium: 
5.0 mM NaCl 
0.17mM KCl 
0.33mM CaCl 
0.33mM MgSO 
Dissolve in 1L ddH2O and adjust to pH 7.0 with 1M NaOH 
 
E3 / PTU Medium: 
Add 0.2mM 1-phenyl-2-thiourea (PTU) to working E3. 
“Blue Water”: 
Add 2ml of 0.1% methylene blue to 1L aquarium tank water. 
Tricaine pH 7.0 (1 litre): 
4g Tricaine powder in 800ml ddH2O 
Adjust solution to pH 7 with 1M Tris-HCl 
Top-up to 1L with ddH2O 
 
 
2.3.2 Zebrafish Lines Used 
The husbandry of adult zebrafish was performed as described in Westerfield, 1995 and all 
procedures were performed under regulations of the Home Office (Westerfield, 1995). The 
AB wildtype line (Zebrafish International Resource Centre) was used for most experiments 
except where stated. The Tg(myl7:EGFP) line (Huang et al., 2003b) was used for fluorescent 
imaging of the heart. The Tg(myl7:EGFP) line has an enhanced green fluorescent protein 
sequence downstream of the cardiomyocyte-specific myosin light chain 7 promoter, and 
EGFP is expressed in the cell cytoplasm.  
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2.3.3 Breeding Strategy and Zygote Collection 
Adult fish were put-out the day prior to use in breeding traps such that male and female 
were separated. The following morning the adults were put-together and eggs fell to the 
bottom of the trap through a grid. Fertilised eggs were collected at fifteen minute intervals 
and washed with blue water prior to use.  
 
2.3.4 Embryo Culture Conditions 
Embryos were grown in plastic petri dishes of E3 media at 28.5oC in a fan incubator. 
Numbers of failed embryos were counted at 8hpf and 24hpf and these were removed. 
Media was replaced at 24hpf with fresh E3 or E3 / PTU when abolition of pigment 
development was required.  
 
2.3.5 Morpholino Protocols 
Start-site (AUG) translation-blocking Morpholino oligonucleotides for the jnk1a and jnk1b 
genes were designed by Gene-Tools®. These morpholinos overlapped the AUG translation 
start site of jnk1a or jnk1b which are found within exon 2 of the respective genes 
(Appendices Figure 63). 
Morpholino Sequence 
jnk1a 5' - CTCTCGCTTA TTTTTGTTCA TGGTG - 3' 
jnk1b 5' - CTTTCTCGCG CTTATTCCTG TTCAT - 3' 
Table 6 Morpholino sequences 
 
Upon arrival 2.5mg of each MO was dissolved in 300µl ddH2O and this master solution was 
kept frozen at -20oC and defrosted when working solutions of MO were required.  
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2.3.5.1 Morpholino Preparation 
Working solutions of MO were generated by thoroughly defrosting the master, and then 
heating to 60oC for 5 min before vigorous vortexing to ensure that the MO was well 
dissolved. A mix of master MO solution, ddH2O and phenol red (0.5%) was then produced to 
create the working solution, with the quantities required depending upon the final dose of 
morpholino that was desired.  
 
 1ng Dose 2ng Dose 3ng Dose 4ng Dose 6ng Dose 8ng Dose 
MO Conc. (µg/µl) 0.5 1.0 1.5 2.0 3.0 4.0 
Master MO Volume (µl) 1.2 2.4 3.6 4.8 7.2 9.6 
0.5% Phenol Red (µl) 2.0 2.0 2.0 2.0 2.0 2.0 
ddH2O (µl) 16.8 15.6 14.9 13.2 10.8 8.4 
Final Volume (µl) 20 20 20 20 20 20 
 
Phenol red was used in the working solutions in order to visualise the morpholino drops 
during the microinjection process. 
 
2.3.5.2 Microinjection 
Morpholinos were injected by glass capillary microneedle into the yolk sac at no later than 
the 4-cell stage (Nasevicius and Ekker, 2000). Microneedles were pulled from 1.2mm 
capillaries using a needle puller (Sutter Instrument Co) under the following conditions: 
Heat=635, Pull=50, Velocity=80, Time=200. Morpholino was rear-loaded and the end of the 
needle was snapped with fine watchmakers forceps. A 1mm graticule was used to measure 
droplet size of the morpholino injected into oil. A 160μm (2nl) droplet was achieved by 
using a Femtojet ® compressor (Eppendorf) with settings: 280 hPa injection pressure, 0.3 sec 
injection time and 17 hPa compensation pressure. The droplet size remained the same (2nl) 
regardless of morpholino dose, and instead the concentration of morpholino loaded was 
altered. Embryos were lined up against a slide and 2nl of morpholino was injected into each 
before embryos were placed in E3 in the incubator at 28.5oC. For compound jnk1a and jnk1b 
knockdown the morpholinos were injected as a mixture in the same needle to ensure equal 
dosing. Morpholino doses trialled: 
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2ng jnk1a 1ng jnk1b 1ng 1a; 1ng 1b 
3ng jnk1a 2ng jnk1b 2ng 1a; 1ng 1b 
4ng jnk1a 4ng jnk1b 1ng 1a; 2ng 1b 
6ng jnk1a  2ng 1a; 2ng 1b 
  4ng 1a; 4ng 1b 
 
2.3.6 Pronase Dechorionation 
Embryos were batch dechorionated in 2mg/ml pronase as in Westerfield et al. (Westerfield, 
1993). Approximately 50 embryos were added to 5ml pronase and incubated at 28.5oC for 1 
minute, before rinsing with 20ml E3 solution 3 times. Swirling of the petri-dish during 
washes helped to release the embryos from the chorions which could then be removed with 
a pipette. 
 
2.3.7 Anaesthetisation of Embryos and Microscopy 
Zebrafish embryos between 24-72hpf were anaesthetised in 0.2mg/ml Tricaine® for five 
minutes prior and during microscopy techniques. Embryos were allowed to recover for 5 
minutes in fresh E3 media before being returned to their petri dish. 
Embryos were imaged under anaesthesia using a dissection light microscope (Leica). The 
samples were orientated using fine watchmakers forceps on a layer of 1.5% agarose. For 
fluorescent images of the heart a fluorescent bulb was applied and samples were viewed 
under GFP filter. 
 
2.3.8 Schedule 1 Methods and Dissection of Adult Tissues 
For the purpose of dissection, adult fish were euthanized in 2mg/ml Tricaine® pH 7.0 for 10 
minutes. The heart, brain, testes, liver, and skeletal muscle were dissected from 4 month 
male zebrafish as per (Gupta and Mullins, 2010). Tissue was added to 0.5ml TRIzol and 
homogenised as in section 2.2.3. 
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2.3.9 Paraformaldehyde Fixation of Zebrafish Embryos 
All zebrafish embryos before 120hpf that were used for sectioning and in situ hybridisation 
were fixed in the same manner. Embryos were transferred to a sterile 20ml bijou tube and 
all E3 solution was removed. The embryos were then submerged in 2.5ml of chilled 4% 
paraformaldehyde / PBS and incubated overnight at 4oc. The following day the PFA was 
removed and embryos were equilibrated through a methanol (MeOH) gradient: 25% MeOH 
/ ddH2O, 50% MeOH/ddH2O, 75% MeOH/ddH2O and finally two replicates of 100% MeOH. 
Embryos were incubated in each solution for 5 minutes at room temperature, before it was 
replaced by the following solution. Once embryos were in 100% MeOH they were 
transferred to an Eppendorf tube in fresh MeOH and stored at -20oc until the tissue was 
used. 
 
2.3.10 Resin Sectioning 
Fixed and dehydrated embryos at the desired timepoints (48hpf and 72hpf) were washed 2x 
30 min in 100% ethanol before being transferred to the Technovit 8100 base solution 
(Electron Microscopy Sciences®). Once equilibration of 10 minutes was complete the 
embryos were moved into Hardner 1 solution and allowed to equilibrate for 1 hour at 4oC. 
The chemical hardening resin was made with the mixture of Hardener 1 and Hardener 2 as 
by the manufacturer’s guidelines and then plastic moulds were filled with this solution. Two 
zebrafish embryos were embedded into each resin block in different orientations (one for 
sagittal and one for coronal sections) by adding then to the plastic mould and orientating 
gently with a pipette tip. The resin was allowed to set briefly on the bench to prevent 
embryos rolling, and then transferred to the fridge surrounded in silica gel to set at 4oC for 
two days in a low humidity environment. 
Sections were cut from the blocks using a glass knife and rotary microtome at 5μm thickness 
and transferred to positively charged glass slides (Leica Biosystems®) and allowed to dry for 
four hours at room temperature. Lee’s Methylene Blue-Basic Fuchsin staining 
(http://www.ebsciences.com/staining/methyl_bl.htm) was performed in order to visualise 
the tissue. Slides were transferred to a rack and stained in batches of 20 at a time as below: 
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20 sec Methylene blue – basic fuchsin 
10 sec ddH2O 
10 sec 95% ethanol 
10 sec ddH2O 
 
Following the staining of the tissue the slides were allowed to dry overnight in the fume 
hood and then mounted using Histomount (National Diagnostics). Images were captured on 
an Axioplan compound microscope (Zeiss) and colour balanced in Adobe Photoshop® CS3. 
 
2.3.11 Jog / Loop Scoring 
In order to assess the zebrafish heart laterality of jnk1 morphants, heart position was 
assessed at two separate timepoints. Morphants were generated at various doses using 
wildtype strains and allowed to develop under normal conditions until 24hpf. At 24hpf the 
E3 media was switched to fresh media containing 0.2mM 1-phenyl 2-thiourea (PTU) which 
inhibits melanogenesis (Karlsson et al., 2001), ensuring that the transparency of embryos 
persisted.  At 28hpf the embryos were anaesthetised in E3 media containing 0.2mg/ml 
Tricaine for five minutes before jogging direction was scored. Fine watchmaker forceps were 
used on the chorion to manipulate each embryo, enabling visualisation of the heart from a 
ventral orientation (through the yolk sac). Jogging status was scored as left, right or midline 
depending on movement of the heart. As proposed by Chin et al. the heart was judged to 
have jogged if the angle formed between the anterior-posterior embryonic axis and linear 
heart tube was 5o or greater; deviation from the midline of less than 5o was considered to 
have not jogged, and scored as a midline heart. In the case of 4ng jnk1a and compound 4ng 
jnk1a; 4ng jnk1b morphants the heart displayed developmental delay. In these cases the 
jogging status was instead determined at 32hpf. Once scoring was complete the morphants 
were separated into different dishes of E3 / PTU depending on their jogging status and 
returned to the incubator. 
Looping of the heart was scored upon the same embryos that were examined for jogging. At 
48hpf the embryos were reanaesthetised in Tricaine-containing media for five minutes and 
then examined under a dissection light microscope. Forceps were again used to orientate 
the embryos (which remained in the chorion at this age) so that visualisation of the heart 
MATERIALS AND METHODS 
92 
 
could be made through the yolk. Looping status was scored by determining the relative 
position of the ventricle compared to the atrium. A D-loop was scored when the ventricle 
had moved to the right side of the atrium, whereas an L-loop was scored when the ventricle 
was present on the left. Where the ventricle remained midline with regard to the atrium it 
was considered that looping had failed to occur and these morphants were scored as O-
loops (see for Figure 46 schematic representation). 
 
2.3.12 Uncoupling Scoring 
The determination of whether morphants displayed uncoupling of heart tube movements 
was performed post-hoc on heart laterality data. Uncoupling was scored as being where the 
jogging status of the embryo was not predictive of the looping status i.e. where left jog did 
not result in D-loop, or where right jog did not result in L-loop. Since the looping status of 
those embryos that fail to jog cannot be predicted (Chin et al., 2000) as looping direction 
appears to be random, this group was discounted from the analysis. 
 
 93 
 
 
 
 
 
 
 
 
 
CHAPTER 3 - BIOINFORMATIC AND GENE 
EXPRESSION ANALYSIS OF ZEBRAFISH JNK1 
BIOINFORMATIC AND GENE EXPRESSION  
ANALYSIS OF ZEBRAFISH JNK1 
94 
 
3.1  INTRODUCTION 
Evidence has shown that zebrafish have two paralogs of the JNK1 gene (jnk1a and jnk1b) 
which may have arisen during the teleost genome duplication event. However, to date there 
have been no publications examining the different transcripts that arise from these two 
genes nor comparisons to the mammalian JNK1 genes which are more well studied. 
Automated predictions of jnk1 splice-variants suggests that several of the variants observed 
in human may also be translated from the zebrafish genes (www.ENSEMBL.org), however 
each gene may be capable of transcribing only a subset of the full human splice-variant 
compliment (See Figure 12). To determine whether the zebrafish is a comparable genetic 
model for human JNK function it is important to characterise the variants which are 
produced in zebrafish. 
In addition, the expression pattern of the jnk1 genes in zebrafish is limited to the gene or 
protein level, and these studies were produced when only a single zebrafish jnk1 gene was 
identified (Krens et al., 2006b, Xiao et al., 2013). However, evidence in human cell lines has 
shown that the different splice-variants have different affinities to downstream effectors, 
and putatively different function (Gupta et al., 1996). If there are indeed functional 
differences between jnk1 splice-variants then this may be reflected in the expression 
pattern of each variant. Examination of splice-specific expression over development and 
within different tissue types could therefore provide further evidence of functional 
differences in between the jnk1 transripts. 
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3.1.1  Aims of the Chapter 
 
The aim of this chapter was to expand upon what is known about the zebrafish jnk1 
paralogs, their different splice variants, and their expression patterns. In order to do this 
there were several objectives: 
1. Identify whether the predicted, core jnk1 transcripts do exist in zebrafish, and obtain 
accurate sequences for them in the AB zebrafish strain.  
2. Determine to what degree the splice-variants differ in sequence and identify any 
regions of high conservation or divergence in the sequence. 
3. Compare the zebrafish jnk1 sequences to their orthologs. 
4. Determine whether it is possible to investigate the specific expression patterns of 
individual splice-variants. 
5. Characterise the expression pattern of jnk1a and jnk1b over development and in adult 
tissues. 
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3.2 RESULTS 
3.2.1 Proposed New Model of ZF jnk1 Splice Variants 
The current model of zebrafish jnk1 splice-variants comes from the ENSEMBL predictive 
pipeline (http://www.ensembl.org) which has annotated the raw genomic sequence of the 
Tübingen line using published protein and cDNA/EST alignments. To achieve the aims of this 
project it is necessary to have accurate sequences of the jnk1 paralogs from which reagents 
can be designed e.g. primers. However, use of the wildtype strain in our lab (AB) meant that 
differences in sequence were likely to be present between the genomes of our animals and 
the animals sequenced by the Zebrafish Genome Project. The first experiment conducted 
was therefore to obtain accurate, full-length sequences from the AB line from which primers 
and morpholinos could be designed. To this end primers were designed that were capable 
of pulling out the full-length splice variants of jnk1a and jnk1b. 
 
3.2.1.1 Primer Design  
Despite there being a total of nine predicted splice-variants shared between the jnk1 
paralogs (Figure 12), evidence for only four full-length variants has been published (Seo et 
al., 2010, Keightley et al., 2013, 2010) i.e. jnk1a-001 and -002, jnk1b-001 and -002. To 
maximise the chance of successfully pulling out jnk1 splice-variants I therefore decided to 
target only those that had published full-length sequences to support their existence 
(Figure 14). Those variants targeted were jnk1a-001 and -002 and jnk1b-001 and -002. 
Once the target variants had been identified, primers were designed that were capable of 
pulling out the full-length sequences (for more detail see section 2.2.8). Two primer pairs 
were designed, one per paralog, where the forward primers overlapped the ATG “START” 
codon, and the reverse primers overlapped the “STOP” codon of the longest variant (see 
appendices Figure 57). For both paralogs of jnk1, only a single primer pair was necessary to 
pull out both predicted splice-variants (See Figure 14).  
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3.2.1.2 Sub-Cloning of Full-Length jnk1 Transcripts 
Tissue from 40 whole AB strain embryos was collected at 72hpf, and RNA extraction was 
conducted via use of TRIzol® reagent via phase separation. cDNA was prepared from 2 μg of 
RNA using the Superscript III kit (Life Technologies) which synthesises full-length cDNA 
transcripts through the use of dT primers. Full-length cDNA transcripts were T-cloned into 
the pGEM-T Easy plasmid (Promega) via T4 ligase and transformed and cultured in DH5α 
competent cells for 16 hours at 37oC. Colony PCR using the same full-length primers 
confirmed the presence of ~1.2kb inserts in a majority of the colonies, and those positive for 
an insert were re-picked and grown up for 16 hours in liquid culture. Plasmid was retrieved 
through the use of a “Mini-Prep Kit” column (QIAgen) and then sent for forward and reverse 
Sanger sequencing (GATC Biotech). 
 
3.2.2 The Identification of Two Unpredicted jnk1a Transcripts 
The full-length sequencing data that was obtained from this experiment confirmed that the 
two full-length jnk1a variants targeted (-001 and -002) had been sub-cloned successfully. 
These two variants were 1284bp long, consisting of a single ORF, and integrated either exon 
7 or exon 8 into the sequence (Figure 17 jnk1a_7;long and 8;long). However, two additional 
and novel jnk1a variants were also present. These previously unpredicted variants 
integrated either exon 7 or exon 8 into the sequence, however, the ORF of these variants 
ended 129bp sooner into the sequence. The discrepancy in length between the long and 
short splice-variants arose from the presence of an alternative splice acceptor site in exon 
13. The two splice-acceptor sites were separated by only 5bps but resulted in a frame-shift 
that introduced a STOP codon much sooner in the sequence (Appendix Figure 58). 
 
3.2.3 The Identification of Exon 7 jnk1b and Two Unpredicted Transcripts 
Analysis of the full-length jnk1b sequences revealed the successful sub-cloning of the two 
targeted splice-variants (-001 and -002). As predicted by the ENSEMBL pipeline the ORF of 
variant -001 was 132bp shorter than -002. This variation was caused by the use of an 
alternative splice-acceptor site, which resulted in the inclusion of an extra 5bp of the final 
exon, resulting in a frame shift (Appendix Figure 59). Both variants also contained a 72bp 
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region in the middle of the sequence which was predicted to arise from the exon 
homologous to exon 8 jnk1a. However, two additional variants were also discovered in the 
sequencing data which had not been previously characterised in zebrafish. These variants 
were similar to variants -001 and -002 in that the length of the reading frame was 1155bp or 
1287bp respectively, however, the two novel variants differed in the sequence contributed 
by the middle exon. These novel variants contained a 72bp sequence in the middle of the 
sequence that shared only 67% sequence identity to the putative exon 8 (Figure 19C). I 
therefore theorised that this sequence arose from an unidentified exon of jnk1b which was 
integrated into the splice-variants in a mutually exclusive manner; this is the same scenario 
that is observed in jnk1a. 
In order to determine whether the novel 72bp of sequence within the jnk1b splice variants 
arose from an annotative error by the ENSEMBL pipeline I aligned the sequence to the raw 
(unannotated) genomic DNA of jnk1b (www.ENSEMBL.org). This 72bp sequence does indeed 
exist within the jnk1b gene data, in a region annotated as being intron 6-7. This novel exon 
is therefore likely to be the seventh exon of the jnk1b gene which has not been correctly 
annotated. Every exon following exon 7 must therefore increase in number by one. From 
this sequencing data I was able to construct a new model for the splice-variants of the 
zebrafish jnk1 paralogs (Figure 17) where each paralog gives rise to four unique splice-
variants that differ in both length and middle exon usage. 
To ensure that the sequences obtained from this experiment were correct I repeated this 
cloning methodology and obtained the same results. This replicate was performed using 
different cDNA samples, a separate PCR reaction and all fresh reagents. Sequencing results 
came back identically proving that all of the sequencing data was correct, and no 
amplification errors had been introduced. 
 
3.2.4 Overview of the Updated Model of Zebrafish jnk1 Splice-Variants  
Discovery of novel splice-variants from both jnk1 paralogs has made it necessary to propose 
a new model of jnk1 transcription. The proposed model consists of four unique splice-
variants per paralog which differ in two regions: the middle exon, and length of the ORF 
(Figure 17). These transcripts represent the variants that I have gained experimental 
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evidence for, however, there may also exist 2-3 shorter transcripts per paralog which have 
been predicted by the ENSEMBL pipeline. I chose not to investigate these variants because 
there is no full-length sequence data to support their existence in the literature, some are 
not protein coding, or are produced from incomplete sequencing data. These variants may 
exist but are left out of my working model because they have not been experimentally 
verified. 
In addition to the model I also proposed a different naming convention for the eight 
variants. The current nomenclature are complex and non-descriptive, so for the purpose of 
this thesis I have decided upon an alternative naming convention. As mentioned above, 
each jnk1 splice-variant differs at only two locations: middle exon (use of either exon 7 or 
exon 8) and the 3’ splice acceptor site (changing the length of the transcript). I have used 
these two features to name each variant (Table 7) e.g. jnk1a_7;short refers to the splice 
variant of jnk1a that contains exon 7 and uses the upstream splice-acceptor of exon 13,  
causing an earlier STOP codon. This table also contains the nomenclature which is used 
upon the ENSEMBL database for reference. 
 
Paralog 
Middle Exon 
Usage 
OFR 
Length 
(bp) 
Naming Convention 
ENSEMBL 
Nomenclature 
jnk1a 
7 1155 jnk1a_7;short unidentified  
7 1284 jnk1a_7;long -002 
8 1155 jnk1a_8;short  unidentified 
8 1284 jnk1a_8;long -001 / -201 
  
jnk1b 
7 1155 jnk1b_7;short  unidentified 
7 1287 jnk1b_7;long  unidentified 
8 1155 jnk1b_8;short -001 
8 1287 jnk1b_8;long -002 
Table 7 Proposed New Naming Convention of the Core jnk1 Splice -Variants. 
Due to the non-descriptive naming convention of the ENSEMBL pipeline I 
propose a naming convention of the jnk1 splice-variants that reflects the 
structure of the transcript. This convention enables easy determination of which 
splicing events have occurred in each variant.  
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Figure 17 A New Model of the Experimentally Proven Splice-Variants of zebrafish jnk1.  
Both jnk1 paralogs contain thirteen exons, of which twelve can contribute to the coding sequence. Above the 
exons are numbered and the transcripts are represented below. Length of each box r epresents how much of 
the exon contributes to the CDS of the splice variant. Alternative exons are shown in light and dark shades 
with UTR in white. Each paralog has four splice -variants that differ depending on which middle exon (7 or 8) 
they use and how much of exon 13 contributes to the CDS.  
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3.2.5  Conservation and Divergence of the two Zebrafish jnk1 Parforms 
Once full-length sequences of both paralogs were obtained I used in silico methods to 
determine how closely conserved the sequences were. The two jnk1 paralogs are likely to 
have arisen from the teleost genome duplication event (Taylor et al., 2001), meaning that 
they arose from a common ancestral gene. Genetic drift will have introduced changes into 
the sequence, however regions critical to function may have experienced selective 
pressures ensuring that they are conserved. Most duplicated genes in the teleost genome 
have lost one of the redundant copies and where both copies do remain it is theorised that 
the paralogs may have different, although possibly overlapping, functions or be 
differentially expressed (Force et al., 1999, Howe et al., 2013). If this is the case within the 
jnk1 paralogs then identifying where the differences in sequence occur could help to predict 
what functional changes have evolved. 
 
3.2.5.1 Sequence Identity is Strongly Conserved between ZF Jnk1 Protein 
Sequences in the Region of the Protein Kinase Domain 
At the level of the DNA there is a considerable amount of divergence in sequence between 
the two paralogs, with only 81.5% sequence identity conserved (Figure 18A, appendix Figure 
60). Furthermore, the changes seem to be shared equally through the sequence without any 
long stretches with high conservation. From this result, all that can be concluded is that that 
the two sequences have changed considerably since their divergence and that the changes 
are spread throughout the DNA sequence. 
Examining these paralogs at the protein level is more informative since multiple codons 
code for the same amino acid. I therefore repeated the alignments but instead used 
translations from the DNA sequence. The result of this alignment shows that the two 
paralogs are indeed very highly conserved (91.6%), particularly within the protein kinase 
domain (Figure 18B+C) which contains the ATP binding domain and the TXY phosphorylation 
site (both conserved). Within the protein kinase domain there are on average 4.7 changes 
per 100 amino acids whereas outside this domain there are 16.5 changes per 100 amino 
acids. Such high conservation within the kinase domain suggests that kinase function is 
conserved between the two paralogs and that any functional changes that are present are 
due to motifs outside of the protein kinase domain. Unfortunately, predictive software was 
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unable to identify functional domains outside of the kinase domain so it is not possible to 
identify exactly what effect these changes have by in silico methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.5.2 Sequence Divergence in the Middle Exon  
Identification of the new splice-variants for both jnk1 paralogs shows that the two paralogs 
are more similar to one another than has been predicted by the ENSEMBL pipeline. The two 
paralogs have the same number of exons, and each produces variants that differ by the 
middle exon usage, and by length. To confirm that the newly identified middle exon of jnk1b 
is indeed homologous to jnk1a exon 7 I ran sequence alignments between both middle 
exons of each paralog to determine which were most similar. Alignment supports the theory 
that the novel jnk1b exon is homologous to jnk1a exon 7 as they share far greater sequence 
identity (89%) to one another than to exon 8 (Figure 19A). The differences that do exist 
between the middle exons (resulting in amino acid changes) largely avoid the major region 
Figure 18 Sequence Alignments between the Zebrafish jnk1 Paralogs DNA and 
Protein Sequences.  
Schematic representation of sequence alignments between jnk1a and jnk1b, 
where white represents a mismatch. A) At the DNA level, many sequence changes 
are present between the two paralogs and sequence identity is 81.5%. B) At the 
protein level there is far more concordance between the sequences, with a 
percentage identity of 91.6%. C) The region with least conservation is at the 3’ 
end of the sequences and lies outside of the protein kinase domain.  
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of secondary structure – a helix (Figure 19B) – and instead fall within the random coil region. 
The low frequency of amino acid changes within the region of secondary structure suggests 
that this structure may be important for protein function, and that function between the 
transcripts may be well conserved. 
 
 
 
 
 
3.2.5.3 Sequence Conservation at the 3’ Alternative Splicing Acceptor 
The 3’ splicing event results from the use of an alternative splice acceptor site in exon 13 of 
jnk1. The two alternative splice acceptor sites are 5bp apart (Figure 19D) but results in a 
frameshift which drastically changes the mRNA: use of the downstream acceptor increases 
the RNA length by 129bp (appendix Figure 58 and Figure 59). Alignment of the 3’ splicing 
event shows that the sequence is identical in both paralogs of jnk1 where the two splicing 
Figure 19 Sequence Alignments at the Region of the Splicing Events.  
A) Nucleotide alignment of the middle exons of jnk1. B) Amino acid alignment of 
the middle exon with predicted secondary structure schematic below.  Helix 
(green), beta-sheet (orange), random coil (black line). C) Table displaying the 
quantitative alignment results between the middle exons of both jnk1 paralogs. D) 
Nucleotide alignment of 3’ splicing event. For all text -based alignments black is 
100% identity (4/4), gray is identity between half the sequences (2/4) and white is 
residue lacking identity to the other sequences.  
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acceptors reside (Figure 19D). The only differences in the sequence that do occur are several 
nucleotides upstream or downstream of the splicing sites in exon 12 of the paralogs. 
 
3.2.6 Sequence Conservation of Zebrafish jnk1 and its Orthologs 
Due to the lack of experimental work performed on zebrafish jnk1 when I started this 
project I searched the literature for homologous jnk1 genes as a way to predict the function 
and expression of the paralogs. Now that I have full length sequences for both jnk1 paralogs 
I am able to gauge whether this was a valid methodology in a post-hoc test for similarity in 
protein sequence. I therefore performed pair-wise sequence alignments on the protein 
sequences of the zebrafish jnk1 genes and orthologous sequences that are published within 
Uniprot; the higher the sequence identity the more likely that function of the proteins will 
be conserved. Protein sequences were compared because this bypasses the issue of silent 
basepair changes that code for the same amino acid.  
Whereas Drosophila melanogaster contains only a single Jnk homologue known as basket, 
vertebrates have three forms of the protein. Comparison of the two zebrafish Jnk1 proteins 
to their orthologs showed how well conserved the proteins are between very distant 
species – basket shares 76% identity with human JNK1 (Table 8). This conservation is even 
higher between the vertebrates and human JNK1; the two zebrafish paralogs share over 
85% homology with human JNK1.  
 
 
 
 
 
 
 
 
Table 8 Percentage Identity of the ZF Jnk1 Paralogs and their Orthologs.  
Sequence alignment of orthologous Jnk1 proteins shows high conservation of the 
protein between species. The zebrafish versions are marked in red. These data 
show that there is greater than 85% of the sequence conserved between 
zebrafish and human JNK1.  
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                                                                                  <-------------------------------------------  
CAEEL  1   MEERLSTTSSYPSHPGRSVEEDHNTLLASSSISSIIRGTRGHLNNFIESVGNWLVPSSSGNLRLIGSGAQGIVCSAFDTVRNEQVAIKKLSRPFQNVTHAKRAYRELKLMSLVNHKNIIG 
DROME     1   ------------------------------------------------------------NLRPIGSGAQGIVCAAYDTITQQNVAIKKLSRPFQNVTHAKRAYREFKLMKLVNHKNIIG 
XENLA    1   ------------------------------------------------------------NLKPIGSGAQGIVCAAFDAVLERHVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 
CHICK   1   ------------------------------------------------------------NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 
HUMAN    1   ------------------------------------------------------------NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 
MOUSE    1   ------------------------------------------------------------NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 
jnk1a_BRARE 1   ------------------------------------------------------------NLRPIGSGAQGIVCSAYDNNLERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 
jnk1b_BRARE   1   ------------------------------------------------------------NLRPIGSGAQGIVCSAYDHVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 
                         ATP binding domain 
 
 
      -------------------------------------------------PROTEIN KINASE DOMAIN-------------------------------------------------- 
CAEEL    181 ILNCFTPQKKLDEFNDLYIVMELMDANLCQVIQMDLDHERLSYLLYQMLCGIRHLHSAGIIHRDLKPSNIVVRSDCTLKILDFGLARTAIEAFMMTPYVVTRYYRAPEVILGMGYKENVD 
DROME       86 LLNAFTPQRNLEEFQDVYLVMELMDANLCQVIQMDLDHDRMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKADCTLKILDFGLARTAGTTFMMTPYVVTRYYRAPEVILGMGYTENVD 
XENLA      88 LLNVFTPQKSLEEFQDLYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 
CHICK    88 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 
HUMAN      88 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 
MOUSE      88 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 
jnk1a_BRARE   88 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERLSYLLYQMLCGIKHLHAAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAATGLLMTPYVVTRYYRAPEVILGMGYQANVD 
jnk1b_BRARE  88 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERLSYLLYQMLCGIKHLHAAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAATGLLMTPYVVTRYYRAPEVILGMGYQANVD 
                             ***  
                    Thr/Tyr 
      -------------> 
CAEEL    301 VWSIGCIFGELIRGRVLFPGGDHIDQWTRIIEQLGTPDRSFLERLQPTVRNYVENRPRYQATPFEVLFSDNMFPMTADSS-RLTGAQARDLLSRMLVIDPERRISVDDALRHPYVNVWFD 
DROME     206 IWSVGCIMGEMIRGGVLFPGTDHIDQWNKIIEQLGTPSPSFMQRLQPTVRNYVENRPRYTGYSFDRLFPDGLFPNDNNQNSRRKASDARNLLSKMLVIDPEQRISVDEALKHEYINVWYD 
XENLA    208 IWSVGCILGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCTEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN-KLKASQARDLLSKMLVIDASKRISVDDALQHPYINVWYD 
CHICK   208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN-KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 
HUMAN    208 LWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN-KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 
MOUSE    208 LWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN-KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 
jnk1a_BRARE   208 IWSVGCILAEMVRHKILFPGRDYIDQWNKVIEQLGTPTQEFLLKLNQSVRTYVENRPRYTGYSFEKLFPDVLFPADSEHS-KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 
jnk1b_BRARE   208 IWAVGCIMAEMVRHKILFPGRDYIDQWNKVIEQLGTPSQEFMMKLNQSVRTYVENRPRYAGYSFEKLFPDVLFPADSDHN-KLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 
 
 
 
CAEEL    420 EIEVYAPPPLPYDHNMDV-EQNVDSWREHIFRELTDYARTHDIYS---------------------------------------------------------- 
DROME     326 AEEVDAPAPEPYDHSVDEREHTVEQWKELIYEEVMDYEAHNTNNRTR-------------------------------------------------------- 
XENLA    327 PLEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVLDWEERAKNGVIRGQPAPLGAAVTDGSQAHT-S-SSSGDASSMSTDPTLPSDTDSSLETSAGTLGCCR- 
CHICK   327 PSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEERTKNGVIRGQPAPLAQVQQ--------------------------------------------- 
HUMAN    327 PSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEERTKNGVIRGQPSPLGAAVINGSQHPS-SSSSVNDVSSMSTDPTLASDTDSSLEAAAGPLGCCR- 
MOUSE    327 PSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEERTKNGVIRGQPSPLAQVQQ--------------------------------------------- 
jnk1a_BRARE 327 PAEVEAPSPLITDKQLDEREHTVEEWKELIYKEVLDWEERMKNGVIRGQPSPLGAAVINGSPQPS-SSSSINDVSSMSTEPTVASDTDSSLEASAGPLSCCR* 
jnk1b_BRARE 327 PSEVEAPPPAITDKQLDEREHSVEEWKELIYKEVLEWEERTKNGVIRGQPASLGAAVSSDSHEPSTSSSSINDVSSMSTEVTLTSDTDSSQETSNGALHCCR* 
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3.2.7 Differential Expression Patterns of the jnk1 Splice-Variants During 
Development 
Having identified eight different splice-variants that are produced by the two zebrafish jnk1 
paralogs I wanted to determine if they showed different expression patterns during 
development. In order to achieve this it was necessary to design primers that were capable 
of distinguishing between the eight different variants. As the variants within the same 
paralog differ in only two locations (the middle exon and the 3’ splicing acceptor) these sites 
were the only places where isoforms-specific primers could be targeted (Figure 16A). 
Primer design for amplification of only one of the eight identified jnk1 splice-variants was 
complex because of the strong sequence homology between multiple variants. However, by 
aligning these sequences it was possible to identify sites of greatest divergence, and the 
most robust primers possible were designed as described in the methods section (See 
section 2.2.11 page 73). These eight primer pairs were then rigorously validated to ensure 
that each was specific to only a single jnk1 splice-variant. 
 
  
Figure 20 Sequence Alignment of the Zebrafish Jnk1 Proteins to their 
Orthologs. 
The Jnk1 protein sequences are well conserved between species, particularly 
within the protein kinase domain. The ATP binding domain (red) and 
Thr/Tyr phosphorylation sites (***) are conserved between all species. 
Conserved amino acids highlighted black, conservation of charge between 
≥50% sequences highlighted grey. jnk1a= translated sequence of 
jnk1a_7;long, jnk1b= translated sequence of jnk1b_7;long, all other 
sequences from UniProt: CAEEL (Q8WQG9), DROME (P92208), XENLA 
(Q8QHK8), CHICK (E1C1H4), HUMAN (P45983), MOUSE (Q91Y86). 
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3.2.7.1 Optimisation of RT-PCR Melting Temperature 
In order to ensure high specificity of the splice-variant specific RT-PCRs I began by optimising 
the melting temperature of each primer pair PCR. The aim was to determine the highest 
melting temperature possible that still allowed primer annealing and yielded high amplicon 
abundance from cDNA. The PCR reactions were performed under the standard conditions 
(see section 2.2.12 page 78) except that a temperature gradient between 62-70oC was 
utilised over five reactions. The products were run out on a 2% agarose gel side-by side to 
determine when melting temperature became too restrictive to allow amplification. A 
positive control (1ng plasmid DNA at 62oc annealing) and negative (water replacing 
template DNA) control were also included. 
The amplicon abundance when using jnk1a primers was reduced when a 66oc Tm was used 
compared to 64oc; by 68oc no product was seen in the wells (Figure 22A). In contrast there 
were still very strong bands visible at 66oc when using jnk1b primers (Figure 22B). Using 
these optimised conditions I decided to perform subsequent splice-variant specific RT-PCRs 
at 64oc when using jnk1a primers and 66oc when using jnk1b primers. 
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Figure 22 Melting Temperature Optimisation of Splice-
Variant Specific Primers.  
Temperature gradient RT-PCR on cDNA to determine how high 
melting temperature could be before becoming restrictive. A) 
jnk1a primers. Positive control is 1ng jnk1a_7;long in pGEM-T 
Easy at 62oc Tm. B) jnk1b primers. Positive control is 1ng 
jnk1b_7;long in pGEM-T Easy at 62oc Tm. All reactions 
performed for 30 cycles and 10μl loaded into 2% agarose gel.  
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3.2.7.2 Testing Primer Specificity 
The design of eight primer combinations each capable of amplifying a single jnk1 splice-
variant was complex. Multiple sequence alignments showed that there were between four 
and six mismatches between the forward primers, and between one and six mismatches 
between the reverse primers and unintended targets (see Table 5). In order to confirm that 
the eight primer sets were each capable of picking out a single jnk1 splice variant I 
performed multiple PCR reactions. A PCR master mix sufficient for 4.5 reactions was made 
containing one of the four jnk1a primer pairs and split between four different tubes before 
template cDNA was added to each tube separately. Template for the reaction was 1ng of 
one of the four full-length jnk1a variants sub-cloned into the pGEM-T Easy plasmid. The 
PCRs were then conducted under the optimised conditions and products were run side-by-
side on an agarose gel. This method was then repeated for the jnk1b templates using the 
jnk1b primers. From this experiment I expected to see that when the primer combinations 
matched that of the template DNA there was amplification, however when primers did not 
match up, no amplification occurred. If amplification was seen when primers did not match 
the target DNA then this would have shown that the primers were not variant-specific. 
However, this experiment did prove primer specificity since PCR amplification was only 
achieved when the template DNA and the primer sets matched up (Figure 23). When other 
primer combinations were used, there was no amplification.  
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Figure 23 The Splice-Variant Primers are Specific to 
only a Single Transcript.  
Parallel RT-PCR reactions of each jnk1 splice-variant 
with different primer pairs of the same jnk1 paralog. A) 
jnk1a variants with jnk1a primers. B) jnk1b variants 
with jnk1b primers. In both panels amplification is only 
seen when the primer set matches exactly the splice -
variant. Each PCR is 1ng template in plasmid, 35x cycles, 
20μl loaded per well and ran out on 2% agarose gel.  
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3.2.7.3 Expression Patterns of jnk1 Splice-Variants during Development 
Once the variant-specific jnk1 primers had been shown to be specific and the PCR conditions 
had been optimised, they were used to determine what the expression pattern of different 
jnk1 variants was during development. In total nine different developmental time-points 
were analysed which spanned both critical, early developmental processes, and late, 
broader time-points (Table 9). 
For splice-variant specific PCRs a master mix sufficient for 47 reactions was made without 
primers or template DNA before being split between nine tubes. To each of the nine tubes 
was added cDNA from a different developmental timepoint (50ng / reaction) and then each 
of these tubes were split (18μl per PCR well) between a further 5 wells of a PCR plate (45 
reactions total). The forward and reverse jnk1a primers and the housekeeping control 
primers (elfa1) were added to each tube individually such that the final plate contained 5 
replicates of the developmental time series PCR each with a different jnk1a primer pair, or 
elfa1 control primer pair. The housekeeping gene elfa1 was chosen because it has been 
shown to have very stable expression levels during development and between different 
tissue types (McCurley and Callard, 2008). This experiment was repeated on cDNA 
generated from three different AB clutches and each band was scored for its intensity, 
before the experiment was repeated with jnk1b primers with an elfa1 control. The average 
and SEM of the intensities were then plotted against hours post fertilisation. 
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Timepoint 
(hpf) Importance 
0 
Maternal 
inheritance 
4 Zygotic expression 
5.25 Start of gastrulation 
12 
Kupffer's vesicle 
stage 
19 
Lateral plate 
mesoderm  
24 
Heart field fused / 
heartbeat 
48 
Heart movements 
completed 
72 Mid-larval stage 
120 Late-larval stage 
 
Table 9 Importance of the Timepoints Chosen for RT-PCR 
 
From the developmental series PCRs of jnk1a splice-variants it was clear that jnk1a_7;short 
was maternally inherited but that band intensity decreased over the next 12 hours until the 
transcript could not be picked up (Figure 24A). Expression of jnk1a_7;short does not return 
until around 24hpf and peaks at 72hpf. When the experiment was finished at 120hpf the 
expression still remained high. Similarly the variant jnk1a_7;long is maternally inherited but 
drops to zero by 12hpf (Figure 24A). Expression is present but very low at 24hpf but peaks at 
72hpf as can be seen on the graph of band intensity (Figure 24B). The expression of 
jnk1a_7;long appears to drop off by 120hpf which is a situation also observed in the other 
exon 7 containing variant. 
The expression pattern of the exon 8 containing jnk1a genes appears very distinct from 
those that contain exon 7. jnk1a_8;short has its highest abundance within the first 5 ½ hours 
of development, before settling to a low but consistent abundance during the other 
timepoints (Figure 24A). A very similar pattern is seen for jnk1a_8;long as maternal 
inheritance is very high and this high level drops over the next 5 ½ hours before becoming 
very low by 12hpf. After 12hpf the abundance remains low but constant until 5 days post 
fertilisation (Figure 24B). 
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The expression patterns of the jnk1b variants over development seem to closely resemble 
those of jnk1a. The variant jnk1b_7;short is inherited in small abundance but by 12hpf no 
transcript can be picked up (Figure 24C). Expression is once again seen by 48hpf and 
remains constant until 120hpf. The other exon 7 containing variant of jnk1b (jnk1b_7;long) 
is also weakly inherited and levels drop to zero by 12hpf. Similarly this expression is seen 
again at 48hpf and over the next two days remains fairly constant (Figure 24D). The exon 8 
containing jnk1b variants have similar expression patterns to one another. jnk1b_8;short is 
highly maternally inherited but abundance drops over the next 12 hours and remains at low 
levels. Similarly the jnk1b_8;long transcript is high at early timepoints but by 12hpf is at a 
low, baseline level until 120hpf (Figure 24D). 
These data seem to suggest segregation in the expression pattern of the jnk1 splice-variants 
based upon middle-exon usage. The expression of the exon 7 containing jnk1a variants is 
low initially but high expression is seen during 48-120hpf. Interestingly this result is mirrored 
in the jnk1b variants that contain exon 7 only reach high expression during late 
development. The exon 8 containing variants of both paralogs contrast this pattern because 
they are most strong at early timepoints before falling to baseline levels by 12hpf. These 
results suggest that the variants are needed at different times in development. 
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Figure 24 Expression Patterns of the jnk1 Splice-Variants During Development.  
A) Representative RT-PCR agarose images of the jnk1a splice-variant expression pattern over development. B) Graph 
of semi-quantitative data of band intensity of variants obtained over three replicates. C) Representative RT -PCR data 
of jnk1b expression patterns over development. D) Semi -quantitative graph of band intensity of jnk1b variants over 
three replicates. 
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3.2.8 Differential Expression Patterns of the jnk1 Splice Variants in 
Adult Tissues 
To examine which tissue types the different jnk1 splice-variants were expressed in, 
young adult zebrafish at 4 months of age were sacrificed and dissected to obtain the 
necessary tissue. Young adults were chosen for this experiment to ensure that the 
results represented the endogenous expression of jnk1 in healthy tissue. Being a 
“stress activated” protein kinase, JNK1 has been shown to have upregulated 
expression in response to disease (Migheli et al., 1997, MagiGalluzzi et al., 1997, Li et 
al., 1998) as well as other cellular stresses (Lo et al., 1996); therefore young, healthy 
adults were selected to avoid any underlying cellular stresses. Dissected tissue was 
immediately processed for RNA extraction and cDNA generation under standard 
methods. 
Splice-specific jnk1 RT-PCRs were performed to determine the expression of each of 
the variants in different adult tissue. A master mix suitable for 26 reactions was 
produced with the absence of primers and template cDNA before being split between 
5 eppendorf tubes. Each tissue specific cDNA was added to a different tube and then 
18μl of each mix was pipetted to a PCR tube. The five different primer pairs 
(jnk1a_7;short, 7;long, 8;short, 8;long, Elfa1) were added directly to the PCR tubes and 
then the PCRs were run at the optimised annealing temperatures (see 2.2.4.3). 
 
3.2.8.1  Exon 7 Containing Variants are Predominantly Restricted to 
the Brain 
Splice-variants of jnk1a which contain exon 7 were primarily restricted to the brain 
(Figure 25A) although the testes also showed low levels of jnk1a_7;short. This pattern 
was also observed in the jnk1b variants. Both jnk1b_7;short and jnk1b_7;long showed 
very high expression within the brain, however no expression was observed in other 
tissue types (Figure 22). 
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3.2.8.2  Exon 8 Containing Variants are Expressed Fairly Ubiquitously 
Exon 8 containing variants appeared to have a much broader pattern of expression 
than those containing exon 7. Both the short and long forms of jnk1a that contained 
exon 8 were expressed in heart, skeletal muscle, testes and the brain. Expression was 
highest in the testes with moderate expression levels in the other tissues (Figure 25A). 
The jnk1b variants that contain exon 8 were also expressed in the heart, skeletal 
muscle, testes and brain (Figure 25B), although expression was fairly equal in all of 
these tissues. There was also weak expression of both jnk1b_8;short and jnk1b_8;long 
in the liver, although band intensity was several fold weaker than in other tissues. 
 
 
 
3.2.9 Comparison of jnk1 Expression in Zebrafish, Human and Mouse 
Adult Tissue 
The expression levels of both zebrafish jnk1 genes were estimated by semi-
quantitative RT-PCR, which provided estimates of how strongly each jnk1 transcript 
was expressed in five different tissue types. However, it is also possible to compare 
this zebrafish tissue-specific expression with mouse and human level expression. This 
analysis was carried out to answer two questions, firstly to see whether the tissue-
specific expression patterns of the zebrafish jnk1 genes matched those of other species 
and so strengthen the case for zebrafish as a model of human JNK1, and secondly to 
determine whether the differences observed in expression between jnk1a and jnk1b 
Figure 25 RT-PCR Expression of jnk1 Splice-Variants in Adult Tissues.  
A) jnk1a splice-variants B) jnk1b splice-variants. The housekeeping gene 
elfa1 is used as a loading control. H heart, Sk skeletal muscle, T testes, L liver, 
B brain 
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meant that one of these genes more closely matched the expression patterns of the 
single vertebrate JNK1 gene. 
Gene expression data for both mouse and human tissues was taken from the European 
Bioinformatics Institute Expression Atlas (https://www.ebi.ac.uk/gxa). This freely-
accessible database compiles information from microarray and RNA-seq experiments 
in order to detail the relative expression levels of each gene in different tissues of the 
adult and embryo. From this database I was able to find six studies of human adult 
tissue which included JNK1 expression and six studies of mouse adult tissue including 
Jnk1. However, two of the studies in mouse had to be discounted during analysis due 
to too few tissue types being represented to make a reliable estimation of Jnk1 
expression levels (see section 2.1.7 on page 59). The levels of JNK1 expression were 
compared between the heart, skeletal muscle, testis, liver and brain in order to 
determine whether the relative expression in each tissue was high, medium or low. 
Similarly, densitometry was performed over the four zebrafish jnk1a and jnk1b genes 
in order to determine their relative expression in each tissue. The results revealed that 
by this measure of gene expression, both zebrafish jnk1a and jnk1b genes are 
expressed at levels similar to the mouse and human in the tissues examined. 
 
 
  
Table 10 Relative tissue-specific expression levels of zebrafish 
jnk1a and jnk1b, mouse Jnk1 and human JNK1 genes. 
A comparisson of the expression patterns as determined by 
densitometry of RT-PCR data in the zebrafish (n=3) and analysis of 
multiple RNA-seq studies in the mouse (n=4) and human (n=6) reveals 
similarities and differences between JNK1 expression in the tissues of 
these species. 
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A comparison of the tissue-specific expression patterns of the jnk1a, jnk1b, Jnk1 and 
JNK1 genes revealed that throughout these species there was similar expression 
patterns conserved in these tissues, although some differences were observed. The 
expression of these genes was low or medium in the heart, low or medium in the 
skeletal muscle, medium or high in the testes, low or medium in the liver and medium 
or high in the brain. There were no instances where low gene expression in one species 
contrasted with high expression in that tissue in a different species. Some conflicts in 
expression level did arise however, such as where jnk1a, jnk1b and Jnk1 had medium 
expression in the skeletal muscle whereas human JNK1 was lowly expressed and where 
low liver expression was found in jnk1a and jnk1b compared to low to medium 
expression in Jnk1 and JNK1. These differences may reveal real changes in gene 
expression between species or be an artefact of the qualitative method of 
measurement used. 
The relative expression levels of the zebrafish jnk1a and jnk1b genes differed in the 
heart and testis. In the heart the jnk1a level was low to medium whereas the jnk1b 
level was medium. In this instance the jnk1a level was more similar to that of human 
JNK1 where low expression was displayed in the heart. In the testis jnk1a was medium 
to high whereas jnk1b had medium expression. In this case the jnk1a expression level 
again matched more closely with what was observed in human JNK1 where medium to 
high expression was found. However, it is important to note that the jnk1a level did 
not always exactly match that found in human JNK1 such as in the skeletal muscle 
where jnk1a was expressed at a medium level compared to low expression of human 
JNK1. In summation these data have provided an interesting comparison of JNK1 gene 
expression between zebrafish, mouse and human, but require further experimental 
validation for more exact comparisons to be made. 
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3.3 DISCUSSION 
In this chapter I designed primers capable of pulling out full-length jnk1 splice-variants 
and discovered four novel variants that had not been predicted by the ENSEMBL 
pipeline. Using in silico techniques the sequences were then compared to determine 
whether functional domains were conserved and where in the sequences the variants 
differed from one another. Further analysis of protein sequences revealed that the 
zebrafish Jnk1 sequences are highly consistent with human and mouse orthologs, and 
that all orthologs have conserved the functional domains of the proteins. Primers were 
then designed to bind specifically to each variant and PCR conditions were optimised 
to ensure specificity. Finally the expression patterns of the individual jnk1 splice 
variants were determined during development of the zebrafish embryo and in 
different adult tissues. 
A large proportion of the research that deals with the JNK family genes do not 
differentiate between the JNK family members (JNK1, 2 or 3) - particularly where the 
methods include small molecule inhibitors that effect all forms. This means that it is 
impossible to differentiate between the individual roles of each JNK family gene, 
despite evidence that in several organisms the genes have non-overlapping expression 
patterns (Kuan et al., 1999, Yamanaka et al., 2002). However, a further level of 
complexity is introduced to the function of JNK when the different splice-variants are 
taken into consideration. In humans the four core variants of JNK1, which differ in 
middle exon and length, were shown to exist in 1996 (Gupta et al., 1996). I have been 
able to show that these four variants also exist within zebrafish jnk1a and jnk1b which 
had not previously been predicted. The conservation of four different variants for both 
paralogs is likely to represent important functional properties that each variant 
possesses. Despite this there are very few papers that take individual splice-variants 
into consideration. In this investigation I have been able to characterise the individual 
transcripts of zebrafish jnk1 in detail, as well as determine their individual expression 
patterns. 
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3.3.1 Identification of Novel Splice-Variants 
3.3.1.1 The ZF jnk1 Paralogs are Highly Similar to One Another and 
their Orthologs 
The discovery of an additional splice acceptor in jnk1a, and the missing exon 7 within 
jnk1b has revealed that the two jnk1 paralogs are more similar than was previously 
thought. Both zebrafish paralogs have thirteen exons, many of which are of identical 
length, and both contain two middle exons that are used in a mutually exclusive 
manner. In addition, both genes give rise to four splice-variants that have homologous 
variants in human JNK1. The implications of this discovery are significant for future 
research into the jnk1 genes both in terms of function designation to each variant and 
when using zebrafish to model human genetics. Since the “core” four variants have 
been conserved between teleosts and humans it is reasonable to conclude that some 
selective pressure must exists to ensure that each of the transcripts are maintained. 
One possible reason for this conservation would be that each variant has a different 
functional role, however, no evidence has been published to show this in JNK1. 
However, it has been shown that middle exon usage of JNK1 causes different binding 
affinity to downstream transcription factors (Gupta et al., 1996). 
The fact that orthologs of the core JNK1 variants exist in zebrafish suggests that it may 
be a good genetic model for understanding human JNK1 function. Zebrafish have 
proved a powerful model for genetic modelling due to their rapid generation time, 
multiple developed forward genetic techniques, and their robustness to survive 
significant insult during development. However the existence of two jnk1 paralogs in 
zebrafish may undermine their use as a genetic model since there is only a single 
human JNK1 gene. If the zebrafish jnk1 genes have gained function which the human 
ortholog does not possess then the two genes would not be directly comparable. 
However, if the function of JNK1 is instead shared between the two jnk1 paralogs, then 
zebrafish may prove more powerful than other models which possess only one gene. 
With different facets of JNK1 function shared between two genes it would be possible 
to examine certain functions of the gene without perturbing all function. Further study 
is required to determine the validity of zebrafish as a human JNK1 model, however, 
this project has begun the process. 
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These data have greatly increased what we know about zebrafish jnk1, proving the 
existence of several ENSMBL splice-variant predictions, as well as discovering several 
unpredicted forms. The methodology used to gain these sequences also meant that 
upon discovery, the sequences were cloned into plasmid vectors and could be used for 
downstream procedures such as generation of RNA for rescue experiments. However 
there are certain limitations to the methodology that was used, primarily since the 
primers were not capable of amplifying all predicted splice-variants. 
The primers that were ordered for this project were designed to bind at the start and 
end of the longest predicted splice-variants. A quirk of the splicing events of the jnk1 
paralogs meant that one primer set was able to pull out multiple transcripts. However, 
the ENSEMBL pipeline predicted the existence of three jnk1a and two jnk1b variants 
which these primers were not capable of amplifying. The choice to target the 
transcripts which had experimental evidence to support their existence was made to 
maximise the chance of successfully cloning full-length jnk1 transcripts. Targeting a 
transcript which did not exist by this RT-PCR methodology would have had significant 
time and financial burdens associated with it because no amplification would occur; in 
this scenario it would be impossible to determine whether the absence of 
amplification was due to a problem with the PCR conditions, problems with the 
primers, the transcript not being expressed at that timepoint or tissue type, or 
whether the transcript simply did not exist. Multiple condition optimisations and 
primer redesigns would be required to say with any certainty that a transcript does not 
exist. An alternative method that would be able to target all predicted variants (as well 
as possible unpredicted ones) is rapid amplification of cDNA ends (RACE). 5’ and 3’ 
RACE have advantages over standard RT-PCR because multiple targets with 
significantly different sequences at their ends can be amplified with a single gene-
specific primer. It would therefore be possible to determine whether the jnk1b 
transcripts -003 and -201 (Figure 12) exist which are predicted to differ only at the 3’ 
end. The major disadvantage to this method is that full-length transcripts cannot be 
cloned without further steps, something that was particularly important in this project. 
Therefore, although it is a viable method for proving the existence of transcripts it is 
not as efficient at generating full-length sequences as standard RT-PCR. 
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3.3.2  Bioinformatical Analysis 
3.3.2.1 The jnk1 Paralogs Differ Most in Sequence Outside of the 
Protein Kinase Domain 
I have shown that despite arising from a common ancestor the two jnk1 paralogs 
contain a surprisingly large number of basepair changes to one another (Figure 18). 
However, the majority of these changes are silent and percentage identity of the 
amino acid sequence is over 90%. The region of greatest amino acid conservation is 
within the protein kinase domain, suggesting that both paralogs are capable of 
functioning as a MAPK. Changes outside of this domain mostly cluster downstream of 
the 3’ splicing event, and therefore reside only in the long paralogs. Since no functional 
domains are known to be present in this region it is not possible to predict what 
functional consequences that these changes might cause. Furthermore, no x-ray 
crystallographic data of the long variant exists, so I cannot ascertain what consequence 
to 3-D structure these changes will cause.  
The two middle exons are used in a mutually exclusive manner and result in amino acid 
changes to the protein. Examination of secondary structure produced by the middle 
exons with Jalview software reveals that the middle exon contributes to a coil and 
short sheet structure (Figure 19B). Interestingly the majority of changes that occur 
between exon 7 and exon 8 of jnk1 reside outside of these regions that produce 
secondary structure, and instead fall within a region of random coils. X-ray 
crystallographic data for zebrafish Jnk1 is not available, however the human JNK1 data 
can be found on the Protein Data Bank (www.rcsb.org/pdb). This data provides a 3-D 
structure of the protein that helps to illustrate how the protein folds. From the 3-D 
rendering of the human protein I was able to identify the region of the protein which 
arises from exon 7 or exon 8 (Figure 26). The helical structure that forms from the 
middle exon contribution runs through the centre of the JNK1 molecule, whereas the 
random coiled region lies at the surface of the molecule. Since the majority of amino 
acid differences that exist between the two zebrafish middle exons reside outside of 
the helix it is unlikely that these changes will affect the secondary or tertiary shape of 
the molecule. Instead the changes exist in the random coiled region, and are likely 
found at the surface of the protein, where they may interact with other molecules. 
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This finding supports the experimental evidence that exists in human JNK1 which 
shows that the isoforms containing either exon 7  or exon 8 have different binding 
abilities to downstream transcription factors (Gupta et al., 1996). 
 
 
 
 
 
 
 
 
 
 
  
A B Figure 26 Structural 3-D Model of the JNK1 Protein Shows the 
Location of the Middle Exon Within the Structure.  
A) Tube rendering of human JNK1 displaying beta-sheets (orange) and 
helices (green) within the protein. The amino acids that originate from 
the middle exon sequence are coloured yellow. The contribution of the 
middle exon to a helix (arrow) and random coil (arrow head) are 
highlighted. B) Space fill rendering of human JNK1 showing the location 
within the protein of the helix (arrow) and random coil (arrowhead) 
that arise from the middle exon. X-ray crystalographic data obtained 
from www.rcsb.org/pdb ref no. 2XRW_A.  
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3.3.2.2 Strong Conservation to Homologous Sequences Suggest 
Function is Preserved 
I have shown that there is a high level of conservation between the zebrafish jnk1 
paralogs and their orthologs in other vertebrates. Since the majority of work on JNK1 
has been conducted on mouse or using human cell lines, this result is important as it 
means that results in these species are probably also relevant to the zebrafish. 
Ortholog information has been invaluable in this investigation to determine predictive 
expression and functional properties of zebrafish jnk1. More importantly though this 
result suggests that findings within zebrafish may be translatable to human. Modelling 
Jnk1 knockout in the mouse has provided underwhelming results because only very 
mild, behavioural changes were seen (Reinecke et al., 2013) due to compensation by 
Jnk2 (Kuan et al., 1999). The mild phenotype is not recapitulated in other species 
though such as in Xenopus where convergent extension defects develop (Yamanaka et 
al., 2002) and Drosophila where gut chirality becomes randomised (Taniguchi et al., 
2007). Now that zebrafish have been shown to possess splice-variants homologous to 
the four core variants seen in human JNK1 they represent a good candidate for 
modelling JNK1 function in the human. It will be very interesting whether deficiency of 
the jnk1 paralogs in zebrafish cause mild defects (as in mouse) or severe defects (as in 
Xenopus). 
 
3.3.3 jnk1 Expression Analysis 
Previously published expression data for the zebrafish jnk1 genes have been 
contradictory and often incomplete. To address this issue I conducted splice-variant 
specific RT-PCRs throughout development and in adult tissues.  I have shown that 
despite all variants being maternally inherited, there is clearly a differential expression 
pattern between variants incorporating different middle exons. Splice-variants 
incorporating exon 8 are most abundantly expressed during early development before 
settling to a baseline level. Exon 7 variants by contrast are weakly expressed early on, 
but become strongly expressed by larval stages (Figure 24).  
The differential expression of individual splice-variants over development is likely to be 
a highly regulated process that is controlled by transcription factor binding to the jnk1 
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gene, although to date no known transcription factors have been identified that up or 
downregulate the expression of individual splice-variants of zebrafish jnk1 or one of its 
orthologs. It would therefore be very interesting to perform analysis of transcription 
factor binding (e.g. chromatin immunoprecipitation) as a method of cataloguing which 
transcription factors bind to the jnk1 genes which may lead on to analysis of splice-
specific expression regulation; overexpression of these transcription factors within cell 
lines could possibly identify which transcription factors differentially affect jnk1 splice-
variant expression. 
 
 
3.3.3.1 Differential Expression of Exon 8 Containing Splice-Variants 
Switch May Coincide with Proliferation Changes 
The differential expression patterns of different jnk1a and jnk1b splice-variants during 
development are probably representative of what developmental processes are 
occurring at these time-points. Although no data for functional differences in the 
zebrafish variants has been published, some evidence may be available from the 
human JNK1 ortholog. The 1996 paper by Gupta et al. investigated the individual 
splice-variants of the ten human splice-variants that arise from JNK1, JNK2, and JNK3 
(Gupta et al., 1996). In addition they examined the binding efficiency of different 
splice-variants to three downstream transcription factors – ATF2, c-JUN and ELK-1 – by 
glutathione-agarose pull down assay. 
In Gupta et al. (1996) the binding affinity of human JNK1 splice-variants to C-JUN was 
found to differ depending upon which “middle-exon” was used in the transcript. These 
results demonstrated that the exon 8 containing variants of JNK1 bound preferentially 
to C-JUN with barely any binding with exon 7 containing variants (Gupta et al., 1996). 
These data therefore suggest that exon 8 containing JNK1 transcripts may be more 
important in regulating cell proliferation since C-JUN has been shown to be important 
for proliferation and progression through G1-phase (Wisdom et al., 1999, Angel and 
Karin, 1991). Such a function would seem to fit with the differential expression pattern 
that has been found for zebrafish exon 8 containing variants of jnk1. Exon 8 containing 
variants are expressed most highly during early development when proliferation rates 
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in the embryo are also high, however expression drops after about 12 hours down to 
baseline. A detailed analysis of proliferation during early development would be a 
logical step to determine whether these rates correlate with the expression of exon 8 
containing jnk1. Furthermore by overexpressing these exon 8 containing variants 
during development we would expect to see an increase in cell proliferation. These 
experiments could help to elucidate a splice-variant specific role for jnk1 during 
development. 
 
3.3.3.2 Differential Expression of Exon 7 Containing Splice Variants 
Coincides with Brain Development 
Exon 7 containing jnk1 variants are maternally inherited and then show highest 
expression during late developmental time-points (24-72hpf). In adult tissue the exon 
7 containing variants are found highly in the brain and very rarely in other tissues that 
were studied. These data suggest that exon 7 jnk1 transcripts are important in neural 
tissue. This hypothesis would fit with the change that is observed during late 
development because exon 7 containing variants are expressed highly during late 
development when brain development in occurring. However, this does not explain 
why these variants are maternally inherited. It may therefore be that exon 7 
containing variants possess other functions during these very early developmental 
timepoints that cannot be answered here. It would be interesting to knockdown and 
overexpress different splice-variants individually in order to determine what role each 
variant had. However, since much of the sequence is identical between different 
splice-variants it may be that such knockdowns would be compensated by other 
transcripts. 
 
3.3.3.3  RT-PCR is Limited by being a Semi-Quantitative Measure of 
Gene Expression 
The use of RT-PCR as a method of measuring splice-variant abundance has greatly 
increased what is known about the expression patterns of jnk1 during development, 
and in different tissue types. However, RT-PCR is a technique that measures mRNA 
abundance in a semi-quantitative manner and therefore does not fully quantify 
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expression levels. The use of RT-PCR was decided upon because of the restrictions of 
where primers can be designed to pick out individual splice-variants. The four variants 
that have been shown to exist per paralog differ in only two place: the middle exon 
and the 3’ splice-acceptor site. These two regions are therefore the only places that 
primers can be designed to which will make them specific to a single splice-variant. The 
two regions where primers have been designed to are ~500bp apart, a distance which 
is much too large to amplify with quantitative real-time PCR (qPCR). To remain efficient 
the amplicon of qPCR is typically 50-100bp in length, therefore this was not an option 
in this experiment. Furthermore, the use of in situ hybridisation to stain tissues that 
express an individual splice-variant during development was also not a viable option. 
The riboprobes used during in situ hybridisation are typically between 500 to >1000bp 
in length and must be significantly unique to the target mRNA so that they do not bind 
off target. Since the different splice-variants of a single jnk1 paralog can differ by as 
little as 5bp, this method of examining expression patterns would be very unlikely to 
produce specific results. 
When measuring the mRNA expression patterns of a particular gene, the main goal is 
most often to estimate the abundance of protein that that cell / embryo is producing 
at that timepoint; mRNA is measured as an indirect measure of protein abundance. 
However, it has been observed that often mRNA expression levels do not equate to 
total protein abundance (Tian et al., 2004, Vogel et al., 2010), so where possible it is 
better to measure protein levels directly. In the case of zebrafish jnk1 there are no 
commercially available antibodies which can distinguish between jnk1, 2 or 3 at the 
time of writing. This lack of specific antibodies was problematic for proving morpholino 
knockdown later in the project, and also meant that measuring splice-variant specific 
protein levels was unachievable with conventional immunoblotting techniques. A 
possible method that could be used is 2D gel electrophoresis followed by mass 
spectrometry which could identify different splice-variants and estimate the 
abundance within the sample. However, this process is considerably more time 
consuming than RT-PCR and requires specialist equipment. Since protein quantification 
of the different jnk1 splice variants was not the major priority of this project it was felt 
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that the additional information gained over RT-PCR did not justify the additional time 
and cost. 
 
3.3.3.4 Evidence of Tissue-Specific Gene Expression Pattern 
Conservation between Zebrafish, Mouse and Human 
In order to compare the tissue-specific jnk1 expression patterns that were observed in 
zebrafish with the mouse and human, data from the EBI Expression Atlas were 
compiled (https://www.ebi.ac.uk/gxa). These levels of gene expression in each tissue 
were then compared against the zebrafish tissue levels that were found by the sum of 
expression of each splice-variant. The comparison revealed that expression levels in 
those tissues examined were well conserved between zebrafish, mouse and human, 
and no tissues had low expression for JNK1 in a species where high levels were 
reported in another species. This result is supportive of a conserved function between 
the zebrafish genes (jnk1a and jnk1b) and the mammalian genes where only a single 
copy is present (Jnk1 or JNK1). Of the differences that were observed the greatest 
differences were found in the heart and skeletal muscle (see Table 10). In the heart 
human JNK1 was expressed at low levels compared to low/medium expression in 
jnk1a, and medium expression in jnk1b and mouse Jnk1. In the skeletal muscle low 
human JNK1 levels were contrary to medium expression of jnk1a, jnk1b and Jnk1. 
These differences could represent a genuine difference in expression level between 
species or be an artefact of the qualitative nature of this study. I believe that further 
evidence is therefore necessary before a definitive difference in expression is 
concluded. 
When comparing the tissue-specific expression of the two zebrafish jnk1 genes to 
human JNK1 it appeared that zebrafish jnk1a was a closer match to human expression 
than jnk1b (Table 10). In both heart and the testis where jnk1a and jnk1b expression 
levels were different from one another, the jnk1a level was closer to human JNK1. This 
result may suggest that of the two zebrafish jnk1 genes the one which is more similar 
to the human gene is jnk1a. However, caution is necessary firstly due to the qualitative 
nature of the test, and also because the zebrafish jnk1a levels did not always closely 
match human JNK1 in all tissues (e.g. in the skeletal muscle). I therefore believe that a 
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side-by-side experimental measure of tissue-specific expression is required before this 
conclusion can be reached. However, this test provides the first indication of similar 
tissue-specific expression patterns between zebrafish and human JNK1 genes. 
 
3.3.3.5 Concluding Remarks 
These data have achieved the aims of this chapter by proving the existence of and 
characterising several jnk1 splice-variants in the zebrafish genetic model. Furthermore 
the expression patterns of these variants have been show in a semi-quantitative 
manner through development and in different adult tissues. In addition, preliminary 
evidence of conserved tissue-specific gene expression has been demonstrated 
between zebrafish, mouse and human. These data can now be used in the design of 
morpholino oligonucleotides to specifically knockdown the zebrafish jnk1 genes, as 
well as attempt a rescue of the knockdown by overexpression of these splice-variants. 
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4.1 INTRODUCTION 
4.1.1 The Role of jnk1 During Development 
As has been previously stated in the introduction, the role of c-Jun N-terminal Kinase 
during development is poorly understood. In Drosophila melanogaster the loss of the 
single JNK ortholog basket (bsk) results in failure of dorsal closure as well as gut 
laterality defects (Taniguchi et al., 2007, Martin-Blanco et al., 1998). In Xenopus loss of 
jnk1 has been linked with convergent extension defects, although this result was not 
recapitulated when zebrafish jnk1a and jnk1b were knocked down by splice modifying 
morpholinos (Kim and Han, 2005, Seo et al., 2010). In a mouse knockout system for 
Jnk1, only mild behavioural defects were demonstrated (Reinecke et al., 2013). The 
relatively mild nature of defects caused by loss of JNK1 in the zebrafish and mouse are 
surprising considering how many processes that the JNK genes have been associated 
with. Furthermore, loss of the major downsteam gene Jun causes embryonic lethality 
with cardiac and hepatic defects (Eferl et al., 1999, Hilberg et al., 1993). It appears 
therefore that the JNK genes have some overlapping function and are capable of 
compensating for loss of one another. Evidence for this comes from mouse where loss 
of a single JNK gene can be tolerated but the JNK1-/- JNK2-/- compound geneotype is 
lethal due to a failure to close the neural tube and hepatic apoptosis (Kuan et al., 
1999). 
Due to the considerable confusion about the role of JNK1 during development I 
decided to investigate jnk1 loss in the zebrafish. As I have shown in the previous 
chapter the two jnk1 paralogs are strongly expressed during development, although 
the splice-variant usage changes during the first five days of development. In order to 
affect the loss of jnk1 I used a morpholino oligonucleotide antisense method which can 
be delivered to every cell of the developing embryo. I then studied the phenotypic 
effects of jnk1 loss by various imaging techniques. 
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4.1.2 Morpholino Oligonucleotides 
4.1.2.1 Morpholino Oligonucleotides Represent an Efficient and 
Specific Anti-Sense Reagent to Knock Down Gene Products 
The ability to knock down the protein product of a gene efficiently and specifically has 
been sought through several iterations of anti-sense technology e.g. RNase-H 
dependent knockdown, siRNA, morpholinos. However, these approaches have often 
been problematic due to cell toxicity and off-target effects (Summerton, 2007). 
Morpholino oligonucleotides (MO) have surpassed earlier technologies because their 
morpholino backbone is resistant to RNase activity and their design as 25-mer chains 
ensures very high sequence specificity compared to other technologies (Summerton 
and Weller, 1997a).  
Morpholinos act by binding to the target mRNA in the cytosol and preventing the 
translation of the correct protein product. In the case of translation-blocking MOs this 
is achieved by binding at, or up to 80bp upstream, of the AUG start site (www.gene-
tools.com). Following binding of the morpholino the ribosome complex is not capable 
of forming on the mRNA and therefore translation of the gene is blocked. Splice 
modifying MOs overlap an intron-exon or exon-intron boundary of the pre- / pri-mRNA 
of interest. Binding of the morpholino prevents correct splicing of the molecule and 
results in either exon skipping or intron inclusion to the mature mRNA. Splice 
modifying MOs are designed to produce non-functional and / or truncated protein 
products following the translation of the modified mRNA (www.gene-tools.com).  
Morpholino oligonucleotides have many advantages as a reverse genetic approach to 
study gene function, and have been a popular technology within the zebrafish 
community. They are readily soluble, have low toxicity and have been shown to be 
target-specific between 1-10µM concentration ranges, resulting in up to 85% in-cell 
protein inhibition (Summerton et al., 1997). In zebrafish they are commonly 
administered directly into the yolk sac before the 8-cell stage by microinjection and are 
shuttled into the cells by microtubule bridges (Shestopalov and Chen, 2010). Injection 
of MOs at this early stage ensures that each cell of the developing embryo is treated 
and allows for results to be generated immediately instead of having to wait 4-5 
months for animals to reach sexual maturity when heterozygous mutants are created. 
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Furthermore, the injection of morpholinos later in development has been utilised to 
knockdown genes in specific tissue types (Wang et al., 2011). Since MOs are not 
degraded by RNases they remain at working concentrations in the embryo until they 
are diluted sufficiently by subsequent mitotic cell divisions, for zebrafish this is at 
around three days after fertilisation (Summerton et al., 1997). In zebrafish this is 
sufficient time for development of all the major organs and is around the time that 
hatching will occur (Kimmel et al., 1995). These features of MOs, as well as the ease of 
microinjection into the large zebrafish embryo, has made the morpholino a popular 
reagent for genetic studies in zebrafish development. 
 
4.1.2.2  Limitations of Morpholino Oligonucleotides 
As with all technologies, MOs have been shown to have limitations and unintended 
effects that must be overcome for them to provide insight into gene function. One 
limitation of MOs experiments is that they are a dose-dependent reagent and that 
there can be very large variance in the morphant phenotype over a dose range. This 
dosing effect, or MO penetrance, means that when new morpholinos are developed it 
is necessary to trial several different doses, and observe the phenotype generated by 
each dose, in order to gauge an effective dose. This problem is further complicated if 
the morpholino causes off-target effects at doses close to the effective dose 
(Heasman, 2002).  
Despite initial reports showing that morpholinos were capable of recapitulating the 
phenotype of N-ethyl-N-nitrosourea generated mutants in 6/6 (Lele et al., 1999) and 
5/5 (Nasevicius and Ekker, 2000) cases, the ability for MOs to phenocopy mutants has 
recently been brought into question. A report by Kok et al (2015) examined fourteen 
MOs previously implicated in causing vascular or lymphatic developmental defects and 
added several novel morpholinos directed at genes that were known to be involved in 
these processes. Of the 24 genes studied, only three of the morpholinos were 
reportedly able to recapitulate the phenotype generated when the authors made a 
mutant with one of either zinc finger nucleases, transcription activator-like effector 
nucleases (TALEN), or clustered regularly interspaced short palindromic repeats 
(CRISPR) reverse genetic techniques (Kok et al., 2015). Such poor correlation between 
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techniques for gene knockdown and knockout are worrying, although a recent 
examination of this issue has provided a possible explanation for the poor correlation 
between the two technologies. Rossi et al. (2015) compared the gene expression 
patterns of zebrafish when two genes (egfl7 and vegfaa) were targeted with 
morpholinos or TALEN / CRISPR genome editing (Rossi et al., 2015). In those mutants 
that did not correlate phenotypically to the morphants it was shown that there was 
upregulation of related genes that the authors claimed could compensate for egfl7 or 
vegfaa loss-of-function. Interestingly these related genes were not upregulated in the 
morphants or in a CRISPR mutant whose phenotype correlated with the morphant. 
Whether genetic compensation via the upregulation of related genes explains the 
discordance between observed mutant and morphant phenotypes remains to be seen, 
and more research is required. However, these publications highlight the need for 
caution when inferring the function of a gene if only one technology is used. 
Off-target effects have plagued the knockdown technologies, and strictly defined they 
relate to any phenotype that occurs via binding of the antisense molecule to a 
transcript other than the target gene. Such off-target effects have been claimed to be 
caused by as many as 15-20% of morpholinos (Eisen and Smith, 2008) although 
empirical evidence to support this claim has not been demonstrated. However 
throughout the history of morpholinos, and the different controls that have been 
implemented in MO experiments, the term “off-target effects” has been used to 
describe phenotypic effects that a) are not replicated in the knockout genetic mutant, 
b) are not replicated by a second, non-overlapping morpholino or c) are not resolved 
by the overexpression of a MO-resistant mRNA in a so-called mRNA rescue experiment 
(Kok et al., 2015, Baden et al., 2007, Eisen and Smith, 2008). Considering the lack of 
correlation between mutants and morphants, and the difficulty of rescue experiments, 
I believe that it is not possible to definitively call a phenotype off-target unless the 
transcript being aberrantly knocked down is identified, and through targeted 
disruption and rescue it is shown that this is the gene responsible for causing the 
phenotype. Despite this difficulty in identifying actual off-target phenotypes caused by 
morpholinos, several groups have provided convincing evidence for non-specific MO 
phenotypes, or morpholino toxicity. 
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 In two instances where MO toxicity was reported the presentation was early 
developmental arrest and gastrula-stage defects in sea urchin (Coffman et al., 2004), 
and as a narrowing of the hindbrain and midbrain ventricles in zebrafish (Wright et al., 
2004). It has also been shown that MO use can cause dark clouding of the CNS and 
failure for the eyes to develop as well as curling of the somites from their normal 
chevron shape into a “U-shape” (Gerety and Wilkinson, 2011). These phenotypes have 
been associated with the upregulation of p53 and an increase in apoptosis within the 
developing CNS and trunk of the embryo. Interestingly, in morphants where clouding 
and increased apoptosis is observed this can be rescued via co-injection of a p53 MO 
(Robu et al., 2007). This technique has been suggested as a way of confirming that 
morphant phenotypes are created via a non-specific or toxic mechanism (Eisen and 
Smith, 2008), however it cannot be used as a control where gene knockdown is 
predicted to increase apoptosis or alter p53 expression. In zebrafish where cytochrome 
c oxidase is knocked down via translation and splice-blocking morpholinos there is an 
increase in apoptosis in the body, including the CNS, which cannot be rescued by p53 
MO co-injection (Baden et al., 2007). These data highlight the need for robust controls 
to be designed into MO experiments to ensure that observed phenotypes are not the 
result of off-target or non-specific effects. 
 
4.1.2.3 Suitable Controls and Validation of MO Experiments 
Suitable controls for morpholino experiments are imperative for the correct 
interpretation of data and validation of results, particularly considering the recent 
reports of failure for MOs to recapitulate the mutant phenotype (KOK, 2015 AND 
ROSSI, 2015). Although the type and rigor of controls differs in morpholino 
experiments, each integrated control can add confidence in the generated results. 
In addition to the gene-of-interest knockdown groups that are to be studied, each 
morpholino experiment should include an appropriate control group which can be 
used as a comparison. This control should be a morpholino administered in the same 
way, but that is not predicted to target endogenous mRNA, and therefore will cause no 
affect within the embryo. Control morpholinos (CMOs) take two common forms, either 
a standard control morpholino which is available from Gene-Tools™ and is specific to 
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human β-globin pre-mRNA, or a MO with identical sequence to the experimental MO 
except for the introduction of five evenly spaced basepair mismatches. These 5 
mismatches have been reported to be sufficient to prevent MO binding to its target 
(ADD GENE-TOOLS WEBSITE TO REF)(Eisen and Smith, 2008). Both controls should be 
ineffectual in the embryo, but provide a more commensurate control than inclusion of 
only an uninjected group of animals. 
When novel morpholino oligonucleotides are developed it is imperative to determine 
whether the MO is knocking down the target gene. In the case of splice-blocking 
morpholinos this is often simple to do with the use of reverse transcription PCR which 
is capable of demonstrating that the mRNA transcript length is truncated or elongated 
when MO is added (Eisen and Smith, 2008). However, when translation-blocking MOs 
are used there is no observable change to the mRNA, and it is therefore necessary to 
demonstrate the change of protein abundance. If an appropriate antibody is available 
then this may be conducted through a standard western blot, however where no 
suitable antibody exists then it may be necessary to create a tagged protein (Eisen and 
Smith, 2008). Through molecular cloning it is possible to tag a transcript with a 
sequence that codes for a protein tag. When mRNA coding for this fusion protein is 
injected into the embryo then MO binding affinity for this transcript can be measured, 
However, it does not provide a clear measure of affinity for the MO to the endogenous 
gene, since the injected mRNA may have a different abundance or accessibility to the 
MO than the endogenous gene product. 
In several publications where morpholino toxicity has been observed in the zebrafish, 
some consistency in phenotype is observed. Morphants present with dark clouding in 
the usually transparent tissue, particularly in the brain, have small or undeveloped 
eyes, and rounded somites (Gerety and Wilkinson, 2011, Robu et al., 2007). These 
phenotypes appear to be associated with upregulation of p53 throughout the embryo, 
and these non-specific effects can be rescued with p53 MO co-injection (Robu et al., 
2007). It is therefore recommended that p53 co-injection is conducted if these 
phenotypes are observed as a means of validating an off-target mechanism underlying 
the phenotype. However, as discussed in the previous section, this technique is not 
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compatible with knockdowns whose on-target effects alter p53 or apoptosis in the 
embryo. 
A method that has been utilised to validate that morpholino oligonucleotides are 
acting through specific binding to the gene of interest is to recapitulate the phenotype 
with a second, non-overlapping morpholino. The rational is that since MO off-target 
effects appear to be sequence specific (Eisen and Smith, 2008) then use of a second 
morpholino targeted to the same gene but with a completely different sequence 
would be very unlikely to also bind to the same off-target transcripts. If the second 
morpholino phenocopies the first then the validation of the phenotypes being caused 
by loss of the gene-of-interest is strengthened. Although this is a good method by 
which to provide evidence that the morpholino acts “on-target” it does not show it 
conclusively, and is likely to be challenged if the morphant phenotype does not match 
that of a mutant. 
Until recently, the gold standard control for identifying off-target activity of MOs was 
to produce a mRNA rescue (Eisen and Smith, 2008). Overexpression of MO-resistant 
mRNA (containing silent mutations at the MO binding site) has been shown to rescue 
the phenotypic defects observed when morpholinos are used to knock down gene 
function (Wang et al., 2011, Little and Mullins, 2005), thus providing evidence that the 
morphant phenotype is caused by knockdown of the target gene specifically. However, 
this methodology can be difficult, and often results in only partial rescue of the 
phenotype (Wang et al., 2011). The over-expression of an artificially introduced mRNA 
in every cell of the developing embryo is unlikely to closely recapitulate the temporal 
and spatial expression of your gene of interest, and may itself cause novel 
developmental defects (Sumanas et al., 2001). In addition, where partial rescue is 
observed the phenotypes that are not rescued may still be due to off-target binding of 
the morpholino. Recently a new gold standard for morpholino experiments has been 
suggested that takes advantage of the efficacy and simplicity of CRISPR site-directed 
mutagenesis. The injection of a morpholino into a null mutant for the gene of interest 
should not result in any phenotypic difference to the null mutant (Stainier et al., 2015). 
Where differences are observed this must be due to an off-target effect of the MO 
since the null mutant will not be producing protein for your gene of interest. Such a 
CHARACTERISATION OF THE JNK1 
MORPHANT PHENOTYPE 
 
138 
 
control could be used as a validation to show that the morpholino does not cause off-
target effects at your effective dose, however, a combination of these different 
controls would be required to increase confidence in the experimental results. 
 
4.1.2.4 Design of the jnk1 Morpholinos 
Translation blocking morpholino oligonucleotides were designed by Gene Tools™ in 
order to bind to zebrafish jnk1a and jnk1b genes. Both of these MOs overlap the 
translation start site of their respective gene (Figure 27A) and are predicted to prevent 
protein translation. Since they arose from a genome duplication, the sequences of the 
two zebrafish paralogs are highly similar to one another; as a result the morpholino 
sequences are also very similar, and there is a possibility that one MO might bind to 
the jnk1 paralog which it is not targeted to i.e. jnk1a MO to the jnk1b transcripts, jnk1b 
MO to the jnk1a transcripts. The morpholinos do contain four and three mismatched 
bases respectively to the opposing gene (Figure 27B), however typically it is thought 
that five mismatches are required to ensure that binding does not occur (Summerton 
and Weller, 1997a). As such there is a possibility of some cross-reactivity whereby each 
MO knocks down both genes to a degree. 
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Figure 27 Morpholino Oligonucleotides were Designed to Bind to the 
jnk1a and jnk1b Genes.  
A) Schematic representation of where the two morpholinos bind (red). Both 
MOs overlap the translation start site (underlined) of the gene. Coding 
sequence is uppercase, 5’ UTR is lowercase. B) Table displaying the number 
of matching bases between each MO and the paralog that it is not d esigned 
to target. 
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4.1.3 Aims of the Chapter 
The aim of this chapter was to optimise and characterise a morpholino-based 
knockdown of jnk1a and jnk1b during development. To achieve this aim the objectives 
were: 
1. Test different doses of jnk1a, jnk1b and compound jnk1a + jnk1b morpholino 
and determine whether they are tolerated or result in lethality. 
2. Determine whether developmental delay is caused by jnk1 knockdown. 
3. Examine the gross phenotype over an appropriate dose range in stage matched 
controls.  
4. Decide upon an optimal dose of each morpholino for further characterisation. 
5. Examine morphant histology at appropriate MO doses for changes at tissue / 
organ level. 
6. Prove that phenotypic changes result from jnk1a and jnk1b knockdown. 
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4.1.4 RESULTS 
4.1.4.1 3.2.1 Effect of the jnk1 MOs on Survival 
Morpholino oligonucleotides act in a dose dependant manner and can result in up to 
an 85% reduction in the production of protein from the target gene (Summerton et al., 
1997). In order to determine whether the newly designed jnk1a and jnk1b 
morpholinos were well tolerated or caused significant embryonic death, the survival 
rate of morphants was monitored over a dose range. Low survival rates during early 
development have been associated with morpholino toxicity in the sea squirt (Coffman 
et al., 2004). However, low survival rates could also indicate that jnk1 knockdown 
during early development is lethal. Survival of morphants was therefore monitored 
until 24hpf in order to determine whether there was a significant difference between 
jnk1 morphants and controls. 
 
4.1.4.2 Survival of the jnk1 Morphants between 7-24hpf 
Morphants were obtained by standard husbandry and injection protocols as described 
in section 2.3 page 86. Approximately fifty embryos per clutch were injected at each 
MO dose (Table 11), and replicates were achieved with different breeding pairs on 
separate days. As controls, 50 uninjected (fitness) and 50 morphants injected with the 
standard Gene-Tools control morpholino (CMO) were also collected. Embryos 
developed in E3 media at 28.5oC until 24hpf.  
Despite an inspection of the eggs at the time of injection, the quality of a clutch of eggs 
can be very poor independent of their appearance. In these cases a large proportion of 
the uninjected embryos will fail during gastrulation and can be identified at 24hpf. At 
24hpf the uninjected (fitness) controls were examined to ensure that fitness of each 
clutch was good. Any clutches of embryos where the fitness of the uninjected controls 
dropped below 80% were immediately dismissed from the experiment. This check of 
fitness was performed during all morpholino experiments. In clutches with good 
fitness of the uninjected controls the survival rate of morphants and controls was 
compared at 24hpf. 
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Individual Morpholino Dose Compound Morpholino Dose 
2ng jnk1a 1ng jnk1a; 1ng jnk1b 
3ng jnk1a 2ng jnk1a; 1ng jnk1b 
4ng jnk1a 1ng jnk1a; 2ng jnk1b 
2ng jnk1b 2ng jnk1a;2ng jnk1b 
3ng jnk1b 4ng jnk1a; 4ng jnk1b 
4ng jnk1b 
 
Table 11 List of jnk1 Morpholino Doses Trialled 
 
 
 
 
 
 
 
 
 
 
 
 
 
The percentage survival of embryos treated with jnk1a or jnk1b morpholinos was not 
found to be different from those treated with a control morpholino (CMO). This result 
shows that the knockdown of jnk1a or jnk1b does not increase the number of embryos 
which fail during early development. Overall the average fitness of all single jnk1 
knockdown experimental groups were >90% (Figure 28A) showing that these jnk1 
Figure 28 Percentage Survival of jnk1a and jnk1b Morphants.  
A) The morphants displayed an ~90% survival rate over the dose ranges 
studied. B) One-way ANOVA suggested a significant difference in the 
fitness of these groups compared to the 4ng CMO sample (p=0.047), 
however a Dunnett post-hoc test was unable to determine which groups 
were significantly different. The lowest p-value (0.304) was generated 
when the 4ng CMO was compared to the uninjected controls.  
A B 
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morpholinos were not causing developmental arrest. Performing a one-way ANOVA 
test on these data did suggest that a significant difference between groups might exist 
(p=0.047), however the power of the Dunnett post-hoc test was not sufficient to 
determine any groups that were significantly different (Figure 28B). The two groups 
with the greatest difference were the uninjected controls and the 4ng CMO 
morphants. If a difference in survival does exist between groups then it may therefore 
be due to the process of injection into the embryo, or as a result of any morpholino 
within the cells. This result highlights the importance of generating control morphants 
instead of comparing results to uninjected controls.  
This test for embryo survival was also carried out over the different doses of 
compound jnk1a; jnk1b knockdown (Table 11). Again, each group was compared to a 
morpholino-injected control; in this case 8ng CMO. The outcome of this analysis was 
that no significant difference was observed between groups (p=0.173) by one-way 
ANOVA, even at the highest dose of 4ng jnk1a; 4ng jnk1b (Figure 29). This result again 
provides evidence that the jnk1 morpholinos used here were well tolerated and that 
jnk1 knockdown during development does not result in failure during embryogenesis. 
 
 
 
 
 
 
 
 
 
 
Figure 29 Percentage Survival of compound jnk1a; jnk1b Morphants.  
Compound jnk1a; jnk1b morpholino doses as high as 4ng jnk1a; 4ng jnk1b 
did not cause an increased frequency of embryo death between 7 and 24hpf. 
One-way ANOVA was used to compare the groups to an 8ng CMO dose 
(p=0.173). 
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In this section I have shown that survival of zebrafish embryos is not affected when 
doses up to 4ng jnk1a, 4ng jnk1b or 4ng 1a; 4ng 1b morpholino is used. This result 
indicates that knockdown of jnk1 by morpholino does not cause early developmental 
failure. Furthermore this provides evidence that the morpholinos were not causing 
embryonic toxicity even at doses as high as 4ng 1a; 4ng 1b and therefore could be 
used to investigate jnk1 function. 
 
4.1.5 Developmental Delay 
Once it was demonstrated that jnk1 morpholinos were well tolerated I wanted to 
determine whether knockdown of jnk1 caused any developmental delay. This analysis 
was very important for informing future experiments because it allowed for the 
analysis of phenotypes between morphants and stage-matched controls. One of the 
most accurate methods by which to stage development is by counting of somites 
during the segmentation stage (Kimmel et al., 1995). The latest timepoint at which this 
method can be performed is at 22hpf when there are expected to be 26 somites in 
normal wildtype embryos. 
Morphants were generated by standard methods and allowed to develop until 22hpf 
in E3 media. The morpholino doses tested were the same as those examined for 
survival rates and both 4ng and 8ng CMO controls were collected. At 22hpf the 
embryos were anaesthetised in 0.1mg/ml Tricaine ® for five minutes and then 
examined under a dissection light microscope. Forceps were used to manipulate the 
embryos within their chorion and the somite number of six embryos was counted per 
morpholino dose, per clutch. The somite number over at least three clutches was then 
plotted and a one-way ANOVA was used to compare statistically. 
It was found that doses of jnk1a or jnk1b morpholino up to 4ng did not delay the 
developmental progress of embryos (Figure 30A). This result was also found for 
compound 2ng 1a; 2ng 1b morphants (Figure 30B) where no difference between 
control morphants and jnk1 morphants were found. However, at the 4ng 1a; 4ng 1b 
dose there was a significant difference between the number of somites present at 
22hpf. These morphants were delayed by around three hours compared to 8ng CMOs 
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since somites appear at a rate of two per hour (Kimmel et al., 1995). This result was 
important for future experiments since stage-matched controls are required for all 
comparisons. The time that 4ng 1a; 4ng 1b morphants were examined was therefore 
adjusted accordingly. 
 
 
Figure 30 High Compound jnk1a;jnk1b Morpholino Doses Cause 
Developmental Delay. Staging of jnk1 morphants by somites counting 
at 22hpf.  
A) morpholino doses up to 4ng jnk1a or 4ng jnk1b did not cause 
developmental delay to the embryo (p=0.554). B) The compound 4ng jnk1a; 
4ng jnk1b dose did result in developmental delay (*** p<0.001).C) Tables 
listing the number of replicates and total number of embryos examined.  
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4.1.6 Gross Phenotype by Light Microscopy 
In order to determine whether jnk1 knockdown caused developmental defects I next 
examined the gross phenotype of jnk1 morphants at 28hpf and 48hpf. Morphants 
were generated by standard methods over different morpholino doses (Table 11). The 
gross phenotype of the morphants was assessed by light microscopy on anaesthetised 
embryos to reveal gross phenotypic changes that affected the body or organ 
development.  
 
4.1.6.1 Characterisation of the jnk1a Morphant Gross Phenotype 
An initial dose of 2ng jnk1a MO was trialled on AB strain embryos, however no 
observable gross phenotypic defects were apparent at 28hpf (Figure 31C) or 48hpf 
(Figure 32C); embryos were indistinguishable from controls. The anterior-posterior axis 
of 2ng jnk1a morphants had extended away from the yolk by 28hpf and the somites 
had formed a regular chevron shape. Furthermore the eyes and otic vesicles were well 
developed and the heartbeat was visible. The 2ng jnk1a morphants remained 
indistinguishable from morphants at 48hpf when the body length was comparable to 
controls and head extension around the yolk had increased. The pectoral fin buds were 
also visible at this time and blood circulation could be seen.  
Due to the 2ng morphants being indistinguishable from controls the dose was raised to 
3ng jnk1a. At 28hpf the 3ng jnk1a embryos were smaller than the controls and the tails 
of morphants did not appear normal (Figure 32D). The tails of morphants had 
successfully extended away from the yolk but they were curled or kinked at the 
posterior end. This defect was more pronounced at 48hpf (Figure 32D) where the tail 
was curled either dorsally (away from the yolk sac) or in the left-right embryonic axis. 
Despite this tail defect, the shape of the somites appeared normal, and normal eyes, 
and otic vesicle had developed. At 48hpf circulation could be observed through the 
caudal artery of the tail. This morphant dose provided an overall mild change in gross 
phenotype.  
At a 4ng jnk1a dose there were more obvious and more frequent phenotypic changes 
between controls and morphants. At 28hpf the 4ng jnk1a embryos were smaller than 
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controls and the tails of the morphants were curved dorsally or kinked (Figure 31E). In 
addition the yolk sac was misshapen; instead of being spherical the yolk of morphants 
was commonly elongated along one axis. Another common defect observed was to the 
head between the cerebellum and the otic vesicle, a region that contains the hindbrain 
ventricles (hbv). This region of the head was sunken in morphants at both 28hpf and 
48hpf. Despite these changes both the eyes and otic vesicle of the morphants 
appeared to have developed normally. The tail and yolk sac defects persisted to 48hpf 
and at this point blood circulation was visibly reduced from controls. Many morphants 
also displayed oedema around the yolk and pericardial sac which deformed the yolk 
sac of affected embryos (Figure 32E).  
 
4.1.6.2 Characterisation of the jnk1b Morphant Gross Phenotype 
The starting dose of jnk1b morpholino was 1ng which resulted in no observable gross 
defects. At 28hpf the embryo had extended away from the yolk with regular chevron-
shaped somite formation and otic vesicle and eye development appeared normal 
(Figure 32F). At 48hpf the head was extending from the yolk (Figure 32F) and blood 
flow was visible in the tail.  
An increase of the dose to 2ng jnk1b resulted in embryos developing a ventral curling 
of the body in the anterior-posterior axis at 28hpf (Figure 32G). In comparison to the 
controls where the tail had extended away from the yolk, the tail of morphants curled 
ventrally around the yolk. Despite this body curling, no other defects were observable; 
somites were chevron-shaped, eyes and otic vesicles were indistinguishable from 
controls, and the heartbeat could be seen. At 48hpf the curled body axis phenotype of 
morphants had persisted and was more pronounced due to the increase in body length 
(Figure 32G). This remained the only observable phenotype defect. 
A higher dose of 4ng jnk1b morpholino was tried in order to increase the severity of 
the morphant phenotype. At 28hpf the morphants again displayed a curling of the 
anterior-posterior axis towards the yolk sac (Figure 31H), however this was again the 
only observable defect as somites, eyes and otic vesicles appearing normal. At 48hpf 
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the anterior-posterior axis remained curled around the yolk and embryos were visibly 
shorter than controls. Blood flow through the tail was present but reduced. 
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Figure 31 Gross morphology of jnk1 morphants at 28hpf.  
Injection of 4ng Control MO (B) did not cause any detectable developmental defects 
within the embryos as compared to uninjected controls (A). At low doses it can be seen 
that 2ng jnk1a (C) and 1ng jnk1b MO (F) do not show any phenotypic difference to 
controls. However, at higher doses the jnk1a morphants (D+E) displayed a curling or 
kinking of the tail (arrowhead). At the highest dose this was associated with misshapen 
yolk sac (*) and a defect of the head (chevron). At doses of 2ng and 4ng jnk1b the only 
defect observed was a ventral curling of the tail (arrow). All other structures appeared 
normal. Scale=1mm 
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Figure 32 Gross morphology of jnk1 morphants at 48hpf.  
The low morphant doses of both jnk1 paralogs (C+F) remain indistinguishable from control 
embryos (A+B) at 48hpf. At 3ng jnk1b (D) the only distinguishin g feature was a dorsal 
curling or kinking of the tail (arrowhead). At the 4ng dose (E) the morphants displayed this 
tail phenotype as well as severe oedema (*) and a defect of the head (chevron). The higher 
doses of jnk1b (G+H) caused a ventral curving of the tail around the yolk sac (arrows) and 
embryos were shorter. Despite this the rest of the embryo appeared to have developed 
normally. Scale = 1mm. 
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4.1.6.3 Morpholino Toxicity at a 6ng jnk1a Dose 
At 4ng jnk1a the embryos displayed some developmental defects, although by light 
microscopy these defects appeared quite mild. A mild phenotype could suggest that 
the morpholino was only partially knocking down protein production, or that loss of 
the gene caused only a mild phenotype. Without a high-affinity, specific antibody it is 
not possible to accurately quantify the knockdown efficiency of a translation modifying 
morpholino in vivo (Eisen and Smith, 2008). To overcome this limitation I trialled a 
higher dose of 6ng jnk1a morpholino and examined whether phenotype severity 
increased; an increase in severity would have been suggestive that greater protein 
reduction was achieved at this higher dose. At a dose of 6ng jnk1a the phenotype of 
morphants was indeed more severe, however there was evidence that this phenotype 
was caused by morpholino toxicity. Approximately 15-20% of morpholinos are 
estimated to cause toxicity (Eisen and Smith, 2008) which manifests in the zebrafish as 
dark clouding within the central nervous system (CNS) and rounded somites (Robu et 
al., 2007). Morpholino toxicity is sequence specific and is caused by upregulation of 
p53 leading to high levels of apoptosis. A knockdown of p53 by morpholino has been 
shown to rescue the toxic phenotype (Robu et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
A 
B 
C 
Figure 33 The Morpholino Toxicity of 6ng 
jnk1a can be rescued by 4ng p53 MO.  
A) Uninjected control at 28hpf displaying 
normal development. B) The 6ng jnk1a 
morphants show dark clouding of the CNS 
(*) as well as curling of the somites 
(arrowhead), both features associated 
with MO toxicity. In addition the embryos 
are much smaller than controls and fail to 
form the eyes. C) A combined dose of 6ng 
jnk1a + 4ng p53 MO is capable of rescuing 
the morpholino toxicity. Embryos are 
smaller than controls but somites are 
chevron shaped (arrow), and no clouding 
of the CNS is present. Scale = 1mm. 
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AB embryos were injected with 6ng jnk1a morpholino before the 4-cell stage and 
allowed to develop at 28.5oc in E3 media. At 28hpf the embryos were inspected by 
light microscopy and were found to be displaying signs of MO toxicity. Overall the 
embryos were far smaller than controls with dark clouding in the head and through the 
tail (Figure 33B). The heads of the morphants were smaller and the eyes failed to 
develop. The somites of 6ng jnk1a morphants were small and rounded, and had failed 
to form the characteristic chevron-shape as is observed in controls. These phenotypes 
have been described previously (Gerety and Wilkinson, 2011, Robu et al., 2007), and 
are associated with p53 upregulatin and morpholinos toxicity. In order to identify 
whether the observed defects were caused by upregulation of p53, a dual injection of 
6ng jnk1a and 4ng p53 morpholino were administered together. This compound p53 
and jnk1a knockdown was only conducted at this 6ng jnk1a dose because this was the 
only dose at which this “cloudy” CNS phenotype was observed. 
This co-knockdown with p53 partially rescued the severe phenotype observed in 6ng 
jnk1a morphants as clouding of the head and tail did not appear and the somites and 
eyes formed normally. Although embryo length was greater in p53 MO rescued 
embryos than 6ng jnk1a morphants, they remained shorter than uninjected controls, 
and tail kinking was still present. These results are consistent with morpholino toxicity 
and therefore the 6ng jnk1a dose was excluded from later experiments. Since 
morpholino toxicity is observed at high doses of jnk1a morpholino, the highest dose 
used in this project was 4ng jnk1a.  
 
4.1.6.4 Compound jnk1a;jnk1b Morphants Display Severe Phenotypic 
Changes 
Gross phenotypic data of either jnk1a or jnk1b knockdowns revealed differences in the 
phenotype when either gene was targeted. Since I showed in Chapter 3 that these two 
genes give rise to proteins which differ in almost 10% of their amino acid sequence 
(Figure 18), it is unsurprising that some functional differences exist. Since higher 
vertebrates have only a single copy of jnk1, compound jnk1a; jnk1b paralog 
knockdown may better model the loss of this gene in higher species. Furthermore, the 
appearance of severe defects at low doses of compound jnk1a; jnk1b knockdown 
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would be suggestive of over-lapping function between the two paralogs. In order to 
create compound jnk1a; jnk1b knockdowns the two morpholinos were mixed at 
various doses and injected into embryos under standard conditions. Gross phenotype 
characterisation at each dose was then carried out at 28hpf and 48hpf. 
At a dose of 1ng jnk1a; 1ng jnk1b there was a mild phenotype observed at 28hpf 
(Figure 34B), consisting of a curling of the tail dorsally away from the yolk. This 
phenotype was observed at a medium (3ng) and high (4ng) dose of jnk1a, but was not 
at 2ng jnk1a. This tail defect was more pronounced by 48hpf due to the increased 
length of the embryo (Figure 35B). However, this was the only noticeable 
developmental defect in the 1ng 1a; 1ng 1b morphants. Increasing the dose to 2ng 
jnk1a; 1ng jnk1b resulted in more pronounced defects that are associated with 2ng 
jnk1a alone. At 28hpf (Figure 34C) the embryos had significant dorsal curling and 
kinking of the tail and by 48hpf the embryos were noticeably smaller than controls 
(Figure 35B). In addition the yolk sac was misshapen and many embryos displayed 
oedema. None of these phenotypes were observed when a 2ng dose of jnk1a was 
injected alone. 
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The 1ng jnk1a; 2ng jnk1b dose interestingly did not display the severe ventral curling of 
the tail at 28hpf (Figure 34D) that was seen in the 2ng jnk1b morphants, although the 
tail did not project away from the yolk as straight as those of the controls. However, by 
48hpf the majority of embryos did display this ventral curling tail (Figure 35D) that is 
observed in the 2ng and 4ng jnk1b morphants. A more severe phenotype was seen at 
the 2ng jnk1a; 2ng jnk1b dose. At 28hpf these morphants were visibly shorter than the 
controls and had ventral curling body defects (Figure 34E). By 48hpf these morphants 
remained shorter and had tails displaying both ventral curling and kinking. In addition, 
Figure 34 Low Compound jnk1a; jnk1b Morpholinos Doses 
Caused Developmental Defects at 28hpf.  
A) Control morphant at 28hpf. B) The compound jnk1a; jnk1b 
morphants caused a curling of the tail (arrowhead) at 24hpf at 
relatively low doses. This tail defect was observed in the 1ng;1ng 
(B), 2ng;1ng (C) and 1ng;2ng (D) morpholino doses. A compound 
4ng jnk1a; 4ng jnk1b morpholino dose (E) resulted in embryo that 
were much smaller than controls. Scale = 1mm.  
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the majority of morphants displayed severe oedema which deformed the yolk sac 
(Figure 35E). Interestingly, the brain defect that was seen in the highest doses of jnk1a 
(4ng) was not seen in the 2ng jnk1a; 2ng jnk1b dose suggesting that it is a feature of 
high jnk1a knockdown only. These defects appear to be a combination of the defects 
which are seen at high doses of jnk1a and jnk1b, but they are occurring at a dose half 
that required when a single jnk1a or jnk1b morpholino is used. 
At the highest compound jnk1a; jnk1b dose tried (4ng jnk1a; 4ng jnk1b) the phenotype 
was the most severe out of all the morpholinos doses examined. In order to determine 
whether this 4ng jnk1a; 4ng jnk1b dose is more severe than an equally large dose of a 
jnk1a or jnk1b morpholino it would be necessary to compare with the phenotype of 
8ng jnk1a or 8ng jnk1b MO. However, at 6ng jnk1a MO these was a toxic effect 
observed (see section 4.1.6.3) that resulted in upregulation of the p53 gene, and non-
specific phenotypic effects such as “clouding” of the CNS and “rounding” of the 
somites. It was therefore not considered to be appropriate to use such high doses of 
the single jnk1a or jnk1b MOs, as the results would be unreliable. 
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Figure 35 The Compound jnk1a; jnk1b Morphants Display Significant Body 
Defects and Oedema at 48hpf.  
A) 4ng control morphant. B) At the 1ng 1a;1ng 1b dose the morphants displayed 
significant curling of the tail (arrowhead) but the length of the embryos is 
unaffected. C) The 2ng 1a;1ng 1b morphants are smaller than controls and have 
curled or kinked tails (arrowhead) and most display oedema and misshapen yolk 
sacs (*). D) The 1ng 1a;2ng 1b jnk1 morphants display ventral curling of the body 
axis (arrow) but the rest of the embryo appears normal. E) The 2ng 1a;2ng 1b dose 
causes the most severe phenotype. Morphants displayed both ventral curling 
(arrow) and kinking (arrowhead) of the tail and displayed sever e oedema and 
misshapen yolk (*). The embryos were also noticeably smaller than controls. 
Interestingly no brain defects were observed at this dose. Scale = 1mm.  
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Morphants of either jnk1a or jnk1b displayed paralog-specific defects when higher 
doses of morpholino were administered (Figure 31 and Figure 32). Since morpholinos 
act in a dose dependent manner it is likely that these higher doses are required to 
cause sufficient reduction in protein levels to result in the morphant phenotype. As the 
defects observed in compound jnk1a; jnk1b morphants were cumulative of those 
observed in single jnk1a or jnk1b morphants, but remained relatively mild, a high 
compound 4ng jnk1a; 4ng jnk1b dose was administered.  This high dose represents the 
highest knockdown of both paralogs that was achieved during this project, and 
therefore is putatively the model that most closely recapitulates a complete loss of 
jnk1. 
At 4ng jnk1a; 4ng jnk1b the phenotype of the morphant embryos was very severe. 
Morphants at 28hpf displayed curling and kinking of the tail as well as misshapen yolk 
sacs (Figure 36C+D). In addition the head of the embryo was sunken posteriorly to the 
cerebellum, recapitulating the defect observed in 4ng jnk1a morphants. Importantly, 
despite such a large dose of morpholino being used there was no evidence of 
morpholino toxicity and clouding within the embryo was not observed. 
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At 48hpf the 4ng 1a; 4ng 1b morphants displayed severe defects of the body and tail 
(Figure 37C+D). The body axis did not project correctly from the yolk and instead 
curled ventrally around it. At the most caudal end of the tail were kinks and sharp 
turns towards the left or right (Figure 37D’). Overall the embryos appeared shorter 
than controls. At this 4ng 1a; 4ng 1b dose morphants also displayed very pronounced 
oedema around the developing heart and yolk sac which deformed the yolk. Despite 
this misshapen appearance the yolk sac appeared larger than in controls. In addition 
the morphants displayed a defect of the head in a region just posterior to the 
cerebellum. This defect was characterised by a sunken region of the head similar to 
what was observed in the 4ng jnk1a morphants. 
  
Figure 36 At 4ng jnk1a; 4ng jnk1b dose the Morphants Display Severe 
Developmental Defects.  
A+B) 8ng control morphants developed normally at 28hpf. Despite the high 
morpholino dose no toxicity was caused. C+D) 4ng 1a; 4ng 1b morphants 
displayed significant curling and kinking of the tail (arrowhead) at 28hpf 
and embryos were smaller. The yolk sac of morphants was often misshapen 
(*) and there was a defect of the head posterior to the cerebellum 
(chevron). 
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The gross phenotype examination of jnk1 morphants revealed that knockdown of both 
genes individually gave rise to paralog-specific defects. These defects were observed at 
the higher doses of morpholino tested, where knockdown of protein was greatest. 
Interestingly these defects were observed at lower doses when compound jnk1a; 
jnk1b MOs were administered, possibly indicating that the two genes possess over-
lapping function. Even when both paralogs of jnk1 were knocked down, embryonic 
development was permissive, although there were unusual phenotypes such as curling 
and kinking of the body axis, anterior-posterior axis shortening, oedema and a defect 
of the brain. These data showed that although jnk1 function was required for normal 
zebrafish development, a loss of these paralogs could be fairly well tolerated for 
general form of the embryo. To determine more precisely what developmental 
processes were perturbed by jnk1 knockdown it was necessary to perform more 
detailed examination of the morphant.  
Figure 37 At 48hpf 4ng 1a; 4ng 1b Morphants Displayed Severe Tail Defects, 
Oedema and Brain Defects.  
A+B) 8ng Control morphants displayed no developmental abnormalities at 48hpf. 
C+D) 4ng 1b; 4ng 1b morphants displayed severe oedema at 48hpf (*) which 
caused the yolk to become misshapen. In addition the head was sunken posteriorly 
of the cerebellum (chevron). The tails of morphants were kinked (arrowhead) 
which often took them out of the microscope focal plane. D’)Rotation of t he embryo 
in D shows the whole of the tail. This orientation revealed that the tail was both 
ventrally curled (arrow) and kinked (arrowhead) at the caudal end.  
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4.1.6.5 Deciding Upon Optimal jnk1 Morpholino Doses 
In order to further analyse the phenotypic defects that were caused by jnk1 
knockdown it was necessary to choose suitable doses for further examination. I have 
shown here that the morpholinos do not cause an increase in death up to a 4ng jnk1a, 
4ng jnk1b or compound 4ng jnk1a; 4ng jnk1b doses. Furthermore, no morpholino 
toxicity was observed at these doses. Analysis of gross morphology revealed that 
phenotypic defects were observed but only at higher doses. I therefore decided to 
proceed with doses of 4ng jnk1a, 4ng jnk1b and 4ng 1a; 4ng 1b for future 
experimentation. These doses represent the highest doses tested and therefore should 
result in the greatest level of protein knockdown. Furthermore these doses caused the 
highest frequency of those phenotypes observed. In order to determine the frequency 
of each phenotypic defect I counted the occurrence of these gross phenotypes in 
samples from these selected doses.  
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4.1.6.6 Frequency of Gross Phenotype Developmental Defects 
The frequency of each developmental defect observed in jnk1 morphants was 
performed at the chosen doses. Fixed morphant samples were investigated at 48hpf 
by dissection light microscopy and the frequency of different developmental defects 
was calculated from at least three replicate clutches (Table 12). In 8ng CMO morphants 
there was a very small incidence of cardiac oedema (6%) but that was the only 
discernible gross defects that could be observed. In 4ng jnk1a morphants the incidence 
of tail defects was very high with 24% having curling and over 50% a kinking in the 
body axis (not mutually exclusive traits). Oedema was also very commonly observed in 
morphants with over 40% of morphants affected and brain and eye defects were 
observed in 33% and 60% respectively. In 4ng jnk1b morphants the ventral curling of 
the body axis was almost ubiquitous with 97% displaying this defect. In addition there 
was oedema around the heart and yolk in almost two-third of embryos (Table 12). At 
4ng 1a; 4ng 1b the morphants displayed high frequency of all the defects examined. In 
particular tail curling and kinking was very common and oedema was observed in 59% 
of morphants. Defects of the brain and eyes were observed in 28% and 37% 
respectively and over a quarter of embryos were considerably smaller than controls.  
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Defect Frequency (%) 
Dose 
8ng CMO 
n=6 
4ng jnk1a 
n=3 
4ng jnk1b 
n=5 
4ng 1a; 4ng 1b 
n=3 
Small 
Embryo 0/189 (0) 31/93 (33) 3/220 (1) 13/46 (28) 
Tail Curl 0/189 (0) 22/93 (24) 
214/220 
(97) 30/46 (65) 
Tail Kink 0/189 (0) 48/93 (52) 0/220 (0) 24/46 (52) 
Oedema 12/189 (6) 40/93 (43) 
136/220 
(62) 27/46 (59) 
Small Eyes 0/189 (0) 56/93 (60) 0/220 (0) 13/46 (28) 
Brain Defect 0/189 (0) 31/93 (33) 0/220 (0) 17/46 (37) 
 
Table 12 The Frequency of Gross Phenotypic Defects at the Chosen 
Optimal Doses. 
The frequency of each developmental defect was counted from fixed 
samples at 48hpf. Total number of morphants displaying the defect is 
shown as well as the percentage frequency in brackets. 
 
 
4.1.7 Histology of the jnk1 Morphants 
In order to characterise the developmental defects of the jnk1 morphants in greater 
detail a sample of morphants at the optimal doses were sectioned. Morphants were 
collected at 48hpf or 72hpf, fixed and embedded in epoxy resin. Embryos were 
orientated in both a coronal and sagittal orientation to enable visualisation of 
morphants through two separate body axes. Slides were stained with Lee’s Trichrome 
(an alternative to hematoxylin and eosin stain) which dyed structures with negative 
charge blue and positive regions pink. Brightfield images of the slides was then 
obtained using a compound microscope and measurements were taken from these 
images using the program FIJI (http://fiji.sc/Fiji) in order to have metrics that could be 
compared statistically. 
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4.1.7.1 Somitic Defects 
At 48hpf the somites of control embryos were highly organised structures that 
segmented the trunk and tail at regular intervals. The somites were tall, chevron 
shaped subunits of parallel muscle fibres that were separated by the epithelial somitic 
furrows (Figure 38A arrow). In the sagittal plane the horizontal myoseptum could be 
distinguished (Figure 38A arrowhead), separating the somite into a ventral and dorsal 
hemisphere at the level of the notochord. Although the somite was already well 
formed at 48hpf, over the next 24 hours the somite increased in height and the somitic 
furrows became better defined. At 72hpf the horizontal myoseptum was also easily 
visible and the surrounding dermis thickness was greater (Figure 38D).  
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Figure 38 jnk1a and jnk1b Morphants Display Different Defects in Somite 
Formation.  
At 48hpf the somites of control embryos (A) have formed into their characteristic 
chevron shape and are segmented by the semitic furrows (arrow). Within each 
somite the muscle fibres run parallel in an organised manner without spaces 
between the fibres. The somites are separated into ventral and dorsal hemispheres 
at the midline by the horizontal myoseptum (arrowhead).Over the next 24 hours 
(D) the somites increase in size and become more clearly separated by the somitic 
furrows and horizontal myoseptum. However the chevron shape of the somites 
remain. In jnk1a morphants (B) the preaxial mesoderm successfully segments and 
forms somitic furrows which separating the somites (arrowhead). In addition the 
horizontal myoseptum forms and runs through the middle of the somite (arrow). 
However, the fibres of jnk1a morphants have large gaps between them (* ). At 72hpf 
(E) the gaps between fibres are still evident but less pronounced, although the 
height of the exon is much less than the control.  jnk1b morphants at 48hpf (C) form 
somites that are rounded and   shorter and wider than controls. Furthermore the  
horizontal myoseptum fails to form, and is still missing by 72hpf (F). At this later 
timepoint the somites still remain smaller and wider than controls and the shape is 
rounded. Scalebar = 100μm. Lee’s Trichrome stained sections at 48hpf and 72hpf in 
sagittal cross-section show the somites at the level of the yolk sac, anterior right, 
posterior left.  
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In comparison to controls, the somites of the 4ng jnk1a morphants appeared quite 
different. The most striking feature of the jnk1a morphant somites was the emergence 
of large gaps between the muscle fibres (Figure 38B asterisks). In control embryos the 
muscle fibres were compacted together in parallel, with no space between adjacent 
fibres. However the jnk1a morphants displayed large gaps between parallel fibres and 
large gaps which no fibres occupied. Despite this deficit in muscle fibre density, other 
structures were conserved within the somites. The horizontal myoseptum appeared to 
be formed normally and the shape and size of the somite was comparable to controls 
at 48hpf (Figure 39). However, by 72hpf there appeared to be a difference in somite 
height evident between the controls and 4ng jnk1a morphants (Figure 38E). When 
compared statistically this disparity was found to be statistically different after 3 
replicates and by calculating the ratio of somite length vs height this value was also 
found to be significantly different compared to controls (Figure 39). The gaps between 
muscle fibres were still apparent at this later timepoint, although they were less 
pronounced than at 48hpf suggesting that there may have been some improvement in 
the histology of the somites. 
The 4ng jnk1b morphants also had defects in the developing somites, however the 
defects were vastly different to what was observed in jnk1a morphants. At 48hpf the 
preaxial mesoderm of the jnk1b embryos had undergone successful segmentation, and 
the somitic furrows were visible separating the neighbouring somites (Figure 38C 
arrows). However, individual somites appeared shorter and wider than the controls 
although at n=3 this was not found to be statistically significant by one-way ANOVA 
(Figure 39). Calculation of the length vs height ratio of the 4ng jnk1b somites was 
performed and variability was found to be much lower than of the somite height itself; 
ANOVA tests showed that this ratio was significantly different between the jnk1b 
morphants and controls. In addition, the shape of the somites was different, and 
instead of the characteristic chevron shape, the somites of jnk1b morphants were 
more rounded or “U-shaped”. Furthermore, the horizontal myoseptum, which forms 
from pioneer slow muscle cells (van Eeden et al., 1996), had failed to form completely. 
Observation at 72hpf showed that the jnk1b morphant somite height did not greatly 
change over the 24 hour period (Figure 39) and both height and length:height ratio 
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were significantly different to controls at this stage. The structural defects to the 
somite remained (Figure 38F) with a rounded appearance and lack a horizontal 
myoseptum at this stage. 
 
  
Figure 39 Somite size was affected by the knockdown of jnk1a and 
jnk1b. 
Metrics of somite length, height and the ratio between the two was 
calculated from histology pictures. At 48hpf the length and height of 
somites were not statistically different from controls, althought there 
appeared to be a trend of reduced somite height in jnk1b morphants. The 
ratio of length to height at 48hpf was significantly different in jnk1b 
morphants compared to controls (p=0.039). At 72hpf the length of the 
somites were not affected by knockdown of the jnk1 paralogs, however 
height was significantly different in jnk1a and jnk1b morphants 
(p<0.001).The ratio of length to height was also significantly different 
between controls and the jnk1a (p=0.001) and jnk1b (p<0.001) morphants 
at 72hpf. All statistical tests performed were one-way ANOVA analysis with 
2-sided Dunnett post-hoc tests where appropriate.  
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4.1.7.2 Eye Defects 
In 8ng CMO embryos the eye was well formed by 48hpf and all of the histological 
layers could be identified (Figure 40A). When stained with Lee’s methylene blue-basic 
fuchsin stain the negatively charged nuclei that reside within the ganglion layer (GL), 
inner nuclear layer (INL), outer nuclear layer (ONL) and the photoreceptor layer (PL) 
were stained a dark blue. In contrast the inner plexiform layer (IPL) and outer 
plexiform layer (OPL) which contain the axonal projections were stained a light pink 
allowing for easy identification. Over the next 24 hours the eye increased in size due 
predominantly to increases in the IPL and INL and these layers become more easily 
detectable (Figure 40D). 
Histology of the jnk1 morphant eye revealed several differences to the controls of the 
same stage. At 48hpf the jnk1a morphants had not yet developed distinguishable 
plexiform layers (Figure 40C), however the lens, optic nerve, and retinal pigmented 
epithelia were all present. By 72hpf all of the retinal cell layers could be distinguished 
(Figure 40D) and therefore it appears that there may have been some developmental 
delay at 48hpf. Despite all of the cell layers being present at 72hpf, the size of the eye 
appeared much smaller than the control, something that was also evident at the 
earlier timepoint. Measurements of eye and lens diameters at 72hpf however did not 
identify any statistically significant differences in eye size after three replicates, 
although variability was high (Figure 41A). In comparison several of the retinal layers 
were significantly smaller in 4ng jnk1a morphants compared to controls, the 
photoreceptor, inner nuclear and inner plexiform layers were all reduced in size 
(Figure 41B).  
The jnk1b morphants also appeared to suffer from some developmental delay at 48hpf 
because again the plexiform layers could not be seen in the retinal sections (Figure 
40E). Despite this the eye appeared to be of the same size as the control and no 
difference was found when these metrics were quantified. By 72hpf the jnk1b 
morphant eye was indistinguishable from the control as all of the retinal layers had 
developed (Figure 40F). Furthermore, the eye and lens size were comparable to the 
control, as were the retinal layers as no differences were found (Figure 41A+B).  
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Figure 40 Histology of the Eye in jnk1a and jnk1b Morphants.  
Lee’s Trichrome staining of 5μm resin sections reveal histological 
organisation of the developing retina at 48hpf (A, C, E) and 72hpf (B, D, F). 
The third panel per row (B’, D’ , F’) is a higher magnification image of the 
retina at 72hpf as represented by the white dashed box. At 48hpf the eye of 
8ng MM control morphant embryos (A) has developed the different cell 
layers of the adult retina and a rounded lens. By 72hpf (B) these layers 
have expanded and are more well defined.  By contrast the jnk1a 
morphants (C) lack clear separation of the two discrete plexiform layers at 
48hpf and eye size appears much smaller. By 72hpf (D) all cellular layers 
can be distinguished (D’) however the eye remains much smaller than that 
of the controls. In comparison he jnk1b morphants have normal eye size at 
48hpf (E), although again there are no clear plexiform layers present at 
48hpf. At 72hpf (F) the eye of jnk1b morphants is again comparable  in size 
to the control, and all of the layers have formed normally (F’). L – lens, GL – 
ganglion cell layer, IPL – inner plexiform layer, INL – inner nuclear layer, 
OPL – outer plaxiform layer, PL – photoreceptor layer, RPL – retinal 
pigmented epithelium, ON – optic nerve. Scalebar = 100μm  
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Figure 41 Retinal lamination sizes were affected by jnk1a knockdown.  
Metrics of the eye and retina were calculated from histology pictures. A) The width 
and length of the morphant eyes did display a statistically significantly change when 
jnk1a or jnk1b was knocked down although there appeared to be a trend of 
reduction in these two values in jnk1a morphants. The width and length of the lens 
was also not significantly affected by jnk1a or jnk1b kno ckdown. B) The size of some 
of the retinal laminations was significantly reduced by loss of jnk1a, although was 
unchanged with loss of jnk1b. The photoreceptor layer, inner nuclear layer, and 
inner plexiform layer were all significantly reduced in size in jnk1a morphants. 
PL=phororeceptor layer, OPL=outer plexiform layer, INL=inner nuclear layer, 
IPL=inner plexiform layer, GCL=ganglion cell layer.  
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4.1.7.3 Heart Defects 
One of the gross developmental defects that were picked up by gross phenotyping was 
oedema around the heart and yolk of jnk1a and jnk1b morphants. One possible cause 
of oedema is poor cardiac function, therefore the histology of the heart was examined 
between morphants and controls. By 48hpf the heart of controls had formed the two 
contractile chambers which both had a distinct histology (Figure 42A). At this stage the 
atrium is a thin, single celled myocardial layer, whereas the ventricle is multiple cells 
thick (Peal et al., 2011). Both chambers are lined with endocardium and are separated 
at the atrioventricular canal by a valve. The ventricle is much smaller than the atrium, 
but both chambers have large lumens to accommodate the passage of blood. Blood 
enters the atrium from the sinus venosis (Figure 42A arrowhead) which is a narrowed 
opening separating the blood that pools in the cardinal vein from the heart itself. Over 
the next 24 hours the heart of the 8ng CMO embryos continued to develop and by 
72hpf the ventricle had moved posteriorly to a location medial of the atrium (Figure 
43A). Furthermore, the wall of the ventricle has thickened further and the valve has 
increased in size. The atrium by 72hpf remained one cell thick. The extracellular matrix 
(ECL) located between the myocardium and endocardium - known as the cardiac jelly 
can be seen at 72hpf in the atrium (Figure 43 asterisks). 
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The hearts of jnk1a morphants appeared as a primitive structure at 48hpf, with two 
chambers that were not separated and formed a tube (Figure 42B). The valve had not 
developed by this stage and the only way to distinguish between the two chambers 
was from the histology of the myocardium. The ventricle (as in controls) had multiple 
cells layers, and the atrium was only one cell thick. However both of the chambers 
were far smaller than the control and lumen size was also drastically reduced. One of 
the contributing factors to the small lumen size was that the cardiac jelly layer was far 
larger around both chambers than in controls. By 72hpf the hearts of jnk1a morphants 
Figure 42 Heart Histology of Single Morphants at 48hpf.  
By 48hpf the 8ng control MO heart (A) has a morphologically distinct 
ventricle (v) and atrium (a) separated by the primitive valve (arrow) which 
forms at the atrio-ventricular canal. Also visible is the sinus venosus 
(arrowhead) which forms a narrow opening for blood to enter the heart. In 
comparison the jnk1a morphant heart (B) is much smaller and more 
primitive than the control at 48hpf. The heart has successfully moved away 
from the midline but still appears like a  primitive tube without formation of 
the valve. The ventricle and atrium can be distinguished by the myocardium 
since the ventricle wall contains multiple cell layers whereas the atrium is 
one-cell thick. Both chambers are much smaller than the control hea rt. The 
jnk1b morphant heart (C) is also smaller than the control but also appears to 
have defects. The atrioventricular valve has formed (arrow) separating the 
ventricle and atrium, but both chambers are smaller than in the control. The 
atrium looks particularly disorganised with abnormal projections of the wall 
at the venous pole. The sinus venosus (arrowhead) appears much more 
dilated in jnk1b morphants but despite this there are very few blood cells 
seen in the heart. Finally the cardiac jelly (*) which is extracellular matrix 
that separates the myocardium and endocardium is greatly expanded in 
morphants. Scalebar = 100µm. 
CHARACTERISATION OF THE JNK1 
MORPHANT PHENOTYPE 
 
172 
 
had grown in size but still appeared primitive in design. The chambers remained 
smaller than in the control and the valve had still failed to form correctly. Additionally 
the cardiac jelly layer was massively expanded (Figure 43B) in comparison to controls 
so that lumen size was very small. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The 4ng jnk1b morphant heart also appeared more primitive than the control heart at 
48hpf. Although the two chambers had formed normally, they were small and irregular 
in shape. Despite this the atrioventricular valve had formed correctly to separate the 
two chambers (Figure 42C arrow). The morphant atrium was considerably smaller in 
Figure 43 Heart Histology of Single Morphants at 72hpf.  
At 72hpf the 8ng control heart (A) had looped round so that t he atrium 
and ventricle were parallel to one other and both chambers had 
expanded to increase cardiac output. The atrium (a) at 72hpf was one -
cell thick whereas the ventricle (v) was multiple cells thick, and the two 
chambers were separated by the atrioventricular valve (arrow). In the 
atrium a thin layer of cardiac jelly (*) was visible which separated the 
myocardium and endocardium. In jnk1a morphants (B) the heart was 
poorly formed without clear chamber separation. Despite this the 
ventricle did have multiple cell layers that helped to distinguish it from 
the atrium. At 72hpf the valve has not formed correctly although the 
beginnings of a primitive valve are visible (arrow), however it was much 
smaller than the valve of the controls and did not separate t he chambers. 
Both the atrium and ventricle of jnk1a morphants are small with a small 
lumen constricted by an expanded cardiac jelly (*). The jnk1b morphant 
heart (C) was fairly well formed at 72hpf with both chambers clearly 
separated and with a mature valve separating them (arrow). However 
the atrium was misshapen with abnormal projections of the myocardium 
at the venous pole. In addition, both chambers were far smaller than the 
control and the lumen of both was restricted by cardiac jelly expansion 
(*). 
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size and there were often projections of the myocardium at the venous pole that give 
the impression of folding in the chamber. Furthermore the opening to the rest of the 
circulatory system is far more dilated in morphants and does not show the narrow 
constriction of the control sinus venosus (Figure 42 arrowhead). Despite this, far fewer 
blood cells were found within the heart or cardinal vein of morphants, suggesting that 
they were not circulating normally. The size of both chambers was increased in jnk1b 
morphants by 72hpf (Figure 43), however, both remained far smaller than normal. 
Looping movements of the heart continued despite the overt defects with the 
ventricle, moving to a more medial and posterior position. The valve also increased in 
size and maturity similar to the control (Figure 43 arrow). Despite this the lumen of the 
chambers remained constricted by an expanded cardiac jelly layer found 
predominantly in the atrium. Overall the heart appeared to be better formed than in 
the jnk1a morphants. 
 
4.1.8 Proof of Knockdown 
4.1.8.1 Knockdown Analysis by Western Blot  
From the gross phenotype and histological data I was able to show that use of jnk1 
morpholinos cause some developmental defects in the zebrafish. Since 25-mer 
morpholino oligonucleotides are usually highly specific for their target (Eisen and 
Smith, 2008) these defects are likely due to the knockdown of jnk1a and jnk1b during 
development. However, these morpholinos are novel and therefore require validation 
to ensure that they are specific for their target. In order to prove specificity of the jnk1 
translational MOs I performed western blot analysis to measure protein abundance 
directly.  
Western blot analysis requires a sensitive and specific antibody that is capable of 
binding to the protein of interest. Unfortunately the only antibodies that were 
commercially available and cross-react with zebrafish are (human) pan-JNK antibodies 
which bind to human JNK1, JNK2 and JNK3 proteins. Despite this limitation in reagent 
availability the western blots were carried out to determine whether protein 
abundance levels of Jnk were reduced in morphants. 
CHARACTERISATION OF THE JNK1 
MORPHANT PHENOTYPE 
 
174 
 
Samples for western blot were generated via standard morpholino injection protocols. 
Approximately 100 embryos at 48hpf were collected at doses of 4ng jnk1a, 4ng jnk1b, 
and uninjected controls, dechorionated and deyolked to improve the resolution on the 
blot (Link et al., 2006). These sample proteins were denatured and stored as described 
in section 2.2.13 and loaded into the acrylamide gel such that protein from five 
embryos ran per lane. The western blots were probed with antibodies against pan-Jnk 
and Gapdh to act as a loading control. This experiment was repeated in triplicate and 
average density changes were calculated from densitometry analysis via one-way 
ANOVA 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
Figure 44 Pan-JNK Western Blot Revealed Partial Knockdown of Jnk 
protein.  
Western blots were used to determine whether single morpholino doses were 
capable of knocking down Jnk abundance. A) Bands are picked up at 46kDa 
and 54kDa which represent the long and short forms of Jnk. The morphant 
samples were run against an uninjected control to compare  protein 
abundance. A Gapdh control antibody was also probed for and loading of the 
wells was normalised against this band. B) Densitometry over three replicates 
revealed a trend of the 54kDa band of morphants being greater relative to 
controls. However this result was not found to be significant (One -Way 
ANOVA, p=0.14). The 46kDa band was found to be significantly lower in 
morphants that controls (One-Way ANOVA, p=0.003) for both paralogs. 
Errorbars=SEM.  
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The western blot results revealed that probing with a pan-Jnk antibody reveals two 
major bands of different sizes (Figure 44A). The 54kDa band corresponded to the long 
transcripts of the jnk genes, whereas the 46kDa band corresponded to the short 
transcripts (Sabapathy et al., 1999). For my analysis these two bands were treated 
separately by densitometry to distinguish whether changes in protein abundance was 
evident in either the long or short protein products. Despite the pan-Jnk antibody 
being used (which also picks up Jnk2 and Jnk3) it was possible to find a significant 
difference in protein abundance between the jnk1 morphants and uninjected controls. 
However, this reduction in band density was only observed for the 46kDa transcripts of 
Jnk, representing the short splice-variants produced by jnk1a, jnk1b, jnk2 or jnk3. For 
jnk1b morphants there was a nearly 40% reduction in the 46kDa band whereas for the 
jnk1a morphants it was reduced by approximately 20% (Figure 44B). Interestingly, the 
abundance of the heavier 54kDa band was not found to significantly change between 
the three groups. This result is unexpected because both long and short transcripts of 
jnk1a and jnk1b share an AUG start site, over which the respective morpholino is 
designed to bind. It is therefore not clear why only short transcript products would 
display a reduced protein abundance.  
 
4.1.8.2 Myc-Tagged Western Blot Analysis 
Western blot analysis of endogenous Jnk protein was unable to definitively answer 
whether the morpholinos were capable of knocking down jnk1 translation. The results 
suggested that the lighter (46kDa) Jnk products did have reduced abundance, but the 
heavier (54kDa) products could be increasing in abundance. Since there could be no 
distinction made between the different Jnk family members (Jnk1,2,3) with the pan-
JNK antibody this result did not show that the jnk1 paralogs specifically were being 
affected by the MOs. To determine whether the morpholinos were capable of 
preventing Jnk1 protein translation I had two of the full-length jnk1 transcripts myc-
tagged. The addition of protein tags was carried out by Dr Lindsay Murphy. 
Western blot samples were generated by microinjection where embryos were 
administered with morpholino or morpholino plus myc-tagged mRNA. There were 
three different morpholino doses used (4ng CMO, 4ng jnk1a, 4ng jnk1b) and three 
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mRNA doses (no RNA, 400pg jnk1a, 400pg jnk1b) which were used in combination 
leading to a total of nine different conditions (Table 13). Three of these doses were 
morpholino only and represent negative controls since no myc-tag protein was present 
in the embryo. There were also two positive controls where myc-jnk1a or myc-jnk1b 
was administered in the presence of the CMO morpholino which does not knockdown 
the jnk1 genes translation. These controls were used to demonstrate the total amount 
of protein produced from both of the 400pg doses of RNA. These positive controls 
were compared to the bands in the jnk1 morphant samples to gauge whether protein 
production was reduced. The final four experimental conditions used were to answer 
whether each of the two morpholinos was capable of knocking down RNA from the 
paralog that it was targeted to, and whether it cross-reacted to knock down RNA from 
the paralog that it was not targeted to i.e. did jnk1a morpholino knock down jnk1b 
translation. Each of these nine conditions were administered to embryos from the 
same clutch to reduce variability. Furthermore, RNA and morpholinos were added as 
two separate injections to ensure that the same amount of RNA was administered to 
the positive controls as to the experimental samples. 
The MO and RNA doses were administered to AB embryos from the same clutch within 
half an hour of being spawned. In each case a morpholino was administered first and 
then the morphants were split into three equal groups: jnk1a mRNA, jnk1b mRNA, no 
mRNA. A total of 400pg mRNA was administered also by microinjection. In this way it 
was possible to work sequentially through the nine different sample groups and use 
the same microneedles for all doses to reduce variability in dose administered. 
However, due to the sheer number of injections required (30 embryos for 9 sample 
groups = 270) it was not possible to perform alone before the embryos had developed 
beyond the eight-cell stage. Therefore I performed the morpholino injections and was 
supported by Dr Simon Ramsbottom who performed the RNA injections. At 48hpf the 
embryos were collected and 20 embryos were added to 400μl of tissue extraction 
buffer. The tissue was homogenised by needle gradient and stored at -80oc until 
needed. 
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mRNA Morpholino Purpose 
- CMO -ve control 
- jnk1a jnk1a -ve control 
- jnk1b jnk1b -ve control 
jnk1a CMO jnk1a +ve control 
jnk1a jnk1a Target specificity 
jnk1a jnk1b Cross-reactivity 
jnk1b CMO jnk1b +ve control 
jnk1b jnk1a Cross-reactivity 
jnk1b jnk1b Target specificity 
 
Table 13 Different Doses of myc-tagged jnk1 RNA and Morpholino used 
to Demonstrate Morpholino Specificity.  
Table showing the nine different conditions used to prove jnk1 morpholinos 
knock down jnk1 protein production. Each of these nine conditions was 
produced within the same clutch of embryos. The tagged jnk1a RNA used 
was jnk1a_8;long and the jnk1b RNA was jnk1b_8;long. Morpholinos were 
all used at a dose of 4ng. 
 
A western blot to determine whether morpholinos could knockdown myc-tagged jnk1 
splice-variants was performed by Dr. Ramsbottom. The tissue was loaded into the 
wells of a 10% acrylamide gel so that protein from one embryo ran per lane. Samples 
that had been injected with the same RNA were loaded side-by-side so that 
comparisons in protein abundance could be made (Figure 45). Equal loading of the gel 
was confirmed by use of a Gapdh loading control antibody that was used to probe the 
bottom half of the PVDF membrane. The top of the membrane was probed with an 
anti-Myc antibody. 
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The process of overexpressing RNA in the embryo that codes for a myc-tagged jnk1a or 
jnk1b transcript makes it possible to gauge the specificity of our morpholinos. The RNA 
variants were introduced artificially and therefore do not represent endogenous 
proteins, however, the sequence of the injected RNA was identical to the endogenous 
counterpart at the morpholino binding site so should act in an identical manner to 
translation blocking MOs. Western blot analysis revealed that both the jnk1a and jnk1b 
morpholinos were capable of knocking down transcription from the gene to which 
they were targeted. However, it was also illustrated that there is cross-reactivity 
between the MOs and the RNA of the opposite paralog i.e. jnk1a MO is capable of 
knocking down jnk1b and vice versa. The MOs do not seem capable of knocking down 
the opposite paralog as strongly as they knockdown their actual target gene, so 
Figure 45 The jnk1 Morpholinos Knockdown both Paralogs of jnk1.  
Myc-tagged jnk1a_8;long or jnk1b_8;long RNA was injected into morphants to 
determine the knockdown ability of the MOs. A) No myc-tagged bands were 
found when morpholino only was injected. B) In embryos in jected with jnk1a-
myc the control MO did not knock down myc-tagged protein, however the jnk1a 
MO abolished this band completely. jnk1b morpholino was found to cross -react 
with the jnk1a RNA and myc-tagged protein abundance was reduced 
considerably. C) Myc-tagged jnk1b protein was abundant when injected with the 
control morpholino, but was completely abolished when injected with jnk1b MO. 
There was cross-reactivity observed with the jnk1a MO as the myc band was 
heavily reduced. Western blot carried out by Dr Simon Ramsbottom. 
A B C 
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compound jnk1a; jnk1b MOs remain the most appropriate way of knocking down both 
jnk1 paralogs. Although this experiment appears to show strong cross-reactivity 
between the jnk1 morpholinos and both paralogs of jnk1, replicates need to be 
performed before this can be shown conclusively.  
 
4.2 DISCUSSION 
c-Jun N-terminal Kinase is a protein which has been shown to have a role in multiple 
signalling pathways and mediate the action of dozens of downstream effectors 
(Bogoyevitch, 2006, Davis, 2000). It is therefore unsurprising that reducing protein 
translation of the two zebrafish jnk1 paralogs results in defects to normal 
development. With the use of morpholino oligonucleotides targeted to jnk1a and 
jnk1b it has been possible to show that these genes are vital for correct development 
of the somitic muscle, heart, brain, and eyes of the zebrafish. This zebrafish morphant 
system may therefore prove to be a useful tool for studying jnk1 function in a versatile 
model organism. 
 
4.2.1 Morpholinos Can Successfully be used to Study jnk1 During 
Development 
4.2.1.1 The jnk1 Morpholinos Successfully Knock Down their Targets 
The use of morpholino oligonucleotides has proved a popular and valuable tool for 
developmental biologists to examine gene function in the zebrafish, particularly in the 
absence of a viable mutant. However, as with all genetic manipulations they require 
thorough validation and study before meaningful conclusions can be drawn. In this 
project I have established that these two morpholinos are a viable option to study jnk1 
function and have provided evidence that they successfully knock down their target 
genes at chosen optimal doses. In the absence of a commercially-available antibody 
which reacts specifically with zebrafish jnk1 it was necessary to examine pan-Jnk 
protein levels in jnk1 morphants. The pan-Jnk antibody is predicted to bind to not only 
Jnk1a and Jnk1b, but also the other family members Jnk2 and Jnk3. Despite this 
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limitation I showed that pan-Jnk levels were significantly reduced in the presence of 
both jnk1a and jnk1b morpholinos, but specifically it was the 46kDa band that was 
reduced. 
The 54kDa pan-Jnk band did not display any significant change in abundance between 
the control and jnk1 morphants. This is an interesting result because it could suggest 
that the morpholinos are capable of knocking down only the short transcripts of jnk1 – 
a theory which seems unlikely considering that the short and long jnk1 splice-variants 
share the same start site. An alternative theory may be that the knockdown of jnk1 
results in an upregulation of jnk2 or jnk3. In fact it has been shown in Jnk1 null mice 
that Jnk2 is upregulated and vice versa (Reinecke et al., 2013). In order to cause the 
result observed in this western blot, the knockdown of jnk1 would have to result in an 
upregulation of the long splice-variant(s) of Jnk2 and/or Jnk3 sufficient to not only 
mask the reduction in Jnk1 protein, but also exceed it. However, in the absence of 
antibodies that are specific for individual zebrafish Jnk proteins it was not possible to 
test this by western blot.  
A further contributor to the western blot result which showed a reduction in the 
46kDa Jnk band only, is that there may be more transcription of the 46kDa splice-
variants at that 48hpf timepoint than the longer 54kDa variant; these two different 
sized proteins correspond to the short and long splice-variants respectively which were 
investigated by RT-PCR in the previous chapter. From the RT-PCR data it was shown 
that the expression pattern of the jnk1 splice-variants was dependent upon which 
middle exon was integrated into the variant, and not whether it was a short or long 
variant (Figure 24A+C). Although absolute abundance of each variant could not be 
measured by this RT-PCR methodology, and nor could direct comparisons be made 
between abundance of each transcript since different primers were used, these data 
still suggest that the short form is not the only transcript expressed at 48hpf. In fact, 
jnk1a_7;long and jnk1b_7;long were approaching their highest expression levels at 
48hpf, so this result contradicts the theory that all long transcripts were only lowly 
expressed at this timepoint. Since this method measures mRNA abundance and not 
protein abundance it is not a direct measure of the proteins that make up the 46 and 
54kDa bands so this theory cannot be ruled out entirely; however without access to 
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specific antibodies for each variant, or use of a sophisticated proteomics approach 
such as 3D gel chromatography and mass spectrometry, this may be the most suitable 
way to predict protein levels.  
Further evidence that the morpholinos are capable of knocking down their target was 
generated by the use of myc-tagged transcripts of jnk1a_8;long and jnk1b_8;long. 
When these tagged transcripts were overexpressed in zebrafish embryos the addition 
of the appropriate morpholino at the optimal dose was sufficient to prevent protein 
production. These data reveals that the morpholinos are capable of knocking down the 
long (54kDa producing) transcript of each paralog, something that was not revealed in 
the western blot. Although both of these experiments reveal that the morpholinos are 
capable of knocking down their target, they do not prove their specificity to jnk1 alone. 
The gold standard method to show that phenotypic changes are causal of a particular 
gene knockdown is to rescue the phenotype with overexpression of a morpholino-
resistant RNA. This experiment would therefore be the next logical step to validate the 
jnk1 morpholinos, although may require some trial and error to determine which of 
the different splice-variant(s) are necessary for phenotypic rescue. Although I did 
attempt this mRNA rescue once, the positive and negative controls did not match with 
what was expected so this data had to be dismissed. Time constraints unfortunately 
meant that repeats were not possible, although this experiment would be a priority for 
future work on this project. 
Morpholinos have previously been used to knockdown jnk1 in a study of convergent 
extension movements (Seo et al., 2010) however no developmental defects were 
reported. The binding sites of these MOs were in exon 3 and exon 4 of jnk1a and jnk1b 
respectively (See appendices Figure 63). One explanation for this absence of defects is 
that the timepoints looked at were during early development (11 and 16hpf) which 
may be before developmental defects can be seen; certainly it is before elongation of 
the body axis would have made curling of the tail apparent, and it is also before heart 
tube formation and appearance of the different retinal layers. Another explanation is 
that in the Seo et al. study (2010), splice-variant MOs were used. Splice-variant 
morpholinos bind to pre-mRNA molecules and cause the skipping of exons or inclusion 
of introns into the translated protein product (www.gene-tools.com). These 
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morpholinos are incapable of knocking down maternally inherited mRNAs which are 
already in a mature state. As was shown in chapter 2, there is considerable inheritance 
of jnk1 mRNA from the mother which persists until at least the start of gastrulation 
(5.25hpf) and may therefore be important during early stages of development. In this 
project translation blocking MOs were used, ensuring that both maternally inherited 
and zygotic jnk1 was knocked down. I would therefore expect to see more severe 
defects using these morpholinos if jnk1 is needed early in development.  
 
4.2.1.2 The jnk1 Morpholinos Cross-React 
The myc-tagged western blot enabled the identification of cross-reactivity between 
each morpholino and the two jnk1 paralogs. This cross-reactivity means that 
phenotypic data generated for single jnk1a or jnk1b knockdowns may not represent a 
true knockdown of only one gene and both paralogs are affected. It is therefore 
interesting to note that the phenotypes of jnk1a and jnk1b morphants were very 
distinctive with very little cross-over (the developmental defects caused by the jnk1a 
morpholino were not the same as those caused by the jnk1b morpholino). This 
difference in phenotype is suggestive that although both paralogs are being knocked 
down to a degree, the morpholino is favouring one gene over the other. Design of new 
morpholinos which target each gene specifically to determine whether they provide a 
phenocopy of what we observed would be a way to confirm that paralog-specific 
phenotypes are caused by our morpholinos.  
Although the cross-reactivity of the morpholinos may be viewed as a limitation, it is 
inconsequential when compound jnk1a; jnk1b knockdown is desired. Since the two 
jnk1 paralogs are specific to the teleost radiation then compound jnk1a; jnk1b 
morphants would provide a more suitable method for investigating the function of 
jnk1 in human development. Although it still remains to be determined how similar the 
function of zebrafish jnk1 is to its human ortholog, this morphant system could be 
utilised to determine what function jnk1 plays in vertebrate development. Trying to 
rescue a zebrafish morphant phenotype with overexpression of human mRNA has 
been utilised in several papers to determine whether function is conserved between 
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species (Anichtchik et al., 2008, Al-Hamed et al., 2014), and could illuminate what 
shared function is conserved in the jnk gene. 
 
4.2.1.3 High Doses of jnk1 Morpholino are Tolerated Without Causing 
Toxicity. 
Toxicity is predicted to arise in between 15-20% of morpholinos and cause 
developmental arrest or CNS apoptosis (Eisen and Smith, 2008). None of these 
features were found to occur in doses up to 4ng jnk1a or 4ng jnk1b. Some toxicity was 
observed at the 6ng jnk1a dose, which rules out this dose from being used in future 
experiments. However, a compound 4ng jnk1a; 4ng jnk1b dose could be used without 
any signs of toxicity. Overall this evidence suggests that the jnk1 morpholinos used 
here represent a robust and reliable tool to investigate the involvement of jnk1 during 
zebrafish development. 
 
4.2.2 The jnk1a and jnk1b Genes Play a Role in Development  
The literature concerning JNK1 function in development is limited and contradictory; in 
mouse JNK1 mutants were found to have only minor neurological changes (Kuan et al., 
1999, Reinecke et al., 2013) whereas in xenopus there were convergent extension 
defects reported (Kim and Han, 2005, Yamanaka et al., 2002). In this project I have 
been able to show that jnk1 does have a role to play in the development of the 
zebrafish, particularly in formation of several organs. Despite the cross-reactivity of the 
morpholinos there is also evidence of paralog-specific function of the two jnk1 genes. 
 
4.2.2.1 jnk1a is Vital for Development of the Heart, Brain and Tail 
Knockdown of jnk1a revealed that this gene is vital for normal zebrafish development. 
Morphants at the 4ng jnk1a dose display dorsal curling or kinking of the tail instead of 
elongating normally from the yolk. Histology of the somites showed that the structure 
was also abnormal, and although the somites successfully segment from the preaxial 
mesoderm there are large gaps between muscle fibres; whether this abnormal 
histology is causal of the tail defect remains to be seen. jnk1a is also important in the 
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development of the brain and eyes.  Loss of jnk1a during development results in the 
eyes being smaller, due primarily to the reduction in size of the two synaptic layers of 
the retina: the inner and outer plexiform layers. These layers are responsible for early 
processing of vision (Masland, 2001) so testing the vision of jnk1a morphants may 
reveal differences to controls. It is interesting to note that small eye size and 
underdevelopment of the retina has been reported previously in pan-jnk inhibition 
with the SP600125 drug (Xiao et al., 2013, Valesio et al., 2013), which suggests that this 
defect is a specific effect of loss of jnk1a. However, it is also important to note that 
small eyes, or failure of eye development, has been associated with morpholino off-
target effects via the increase of apoptosis in the central nervous system (Robu et al., 
2007). Although no CNS clouding was observed in these jnk1a morphants it would be 
beneficial to prove that the eye phenotype is rescued by mRNA co-injection before this 
can be confirmed as a specific effect of jnk1a knockdown. 
 In addition, it was found that a loss of jnk1a resulted in a defect of the brain posterior 
of the cerebellum. This region is where the hindbrain ventricle develops, and may be 
suggestive of a failure for the ventricle to inflate. Knockdown of jnk1a also resulted in 
severe oedema around the heart around 72hpf. Further analysis revealed that the 
morphant heart was primitive in construction and failed to have developed a valve. 
The hearts appeared smaller and had expansion of the cardiac jelly. It would be 
interesting to determine whether fewer cells were present in these hearts to 
contribute to their smaller size since the JNK genes have been linked with the 
processes of proliferation, apoptosis and differentiation (BossyWetzel et al., 1997, 
Mingo-Sion et al., 2004, Gururajan et al., 2005, Wei et al., 2014).  
Although these developmental defects were reproducible there remains much work to 
be done in order to fully characterise the jnk1a morphant phenotype and investigate 
the mechanisms by which jnk1a is acting during development. Firstly, much of the 
histology characterisation requires further replication in order to become convincing 
and in order to quantify the differences in metrics associated with morphant tissue vs 
controls e.g. somite length, retinal layer size. Only with further replicates will it be 
possible to determine how much smaller the somites are or what the average 
reduction in heart lumen size is in jnk1a morphants. Once phenotype is fully 
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characterised to a high standard it would also be interesting to investigate the 
mechanism by which the jnk1a knockdown is causing these phenotypes. Analysis of 
proliferation and apoptosis rates for example would help to identify why certain layers 
of the retina are smaller, and lineage tracing of the cardiomyocytes could be used to 
determine whether cells are successfully differentiating and migrating to the heart 
tube. Determining the mechanism by which these defects are occurring would help to 
determing the role of this gene during development but is unfortunately something 
that I did not have the time to explore in this thesis. 
 
4.2.2.2 jnk1b is Vital for Development of the Tail and Heart 
Loss of jnk1b by MO knockdown caused the embryos to be shorter than controls with a 
very pronounced curling of the body axis ventrally towards the yolk, a feature that was 
accompanied by loss of the horizontal myoseptum from the somitic muscle. 
Interestingly horizontal myoseptum formation has been shown to fail in mutants with 
convergent extension defects via altered sonic hedgehog signalling (Yin and Solnica-
Krezel, 2007). Whether deficient convergent extension is a feature of jnk1b morphants 
remains to be shown conclusively, as previous work has failed to show that jnk1 
functions in this process (Seo et al., 2010). However, other mutations in the PCP 
pathway have been shown to affect convergent extension (Jessen et al., 2002, Veeman 
et al., 2003, Wang et al., 2006a). Further work should address whether slow muscle is 
successfully differentiating in jnk1b morphants as this may provide a mechanism by 
which the horizontal myoseptum is failing to form. 
The development of the heart also appears to be affected by jnk1b knockdown. In 
contrast to the histology of the jnk1a morphant heart, knockdown of jnk1b does not 
cause a failure for the atrioventricular valve to form which separates the two cardiac 
chambers. However, the chambers of the heart do appear to be smaller, particularly 
the lumen which may be hampered by the expansion of the cardiac jelly. Again, further 
investigation is required to determine whether number of cells is reduced in the jnk1b 
morphant heart and determination of whether apoptosis and proliferation rates are 
affected could help to determine a mechanism for the smaller size of the cardiac 
chambers. These heart results seem to fit with what has been observed in pan-jnk 
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inhibited morphants treated with SP600125 where curled tail and pericardial oedema 
were observed (Xiao et al., 2013, Valesio et al., 2013). 
 
4.2.2.3 The Zebrafish jnk1 Morphant Results in Context of PCP 
As has been discussed at some length, the JNK genes are known to be active in the 
planar cell polarity pathway where they lie downstream of the core protein complex. 
This signalling pathway is known to be critically important for several developmental 
processes, with disruption of several different genes resulting in similar developmental 
defects (see section 1.2.2 page 17). It is therefore necessary to put the results of this 
study into the context of the PCP family and determine whether the developmental 
defects observed in jnk1 morphants resemble or contrast those seen in other loss-of-
PCP studies. 
Convergence and extension movements during gastrulation are important for 
extending the embryonic axis while reducing the medio-lateral axis and are critical for 
normal body patterning. Many instances have been shown where loss of normal PCP 
signalling results in the reduction of CE cell migration (Heisenberg et al., 2000, Seo et 
al., 2010, Kilian et al., 2003, Veeman et al., 2003, Jessen et al., 2002, Carreira-Barbosa 
et al., 2009) in the zebrafish and Xenopus vertebrate models, suggesting that these 
organisms are particularly susceptible to CE defects. It is therefore interesting to find 
that 4ng jnk1b and 4ng jnk1a; 4ng jnk1b morphants display a shortening of body length 
at 48hpf compared to controls. Although this body-length shortening could be the 
result of a CE-like defect I was not able to investigate this further. In order to 
determine whether jnk1a is required for convergent and extension (something which 
has been suggested in Xenopus (Yamanaka et al., 2002) it would be necessary to 
examine the migration of cells during the two phases of convergent and extension.   
Interestingly this same shortening is not observed in jnk1b morphants, possibly 
suggesting a divergence in function between the two genes. However, the jnk1b 
morphants do display a failure to form the horizontal myoseptum during somatic 
development. Published work shows that there is a link between normal zebrafish CE 
movement and the patterning of the horizontal myoseptum progenitors via SHH 
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signalling (Yin and Solnica-Krezel, 2007, van Eeden et al., 1996). Since jnk1b morphants 
do not display shortening it is therefore possible that a mechanism other than CE is the 
cause of this somatic defect, or that the length reduction is too mild in jnk1b 
morphants to be detected by the methods used. Indeed it would be very interesting to 
determine whether the pioneer slow muscle cells are correctly patterned within jnk1b 
morphants as a possible mechanism for this defect. 
Another common phenotype that has been associated with PCP disruption is a failure 
for the neural tube to close in mouse and Xenopus genetic models (Goto and Keller, 
2002, Wallingford and Harland, 2002). A failure for the neural tube to close during 
primary neurulation has also been shown in Jnk1 and Jnk2 null mice due to a reduction 
in the controlled apoptosis of the hindbrain neural tube resulting in exencephaly (Kuan 
et al., 1999). Similar phenotypes have not been observed in zebrafish PCP mutants, 
perhaps due to the different mechanism by which the neural tube is formed (Kimmel 
et al., 1995), therefore it is not surprising that no neural tube defects are detectable in 
the jnk1 morphants. However, there was a defect of the brain observed in the 4ng 
jnk1a and 4ng jnk1a; 4ng jnk1b morphants which presented as a depression of the 
hindbrain (Figure 32 page 150). It is not clear from these results whether this defect is 
a result of neural tube development, or through a different process, however it will be 
interesting to examine this phenotype in greater detail. 
In the Drosophila wing as well as ciliated mammalian tissues and Kupffer’s vesicle in 
the zebrafish, loss of PCP can result in loss of polarization in ciliated cells. 
Randomisation of tissue polarity can significantly reduce tissue function and also result 
in aberrant left-right patterning in certain models. During the gross phenotype 
characterisation of the jnk1 morphants, it appeared that left-right formation of the 
visceral organs may well be affected. I therefore decided to investigate this feature 
more closely (see chapter 5 page 191). 
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4.2.2.4 Similarities of the jnk1 Retinal Phenotype to Ciliopathy-
Associated Gene Knockdowns 
One of the most striking changes to be seen between the control and jnk1a histology 
data was that of the loss of retinal lamination. In addition both 4ng jnk1a and 4ng 
jnk1a; 4ng jnk1b morphants display a smaller eye size (microphthalmia) phenotype 
when gross phenotype is observed by light microscopy. Considering the association 
between PCP pathway genes and cilia (for review see (Karner et al., 2006a) it is 
therefore interesting to note the similarities that are observed between the eye 
phenotypes of the jnk1 morphants and those with disruption of cilia function. 
Many ciliopathies have been shown to have associated retinal phenotypes such as 
Usher Syndrome, macular degeneration, Joubert Syndrome, primary ciliary dyskinesia, 
and Bardet-Biedl syndrome (for review see (Adams et al., 2007)). This association is not 
surprising considering that the photoreceptor cells arise from primitive primary cilia 
(Wheway et al., 2014).  The zebrafish has become a popular model for the retinal 
ciliopathies because of their well studied genetics and highly developed retina by only 
three days of age. This has led to several human cilia-associated orthologs being 
mutated or knocked down in zebrafish to determine the role of these genes in eye 
development and retinal patterning (Wheway et al., 2014).  
Shu et al. knocked down the retinitis pigmentosa 2 homolog rp2 with morpholino 
oligonucleotides and found that retinal lamination failed to form the ganglion cell 
layer, inner nuclear layer and outer nuclear layer of the retina by 72hpf. In addition 
these morphants displayed a smaller global eye size than controls (microphthalmia) 
and smaller lens size. This phenotype was then successfully rescued by injection of 
human RP2 mRNA which was resistant to the MOs (Shu et al., 2011). A similar result 
was found to occur with loss of the cilial gene ahi1 which is associated with Joubert 
syndrome in humans. Knockdown of this gene in zebrafish showed that again the 
lamination of the retina failed to differentiate and microphthalmia was apparent as 
well as a loss of cilia developing in the left-right organiser Kupffer’s Vesicle (Simms et 
al., 2009). This consistency of microphalmia and loss of lamination has also been 
observed in the topors and bbs5 morphants (Al-Hamed et al., 2014, Chakarova et al., 
2011) suggesting a strong association between ciliogenesis and eye development 
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within the zebrafish. In the topors morphant this lamination loss was coincident wish 
increased levels of apoptosis, although causation was not established. 
In jnk1a morphants there is indeed a small-eye phenotype with no laminations being 
developed by 48hpf. However, by 72hpf there are retinal laminations present in jnk1a 
morphants although some of these layers are significantly smaller than controls. The 
photoreceptor, inner nuclear and inner plexiform layers are smaller in 4ng jnk1a 
morphants than controls, in comparison to the ganglion, inner and outer nuclear layers 
defects and photoreceptor absence observed when rp2 morphants. These phenotypes 
do therefore appear similar although not identical as jnk1a morphants have reduced 
size of the IPL. However, in ahi1 and bbs5 morphants there was a loss of both the inner 
and outer plexiform layers demonstrating that these layers may also be affected in 
zebrafish-modelled ciliopathies. Furthermore, in those journal articles mentioned 
there was an absence of the laminations whereas in 4ng jnk1a morphants there was 
only a reduction in the lamination size. This could be suggestive of a reduced MO 
penetrance of the jnk1a MO and require a larger dose to achieve a full loss of 
lamination, or it could arise because jnk1a is not as crucial for retinal development as 
those other cilial genes studied. Further work is required to determine which of these 
possibilities is correct, and whether the mechanisms by which these ocular defects 
arise is shared. However, since JNK activity is linked to increased cellular apoptosis  
(Fuchs et al., 1998, Kuan et al., 1999) it does not seem likely that this is the mechanism 
for reduced lamination size in the jnk1a morphants. Despite these inconsistencies with 
ciliopathy related genes, these data are suggestive of a function of jnk1a in cilia 
development, and further investigation is warrented. 
 
4.2.2.5 Concluding Remarks 
Overall these results have successfully demonstrated that morpholinos are a viable 
way to examine developmental function of the jnk1 paralogs, although it does appear 
that some cross-reactivity occurs. Further replicates of this myc-tagged western blot 
are required to confirm this cross-reactivity and to quantify the degree to which cross 
reactivity occurs. Despite this cross-reactivity the two jnk1 morpholinos cause different 
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phenotypes when administered which has begun to address the paralog-specific roles 
of the two zebrafish genes. 
Broadly jnk1a appears to function in development of the brain and eye - where retinal 
laminations appear to be reduced in size. However, further work is required to 
quantify the retinal reduction and determine the mechanisms by which this defect 
arises. Heart development is also severely disrupted by jnk1a knockdown and the 
organ appears as a very primitive structure even at 72hpf, without a visible valve and 
with a much smaller lumen. It would be interesting to determine whether reduction in 
function of these morphant hearts contributes to the cardiac oedema that was 
observed at the 4ng jnk1a MO dose. 
The jnk1b morphants displayed far more severe curling of the body axis compared to 
the jnk1a morphants, as well as a failure for the somitic horizontal myoseptum to 
form. To further investigate this defect it would be interesting to perform wholemount 
immunohistochemistry for slow muscle markers to determine whether these cells 
were differentiating correctly adjacent to the notochord. If failure to form the 
horizontal myoseptum was confirmed then it could help to explain the more rounded 
appearance of the somites, as this is one of the features which has been shown to 
occur when the horizontal myoseptum fails to develop (van Eeden et al., 1996).   
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5.1 INTRODUCTION 
5.1.1 Breaking Symmetry of the Visceral Organs 
Despite the external appearance of left-right symmetry in the zebrafish, internally many 
organs are positioned on one side of the body, or are themselves asymmetrical e.g. the 
heart, liver, pancreas, gut, pineal gland (Ahmad et al., 2004, Field et al., 2003, Liang et al., 
2000). Establishment of this asymmetry is critical for development, and just like in other 
species, incorrect left-right patterning can lead to disruptions in development or function. 
One of the signalling pathways shown to be critical for left-right patterning of the zebrafish 
visceral organs is the planar cell polarity (PCP) pathway. It has been shown that when 
members of this pathway are disrupted in zebrafish it results in left-right patterning defects 
(Song et al., 2010, Walentek et al., 2013, Wang et al., 2011). Interestingly it has also been 
shown that rock2b, one of the two kinases downstream of the core PCP proteins, is vital for 
left-right patterning, and knockdown of this gene by morpholino oligonucleotides (MO) 
causes disruption of left-right patterning of the visceral organs (Wang et al., 2011). As the 
other kinase downstream of the PCP core proteins, the jnk family are prime candidates for 
regulating left-right asymmetry during development. I therefore decided to determine 
whether jnk1 knockdown during zebrafish development resulted in left-right situs defects of 
the visceral organs.  
 
5.1.1.1 Jogging and Looping Movements of the Heart 
The mature zebrafish heart is asymmetrical in both position of the organ in the body as well 
as its structure. However, the organ originally develops as a primitive tube that is 
superficially symmetrical across the left-right axis. This primitive linear heart tube develops 
at the embryonic midline by 24hpf and beats in a peristaltic manner (Glickman and Yelon, 
2002). Although there are no observable boundaries between the two chambers at this 
stage, the anterior region is patterned to become the ventricle, with the posterior region 
becoming the atrium. Over the next 24 hours two key morphogenetic movements occur 
that break symmetry and align the chambers to their mature positions. These two 
movements of the heart are known as jogging and looping. Cardiac jogging is the first break 
of symmetry conducted by the linear heart tube, but there is minimal evidence that this 
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occurs in mammals (Biben and Harvey, 1997). The gene ontology (GO) consortium defines 
cardiac jogging as the leftward displacement of the heart with respect to the anterior-
posterior axis (http://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0003146). This process occurs 
in wildtype zebrafish embryos between 24 and 30hpf and results in the heart projecting 
diagonally away from the midline (Figure 46 A) such that the venous pole is most lateral 
(Chin et al., 2000) before moving back towards the midline. Over the next 10 hours the 
heart undergoes a second movement known as looping (Chin et al., 2000), a process that is 
also observed in mammalian heart development. Looping of the zebrafish heart, which has 
only two chambers, is a much more simplified process than mammalian cardiac looping; the 
primitive ventricle of the linear heart tube moves rightwards (medially) and posteriorly in 
relation to the primitive atrium. The rightward looping that is observed in a majority (>95%) 
of wildtype embryos is known as D-looping (Chin et al., 2000) and is completed by about 
36hpf (Stainier et al., 1993). The final location of the ventricle is to the right side, and 
adjacent to the leftward-lying atrium. During the looping process the two chambers become 
delineated and a constriction between the two chambers reveals the location of the 
primitive atrio-ventricular valve (Peal et al., 2011). 
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Figure 46 Schematic Representation of Jogging and Looping Movements of 
the Zebrafish Heart Tube.  
Observations of heart tube development in zebrafish can be made through the 
transluscent yolk. From this ventral orientation the right of the image is the 
embryo’s left. The linear heart tube (lht)  forms by 24hpf on the embryonic 
midline and over the next few hours it breaks asymmetry in a movement 
known as jogging (A-C). Normal jogging (A) involves moving over to the left 
side of the embryo, although in a small proportion of  untreated wildtypes the 
heart tube may remain on the midline (B) or jog to the right (C). Over the next 
10 hours the ventricle (v) moves rightwards and medially in relation to the 
atrium (a) in a process known as looping. This rightward ventricular looping 
known as a D-loop heart (D) establishes the positioning of the mature heart 
chambers. However, the heart may fail to loop (E) producing an O -loop, or 
display reversed looping (F) resulting in an L-loop heart, both of which are 
seen rarely in wildtypes. lht=linear heart tube, v=ventricle, a=atrium, 
ba=bulbous arteriosus, sv=sinus venosus.  
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5.1.1.2 Uncoupling of Heart Movement 
The maturation of the asymmetrical zebrafish heart is different from that of mammals 
in that there are two processes which break symmetry: jogging and looping. The 
“normal” progression which >95% untreated wildtype embryos follow is an initial 
leftward jogging of the organ, before rightward heart looping occurs (Chen et al., 
1997). However, a small proportion of untreated wildtype embryos undergo a 
complete reversal of normal heart movements (situs inversus) or a failure to break 
symmetry at all. In zebrafish with mutations / knockdowns that affect left-right 
signalling the proportion of embryos which undergo normal heart movements are 
significantly reduced. In these cases the proportion of embryos with R-looped, O-
looped and L-looped hearts approaches 33% which represent a total randomisation of 
heart laterality (Wang et al., 2011, Ahmad et al., 2004, Chin et al., 2000). However, in 
the majority of those mutants studied, once the initial jogging direction is completed 
the looping movement is also determined i.e. a leftward jog is followed by a rightward 
D-loop, or a rightward jog is followed by a leftward L-loop. In these instances the 
jogging status of the embryo was predictive of which way the heart would loop over 
the next 10 hours, and the two processes were thought to be coupled to one another. 
Where the heart fails to jog during early development the looping direction appeared 
to be randomised (Chen et al., 1997). These data lead to the theory that jogging and 
looping of the zebrafish heart were controlled by the same genetic mechanisms. 
Interestingly it has been shown that there is a subset of mutations where cardiac 
jogging status is not predictive of looping, effectively displaying an uncoupling of 
zebrafish heart movements (Chin et al., 2000). Most of the genes identified that cause 
uncoupling are associated with development of the physical midline barrier or 
notochord, such as noto (floating head), dharma (bozozok) and ta (no tail) (Chin et al., 
2000). However, it has also been observed that knockdown of spaw (zebrafish nodal) 
results in uncoupling of jog / loop progression (Ahmad et al., 2004). Despite the major 
role of nodal being to pattern “left-ness” in the lateral plate mesoderm, in mouse it 
has also been suggested to play a part in formation of the molecular midline barrier; 
Nodal induces expression of its antagonist Lefty1 in the embryonic midline (Yamamoto 
et al., 2003). Whether heart uncoupling defects are therefore restricted to incorrect 
midline barrier development remains to be seen. Unfortunately, most research into 
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zebrafish heart laterality investigates the heart laterality at a single timepoint only. 
This methodology means that it is not possible to determine whether uncoupling of 
heart movement is a common occurrence, or a feature specific to a particular genetic 
pathway. 
 
 
5.1.2 Aims of the Chapter 
The aim of this chapter is to determine whether jnk1a or jnk1b is involved in left-right 
patterning of the visceral organs, and if so what laterality defects are observable in 
morphants. This aim was investigated by completion of several objectives: 
1. Determination of whether heart laterality defects arise in jnk1a, jnk1b or 
compound jnk1a; jnk1b morphants. 
2. Investigation of whether any laterality defects also result in an uncoupling of 
cardiac jogging and looping movements during development. 
3. Examination of whether the jnk1 morphants possess laterality defects of the 
gut. 
4. Comparison of heart and gut position to see whether heart and gut laterality is 
coupled, or whether there is heterotaxy in jnk1 morphants. 
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5.2 RESULTS 
5.2.1 Left-Right Patterning Defects of the jnk1 Morphant Heart 
5.2.1.1 Zebrafish jnk1 Knockdown Causes L-R Heart Defects in a 
Dose  Dependent Manner 
Determination of heart laterality was initially assessed as heart looping status at 48hpf 
(see section 2.3.11 page 91) by light and fluorescent microscopy. Around 50 embryos 
per clutch of the Tg(myl7:EGFP) line (which express eGFP in cardiomyocytes) were 
injected with morpholino and at 24hpf the embryos were switched to a pigment 
inhibiting media (E3 / PTU). Heart laterality of the anaesthetised embryos was 
assessed at 48hpf and heart looping status was scored by light microscopy as D-loop, 
O-loop or L-loop. At this time, example pictures were also taken by fluorescent 
microscopy, taking advantage of the eGFP that is expressed in cardiomyocytes of the 
Tg(myl7:EGPF) line (Figure 47). These pictures revealed that both control and 
morphant hearts alike display “normal” D-looping, as well as “abnormal” O-looping 
and L-looping. 
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Figure 47 Heart Laterality Defects are Observable in Controls and 
Morphants at 48hpf.   
A-C) 4ng control morpholino, D-F) 2ng jnk1a morpholino, G-I) 2ng jnk1b 
morpholino. Visualisation of the heart by fluorescent microscopy reveals 
that looping laterality defects occur in controls and jnk1 morphants. 
Normal heart movement results in a D-loop (A, D, G) where the ventricle 
moves to the right of the atrium, however there may also be a failure to 
loop (B, E, H) where the heart remains on the midline, or a reversal of 
looping status (C, F, I) known as an L-Loop. As shown here, all three of 
these phenotypes occur in controls and jnk1 knockdowns.  
All images using the Tg(myl7:EGFP) line at 48hpf. Embryo s positioned 
ventral-side-up so that left of image equates to right side of the embryo 
and right of image is left side of embryo. Scalebar=50µm . 
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The heart looping of both controls and morphants was scored for at least three 
different clutches per dose. From this laterality frequency data we are able to see that 
control morphants (4ng CMO) have 94% in the D-loop group with~2% O-loop and ~4% 
L-loop. In comparison the uninjected controls displayed a higher incidence of D-loops 
with 98% of embryos developed a D-loop, ~1% O-loop, and ~1% L-loop. This deviation 
was found not to be significant by one-way ANOVA (Figure 49), revealing that injection 
of MO by itself does not significantly raise heart laterality defects.  
In jnk1a morphants the frequency of D-loop hearts decreased in a dose-dependent 
manner between 2ng, 3ng and 4ng MO (Figure 48A). However, of those morphants 
that failed to form a D-loop heart there was no bias observed between the other two 
groups; at the 3ng jnk1a dose the frequency of L-looped hearts was greater whereas at 
4ng jnk1a the frequency of O-looped hearts was greater (Figure 48B). From these data 
it was possible to determine that at the 4ng jnk1a dose the frequency of morphants 
that formed a “normal” D-loop heart was significantly reduced (p<0.05) compared to 
morphant controls (Figure 49).  
In jnk1b morphants there was also a dose-dependent reduction of L-loop hearts over 
the 1ng, 2ng and 4ng doses, however the jnk1b morpholino caused a lower frequency 
of D-looped hearts than the jnk1a MO at the same dose (Figure 48A). Furthermore, 
where morphants fail to develop D-loop hearts there appears to be a preference for 
the formation of an L-loop at higher doses i.e. at the 2ng and 4ng jnk1b doses there 
were greater than 3x as many L-loop hearts as O-looped (Figure 48B). Performing a 
one-way ANOVA revealed that there is significant divergence from the “normal” D-
loop heart at both 2ng (p<0.001) and 4ng (p<0.000) jnk1b (Figure 49). 
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Figure 48 jnk1 Knockdown Results in an Increased Prevalence of Heart O -
loop and L-loop Formation in a Dose Dependent Manner.  
A) Stacked column graph shows the prevalence of heart looping phenotypes in 
controls and morphants of both jnk1a and jnk1b. Although O - and L-looping 
are both observed in controls the frequency is low. In jnk1a morphants these 
two “abnormal” looping statuses become more frequent as dose of morpholino 
increases. This heart defect prevalence is greater still in jnk1b morphants at 
the same dose, and appears to cause L-looping preferentially over O-looping. 
Graph represents mean frequency of each phenotype per dose. The number of 
replicates and total number of individuals per dose is shown at the left side of 
each column. Error bars = SEM. B) Table displaying the mean percentage 
distribution of each looping phenotype per dose. Figures are equal to those 
represented in the graph.  
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Figure 49 jnk1 Knockdown Results in Significant Loss of Normal Heart 
Laterality.  
Reorganisation of the heart laterality data into two groups allowed for 
statistical analysis to be performed. One-way ANOVA revealed that heart 
laterality was significantly disrupted in 4ng jnk1a, 2ng jnk1b, and 4ng 
jnk1b morphants (* p<0.05, ** p<0.01, *** p<0.001) when compared to 
control morphants.  
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5.2.1.2 Uncoupling of the Jog-Loop Heart Progression 
The asymmetrical movements of the developing zebrafish heart normally follow one 
another such that leftward jogging results in a D-loop heart and rightward jogging 
results in an L-Loop. However, it has been shown that these two movements can be 
uncoupled from one another by disrupting certain genes (Chin et al., 2000). In order to 
determine whether jog and loop progression was uncoupled in jnk1 morphants I 
followed the hearts of jnk1 morphants through both of these processes.  
Approximately 50 morphants were generated per dose of jnk1 morpholino and again 
switched to pigment-reducing media at 24hpf. These morphants were assessed for 
heart jogging status at 28hpf by dissection microscopy and scored as either left, 
midline, or right jog status. An angle of at least 5o between the anterior-posterior axis 
and linear heart tube was required for the scoring of a left or right jogged heart (as per 
Chin et al. 2000). Looping status was assessed as before at 48hpf to score the embryos 
as D-loop, O-loop, or L-loop. Heart jogging was found to be completed at 28hpf in all 
morphants (Figure 50A) except for the 4ng jnk1a morphants which displayed a delay in 
heart formation. At 28hpf the heart had not elongated into a mature heart tube, and 
instead appeared as a roughly spherical mass of beating cells on the midline (Figure 
50B). The morphants that displayed delay in heart maturation were screened for 
jogging at two-hour intervals and were found to have jogged by 32hpf – displaying a 
four hour delay compared to controls. This delay was not observed at the time of 
looping assessment (48hpf), although heart looping is complete in wildtype zebrafish 
by around 40hpf (Chin et al., 2000). 
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The laterality data at both timepoints (jog and loop) was analysed to determine 
whether uncoupling of heart movement occurred at any dose of jnk1 knockdown. In 
both control morphants as well as uninjected controls there was a very small incidence 
of uncoupling observed (Figure 50); this feature has been previously reported in the 
literature (Chin et al., 2000). In the case of jnk1a knockdown there was a dose-
dependent increase of heart uncoupling so that at the 4ng jnk1a dose there were 
almost 12% of morphants displaying uncoupling (Figure 50). At this high 4ng jnk1a 
dose, it was found that there was a significant increase in heart uncoupling compared 
to 4ng control morphants. The incidence of heart uncoupling was also raised over 
different jnk1b doses but not significantly. The incidence of uncoupling over the jnk1b 
Figure 50 The 4ng jnk1a Morphants Displayed Heart Formation Delay 
and Uncoupling of Jog / Loop Movements.  
A+B) Fluorescent heart pictures at 28hpf in the Tg(myl7:EGFP) line 
revealed that normal heart jogging to the left of the embryo was achieved 
in uninjected embryos (A) by this timepoint. However, the 4ng jnk1a 
morphants (B) displayed a delay in formation of the heart tube and at 
28hpf the cardiomyocytes sat as a rounded mass on the midline (dotted 
line runs through the middle of the head). C) Plotting the number of jnk1 
morphants that do not follow the normal jog / loop heart progression 
revealed that the 4ng jnk1a morphants displayed a statistically significant 
uncoupling of the two processes (** p<0.01) compared to the 4ng control 
morphants (4ng CMO). Graph represents the mean percentage prevalence 
of heart uncoupling. Error bars = SEM.  
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doses peaked at 2ng and was lower at 4ng jnk1b. However, for all of these jnk1b doses 
the absolute number of unlooped phenotypes was very low compared to the sample 
that was taken (6, 15 and 9 embryos respectively); therefore large numbers of 
embryos are necessary to accurately gauge the prevalence.  
 
5.2.1.3 The Hearts of Compound jnk1a; jnk1b Morphants Display an 
Inability to Loop 
Individual knockdown of jnk1a and jnk1b revealed that these genes are important for 
correct cardiac jogging and looping, and disruption leads to an increased frequency of 
abnormal heart laterality. Despite evidence that the morpholinos cross-react (see 
4.1.8.2), individual morphants displayed distinct gross phenotypes that were unique to 
jnk1a or jnk1b knockdown (sections 4.1.6 and 4.1.7); compound jnk1a; jnk1b 
morphants displayed the combined phenotypes. These data suggested that injection of 
a single jnk1a or jnk1b morpholino was not sufficient to completely abolish pan jnk1 
signalling. To investigate the effect on heart laterality of knocking down both jnk1 
paralogs I performed dual jnk1a and jnk1b MO injections together and examined the 
cardiac jog / loop movements during development. 
Approximately 50 compound jnk1a; jnk1b morphants (various doses) and 8ng control 
morphants were generated per clutch and allowed to develop until 24hpf. At 24hpf the 
media was changed to include PTU to inhibit pigment development and jogging was 
scored at 28hpf. The 4ng jnk1a; 4ng jnk1b dose displayed developmental delay of 
approximately 4 hours (Figure 30) and were therefore assessed at 32hpf (see Figure 
30). Cardiac looping was scored at 48hpf for all doses except the 4ng;4ng dose which 
was performed at 52hpf. From these data the frequency of jog/loop uncoupling was 
calculated for each of the different populations. 
Compound jnk1a; jnk1b morphants displayed heart laterality defects in a dose-
dependent manner; as the MO dose was increased, the frequency of D-loop hearts 
was reduced. For the 1ng jnk1a; 1ng jnk1b morphants the frequency of D-Looped 
hearts was about 80% but by the 4ng jnk1a; 4ng jnk1b dose only 30% of morphants 
displayed D-looping (Figure 51A). These results resemble the knockdowns of jnk1a or 
jnk1b where dose-dependency is also observed. Where morphants failed to form a D-
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loop, the frequency of O and L-looped hearts was increased. Interestingly at both 1ng 
jnk1a; 1ng jnk1b and 2ng jnk1a; 2ng jnk1b doses the percentage of morphants with an 
O-loop or L-loop was roughly equal, with only a few percent difference between them 
(Figure 51B). However, at the high dose of 4ng; 4ng the frequency of hearts which 
failed to undergo cardiac looping was several-fold higher than the other two groups. 
This large jump in O-looped heart frequency in 4ng; 4ng morphants may represent a 
dosage threshold whereby there is a bias towards a failure of the heart to loop. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to determine whether compound jnk1a; jnk1b knockdown caused a 
statistically significant divergence from normal heart laterality these data were 
Figure 51 Compound jnk1a; jnk1b Morphants Display High Levels of Heart 
Laterality Defects and a Preference for O-Loop at the High Dose.  
A) The frequency of heart L-looping decreases in a dose-dependent manner as 
compound jnk1a; jnk1b morpholino doses increased. The hearts of morphants 
instead displayed an increased prevalence of forming O -loop or L-loop hearts. 
At the 4ng 1a; 4ng 1b dose the most prevalent phenotype is an O -loop heart. 
Graph plots the mean percentage incidence of each heart looping phenotype at 
48hpf. Error bars = SEM. B) Table listing the percentage frequency of each 
looping phenotype per group, as shown in the graph.  
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categorised as “normal” (D-loop) or “Abnormal” (O-loop + L-loop) laterality. The 
normality frequency was then compared between the control morphant group and 
compound jnk1a; jnk1b MO groups by one-way ANOVA and a Dunnett post-hoc test 
revealed which groups were different. Statistical significance was found at both the 
2ng jnk1a; 2ng jnk1b (p<0.05) and 4ng jnk1a; 4ng jnk1b (p<0.01) doses (Figure 52). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Once normal looping laterality was shown to be disrupted in several compound jnk1a; 
jnk1b MO doses I assessed whether the heart movements of jogging and looping were 
Figure 52 Normal Heart Looping Laterality is Greatly 
Disrupted by Knockdown of both jnk1 Paralogs.  
Plot showing the mean percentage of compound jnk1a; jnk1b 
morphants that display a normal cardiac looping phenotype. 
This analysis reveals that normal heart looping laterality was 
significantly disrupted in 2ng jnk1a; 2ng jnk1b (p=0.026) and 
4ng jnk1a; 4ng jnk1b morphants (p=0.000) as assessed by 
one-way ANOVA and Dunnett post-hoc test. Error bars = SEM. 
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uncoupled in these groups. Uncoupling was calculated by analysing the progression 
between jog and looping data to determine whether jog position was predictive of 
loop direction. Since midline jogging is not predictive of heart looping, this group was 
discounted from the analysis. It was found that uncoupling of the heart movements 
increased in a dose-dependent manner as the amount of morpholino was raised. 
However, only at the 4ng 1a; 4ng 1b dose was this uncoupling statistically significant 
when compared to 8ng control morphants. At this high 4ng jnk1a; 4ng jnk1b dose, 
uncoupling of the jog and looping position approaches 30% of the total morphant 
population (Figure 53). 
 
 
 
 
 
 
 
  
Figure 53 Compound jnk1a; jnk1b Knockdown Results in 
Heart Movement Uncoupling in a Dose-dependent 
Manner.  
Plot of mean percentage compound jnk1a; jnk1b 
morphants that display an uncoupling of heart jogging and 
looping. The frequency of heart uncoupling was found to 
increase in a dose-dependent manner but was only 
statistically significant at the 4ng 1a; 4ng 1b dose as 
compared to controls. One-way ANOVA followed by 
Dunnett post-hoc test performed. (** p<0.001) errorbars = 
SEM. 
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5.2.2 Patterning Defects of the Gut 
5.2.2.1 Normal Liver Laterality is Disrupted in jnk1 Morphants 
In addition to the heart, several other organs in the zebrafish show left-right 
asymmetry in position and structure. One organ that develops asymmetric laterality is 
the liver which sits on the left side of wildtype embryos. In order to determine whether 
the laterality defects of jnk1 morphants was restricted to the heart, or whether it also 
affecting other visceral organs, I performed two-probe, wholemount in situ 
hybridisation. The two probes used were myl7 (cmlc2) which is expressed within 
cardiomyocytes, and foxa3 which is expressed in the developing liver, pancreas and 
gut. From these data I was able to examine the location of the liver in zebrafish 
embryos as well as investigate whether positioning of the heart and gut were 
correlated; discordant organ laterality is known as heterotaxy. 
The in situ hybridisations were performed on 8ng CMOs, 4ng jnk1a, 4ng jnk1b and 4ng 
1a; 4ng 1b morphants at 48hpf. Approximately thirty-five embryos were generated per 
clutch and grown in PTU containing media after 24hpf to reduce pigment generation. 
At 48hpf the embryos were collected, dechorionated with pronase, and fixed in 4% 
PFA. Wholemount in situ hybridisation was performed using a protocol modified from 
Thisse et al. (Thisse and Thisse, 2008) using antisense probes against the developing 
gut (foxa3) and heart (myl7) within the same embryos. 
From the in situ hybridisation data I was able to observe liver position within the 
morphants. The liver is predominantly positioned on the left side of wildtype zebrafish 
(Figure 54B), however, from my results I also found embryos without any observable 
liver formation (Figure 54C), with bilateral symmetry of the liver (Figure 54D), and right 
sided (reversed) positioning (Figure 54E). These phenotypes are rare in untreated 
embryos but have been described previously in the literature, such as when there is a 
disruption of left-right patterning (Wang et al., 2011).  
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Figure 54 jnk1 Morphants May Display Laterality Defects of the 
Developing Liver.  
Preliminary data suggests that knockdown of jnk1a, jnk1b, or compound 
jnk1a; jnk1b genes causes laterality defects of the liver. Quantification of 
liver placement at 48hpf via in situ hybridisation analysis (foxa3 probe)  (A) 
appears to show that normal liver positioning is disrupted when jnk1 
morpholinos are used. These laterality defects are greatest with the 4ng 
jnk1a; 4ng jnk1b injections. In situ hybridisation images show examples of 
normal liver laterality (B), a failure to develop (C), bilateral symmetry of 
the liver (D) or reversal of liver asymmetry (E). The percenta ge frequency 
of each phenotype at different doses is displayed in (F). Images are taken 
from a ventral perspective so left of image is left of embryo.  
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To quantify the laterality disturbance of the liver I counted the prevalence of each 
phenotype at the desired MO doses. Preliminary findings (n=1 or 2) from this dataset 
seem to suggest that in uninjected controls 90% of embryos have the liver on the left 
side of the body. However, 10% of CMO treated embryos show defects of correct liver 
positioning (Figure 54A). The most prevalent defect that was observed in the control 
group was a bilateral symmetry of the liver. In comparison, each of the jnk1 
morpholino doses used resulted in a lower frequency of normal, leftward liver position 
compared to controls. In the 4ng jnk1a group only 60% of embryos had the liver on the 
left side of the body and instead there were high incidences of absent or bilaterally 
(Figure 54F) symmetrical liver formation (13% and 17% respectively). Very few 4ng 
jnk1a morphants displayed reversed asymmetry of the liver (7%).  The same cannot be 
said for the 4ng jnk1b morphants; at this dose only around 40% of morphants display 
normal liver laterality (Figure 54A) - considerably fewer than the 60% that achieve 
normal heart laterality at this dose (Figure 48A). The 4ng jnk1b morphants also 
displayed large frequencies of absent or bilateral liver literality (12% and 18% 
respectively), although these groups were not as highly populated as the reversed liver 
asymmetry; right-sided development of the liver was found in almost 30% of jnk1b 
morphants examined (Figure 54B). Finally the laterality of the liver in the 4ng jnk1a; 
4ng jnk1b morphants seemed to be most greatly disturbed with only 26% of 
morphants forming the liver on the left of the body (Figure 54A). Although reversal of 
the liver was highly represented (14%), both an absence of the liver (31%) and bilateral 
(29%) liver development had a two-fold higher incidence (Figure 54B). Unfortunately 
this data could not be repeated with sufficient replications to perform statistical tests, 
and instead must be considered as preliminary data. However, these initial results 
appear to suggest that global organ laterality is disturbed in jnk1 morphants. 
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The in situ hybridisation analysis performed made use of two non-overlapping probes 
which separately mark the liver and heart position. From this data I was therefore able 
to determine whether the position of the visceral organs correlated, or whether the 
morphants displayed visceral organ heterotaxy. In the case of the laterality defect situs 
inversus totalis the visceral organs all develop asymmetrically, but are mirrored 
(reversed) from their normal arrangement. In comparison, heterotaxy (situs 
ambiguous) is characterised by randomised and discordant organ laterality. I therefore 
examined the in situ results to determine whether the heart position and liver position 
correlated, or whether these two organs were independent of one another. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 55 jnk1 Morphants Display Heterotaxy of the 
Visceral Organs.  
Preliminary data showing percentage heterotaxy in jnk1 
knockdowns. This data shows a trend of jnk1 knockdown 
increasing the amount of organ heterotaxy in developing 
zebrafish. Mean percentage of heart and liver 
discordance plotted. Error bar = SEM.  
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Although these results are preliminary and few replicates are available, they suggest 
that knockdown of jnk1 may cause visceral organ heterotaxy. Surprisingly in 8ng 
control morphants I found that organ placement does not correlate in over 10% of 
morphants. However, this figure is far greater in jnk1a and jnk1b morphants; at both of 
these doses the incidence of heterotaxy is around 35% although variability was high 
(Figure 55). In 4ng jnk1a; 4ng jnk1b morphants the incidence of heterotaxy was almost 
60% in the one clutch that was investigated. As explained the number of replicates 
that were performed does not allow for any conclusions to be drawn, however there 
does seem to be a degree of organ discordance in these morphants. 
 
5.3 Discussion 
c-Jun N-terminal kinase 1 is a MAP kinase and member of the planar cell polarity 
pathway. In this latter role it sits downstream of the core PCP genes and is activated in 
response to non-canonical Wnts (Yamanaka et al., 2002). Since the PCP pathway has 
been comprehensively linked to patterning of the left-right axis during embryogenesis 
(Song et al., 2010, Wang et al., 2011, Walentek et al., 2013) I decided to investigate 
whether jnk1 knockdown disrupts normal L-R patterning. 
The laterality results show that the two jnk1 paralogs do play a role in left-right 
patterning of the zebrafish visceral organs. At the highest dose (4ng) both jnk1a and 
jnk1b morphants displayed a significant divergence from formation of the normal 
cardiac D-loop; however the degree to which laterality defects were observed, and the 
mechanism by which they occurred appeared to be distinct between the two genes. 
Knockdown of jnk1a caused a lower overall occurrence of heart laterality defects but 
with a significant number of hearts that displayed jog / loop uncoupling. Conversely 
jnk1b morphants displayed a higher level of laterality defects without heart movement 
uncoupling. Preliminary investigation of liver laterality shows a similar trend whereby 
jnk1b knockdown causes greater frequency of laterality defects, but more replicates 
are required before this can be confirmed.  
The jnk1a and jnk1b findings suggest that the two paralogs may possess different 
(possibly overlapping) function in patterning of the embryonic left-right axis because 
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despite some cross reactivity of the MOs they do produce different phenotypes. 
Functional differences between paralogs have been reported in the teleost literature 
previously, such as in the JAK family of kinases in zebrafish (Oates et al., 1999) and the 
Wnt8a paralogs of medaka (Mwafi et al., 2014). These jnk1 paralog results therefore 
strengthen the theory that paralogs which survive a genome duplication event have 
developed novel functions or shared ancestral function (Force et al., 1999). Further 
investigation of what function each jnk1 paralog has acquired is therefore necessary.  
 
5.3.1 The Left-Right Patterning defects of the jnk1a Morphant May be 
due to Midline Barrier Defects. 
At the 4ng dose of jnk1a morpholino there was a significant divergence of heart 
laterality away from normality (Figure 49) as well as jog / loop uncoupling (Figure 50). 
These data suggest that jnk1a is indeed involved in patterning of the left-right axis, 
however they may also reveal a role in formation of the midline barrier. All of the 
previous genes found to cause heart uncoupling have been shown to affect midline 
barrier formation or southpaw (zebrafish NODAL) signalling directly - although the 
literature is by no means exhaustive (Ahmad et al., 2004, Chin et al., 2000). Were jnk1a 
to participate in midline barrier regulation we could expect morphants to display 
changes within markers of the physical midline barrier such as ta (no tail) or noto 
(floating head) (Chin et al., 2000) or possibly the gene expression of molecular midline 
barrier members such as lefty1 or lefty2. A breakdown of the midline barrier results in 
free diffusion of left-sided signalling molecules through the lateral plate mesoderm, 
resulting in aberrant spatial and temporal left-sided signalling (Lenhart et al., 2011). 
Preliminary results from our lab suggest that lefty1 expression is dampened in jnk1a 
morphants which supports the theory that jnk1a has a role in midline barrier 
formation. If confirmed, this would supply mechanistic evidence for how jnk1a 
knockdown results in heart uncoupling defects – by altering the midline barrier. 
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5.3.2 The jnk1b Gene has a Greater Role in L-R Patterning of the 
Visceral Organs 
Cardiac laterality defects were consistently observed in jnk1b morphants at a higher 
frequency than jnk1a morphants of the same dose (Figure 48B). This higher prevalence 
of laterality defects also appeared to occur in liver formation, although more replicates 
are required to prove this. These data suggest that jnk1b may be the major paralog 
required for patterning of the left-right axis in the lateral plate mesoderm.  
The prevalence of heart defects observed when jnk1b was knocked down at a dose of 
4ng (~40%) was comparable to what was found when the other downstream PCP 
kinase was targeted; the frequency of defects observed when rock2b was knocked 
down at a dose of 4.4ng was between 35-40% based on two different MOs (Wang et 
al., 2011). jnk1b therefore appears to have an equal role in left-right patterning as the 
other kinase in the PCP pathway. Disruption of either kinase in this pathway has a 
significant effect on positioning of the visceral organs suggesting that both are vital. 
Knockdown of both kinases together to determination whether any genetic 
redundancy exists between these two kinases may be an interesting experiment for 
the future.  
An interesting feature that has been discovered in my heart laterality analysis is that 
when jnk1b is knocked down there appears to be a bias toward reversal of heart 
looping laterality. At both a 2ng and 4ng dose the prevalence of reversed heart looping 
(L-loop) is >2.5 times greater than a failure to loop (O-loop). A possible explanation for 
this is that loss of jnk1b results in an increase of aberrant southpaw expression on the 
right side of the embryo. In the inversin mouse mutant there is consistent right-sided 
expression of Nodal, and mutants develop situs inversus totalis (Yokoyama et al., 
1993). Although the jnk1b morphants do not appear to have the same 100% 
penetrance of reversed organ laterality that is observed in inversin mutants, there may 
be a bias towards reversal. Investigation of southpaw expression in morphants is 
therefore an important future experiment which would determine whether jnk1b acts 
through the same mechanism as inversin.  
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5.3.3 Compound jnk1a; jnk1b Knockdown Effects the Ability of the 
Heart to Loop 
Knockdown of both jnk1 paralogs together results in a severe loss of normal organ 
laterality which appears to be the summation of what is observed at individual doses. 
Compound jnk1a; jnk1b morphants display approximately double the laterality defects 
of the morphants with either jnk1a or jnk1b knocked down, and both organ laterality 
and organ uncoupling defects are observed. This observation further supports the idea 
that each paralog may possess a different function, although a doubling of organ 
laterality defects highlights their overlapping functions.  
At the highest compound jnk1a; jnk1b dose that was administered (4ng jnk1a; 4ng 
jnk1b) only ~30% of hearts form a D-loop, a percentage which corresponds with 
complete randomisation of which way the heart moves given that there are three 
possible choices: D-loop, O-loop, L-loop. However, as shown in Figure 51 many more 
morphants at this dose fail to loop than achieve it. The prevalence of O-loops is 
suggestive that knockdown of both jnk1 paralogs may result in an inability of the heart 
tube to loop. It is not clear why jnk1 knockdown might bias O-loop formation, although 
it could be due to a loss of left-sided signalling, an inability to respond to these signals, 
or even due to mechanical forces that arise from the pericardial oedema that develops 
in compound jnk1a; jnk1b morphants. In the latter case the mechanical forces that the 
heart is subjected to cause it to form a very distinct “strung-out” phenotype, where 
the heart develops in a very long and thin tube as it is stretched (Ghosh et al., 2009). 
Although this phenotype is not observed in fluorescent microscopy or sectioning of 
compound jnk1a; jnk1b morphant hearts, it cannot be thoroughly ruled out in this 
study. Determination of the mechanism by which these hearts fail to loop could be an 
interesting experiment which could shed light on the exact signalling role of jnk1 in the 
left-right patterning pathway. 
Uncoupling of heart movement was also significantly effected in the 4ng jnk1a; 4ng 
jnk1b morphants which may be judged as evidence that the midline barrier is failing to 
form correctly. However, due to the way that heart uncoupling is scored, proposed by 
Chin et al., caution should be taken when making any conclusion. As described above, 
there may be some mechanism which is preventing the hearts of compound jnk1a; 
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jnk1b morphants from looping. Uncoupling of the heart is considered to be where the 
jogging position of the heart (left or right) is not predictive of the looping direction that 
follows (Chin et al., 2000), therefore a left jog followed by O-loop is scored as 
uncoupled. Were some secondary defect such as oedema causing the heart to fail in 
looping, then uncoupling of heart movement may be falsely scored. This possible 
explanation highlights a limitation of uncoupling scoring; uncoupling of the heart may 
be overestimated if mechanical forces prevent looping from occurring.  
 
5.3.4 Evidence for left-right patterning and ciliogenesis defects in jnk1 
morphants 
As discussed above, both heart and gut scoring revealed left-right situs defects of the 
visceral organs in jnk1 morphants. These situs defects were suggestive of aberrant left-
right patterning of the lateral plate mesoderm from which the visceral organs 
originate. To determine whether there was indeed aberrant LPM left-right patterning 
Dr. Simon Ramsbottom conducted in situ hybridisation experiments to visualise the 
expression of spaw (zf NODAL), lefty1 and lefty2 at the 18 somite stage. These 
preliminary results seem to confirm the hypothesis that left-right patterning of the 
lateral plate mesoderm is indeed disrupted in jnk1 morphants. 
In controls embryos at the 18 somite stage spaw is highly expressed throughout the 
length of the body in the left lateral plate mesoderm (Long et al., 2003b), lefty1 is 
expressed just left of the notochord and medially of spaw, and lefty2 is expressed in 
the distal left lateral plate mesoderm, partially overlapping spaw expressing regions, 
where it experiences upregulation by spaw (Bisgrove et al., 1999). However, both 4ng 
jnk1a morphants and 4ng jnk1b morphants were shown to have aberrant expression of 
these three genes which could help to explain the observed organ situs defects. 
In 4ng jnk1a morphants expression of southpaw was left-sided (normal) in <50% of 
embryos, whereas around 15% had right-sided (reversed) and >30% had absent or 
substantially reduced spaw expression domains that did not extend into the embryonic 
trunk. Lefty2 expression was found to be <80% left-sided in 4ng jnk1a morphants with 
<20% displaying midline and almost 5% having bilateral expression profiles. The 
molecular midline-barrier component gene lefty1 was also found to display an 
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aberrant expression domain with <60% having normal medial expression in the tail and 
trunk and ~40% having faint or reduced expression regions and ~8% having very short 
expression restricted to the tail alone. This disruption of normal left-right patterning 
gene expression could prove to be the mechanism for organ situs defects within the 
jnk1a morphants. 
In 4ng jnk1b morphants normal left-sided expression of spaw was only observed in 
about 15% of morphants whereas ~20% had right-sided, ~55% displayed absent spaw 
and ~10% had spaw expression restricted to the posterior tail. Despite this severe 
divergence from normality >50% embryos expressed lefty2 on the left side of the 
embryo in 4ng jnk1b morphants. Of those that diverged from normal lefty2 expression 
profiles there were ~20% with midline and ~20% right lefty2 expression. Finally, for 
lefty1 expression the 4ng jnk1b morphants had only ~40% with normal midline 
expression whereas ~60% were far weaker or had reduced expression regions. 
Interestingly the most severe phenotype – very short and weak expression restricted 
to the tail – was not observed in 4ng jnk1b morphants. 
These preliminary results performed by Dr. Ramsbottom support and strengthen what 
I found during my PhD, that knockdown of jnk1 during development disrupts normal 
left-right patterning of the embryo. In particular the observation that normal nodal 
expression is as low as ~50% in 4ng jnk1a and ~15% in 4ng jnk1b morphants is broadly 
consistent with the significantly reduced rates of normal heart and gut situs observed 
during phenotyping (Figure 49 and Figure 54). In addition, these nodal in situ results 
support my hypothesis that jnk1b is more important in establishing left-right 
asymmetry within the visceral organs since loss of this gene shows a greater impact 
upon nodal signalling than the jnk1a MO at the same dose. Furthermore, the patterns 
of lefty2 expression also support this greater role of the jnk1b gene since 4ng jnk1a 
morphants have <80% normal expression compared to the ~50% of jnk1b mophants. 
Although further investigation is required, this correlation between left-right situs 
defects and aberrant left-right patterning genes could be causative. Finally the 
observation that the most severe lefty1 expression defects are seen only in jnk1a 
morphants appear to correlate with the small but significant percentage of heart 
uncoupling that is observed at the 4ng jnk1a dose (Figure 50). Again, further work is 
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required to confirm this link, particularly in light of experiments showing that spaw 
knockdown can also cause cardiac uncoupling (Ahmad et al., 2004) and the high 
frequency of jnk1 morphants that displayed a reduced spaw expression range. 
To further probe the possibility of whether left-right patterning was disrupted in jnk1 
morphants, Dr. Ramsbottom conducted some immunofluorescent examination of cilia 
within Kupffer’s vesicle of morphants. These preliminary results showed that for both 
4ng jnk1a and 4ng jnk1b morphants the size of Kupffer’s vesicle and the length of the 
cilia within the vesicle were shorter. Similar phenotypes have been demonstrated in 
zebrafish embryos with left-right patterning defects and a causative link has been 
shown to exist between Kupffer’s vesicle defects and aberrant left-right patterning 
gene expression (Song et al., 2010, Walentek et al., 2013, Wang et al., 2011), however 
further work is required to demonstrate a causative link in the jnk1 morphants. 
 
5.3.5 Concluding Remarks 
These data have been able to show that jnk1 is indeed involved in left-right patterning 
of the embryo, as are many other members of the PCP pathway. The two zebrafish 
paralogs are implicated in patterning laterality of the visceral organs the heart and 
liver, although loss of each individually does not result in the same phenotype. These 
data provide further evidence for a distinct functional difference between the two 
zebrafish jnk1 paralogs in embryonic development, specifically organogenesis. Further 
work is required to fully elucidate the exact roles and mechanisms by which the jnk1 
genes act, although this study provides a solid foundation upon which any future work 
can be based. 
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6.1 SUMMARY 
The aim of this thesis was to increase what was known about zebrafish jnk1 genetics, 
develop a robust model system for the study of jnk1 function during development, and 
explore the phenotypic consequences of jnk1 knockdown during embryogenesis. The 
role of JNK1 during development is a contested and poorly understood topic due in 
part to the lack of a suitable model system. Much of the early research favoured small 
molecule inhibitors of JNK which did not differentiate between different JNK family 
members. Furthermore the knockout of mouse Jnk1 resulted in no observable 
morphological changes, although behaviour was affected as determined by exposure 
to different maze tests (Reinecke et al., 2013). This mild phenotype is likely due to 
genetic redundancy between Jnk1 and Jnk2 function since compound Jnk1/Jnk2 null 
mutants die displaying neural tube closure defects (Kuan et al., 1999); this 
compensatory function between isoforms was not observed in Xenopus however. 
Morpholino knockdown of Xenopus jnk1 (as well as mkk7, an activator of all jnk 
isoforms) resulted in short and wide embryos reminiscent of a convergent extension 
defect. These inconsistencies between models therefore confound the understanding 
of JNK1 function during development because they imply vastly different importance 
of JNK1 during development in each case. Zebrafish, which are a favourable model for 
the study of vertebrate embryogenesis, may therefore provide an amenable model to 
better understand the function of this gene during development. 
The objectives of this project were met by a combination of in silico bioinformatics and 
general developmental biology techniques. Use of the ENSEMBL and NCBI databases 
provided a starting point from which to study the two jnk1 paralogs and allowed for 
primers to be designed for full-length transcript PCR. Once precise sequences had been 
determined for the AB zebrafish strain jnk1 genes, it was possible to generate accurate 
morpholinos and primers for further studies. Morpholino oligonucleotides provided a 
“forward genetic method” by which jnk1 function could be studied. During the project 
the morphant dose was refined and phenotype was characterised, which revealed 
several organs and tissues that required jnk1 function for normal development. 
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6.2 DISCUSSION 
6.2.1 Summary of Findings 
Through the amplification of full-length transcripts I was able to demonstrate that at 
least four splice-variants are generated by each of the two jnk1 paralogs (jnk1a and 
jnk1b). These variants differ in their inclusion of either exon 7 or exon 8, and in the 
exon 13 splice-acceptor site used, determining the ORF length. Via semi-quantitative 
RT-PCR it was shown that although these transcripts have different expression 
patterns, the pattern generally depends upon “middle exon” usage; exon 7 containing 
variants were absent at early segmentation stages (12hpf) and restricted to the adult 
brain, whereas exon 8 containing variants were most abundant very early in 
development (0-5.25hpf) and were expressed in most tissues examined. This data is 
suggestive of different roles for the jnk1 splice-variants dependent upon which exon is 
included. 
Morpholino oligonucleotide knockdown of each paralog enabled a global overview of 
jnk1 function during development. Interestingly the phenotype of jnk1a or jnk1b 
morphants was paralog-specific, demonstrating that the two genes have at least some 
non-overlapping functions. Knockdown of jnk1a resulted in defects of the somitic 
muscle and smaller eye size, as well as severe underdevelopment of the heart and 
pericardial oedema. Furthermore the cardiac jog-loop progression was uncoupled in 
these morphants suggestive of midline barrier disruption. In jnk1b morphants the 
embryonic axis was severely curled ventrally and the somitic horizontal myoseptum 
failed to develop. The structural heart defects of jnk1b morphants were milder, 
although reversal of cardiac looping was more prevalent in these morphants. 
Compound jnk1a; jnk1b morphants displayed a combination of defects seen in jnk1a or 
jnk1b morphants, and demonstrated the most severe phenotypic effects. Of particular 
note was the high frequency of morphants that failed to undergo cardiac looping and 
remained as O-looped hearts. These data demonstrate how critical the role of jnk1 is in 
orchestrating the process of heart looping. 
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6.2.2 Validity of Studying jnk1 Function in the Zebrafish 
6.2.2.1 Sequence Conservation to Human JNK1 
In order to provide meaningful insight into the function of human JNK1 it is necessary 
to demonstrate that some aspects of jnk1 function are conserved in zebrafish. In this 
thesis I have shown that the two zebrafish jnk1 proteins each share >85% sequence 
identity to that of the human form, with still greater conservation in the protein kinase 
domain. A comparable level of sequence identity has also been reported previously 
(87%) at the DNA level when jnk1b was aligned to human JNK1 (Krens et al., 2006b). 
However, the zebrafish jnk1a gene is a more recent discovery so this has not been 
previously compared. In addition to sequence identity, it is interesting to find that the 
splicing events of zebrafish jnk1 genes are conserved with those of human JNK1. 
Human JNK1 has been shown to give rise to four different splice-variants which differ 
in their exon usage (exon 7 or 8) and amino acid length (384 or 427 amino acids). 
These variants have homologous zebrafish variants that arise from both jnk1a and 
jnk1b, strengthening the idea of functional conservation (Figure 56). 
Figure 56 The zebrafish jnk1 splice-variants are homologous to human JNK1.  
Schematic representation of the human JNK1 and zebrafish jnk1a and jnk1b splice-variants 
in the style of (Barr and Bogoyevitch, 2001). Both human JNK1 and the two zebrafish 
paralogs give rise to at least four different splice-variants which differ in the inclusion of 
either exon 7 or 8, and the length of the transcript (dependent upon the choice of 3’ splice 
acceptor site). The similarities is transcript length and structure between human are 
suggestive that these eight zebrafish splice-variants are homologous. Black and diagonally 
striped boxes representative of exon 7 or exon 8 integration. Horizontal striped box 
represents longer open reading frame created by use of the alternative 3’ splice acceptor 
site. Asterisks represent the thr/tyr phosphorylation site.    
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Despite the observed conservation, it remains an inconsistency that zebrafish possess 
two jnk1 copies whereas there is only a single human ortholog. Preservation of both 
zebrafish copies indicates that some selective pressure is experienced to retain both 
paralogs, either by creation of a new function (neofunctionalization) or distribution of 
the ancestral gene functions amongst the two paralogs (subfunctionalization) (Force et 
al., 1999). Were the zebrafish jnk1 genes to have evolved novel functions since the 
divergence of the two species then their validity to model human JNK1 might be 
limited.  
The accepted model of duplicate gene conservation (duplication-degeneration-
complementation) proposes that the sharing of a gene’s functions 
(subfunctionalization) accounts for a significant amount of duplicate genes which have 
been retained; primarily this is suggested because the incidence of random mutations 
which cause novel functions is much smaller than the deleterious mutations which 
result in subfunctionalization (Lynch and Force, 2000). Evidence of this theory is 
observed in the zebrafish pax6 (Kleinjan et al., 2008), hoxb5 (Bruce et al., 2001) and 
fabp1 (Sharma et al., 2006) paralogs, each of which possess partial function of their 
ortholog. However, for each of these duplications the two transcripts were shown to 
have differential expression patterns (which when combined mirror the expression 
patterns in mouse), meaning that both forms are necessary for function in all the 
tissues of the body (i.e. pax6b is the only variant expressed in the pancreas). This 
difference in expression pattern might also be observed in the jnk1 genes, although my 
experiments did not find any evidence of this at the timepoints and tissues examined. 
Instead I found that there was different expression patterns between different splice-
variants, although these patterns were largely similar for both jnk1 paralogs. It still 
remains to be shown whether each of the jnk1 paralogs has partial function of the 
human JNK1 gene, however, were this to be shown then it would further validate the 
use of a zebrafish jnk1 model.  
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6.2.2.2 Off-target Effects of Morpholinos 
The use of morpholinos targeted to jnk1a and jnk1b produces phenotypes that are 
reproducible and which do not resemble features which have previously been found to 
be due to morpholino toxicity – namely gastrula arrest and clouding of the central 
nervous system due to increased apoptosis (Coffman et al., 2004, Robu et al., 2007). 
However, further tests are required in order to confirm that off-target effects are not 
caused by the two morpholinos. Generally co-injection with p53 MO is advised in order 
to abrogate any increased p53 activity that MOs can provoke; if the morphant 
phenotype is not rescued by knockdown of p53 then this is further evidence that the 
phenotype is a specific effect. Furthermore a phenotypic rescue with MO-resistant 
mRNA further demonstrates that the morphant phenotype is due to knockdown of 
your target, and not some off-target gene. Both of these experiments would be 
suitable for future work in order to increase confidence in the specific effect of the 
jnk1 morpholinos. 
In both jnk1a and jnk1b morphants we see cardiac oedema, and curling/kinking of the 
body axis which are phenotypes that are very commonly observed in morpholino 
experiments. The zebrafish gene lingo1b (Leucine-rich repeat and immunoglobulin-like 
domain-containing nogo receptor-interacting protein 1) is necessary for axonal growth 
and in situ hybridisation reveals that it is expressed only in the central nervous system 
during development. Despite this restricted expression, lingo1b morphants display a 
curled tail phenotype and cardiac oedema at 96hpf (Yin and Hu, 2014), suggestive that 
these two features may be non-specific morpholino phenotypes. Interestingly both 
features were reported to be alleviated by mRNA rescue, although this could be 
explained by a binding of the MO to the exogenous mRNA; the injected mRNA was not 
modified to protect it from the binding of the MO. This experiment highlights the need 
for caution when interpreting morpholino experiments, especially for commonly seen 
traits such as tail curling, because there have been several phenotypes attributed to 
off-target or non-specific effects of morpholinos (Robu et al., 2007, Coffman et al., 
2004, Eisen and Smith, 2008).  
Despite the jnk1 morphants displaying phenotypes commonly observed in other 
morpholino experiments this does not prove that they are off-target effects. Both 
jnk1a and jnk1b knockdown resulted in cardiac oedema which is not surprising 
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considering the severity of the heart phenotypes. The histology of the jnk1a morphant 
heart at 48hpf and 72hpf resembled the immature linear tube observed between 24-
28hpf in normal development. Furthermore the absence of a recognisable 
atrioventricular valve and the small lumen size (exacerbated by expansion of the 
cardiac jelly) suggest that cardiac function would be severely compromised in these 
embryos. In sections of jnk1b morphants, although cardiac looping did occur the heart 
chamber and lumen size appeared smaller than controls and function may therefore 
be reduced. Were this to be the case then this could explain the oedema phenotype. 
It has been shown comprehensively that several unrelated chemicals (2,3,7,8-tetra-
chlorodibenzo-p-dioxin, retinoic acid carbaryl and valproic acid) and a MO for the tbx5 
gene all result in a strikingly similar pericardial oedema and a heart failure-like 
phenotype in zebrafish embryos between 72-120hpf (Chen, 2013); the authors 
conclude that each of the heart development insults had initially different 
mechanisms, but resulted in the same  phenotype later in development, including 
reduced cardiomyocyte proliferation, lower organ contractility and a common 
transcriptional response. Whether this represents a common end-point for all insults 
that perturb early heart formation remains to be seen, although it could potentially 
explain the jnk1 morphant oedema. An alternative mechanism whereby renal failure 
results in the oedema could also explain this fluid accumulation therefore further 
investigation is necessary (Rider et al., 2012).  
 
6.2.2.3 Similarity and Conflicts with other jnk1 Research 
Further evidence that the phenotypes reported in this thesis are due to jnk1 
knockdown and not non-specific effects come from the literature. As discussed earlier, 
the role of the zebrafish jnk genes has been studied before using shRNAs (small hairpin 
RNAs) and the JNK inhibitor SP600125 (Xiao et al., 2013). When jnk1b was knocked 
down with shRNA this resulted in embryonic lethality of around 90%. Those embryos 
that survived the treatment displayed developmental delay, body axis bending and 
yolk deformities (Xiao et al., 2013). Certainly the body axis defects are consistent with 
my own results and also developmental delay was found when both jnk1a and jnk1b 
was knocked down at the 4ng jnk1a; 4ng jnk1b dose. However, the fact that a majority 
of embryos failed before 24hpf contradicts what I have shown because morpholino 
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jnk1 knockdown did not significantly affect embryonic survival. It is possible that this 
embryonic death is therefore an artefact of the methodology or dosage (300ng) used 
in the Xiao et al. paper (2013). The authors went on to utilise the drug SP600125 to 
inhibit pan-jnk function, and these experiments also show some similarity to what I 
have found. 
Xiao et al. (2013) reported that embryos dosed with SP600125 before the hatching 
period (48-72hpf) commonly had pericardial oedema, body length reductions and 
undifferentiated gonads in comparison to controls. Furthermore, histology of this 
group revealed that the retina was underdeveloped and had not formed laminations 
(Xiao et al., 2013); comparatively dosing after hatching caused almost 100% mortality 
at high (1.4μM) doses and a reduced body length and cranial bone deficiencies of the 
embryos at a lower dose (0.8μM). Several of these phenotypes had previously been 
reported in Valesio et al. (2011) where SP600125 was administered from 0-30hpf, 18-
24hpf or 22-28hpf at 1.25μM and 5μM. The most severe phenotypes were observed 
when SP600125 was administered for the first 30 hours of development, however in 
each treatment group there was oedema and failure of the swim bladder to inflate. 
However, at the 5μM dose between 0-30hpf it was also shown that embryos had 
reduced body length, bent tail and trunk, jaw and retina defects, multiple or ectopic 
lens formation, and disorganisation of brain structures.  
Previous work within our lab also supports these results when the SP600125 drug is 
used. Dosing embryos during gastrulation (5.25-10hpf) or segmentation (10-22hpf) 
resulted in an increased prevalence of tail curling/kinking, shortened body length, 
small eye development, and cardiac oedema. In addition it was found that about 25% 
of embryos had abnormal heart looping situs, reduced cardiomyocyte numbers and 
approximately 10% had otic vesicle defects (Unpublished data – Papoutsi, 2011 PhD 
Thesis).  
These previous findings strengthen the validity of the jnk1 morpholino system since 
there is a consistency of several defects between these different methodologies (i.e. 
body length reduction, bent/kinked tail, retinal defects, cardiac oedema and heart 
situs defects). It is also unsurprising that not all of the defects were observed in the 
morphants because the morpholinos target only jnk1a or jnk1b, whereas all jnk 
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proteins are inhibited by the SP600125 drug (Bennett et al., 2001). Furthermore, 
although the frequency of situs defects, oedema, and small eye development are 
greater in jnk1 morphants than those treated with a jnk inhibitor, this inconsistency 
probably reflects the methodologies that were used. The drug must be used at low 
doses (Valesio et al., 2013, Xiao et al., 2013) and over restricted timepoints to avoid 
embryonic lethality (Papoutsi, 2011 PhD Thesis). Conversely the jnk1 morpholinos are 
specific to jnk1 and are effective between the one-cell stage and 72hpf (Summerton et 
al., 1997). These morphants therefore represent only jnk1 loss of function, but over 
the duration of the experiment. 
Although the jnk1 morphant phenotype in this thesis recapitulates some of the 
phenotypes observed in pan-jnk inhibited zebrafish, there are inconsistencies with 
other studies that have been published. In Seo et al. (2010) they used splice-modifying 
morpholinos to knock-down jnk1a+jnk1b or jnk2 to determine whether convergence 
extension was affected (Seo et al., 2010). Convergent extension-like defects were not 
observed in the compound jnk1a; jnk1b knockdowns in this paper and no phenotypic 
defects or developmental delay was reported. Since no data was shown beyond 16hpf 
for jnk1 morphants it may be that observable defects only occur at later timepoints 
(certainly for eye and heart defects). However, it seems unusual that developmental 
delay would not be present at 16hpf whereas my data shows delay in compound 
jnk1a; jnk1b morphants at 22hpf. One possible explanation for this difference is that 
the morpholinos used initiate knockdown at different timepoints. Splice-modifying 
morpholinos like those used in Seo et al. (2010) target immature RNA molecules (i.e. 
pre-mRNA) before splicing occurs in order to knock down functional protein 
production, and therefore do not affect the maternally inherited mRNAs in the zygote. 
Knockdown of the target therefore begins when zygotic transcription commences, 
shortly after 3hpf (Aanes et al., 2011). Translation-blocking MOs like those used in this 
thesis are capable of knocking down maternal and zygotic protein production, 
therefore ensuring knockdown from the 1-cell stage. 
In the Jnk1 null mouse the mice develop normally and are fertile, only displaying 
behavioural changes when run through maze tests (Kuan et al., 1999, Reinecke et al., 
2013). The mildness of the phenotype has been hypothesised to be due to genetic 
redundancy with Jnk2 since loss of both isoforms is lethal (Kuan et al., 1999, Sabapathy 
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et al., 1999). However, this redundancy was not observed in the zebrafish jnk1 
morphant, a conflict which could be advantageous (allowing for functional 
investigation of jnk1) or a limitation of studying jnk1 function in zebrafish (if for 
example human JNK1 is also compensated for by JNK2). Although this project cannot 
rule out some genetic redundancy between the zebrafish jnk genes, the degree to 
which they are able to compensate for loss of jnk1 is not the same in the zebrafish as 
in the mouse; I have shown clear morphological defects when jnk1 is knocked down by 
morpholino so the jnk2 and jnk3 genes cannot completely compensate in zebrafish. 
Since no reports of mutations to human JNK1 have been reported, it is unclear 
whether JNK1 loss can be compensated for, or is lethal in humans. However, the 
absence of the zebrafish genes to completely compensate for the loss of jnk1 allows 
for us to examine the role of jnk1 in a way that would not be possible in the mouse. In 
zebrafish we can knockdown jnk1 and observe which developmental processes are 
perturbed during normal embryogenesis. A similar experiment in the mouse would 
produce results that are masked by the compensatory function of the jnk2 gene. 
 
6.2.3 Evidence of jnk1 Action through the PCP Pathway 
JNK can function in the MAPK and PCP signalling pathways, both of which have been 
found to be crucial for normal development e.g. heart development (Phillips et al., 
2007, Yu et al., 2007, Moeller et al., 2006, Keren-Politansky et al., 2009, Kelly et al., 
2014), kidney development (Balbi et al., 2009, Omori et al., 2000, Saburi et al., 2008, 
Simons et al., 2005), convergent and extension cell movement (Wang et al., 2006a, 
Veeman et al., 2003, Jessen et al., 2002, Yamanaka et al., 2002, Nie and Chang, 2007, 
Nutt et al., 2001, Keren et al., 2005). In this thesis I have not tried to tease apart which 
of these signalling pathways jnk1 is acting through during development, or which 
pathway gives rise to the individual developmental defects that are observed. 
However there appears to be circumstantial evidence that the PCP pathway (at least) is 
perturbed in jnk1 morphants which gives rise to the left-right patterning defects.  
The planar cell polarity pathway has been extensively linked to establishment of the 
left-right axis during embryogenesis (Zhang and Levin, 2009, Mochizuki et al., 1998, 
Marques et al., 2004, May-Simera et al., 2010, Oishi et al., 2006, Walentek et al., 
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2013). The major line of thought is that PCP signalling is required for uniform 
alignment of epidermal cells in the node which project cilia into the vesicle and 
contribute to nodal flow (Borovina et al., 2010, Oteiza et al., 2010, Wang et al., 2011, 
Song et al., 2010). Critically the MAPK pathway has not been observed to contribute to 
the left-right patterning of the embryo at the time of writing. 
Knockdown of both jnk1a and jnk1b has been found to result in left-right patterning 
defects of the heart, although this defect is more frequent with jnk1b knockdown. 
Initial in situ hybridisation results also suggest that normal liver situs is disrupted by 
jnk1 loss, putatively revealing a systemic aberration in left-right patterning; however 
due to the number of repeats that were achieved this cannot be confirmed in this 
study. These data suggest that jnk1 may function through the PCP pathway to regulate 
left-right patterning as has been observed in the Rho kinase2b morphant (Wang et al., 
2011). Rho kinase lies downstream of the core PCP proteins at the same level in the 
signalling pathway as JNK and has been shown to be crucial for Kupffer’s vesicle (the 
node) cell alignment, and establishment of nodal flow in the zebrafish. In order to 
confirm this hypothesis it would be necessary to examine Kupffer’s vesicle in jnk1 
morphants to determine whether cilia positioning or nodal flow was indeed affected. 
This would provide strong evidence that jnk1 does function through the PCP pathway 
to mediate left-right patterning. 
 
6.2.4 Evidence of a Role in Left-Right Patterning and Ciliogenesis 
Previous research on the role of JNK1 in vertebrate development had not linked the 
gene to left-right patterning of the embryo or ciliogenesis, however in part this may 
have been due to the very mild phenotype that was observed when Jnk1 was knocked 
out in the mouse and the embryonic lethality caused by Jnk1 + Jnk2 loss (Kuan et al., 
1999). In Drosophila melanogaster where only a single JNK orthologue exists it was 
shown that loss or upregulation of JNK resulted in laterality defects of the developing 
gut (Martin-Blanco et al., 1998). I believe that my own work has further strengthened 
the link between the JNK genes, and in zebrafish jnk1 specifically, and left-right 
patterning during embryogenesis. 
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Knockdown of jnk1a and jnk1b in the zebrafish revealed that the heart (and possibly 
the gut) developed laterality defects consistent with embryonic left-right patterning 
defects. Furthermore, uncoupling of the jog-loop heart movements was observed in 
jnk1a knockdowns which have previously been identified when members of the 
molecular midline barrier or southpaw (zebrafish NODAL) has been disrupted; both of 
these contribute toleft-right patterning in the zebrafish (Yamamoto et al., 2003, 
Ahmad et al., 2004, Chin et al., 2000). Although I was not able to investigate the effect 
of jnk1 knockdown on embryonic left-right patterning, Dr. Simon Ramsbottom did 
perform some preliminary experiments which supports a role of jnk1 in this process. In 
these preliminary experiments it was shown that the main signalling molecule of left-
sidedness – NODAL – was aberrantly expressed in some, and displayed reduced 
expression region in other jnk1 morphants. Furthermore the NODAL antagonists lefty1 
and lefty2 showed a similar aberrant expression or reduced expression pattern. These 
data are suggestive that jnk1 function does indeed play some role in left-right 
patterning of the embryo.  
To further examine the underlying mechanism of left-right patterning defects in jnk1 
morphants Dr. Ramsbottom investigated Kupffer’s Vesicle size and cilia length in jnk1a 
and jnk1b morphants. Both node size and cilia length were reduced in this analysis 
suggesting that jnk1 may also have a role in KV development and ciliogenesis. Although 
anecdotal, my own results also support a role for jnk1 in ciliogenesis. The 4ng jnk1a 
morphants were shown to have retinal lamination defects that were strikingly similar 
to those of genes known to be involved in ciliogenesis (Shu et al., 2011, Simms et al., 
2012, Al-Hamed et al., 2014). Considering the development of photoreceptors from 
primary cilia these retinal defects are common in mutants for ciliogenesis-related 
genes (Wheway et al., 2014). 
In conclusion I believe that my own research in addition to the preliminary work 
carried out by Dr. Ramsbottom in the Chaudhry lab has uncovered a role for jnk1 in 
left-right patterning of the zebrafish embryo. I hypothesise that this role is directly or 
indirectly mediated by a contribution to development of Kupffer’s Vesicle and the KV 
cilia. The retinal phenotypes in jnk1a morphants suggest that cilia outside of KV may 
require jnk1 for normal function. I believe that further investigation into these roles for 
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jnk1 are necessary but may not be possible in the mouse where genetic redundancy 
has been found between the Jnk genes (Kuan et al., 1999).  
 
6.3 Future Work 
This project has succeeded in establishing a jnk1 morphant in the zebrafish, however 
there is far more that needs to be done in order to determine the full role of jnk1 
during development. Firstly, although four splice-variants were discovered for each 
jnk1 gene, there are additional predicted transcripts from the ENSEMBL pipeline which 
I have not investigated. Use of additional primers to target these predicted transcripts 
specifically, or 5 ’and 3’ RACE (Rapid amplification of cDNA ends), could be used in 
order to look for additional transcripts. Furthermore, temporal and tissue-specific 
expression of these splice-variants was examined in a semi-quantitative manner by RT-
PCR, however, this methodology does not provide accurate expression levels, and 
because different primers were used there cannot be any accurate comparison 
between levels of different variants. A more accurate measure of expression patterns 
would be qRT-PCR (quantitative RT-PCR), although this technique requires amplicons 
of around 100bp, whereas the eight variants described here differ only in sequences 
that are ~500bp apart. Instead it may be possible to use a proteomics approach such 
as 3D gel electrophoresis followed by consecutive mass spectrometry (MS/MS) to 
quantify total amounts of protein from each variant. In addition to being a more 
quantitative approach than the RT-PCR methodology used here, it would measure 
protein levels directly, since mRNA and protein abundances don’t always strongly 
correlate (Gygi et al., 1999). 
In addition, only a rather small number of developmental timepoints and tissues were 
examined as a way of gaining a broad overview of expression patterns through 
development and tissue-types. For future analysis it would be more useful to answer 
specific questions using this technique, particularly looking at both spatial and 
temporal expression during development. Since the different variants are identical to 
one another for runs of hundreds of basepairs it is unlikely that in situ hybridisation 
probes would be capable of differentiating between them. It is possible though that 
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microdissection of different tissues would make it possible to examine expression in 
different tissues during development. For example the Tg(myl7:EGFP) zebrafish line 
which has green fluorescent protein expression is under the control of the myosin light 
chain 7 promoter enables these cells to be identified from stages of the linear heart 
tube. The use of several such reporter lines could allow for embryonic tissue 
expression to be analysed in greater detail than it was here. 
Although much of this thesis was dedicated to exploring the phenotype of jnk1 
morphants, several of the experiments require further work in order to confirm the 
results; the in situ hybridisation experiments appear to suggest that left-right 
patterning is disrupted throughout the whole embryo, and not simply within the heart. 
However, too few replicates were performed in order to show this conclusively. In 
addition to repeats it may also be possible to examine other asymmetrical organs such 
as the pancreas, gall bladder, gut and habenula (part of the pineal gland) which have 
all been shown to be asymmetrical in the zebrafish (Concha et al., 2000, Long et al., 
2003b, Essner et al., 2005a). These data which could be obtained through further in 
situ hybridisations would demonstrate whether the organ situs defects were indeed 
global or were restricted to certain organs. 
In situ hybridisation could be further utilised to explore the mechanism by which the 
jnk1 morphant organs are developing with incorrect situs. Analysis of southpaw (nodal) 
and pitx2 expression have been shown to be required on the embryonic left for normal 
organ situs (Ahmad et al., 2004, Campione et al., 1999), so this may be affected in the 
jnk1 morphants as it has been shown to be in morphants that display organ situs 
defects (Wang et al., 2011, Bisgrove et al., 2005, Francescatto et al., 2010). If these 
determinants of left-sidedness were shown to be abberantly expressed then greater 
analysis of structure of the node, nodal cilia and the nodal flow would be beneficial to 
determine whether loss of jnk1 was affecting the polarisation of nodal cells or 
preventing proper nodal flow. As jnk1a morphants also cause a disparity between 
cardiac jog and loop directions there may also be improper molecular midline barrier 
formation, as has been observed in other genetic models that have uncoupled cardiac 
movements (Chin et al., 2000). The use of in situ hybridisation for the molecular 
midline barrier gene lefty1 could highlight whether the molecular midline barrier was 
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successfully formed in jnk1a morphants, a possible mechanism for the left-right 
patterning defects and the uncoupling of the heart. 
The use of morpholinos for targeted knockdown has been hampered by the frequency 
(15-20%) of off-target effects (Eisen and Smith, 2008) and therefore it is necessary to 
further qualify this method of knockdown before further investigation. Previously the 
gold-standard model for proof of knockdown was to perform a rescue experiment 
whereby a MO resistant mRNA for the gene of interest was overexpressed in order to 
rescue the morphant phenotype. However, as this exogenous mRNA is overexpressed 
in the embryo and expression may not bear any resemblance to the temporal and 
spatial restrictions of endogenous gene expression, rescue experiments are often 
problematic and show only partial rescue (Wang et al., 2011, Bauer et al., 2001, 
Hernandez-Lagunas et al., 2005). 
An alternative method of morpholino validation is to demonstrate that the MO 
recapitulates the phenotype of a mutant. The introduction of CRISPR (clustered 
regularly interspaced short palindromic repeats) technology has significantly increased 
the ease and efficiency of directed mutagenesis generation in zebrafish (Cong et al., 
2013, Hwang et al., 2013b) and would be a sensible next step for investigating jnk1 
function. Generation of jnk1a and jnk1b mutant zebrafish would allow for further 
validation of, or could supercede the morphant methodology. The mutant would result 
in 100% loss of the target genes as opposed to the partial (~85%) knockdown that is 
caused by MO injection, and no cross-reactivity between paralogs would be caused. 
Furthermore, a mutant would not experience the dosing effects that are observed by 
morphant generation, reducing the variability of the observed phenotypes. These two 
systems could also complement each other with mutants modelling systemic jnk1 loss 
and morpholinos being used at later developmental stages to knockdown function 
specifically in the dorsal forerunner cells that give rise to Kupffer’s vesicle (Wang et al., 
2011). Generation of a jnk1 mutant would certainly aid in the investigation of jnk1 
during development. 
Both jnk1a and jnk1b morpholino injections resulted in left-right patterning defects of 
the embryo, which is a feature that requires further investigation. If the defect is 
systemic, as preliminary liver in situ data was suggesting, then there may be 
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perturbation in the NODAL (southpaw) cascade that has been shown to propagate left-
sided signalling through the lateral plate mesoderm (Brennan et al., 2002, Lowe et al., 
1996, Ahmad et al., 2004). This mechanism would correlate with several other PCP 
members which have been shown to cause left-right patterning defects, including 
rock2b (Wang et al., 2011, Borovina et al., 2010, Song et al., 2010, Walentek et al., 
2013). In situ hybridisation of southpaw expression, as well as genes whose protein 
products make up the midline barrier (e.g. lefty 1, lefty 2, bmp) could determine 
whether these core left-right patterning members are affected. Further testing of this 
hypothesis could be performed by examination of cell alignment and nodal flow within 
Kupffer’s vesicle. Finally knockdown of jnk1 specifically into Kupffer’s vesicle cells could 
help to determine which developmental defects are caused by systemic loss of jnk1 
and which result specifically from loss of left-right patterning signals.  
Oedema around the pericardial sac and yolk are observed in both jnk1a and jnk1b 
morphants. The cause of this oedema could be due to poor circulation of the heart, or 
reduced pronephric duct function. Normal kidney development has been shown to 
require proper PCP pathway signalling (Mochizuki et al., 1998, Saburi et al., 2008, 
Simons et al., 2005), and loss of normal signalling can result in pronephric cysts. In 
order to determine whether jnk1 loss affects the kidney it may be possible to observe 
cysts by light microscopy. Insulin clearance methods also provide accurate measures of 
renal function, and take into account both renal and cardiac impact (Rider et al., 2012).   
 
6.4 Concluding Remarks 
This project has increased our knowledge of the zebrafish jnk1 genes, and established 
zebrafish as an appropriate model for the study of JNK1 during development. The lack 
of any identified human cases of congenital inherited or de novo mutations in the JNK 
genes may suggest that such mutations are not amenable to life as proposed by 
Sabapathy et al. (Sabapathy, 2012), or that sufficient genetic redundancy exists, as is 
seen in mouse, to prevent any overt developmental defects (Kuan et al., 1999). 
However, zebrafish have proven to be a useful model for examining jnk1 function 
during development because developmental defects do arise when gene function is 
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knocked down, and there is conservation of splice-variants common between the 
zebrafish and human gene. From these results I propose that jnk1 is critical for 
establishment of the left-right axis during zebrafish embryogenesis and that loss of 
jnk1 function can result in improper situs development of the heart and liver. The 
mechanism by which these defects arise is not fully elucidated, however preliminary 
evidence suggests that a reduction in Kupffer’s Vesicle size and/or ciliogenesis could be 
altered in jnk1 knockdowns which could result in L-R patterning defects. Histology 
analysis later in development may also support a role for jnk1 in ciliogenesis within the 
retina, whereas heart and somite defects at these later timepoints also suggests that 
jnk1 function is required for normal development of these tissues. The exact role of 
jnk1 in the development of these organs is yet to be discovered, however this project 
has identified the importance of jnk1 in organ development. 
Importantly the analyses presented here represent only the beginning of elucidating 
the function of JNK1 during development, and much more research is needed to 
discover the exact role of this gene. Due to the complexity of the JNK genes and all the 
numerous processes that they have been implicated in regulating, there must exist 
very sophisticated regulatory networks that ensure these genes mediate the correct 
response in temporal and tissue-specific scenarios. I believe that one method of 
achieving this may be through the use of different splice-variants which have different 
affinities to downstream affectors. In future research I propose that it will not be 
appropriate to talk about “JNK function” and instead the individual genes and indeed 
specific splice-variants will need to be analysed as separate entities. In this work the 
zebrafish model may play a role, due to its high conservation of different splice-
variants. Until then there is far more to be learnt about the role of jnk1 in the 
developing heart, eye, somitic muscle, Kupffer’s vesicle, and left-right signalling 
pathway. This thesis will hopefully provide a foundation for future work in the field. 
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A 
B 
>jnk1a-002_CodingSequence 
 
Fwd    5’ AGAGAGGGATCCATGAACAAAAATAAGCGAGAG 3’ 
    ||||||||||||||||||||| 
   1 ------------ATGAACAAAAATAAGCGAGAGAAAGAATTCTACAGTGTAGATGTGGGG 
  49 GATTCGACATTCACAGTGTTGAAGCGCTATCAGAATCTAAGACCCATTGGCTCGGGTGCT 
 109 CAGGGAATAGTCTGCTCAGCGTATGACAACAACCTTGAGCGAAACGTGGCTATAAAGAAA 
 169 CTCAGCCGGCCTTTTCAAAATCAAACTCATGCCAAACGTGCGTACAGAGAGCTGGTGCTC 
 229 ATGAAATGTGTCAACCATAAAAATATAATAGGCCTCTTAAATGTTTTTACACCGCAAAAA 
 289 ACATTAGAAGAATTCCAAGATGTTTACCTAGTAATGGAGCTGATGGATGCGAACCTCTGC 
 349 CAAGTCATTCAGATGGAGCTGGACCACGAGCGGCTGTCCTATCTGCTGTACCAGATGCTG 
 409 TGTGGAATAAAACACCTCCACGCGGCGGGGATCATCCACAGGGACCTGAAACCCAGTAAC 
 469 ATCGTGGTAAAGTCAGACTGTACCCTGAAGATCCTGGATTTCGGTCTGGCGCGGACAGCA 
 529 GCTACAGGTCTGCTGATGACACCATATGTGGTGACCCGTTACTACAGAGCCCCTGAAGTC 
 589 ATCCTGGGAATGGGATATCAAGCCAATGTGGACATTTGGTCTGTGGGCTGCATTTTGGCA 
 649 GAAATGGTCCGTCACAAAATCCTTTTTCCTGGGAGGGACTATATTGATCAGTGGAATAAA 
 709 GTAATAGAGCAGCTGGGAACGCCAACTCAGGAGTTCCTGTTGAAACTCAACCAGTCTGTG 
 769 CGGACCTATGTGGAGAACAGGCCCCGGTACACTGGATATAGCTTTGAGAAGCTGTTTCCT 
 829 GATGTCCTGTTCCCTGCTGATTCAGAACACAGCAAACTAAAAGCGAGTCAGGCGCGGGAC 
 889 CTGCTGTCTAAAATGCTGGTGATTGATGCATCAAAACGAATCTCGGTGGATGAGGCTTTG 
 949 CAGCACCCCTACATTAACGTGTGGTACGACCCGGCTGAAGTGGAAGCGCCTTCTCCTCTG 
1009 ATCACAGACAAACAGCTCGATGAGAGGGAACACACAGTGGAAGAGTGGAAAGAACTGATC 
1069 TATAAAGAAGTGCTGGATTGGGAAGAACGGATGAAGAACGGTGTTATTCGAGGTCAGCCC 
1129 TCCCCCCTAGGTGCAGCAGTGATCAACGGCTCACCCCAGCCCTCATCCTCATCCTCCATC 
1189 AACGACGTGTCCTCCATGTCCACAGAGCCCACCGTGGCCTCAGACACAGACAGCAGCTTA 
1249 GAGGCCTCGGCGGGACCCCTGAGCTGCTGCAGATGA------------ 
    |||||||||||||||||| 
                 3’ GACTCGACGACGTCTACTGAGCTCGATGAT 5’    Rev 
 
>jnk1b-002_CodingSequence 
 
Fwd    5’ AGAGAGGGATCCATGAACAGGAATAAGCGCGAG 3’ 
   ||||||||||||||||||||| 
1 ------------ATGAACAGGAATAAGCGCGAGAAAGAATATTACAGCATAGATGTAGGA 
49 GATTCAACGTTCACCGTTTTGAAGCGCTATCAGAATTTAAGACCAATCGGGTCCGGAGCA 
109 CAAGGCATCGTCTGCTCAGCGTATGACCACGTCCTCGATCGAAATGTGGCAATTAAGAAA 
169 CTCAGCCGACCCTTTCAAAACCAAACTCATGCCAAACGGGCCTACAGAGAACTGGTCCTG 
229 ATGAAATGCGTCAACCACAAAAATATAATTGGCTTACTAAACGTGTTCACACCACAGAAG 
289 ACACTTGAAGAGTTCCAGGATGTTTATCTGGTGATGGAGCTGATGGATGCAAACCTGTGT 
349 CAGGTGATTCAGATGGAGCTGGACCACGAGAGGCTGTCCTACCTGCTCTATCAGATGCTC 
409 TGCGGCATTAAACACCTGCACGCTGCTGGCATCATACACAGGGATCTGAAACCCAGTAAT 
469 ATAGTAGTGAAATCGGACTGCACGCTGAAGATCCTGGATTTCGGTCTGGCCCGAACGGCT 
529 GCAACCGGCCTCCTCATGACTCCTTATGTCGTGACACGCTATTATCGGGCCCCAGAGGTC 
589 ATCCTGGGCATGGGTTATCAAGCTAACGTTGATGTCTGGTCTATTGGCTGCATCATGGCT 
649 GAAATGGTCAGAGGTAGTGTGTTGTTTCCTGGCACAGACCATATTGACCAGTGGAATAAA 
709 GTGATCGAGCAGCTGGGCACGCCGTCACAGGAGTTCATGATGAAGCTGAATCAGTCTGTG 
769 AGGACGTATGTGGAGAACCGGCCTCGGTATGCGGGATACAGCTTTGAGAAGCTCTTCCCA 
829 GACGTGCTCTTCCCCGCAGACTCGGACCACAACAAACTCAAGGCGAGTCAGGCACGAGAC 
889 TTGTTATCCAAAATGCTGGTAATAGATGCATCCAAGCGGATCTCTGTAGACGAGGCGCTT 
949 CAGCACCCCTACATCAACGTTTGGTACGACCCATCAGAAGTGGAGGCGCCGCCACCAGCG 
1009 ATCACGGATAAACAGCTCGATGAGAGAGAACACTCAGTGGAAGAGTGGAAAGAGCTCATA 
1069 TACAAGGAAGTGCTGGAATGGGAGGAGCGAACAAAAAATGGAGTGATCAGAGGACAGCCG 
1129 GCCTCGCTAGGTGCAGCAGTGAGCAGTGACTCCCATGAGCCCTCGACGTCGTCCTCCTCC 
1189 ATAAACGATGTGTCGTCCATGTCCACCGAGGTCACGCTGACCTCAGACACCGACAGCAGT 
1249 CAGGAGACGTCCAACGGAGCGCTGCACTGCTGCAGATGA 
    ||||||||||||||||||||| 
                 3’ CGCGACGTGACGACGTCTACTAGATCTGAGAGA 5’   Rev 
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Figure 57 The Binding Sites of the Full-Length jnk1 Primers.    
The complete CDS of the ENSEMBL predicted jnk1a-002 (A) and jnk1b-002 (B) 
variants displaying the primer binding sites of the full -length primers (Black). 
Each primer contains additional bases at the 5’ end consisting of a restriction 
site and some non-sense sequence to allow for the production of sticky ends for 
directional sub-cloning. 
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        <----------------------------------------------------------- 
jnk1a_7;short        1 ATGAACAAAAATAAGCGAGAGAAAGAATTCTACAGTGTAGATGTGGGGGATTCGACATTC 
jnk1a_7;long         1 ATGAACAAAAATAAGCGAGAGAAAGAATTCTACAGTGTAGATGTGGGGGATTCGACATTC 
jnk1a_8;short        1 ATGAACAAAAATAAGCGAGAGAAAGAATTCTACAGTGTAGATGTGGGGGATTCGACATTC 
jnk1a_8;long         1 ATGAACAAAAATAAGCGAGAGAAAGAATTCTACAGTGTAGATGTGGGGGATTCGACATTC 
 
        ------------------Exon 2------------------------------------ 
jnk1a_7;short      61 ACAGTGTTGAAGCGCTATCAGAATCTAAGACCCATTGGCTCGGGTGCTCAGGGAATAGTC 
jnk1a_7;long       61 ACAGTGTTGAAGCGCTATCAGAATCTAAGACCCATTGGCTCGGGTGCTCAGGGAATAGTC 
jnk1a_8;short      61 ACAGTGTTGAAGCGCTATCAGAATCTAAGACCCATTGGCTCGGGTGCTCAGGGAATAGTC 
jnk1a_8;long       61 ACAGTGTTGAAGCGCTATCAGAATCTAAGACCCATTGGCTCGGGTGCTCAGGGAATAGTC 
 
        -><--------------------------------------------------------- 
jnk1a_7;short    121 TGCTCAGCGTATGACAACAACCTCGAGCGAAACGTGGCTATAAAGAAACTCAGCCGGCCT 
jnk1a_7;long     121 TGCTCAGCGTATGACAACAACCTCGAGCGAAACGTGGCTATAAAGAAACTCAGCCGGCCT 
jnk1a_8;short    121 TGCTCAGCGTATGACAACAACCTCGAGCGAAACGTGGCTATAAAGAAACTCAGCCGGCCT 
jnk1a_8;long     121 TGCTCAGCGTATGACAACAACCTCGAGCGAAACGTGGCTATAAAGAAACTCAGCCGGCCT 
 
        -------------------------Exon 3----------------------------- 
jnk1a_7;short    181 TTTCAAAATCAAACTCATGCCAAACGTGCGTACAGAGAGCTGGTGCTCATGAAATGTGTC 
jnk1a_7;long     181 TTTCAAAATCAAACTCATGCCAAACGTGCGTACAGAGAGCTGGTGCTCATGAAATGTGTC 
jnk1a_8;short    181 TTTCAAAATCAAACTCATGCCAAACGTGCGTACAGAGAGCTGGTGCTCATGAAATGTGTC 
jnk1a_8;long     181 TTTCAAAATCAAACTCATGCCAAACGTGCGTACAGAGAGCTGGTGCTCATGAAATGTGTC 
 
        ----------><-----------------------------Exon 4------------- 
jnk1a_7;short    241 AACCATAAAAATATAATAGGCCTCTTAAATGTTTTTACACCGCAAAAAACATTAGAAGAA 
jnk1a_7;long     241 AACCATAAAAATATAATAGGCCTCTTAAATGTTTTTACACCGCAAAAAACATTAGAAGAA 
jnk1a_8;short    241 AACCATAAAAATATAATAGGCCTCTTAAATGTTTTTACACCGCAAAAAACATTAGAAGAA 
jnk1a_8;long     241 AACCATAAAAATATAATAGGCCTCTTAAATGTTTTTACACCGCAAAAAACATTAGAAGAA 
 
        ---------><------------------------------------------------- 
jnk1a_7;short    301 TTCCAAGATGTTTACCTAGTAATGGAGCTGATGGATGCGAACCTCTGCCAAGTCATTCAG 
jnk1a_7;long     301 TTCCAAGATGTTTACCTAGTAATGGAGCTGATGGATGCGAACCTCTGCCAAGTCATTCAG 
jnk1a_8;short    301 TTCCAAGATGTTTACCTAGTAATGGAGCTGATGGATGCGAACCTCTGCCAAGTCATTCAG 
jnk1a_8;long     301 TTCCAAGATGTTTACCTAGTAATGGAGCTGATGGATGCGAACCTCTGCCAAGTCATTCAG 
 
        -------------------------Exon 5----------------------------- 
jnk1a_7;short    361 ATGGAGCTGGACCACGAGCGGCTGTCCTATCTGCTGTACCAGATGCTGTGTGGAATAAAA 
jnk1a_7;long     361 ATGGAGCTGGACCACGAGCGGCTGTCCTATCTGCTGTACCAGATGCTGTGTGGAATAAAA 
jnk1a_8;short    361 ATGGAGCTGGACCACGAGCGGCTGTCCTATCTGCTGTACCAGATGCTGTGTGGAATAAAA 
jnk1a_8;long     361 ATGGAGCTGGACCACGAGCGGCTGTCCTATCTGCTGTACCAGATGCTGTGTGGAATAAAA 
 
        ----------------------------><------------------------------ 
jnk1a_7;short    421 CACCTCCACGCGGCGGGGATCATCCACAGGGACCTGAAACCCAGTAACATCGTGGTAAAG 
jnk1a_7;long     421 CACCTCCACGCGGCGGGGATCATCCACAGGGACCTGAAACCCAGTAACATCGTGGTAAAG 
jnk1a_8;short    421 CACCTCCACGCGGCGGGGATCATCCACAGGGACCTGAAACCCAGTAACATCGTGGTAAAG 
jnk1a_8;long     421 CACCTCCACGCGGCGGGGATCATCCACAGGGACCTGAAACCCAGTAACATCGTGGTAAAG 
 
        -------------------------Exon 6----------------------------- 
jnk1a_7;short    481 TCAGACTGTACCCTGAAGATCCTGGATTTCGGTCTGGCGCGGACAGCAGCTACAGGTCTG 
jnk1a_7;long     481 TCAGACTGTACCCTGAAGATCCTGGATTTCGGTCTGGCGCGGACAGCAGCTACAGGTCTG 
jnk1a_8;short    481 TCAGACTGTACCCTGAAGATCCTGGATTTCGGTCTGGCGCGGACAGCAGCTACAGGTCTG 
jnk1a_8;long     481 TCAGACTGTACCCTGAAGATCCTGGATTTCGGTCTGGCGCGGACAGCAGCTACAGGTCTG 
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        ------------------------------------------------------------ 
jnk1a_7;short    541 CTGATGACACCATATGTGGTGACCCGTTACTACAGAGCCCCTGAAGTCATCCTGGGAATG 
jnk1a_7;long     541 CTGATGACACCATATGTGGTGACCCGTTACTACAGAGCCCCTGAAGTCATCCTGGGAATG 
jnk1a_8;short    541 CTGATGACACCATATGTGGTGACCCGTTACTACAGAGCCCCTGAAGTCATCCTGGGAATG 
jnk1a_8;long     541 CTGATGACACCATATGTGGTGACCCGTTACTACAGAGCCCCTGAAGTCATCCTGGGAATG 
 
        ---------------><--------------------------Exon 7/8--------- 
jnk1a_7;short    601 GGATATCAAGCCAATGTGGACATTTGGTCTGTGGGCTGCATTTTGGCAGAAATGGTCCGT 
jnk1a_7;long     601 GGATATCAAGCCAATGTGGACATTTGGTCTGTGGGCTGCATTTTGGCAGAAATGGTCCGT 
jnk1a_8;short    601 GGATATCAAGCCAATGTGGATGTGTGGTCTGTCGGCTGTATCATGGCTGAAATGGTCAGA 
jnk1a_8;long     601 GGATATCAAGCCAATGTGGATGTGTGGTCTGTCGGCTGTATCATGGCTGAAATGGTCAGA 
 
        ---------------------------><------------------------------- 
jnk1a_7;short    661 CACAAAATCCTTTTTCCTGGGAGGGACTATATTGATCAGTGGAATAAAGTAATAGAGCAG 
jnk1a_7;long     661 CACAAAATCCTTTTTCCTGGGAGGGACTATATTGATCAGTGGAATAAAGTAATAGAGCAG 
jnk1a_8;short    661 GGTAGTGTATTATTTCCGGGTTCAGATCATATTGATCAGTGGAATAAAGTAATAGAGCAG 
jnk1a_8;long     661 GGTAGTGTATTATTTCCGGGTTCAGATCATATTGATCAGTGGAATAAAGTAATAGAGCAG 
 
        ------------------------------------------------------------ 
jnk1a_7;short    721 CTGGGAACGCCAACTCAGGAGTTCTTGTTGAAACTCAACCAGTCTGTGCGGACCTATGTG 
jnk1a_7;long     721 CTGGGAACGCCAACTCAGGAGTTCTTGTTGAAACTCAACCAGTCTGTGCGGACCTATGTG 
jnk1a_8;short    721 CTGGGAACGCCAACTCAGGAGTTCTTGTTGAAACTCAACCAGTCTGTGCGGACCTATGTG 
jnk1a_8;long     721 CTGGGAACGCCAACTCAGGAGTTCTTGTTGAAACTCAACCAGTCTGTGCGGACCTATGTG 
 
        --------------------------Exon 9---------------------------- 
jnk1a_7;short    781 GAGAACAGGCCCCGGTACACTGGATATAGCTTTGAGAAGCTGTTTCCTGATGTCCTGTTC 
jnk1a_7;long     781 GAGAACAGGCCCCGGTACACTGGATATAGCTTTGAGAAGCTGTTTCCTGATGTCCTGTTC 
jnk1a_8;short    781 GAGAACAGGCCCCGGTACACTGGATATAGCTTTGAGAAGCTGTTTCCTGATGTCCTGTTC 
jnk1a_8;long     781 GAGAACAGGCCCCGGTACACTGGATATAGCTTTGAGAAGCTGTTTCCTGATGTCCTGTTC 
 
        ------------------------------><---------------------------- 
jnk1a_7;short    841 CCTGCTGATTCAGAACACAGCAAACTAAAAGCGAGTCAGGCGCGGGACCTGCTGTCTAAA 
jnk1a_7;long     841 CCTGCTGATTCAGAACACAGCAAACTAAAAGCGAGTCAGGCGCGGGACCTGCTGTCTAAA 
jnk1a_8;short    841 CCTGCTGATTCAGAACACAGCAAACTAAAAGCGAGTCAGGCGCGGGACCTGCTGTCTAAA 
jnk1a_8;long     841 CCTGCTGATTCAGAACACAGCAAACTAAAAGCGAGTCAGGCGCGGGACCTGCTGTCTAAA 
 
        --------------------------Exon 10--------------------------- 
jnk1a_7;short    901 ATGCTGGTGATTGATGCATCAAAACGAATCTCGGTGGATGAGGCTTTGCAGCACCCCTAC 
jnk1a_7;long     901 ATGCTGGTGATTGATGCATCAAAACGAATCTCGGTGGATGAGGCTTTGCAGCACCCCTAC 
jnk1a_8;short    901 ATGCTGGTGATTGATGCATCAAAACGAATCTCGGTGGATGAGGCTTTGCAGCACCCCTAC 
jnk1a_8;long     901 ATGCTGGTGATTGATGCATCAAAACGAATCTCGGTGGATGAGGCTTTGCAGCACCCCTAC 
 
        -----------------------------------><----------------------- 
jnk1a_7;short    961 ATTAACGTGTGGTACGACCCGGCTGAAGTGGAAGCGCCTTCTCCTCTGATCACAGACAAA 
jnk1a_7;long     961 ATTAACGTGTGGTACGACCCGGCTGAAGTGGAAGCGCCTTCTCCTCTGATCACAGACAAA 
jnk1a_8;short    961 ATTAACGTGTGGTACGACCCGGCTGAAGTGGAAGCGCCTTCTCCTCTGATCACAGACAAA 
jnk1a_8;long     961 ATTAACGTGTGGTACGACCCGGCTGAAGTGGAAGCGCCTTCTCCTCTGATCACAGACAAA 
 
        -------Exon 11-------------------------><------------------- 
jnk1a_7;short  1021 CAGCTCGATGAGAGGGAACACACAGTGGAAGAGTGGAAAGAACTGATCTATAAAGAAGTG 
jnk1a_7;long   1021 CAGCTCGATGAGAGGGAACACACAGTGGAAGAGTGGAAAGAACTGATCTATAAAGAAGTG 
jnk1a_8;short  1021 CAGCTCGATGAGAGGGAACACACAGTGGAAGAGTGGAAAGAACTGATCTATAAAGAAGTG 
jnk1a_8;long   1021 CAGCTCGATGAGAGGGAACACACAGTGGAAGAGTGGAAAGAACTGATCTATAAAGAAGTG 
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        ---------------Exon 12-----------------------------------><- 
jnk1a_7;short  1081 CTGGATTGGGAAGAACGGATGAAGAACGGTGTTATTCGAGGTCAGCCCTCCCCCCTAGCA 
jnk1a_7;long   1081 CTGGATTGGGAAGAACGGATGAAGAACGGTGTTATTCGAGGTCAGCCCTCCCCCCTAG-- 
jnk1a_8;short  1081 CTGGATTGGGAAGAACGGATGAAGAACGGTGTTATTCGAGGTCAGCCCTCCCCCCTAGCA 
jnk1a_8;long   1081 CTGGATTGGGAAGAACGGATGAAGAACGGTGTTATTCGAGGTCAGCCCTCCCCCCTAG-- 
 
 
        ------------------------------------------------------------ 
jnk1a_7;short  1141 CAGGTGCAGCAGTGAtcaacggctcaccccagccctcatcctcatcctccatcaacgacg 
jnk1a_7;long   1137 ---GTGCAGCAGTGATCAACGGCTCACCCCAGCCCTCATCCTCATCCTCCATCAACGACG 
jnk1a_8;short  1141 CAGGTGCAGCAGTGAtcaacggctcaccccagccctcatcctcatcctccatcaacgacg 
jnk1a_8;long   1137 ---GTGCAGCAGTGATCAACGGCTCACCCCAGCCCTCATCCTCATCCTCCATCAACGACG 
 
        ----------------------Exon 13------------------------------- 
jnk1a_7;short  1201 tgtcctccatgtccacagagcccaccgtggcctcagacacagacagcagcttagaggcct 
jnk1a_7;long   1196 TGTCCTCCATGTCCACAGAGCCCACCGTGGCCTCAGACACAGACAGCAGCTTAGAGGCCT 
jnk1a_8;short  1201 tgtcctccatgtccacagagcccaccgtggcctcagacacagacagcagcttagaggcct 
jnk1a_8;long   1196 TGTCCTCCATGTCCACAGAGCCCACCGTGGCCTCAGACACAGACAGCAGCTTAGAGGCCT 
 
        ----------------------------> 
jnk1a_7;short  1261 cggcgggacccctgagctgctgcagatga 
jnk1a_7;long   1256 CGGCGGGACCCCTGAGCTGCTGCAGATGA 
jnk1a_8;short  1261 cggcgggacccctgagctgctgcagatga 
jnk1a_8;long   1256 CGGCGGGACCCCTGAGCTGCTGCAGATGA 
* 
Figure 58 Alignment of the Four jnk1a Variants Identified in this Study.   
The four different splice-variants of jnk1a identified by sequencing of the sub-cloned 
products aligned to each other. Conserved bases are highlighted in black, above the 
sequence is annotation showing exon contribution. There are two regions where the four 
variants differ from one another: the middle exon usage (red) and the exon 13 splicing 
acceptor (*). The region of jnk1a_7;short and jnk1a_8;short that forms part of the 3’ UTR 
is shown in lower case. 
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        <----------------------------------------------------------- 
jnk1b_7;short        1 ATGAACAGGAATAAGCGCGAGAAAGAATATTACAGCATAGATGTAGGAGATTCGACGTTC 
jnk1b_7;long         1 ATGAACAGGAATAAGCGCGAGAAAGAATATTACAGCATAGATGTAGGAGATTCGACGTTC 
jnk1b_8;short        1 ATGAACAGGAATAAGCGCGAGAAAGAATATTACAGCATAGATGTAGGAGATTCGACGTTC 
jnk1b_8;long         1 ATGAACAGGAATAAGCGCGAGAAAGAATATTACAGCATAGATGTAGGAGATTCGACGTTC 
 
        ------------------Exon 2------------------------------------ 
jnk1b_7;short      61 ACCGTTTTGAAGCGCTATCAGAATTTAAGACCAATCGGGTCCGGAGCACAAGGCATCGTC 
jnk1b_7;long       61 ACCGTTTTGAAGCGCTATCAGAATTTAAGACCAATCGGGTCCGGAGCACAAGGCATCGTC 
jnk1b_8;short      61 ACCGTTTTGAAGCGCTATCAGAATTTAAGACCAATCGGGTCCGGAGCACAAGGCATCGTC 
jnk1b_8;long       61 ACCGTTTTGAAGCGCTATCAGAATTTAAGACCAATCGGGTCCGGAGCACAAGGCATCGTC 
 
        -><--------------------------------------------------------- 
jnk1b_7;short    121 TGCTCAGCGTATGACCACGTCCTCGATCGAAATGTGGCGATTAAGAAACTCAGCCGACCC 
jnk1b_7;long     121 TGCTCAGCGTATGACCACGTCCTCGATCGAAATGTGGCGATTAAGAAACTCAGCCGACCC 
jnk1b_8;short    121 TGCTCAGCGTATGACCACGTCCTCGATCGAAATGTGGCGATTAAGAAACTCAGCCGACCC 
jnk1b_8;long     121 TGCTCAGCGTATGACCACGTCCTCGATCGAAATGTGGCGATTAAGAAACTCAGCCGACCC 
 
        -------------------------Exon 3----------------------------- 
jnk1b_7;short    181 TTTCAAAACCAAACTCATGCCAAACGGGCCTACAGAGAACTGGTCCTGATGAAATGCGTC 
jnk1b_7;long     181 TTTCAAAACCAAACTCATGCCAAACGGGCCTACAGAGAACTGGTCCTGATGAAATGCGTC 
jnk1b_8;short    181 TTTCAAAACCAAACTCATGCCAAACGGGCCTACAGAGAACTGGTCCTGATGAAATGCGTC 
jnk1b_8;long     181 TTTCAAAACCAAACTCATGCCAAACGGGCCTACAGAGAACTGGTCCTGATGAAATGCGTC 
 
        ----------><-----------------------------Exon 4------------- 
jnk1b_7;short    241 AACCACAAAAATATAATTGGCTTACTAAACGTGTTCACACCACAGAAGACCCTTGAAGAG 
jnk1b_7;long     241 AACCACAAAAATATAATTGGCTTACTAAACGTGTTCACACCACAGAAGACCCTTGAAGAG 
jnk1b_8;short    241 AACCACAAAAATATAATTGGCTTACTAAACGTGTTCACACCACAGAAGACCCTTGAAGAG 
jnk1b_8;long     241 AACCACAAAAATATAATTGGCTTACTAAACGTGTTCACACCACAGAAGACCCTTGAAGAG 
 
        ---------><------------------------------------------------- 
jnk1b_7;short    301 TTCCAGGATGTTTATCTGGTGATGGAGCTGATGGATGCAAACCTGTGTCAGGTGATTCAG 
jnk1b_7;long     301 TTCCAGGATGTTTATCTGGTGATGGAGCTGATGGATGCAAACCTGTGTCAGGTGATTCAG 
jnk1b_8;short    301 TTCCAGGATGTTTATCTGGTGATGGAGCTGATGGATGCAAACCTGTGTCAGGTGATTCAG 
jnk1b_8;long     301 TTCCAGGATGTTTATCTGGTGATGGAGCTGATGGATGCAAACCTGTGTCAGGTGATTCAG 
 
        -------------------------Exon 5----------------------------- 
jnk1b_7;short    361 ATGGAGCTGGACCACGAGAGGCTGTCCTACCTGCTCTATCAGATGCTCTGCGGCATTAAA 
jnk1b_7;long     361 ATGGAGCTGGACCACGAGAGGCTGTCCTACCTGCTCTATCAGATGCTCTGCGGCATTAAA 
jnk1b_8;short    361 ATGGAGCTGGACCACGAGAGGCTGTCCTACCTGCTCTATCAGATGCTCTGCGGCATTAAA 
jnk1b_8;long     361 ATGGAGCTGGACCACGAGAGGCTGTCCTACCTGCTCTATCAGATGCTCTGCGGCATTAAA 
 
        ----------------------------><------------------------------ 
jnk1b_7;short    421 CACCTGCACGCTGCTGGCATCATACACAGGGACCTGAAACCCAGTAATATAGTAGTGAAA 
jnk1b_7;long     421 CACCTGCACGCTGCTGGCATCATACACAGGGACCTGAAACCCAGTAATATAGTAGTGAAA 
jnk1b_8;short    421 CACCTGCACGCTGCTGGCATCATACACAGGGACCTGAAACCCAGTAATATAGTAGTGAAA 
jnk1b_8;long     421 CACCTGCACGCTGCTGGCATCATACACAGGGACCTGAAACCCAGTAATATAGTAGTGAAA 
 
        -------------------------Exon 6----------------------------- 
jnk1b_7;short    481 TCGGACTGCACGCTGAAGATCCTGGATTTCGGTCTGGCCAGAACGGCTGCAACCGGCCTC 
jnk1b_7;long     481 TCGGACTGCACGCTGAAGATCCTGGATTTCGGTCTGGCCAGAACGGCTGCAACCGGCCTC 
jnk1b_8;short    481 TCGGACTGCACGCTGAAGATCCTGGATTTCGGTCTGGCCAGAACGGCTGCAACCGGCCTC 
jnk1b_8;long     481 TCGGACTGCACGCTGAAGATCCTGGATTTCGGTCTGGCCAGAACGGCTGCAACCGGCCTC 
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        ------------------------------------------------------------ 
jnk1b_7;short    541 CTCATGACTCCTTATGTAGTGACACGCTATTATCGGGCCCCAGAGGTCATCCTGGGCATG 
jnk1b_7;long     541 CTCATGACTCCTTATGTAGTGACACGCTATTATCGGGCCCCAGAGGTCATCCTGGGCATG 
jnk1b_8;short    541 CTCATGACTCCTTATGTAGTGACACGCTATTATCGGGCCCCAGAGGTCATCCTGGGCATG 
jnk1b_8;long     541 CTCATGACTCCTTATGTAGTGACACGCTATTATCGGGCCCCAGAGGTCATCCTGGGCATG 
 
 
        ---------------><--------------------------Exon 7/8--------- 
jnk1b_7;short    601 GGTTATCAAGCTAACGTGGATATTTGGGCTGTTGGCTGCATTATGGCAGAGATGGTGCGG 
jnk1b_7;long     601 GGTTATCAAGCTAACGTGGATATTTGGGCTGTTGGCTGCATTATGGCAGAGATGGTGCGG 
jnk1b_8;short    601 GGTTATCAAGCTAACGTTGATGTCTGGTCTATTGGCTGCATCATGGCTGAAATGGTCAGA 
jnk1b_8;long     601 GGTTATCAAGCTAACGTTGATGTCTGGTCTATTGGCTGCATCATGGCTGAAATGGTCAGA 
 
        ---------------------------><------------------------------- 
jnk1b_7;short    661 CACAAAATCCTTTTTCCAGGGAGGGACTATATTGACCAGTGGAATAAAGTGATCGAGCAG 
jnk1b_7;long     661 CACAAAATCCTTTTTCCAGGGAGGGACTATATTGACCAGTGGAATAAAGTGATCGAGCAG 
jnk1b_8;short    661 GGTAGTGTGTTGTTTCCTGGCACAGACCATATTGACCAGTGGAATAAAGTGATCGAGCAG 
jnk1b_8;long     661 GGTAGTGTGTTGTTTCCTGGCACAGACCATATTGACCAGTGGAATAAAGTGATCGAGCAG 
 
        ------------------------------------------------------------ 
jnk1b_7;short    721 CTCGGCACGCCGTCACAGGAGTTCATGATGAAGCTGAATCAGTCTGTGAGGACGTATGTG 
jnk1b_7;long     721 CTCGGCACGCCGTCACAGGAGTTCATGATGAAGCTGAATCAGTCTGTGAGGACGTATGTG 
jnk1b_8;short    721 CTCGGCACGCCGTCACAGGAGTTCATGATGAAGCTGAATCAGTCTGTGAGGACGTATGTG 
jnk1b_8;long     721 CTCGGCACGCCGTCACAGGAGTTCATGATGAAGCTGAATCAGTCTGTGAGGACGTATGTG 
 
        --------------------------Exon 9---------------------------- 
jnk1b_7;short    781 GAGAACCGGCCTCGGTATGCGGGATACAGCTTTGAGAAGCTCTTCCCAGACGTGCTCTTC 
jnk1b_7;long     781 GAGAACCGGCCTCGGTATGCGGGATACAGCTTTGAGAAGCTCTTCCCAGACGTGCTCTTC 
jnk1b_8;short    781 GAGAACCGGCCTCGGTATGCGGGATACAGCTTTGAGAAGCTCTTCCCAGACGTGCTCTTC 
jnk1b_8;long     781 GAGAACCGGCCTCGGTATGCGGGATACAGCTTTGAGAAGCTCTTCCCAGACGTGCTCTTC 
 
        ------------------------------><---------------------------- 
jnk1b_7;short    841 CCCGCAGACTCGGACCACAACAAACTCAAGGCGAGTCAGGCACGAGACTTGTTATCCAAA 
jnk1b_7;long     841 CCCGCAGACTCGGACCACAACAAACTCAAGGCGAGTCAGGCACGAGACTTGTTATCCAAA 
jnk1b_8;short    841 CCCGCAGACTCGGACCACAACAAACTCAAGGCGAGTCAGGCACGAGACTTGTTATCCAAA 
jnk1b_8;long     841 CCCGCAGACTCGGACCACAACAAACTCAAGGCGAGTCAGGCACGAGACTTGTTATCCAAA 
 
        --------------------------Exon 10--------------------------- 
jnk1b_7;short    901 ATGCTGGTAATAGATGCGTCCAAGCGGATCTCTGTAGACGAGGCGCTTCAGCACCCCTAC 
jnk1b_7;long     901 ATGCTGGTAATAGATGCGTCCAAGCGGATCTCTGTAGACGAGGCGCTTCAGCACCCCTAC 
jnk1b_8;short    901 ATGCTGGTAATAGATGCGTCCAAGCGGATCTCTGTAGACGAGGCGCTTCAGCACCCCTAC 
jnk1b_8;long     901 ATGCTGGTAATAGATGCGTCCAAGCGGATCTCTGTAGACGAGGCGCTTCAGCACCCCTAC 
 
        -----------------------------------><----------------------- 
jnk1b_7;short    961 ATCAACGTTTGGTACGACCCGTCAGAAGTGGAGGCGCCACCACCAGCGATCACGGATAAA 
jnk1b_7;long     961 ATCAACGTTTGGTACGACCCGTCAGAAGTGGAGGCGCCACCACCAGCGATCACGGATAAA 
jnk1b_8;short    961 ATCAACGTTTGGTACGACCCGTCAGAAGTGGAGGCGCCACCACCAGCGATCACGGATAAA 
jnk1b_8;long     961 ATCAACGTTTGGTACGACCCGTCAGAAGTGGAGGCGCCACCACCAGCGATCACGGATAAA 
 
        -------Exon 11-------------------------><------------------- 
jnk1b_7;short  1021 CAGCTCGATGAGAGAGAACACTCAGTGGAAGAGTGGAAAGAGCTCATATATAAGGAAGTG 
jnk1b_7;long   1021 CAGCTCGATGAGAGAGAACACTCAGTGGAAGAGTGGAAAGAGCTCATATATAAGGAAGTG 
jnk1b_8;short  1021 CAGCTCGATGAGAGAGAACACTCAGTGGAAGAGTGGAAAGAGCTCATATATAAGGAAGTG 
jnk1b_8;long   1021 CAGCTCGATGAGAGAGAACACTCAGTGGAAGAGTGGAAAGAGCTCATATATAAGGAAGTG 
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        ---------------Exon 12-----------------------------------><- 
jnk1b_7;short  1081 CTGGAATGGGAGGAGCGAACAAAAAATGGAGTGATCAGAGGACAGCCGGCCTCGCTAGCA 
jnk1b_7;long   1081 CTGGAATGGGAGGAGCGAACAAAAAATGGAGTGATCAGAGGACAGCCGGCCTCGCTAG-- 
jnk1b_8;short  1081 CTGGAATGGGAGGAGCGAACAAAAAATGGAGTGATCAGAGGACAGCCGGCCTCGCTAGCA 
jnk1b_8;long   1081 CTGGAATGGGAGGAGCGAACAAAAAATGGAGTGATCAGAGGACAGCCGGCCTCGCTAG-- 
 
 
        ------------------------------------------------------------ 
jnk1b_7;short  1141 CAGGTGCAGCAGTGAgcagtgactcccatgagccctcgacgtcgtcctcctccataaacg 
jnk1b_7;long   1138 ---GTGCAGCAGTGAGCAGTGACTCCCATGAGCCCTCGACGTCGTCCTCCTCCATAAACG 
jnk1b_8;short  1141 CAGGTGCAGCAGTGAgcagtgactcccatgagccctcgacgtcgtcctcctccataaacg 
jnk1b_8;long   1138 ---GTGCAGCAGTGAGCAGTGACTCCCATGAGCCCTCGACGTCGTCCTCCTCCATAAACG 
 
        ----------------------Exon 13------------------------------- 
jnk1b_7;short  1201 atgtgtcgtccatgtccaccgaggtcacgctgacctcagacaccgacagcagtcaggaga 
jnk1b_7;long   1196 ATGTGTCGTCCATGTCCACCGAGGTCACGCTGACCTCAGACACCGACAGCAGTCAGGAGA 
jnk1b_8;short  1201 atgtgtcgtccatgtccaccgaggtcacgctgacctcagacaccgacagcagtcaggaga 
jnk1b_8;long   1196 ATGTGTCGTCCATGTCCACCGAGGTCACGCTGACCTCAGACACCGACAGCAGTCAGGAGA 
 
        -------------------------------> 
jnk1b_7;short  1261 cgtccaacggagcgctgcactgctgcagatga 
jnk1b_7;long   1256 CGTCCAACGGAGCGCTGCACTGCTGCAGATGA 
jnk1b_8;short  1261 cgtccaacggagcgctgcactgctgcagatga 
jnk1b_8;long   1256 CGTCCAACGGAGCGCTGCACTGCTGCAGATGA 
 
Figure 59 Alignment of the Four jnk1b Variants Identified in this Study .  
The four different splice-variants of jnk1b identified by sequencing of the sub-cloned 
products aligned to each other. Conserved bases are highlighted in black and above the 
sequence is annotation showing exon contribution. There are two regions where the four 
variants differ from one another: the middle exon usage (red) and the exon 13 splicing 
acceptor (*). The region of jnk1a_7;short and jnk1a_8;short that forms part of the 3’ UTR 
is in lower case. 
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jnk1a   1 ATGAACAAAAATAAGCGAGAGAAAGAATTCTACAGTGTAGATGTGGGGGATTCGACATTC 
jnk1b   1 ATGAACAGGAATAAGCGCGAGAAAGAATATTACAGCATAGATGTAGGAGATTCGACGTTC 
 
jnk1a  61 ACAGTGTTGAAGCGCTATCAGAATCTAAGACCCATTGGCTCGGGTGCTCAGGGAATAGTC 
jnk1b  61 ACCGTTTTGAAGCGCTATCAGAATTTAAGACCAATCGGGTCCGGAGCACAAGGCATCGTC 
 
jnk1a 121 TGCTCAGCGTATGACAACAACCTCGAGCGAAACGTGGCTATAAAGAAACTCAGCCGGCCT 
jnk1b 121 TGCTCAGCGTATGACCACGTCCTCGATCGAAATGTGGCGATTAAGAAACTCAGCCGACCC 
 
jnk1a 181 TTTCAAAATCAAACTCATGCCAAACGTGCGTACAGAGAGCTGGTGCTCATGAAATGTGTC 
jnk1b 181 TTTCAAAACCAAACTCATGCCAAACGGGCCTACAGAGAACTGGTCCTGATGAAATGCGTC 
 
jnk1a 241 AACCATAAAAATATAATAGGCCTCTTAAATGTTTTTACACCGCAAAAAACATTAGAAGAA 
jnk1b 241 AACCACAAAAATATAATTGGCTTACTAAACGTGTTCACACCACAGAAGACCCTTGAAGAG 
 
jnk1a 301 TTCCAAGATGTTTACCTAGTAATGGAGCTGATGGATGCGAACCTCTGCCAAGTCATTCAG 
jnk1b 301 TTCCAGGATGTTTATCTGGTGATGGAGCTGATGGATGCAAACCTGTGTCAGGTGATTCAG 
 
jnk1a 361 ATGGAGCTGGACCACGAGCGGCTGTCCTATCTGCTGTACCAGATGCTGTGTGGAATAAAA 
jnk1b 361 ATGGAGCTGGACCACGAGAGGCTGTCCTACCTGCTCTATCAGATGCTCTGCGGCATTAAA 
 
jnk1a 421 CACCTCCACGCGGCGGGGATCATCCACAGGGACCTGAAACCCAGTAACATCGTGGTAAAG 
jnk1b 421 CACCTGCACGCTGCTGGCATCATACACAGGGACCTGAAACCCAGTAATATAGTAGTGAAA 
 
jnk1a 481 TCAGACTGTACCCTGAAGATCCTGGATTTCGGTCTGGCGCGGACAGCAGCTACAGGTCTG 
jnk1b 481 TCGGACTGCACGCTGAAGATCCTGGATTTCGGTCTGGCCAGAACGGCTGCAACCGGCCTC 
 
jnk1a 541 CTGATGACACCATATGTGGTGACCCGTTACTACAGAGCCCCTGAAGTCATCCTGGGAATG 
jnk1b 541 CTCATGACTCCTTATGTAGTGACACGCTATTATCGGGCCCCAGAGGTCATCCTGGGCATG 
 
jnk1a 601 GGATATCAAGCCAATGTGGACATTTGGTCTGTGGGCTGCATTTTGGCAGAAATGGTCCGT 
jnk1b 601 GGTTATCAAGCTAACGTGGATATTTGGGCTGTTGGCTGCATTATGGCAGAGATGGTGCGG 
 
jnk1a 661 CACAAAATCCTTTTTCCTGGGAGGGACTTGGATGTGTGGTCTGTCGGCTGTATCATGGCT 
jnk1b 661 CACAAAATCCTTTTTCCAGGGAGGGACTTTGATGTCTGGTCTATTGGCTGCATCATGGCT 
 
jnk1a 721 GAAATGGTCAGAGGTAGTGTATTATTTCCGGGTTCAGATCATATTGATCAGTGGAATAAA 
jnk1b 721 GAAATGGTCAGAGGTAGTGTGTTGTTTCCTGGCACAGACCATATTGACCAGTGGAATAAA 
 
jnk1a 781 GTAATAGAGCAGCTGGGAACGCCAACTCAGGAGTTCTTGTTGAAACTCAACCAGTCTGTG 
jnk1b 781 GTGATCGAGCAGCTCGGCACGCCGTCACAGGAGTTCATGATGAAGCTGAATCAGTCTGTG 
 
jnk1a 841 CGGACCTATGTGGAGAACAGGCCCCGGTACACTGGATATAGCTTTGAGAAGCTGTTTCCT 
jnk1b 841 AGGACGTATGTGGAGAACCGGCCTCGGTATGCGGGATACAGCTTTGAGAAGCTCTTCCCA 
 
jnk1a 901 GATGTCCTGTTCCCTGCTGATTCAGAACACAGCAAACTAAAAGCGAGTCAGGCGCGGGAC 
jnk1b 901 GACGTGCTCTTCCCCGCAGACTCGGACCACAACAAACTCAAGGCGAGTCAGGCACGAGAC 
 
jnk1a 961  CTGCTGTCTAAAATGCTGGTGATTGATGCATCAAAACGAATCTCGGTGGATGAGGCTTTG 
jnk1b 961  TTGTTATCCAAAATGCTGGTAATAGATGCGTCCAAGCGGATCTCTGTAGACGAGGCGCTT 
 
jnk1a 1021  CAGCACCCCTACATTAACGTGTGGTACGACCCGGCTGAAGTGGAAGCGCCTTCTCCTCTG 
jnk1b 1021  CAGCACCCCTACATCAACGTTTGGTACGACCCGTCAGAAGTGGAGGCGCCACCACCAGCG 
 
jnk1a 1081  ATCACAGACAAACAGCTCGATGAGAGGGAACACACAGTGGAAGAGTGGAAAGAACTGATC 
jnk1b 1081  ATCACGGATAAACAGCTCGATGAGAGAGAACACTCAGTGGAAGAGTGGAAAGAGCTCATA 
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Figure 60 DNA Alignment of All Thirteen Exons of jnk1a and jnk1b.  
This DNA alignment corresponds to Figure 18 and represents the raw data 
that was used to produce this figure. This alignment involves the sequence 
that was produced from my own sequencing experiments. The CDS of all 13 
jnk1a and jnk1b exons was aligned to determine where there were regions 
of relative sequence conservation within the sequence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 61 Protein Alignment of All Thirteen Exons of jnk1a and jnk1b.   
This protein alignment corresponds to Figure 18 and represents the raw 
data that was used to produce this figure. This alignment is of the protein 
sequence produced by the CDS of all 13 exons of jnk1a and jnk1b. The 
protein sequence was generating by translating the DNA sequencing data 
that was produced from my own sequencing experiments. This alignment 
was produced to determine whether the sequences had large stretches of 
sequence conservation.  
jnk1a 1141  TATAAAGAAGTGCTGGATTGGGAAGAACGGATGAAGAACGGTGTTATTCGAGGTCAGCCC 
jnk1b 1141  TATAAGGAAGTGCTGGAATGGGAGGAGCGAACAAAAAATGGAGTGATCAGAGGACAGCCG 
 
jnk1a 1201  TCCCCCCTAGGTGCAGCAGTGATCAACGGCTCACCCCAGCCCTCATC---CTCATCCTCC 
jnk1b 1201  GCCTCGCTAGGTGCAGCAGTGAGCAGTGACTCCCATGAGCCCTCGACGTCGTCCTCCTCC 
 
jnk1a 1258  ATCAACGACGTGTCCTCCATGTCCACAGAGCCCACCGTGGCCTCAGACACAGACAGCAGC 
jnk1b 1261  ATAAACGATGTGTCGTCCATGTCCACCGAGGTCACGCTGACCTCAGACACCGACAGCAGT 
 
jnk1a 1318  TTAGAGGCCTCGGCGGGACCCCTGAGCTGCTGCAGATGA 
jnk1b 1321  CAGGAGACGTCCAACGGAGCGCTGCACTGCTGCAGATGA 
 
jnk1a    1 MNKNKREKEFYSVDVGDSTFTVLKRYQNLRPIGSGAQGIVCSAYDNNLERNVAIKKLSRP 
jnk1b    1 MNRNKREKEYYSIDVGDSTFTVLKRYQNLRPIGSGAQGIVCSAYDHVLDRNVAIKKLSRP 
 
jnk1a   61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 
jnk1b   61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 
 
jnk1a  121 MELDHERLSYLLYQMLCGIKHLHAAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAATGL 
jnk1b  121 MELDHERLSYLLYQMLCGIKHLHAAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAATGL 
 
jnk1a  181 LMTPYVVTRYYRAPEVILGMGYQANVDIWSVGCILAEMVRHKILFPGRDLDVWSVGCIMA 
jnk1b  181 LMTPYVVTRYYRAPEVILGMGYQANVDIWAVGCIMAEMVRHKILFPGRDFDVWSIGCIMA 
 
jnk1a  241 EMVRGSVLFPGSDHIDQWNKVIEQLGTPTQEFLLKLNQSVRTYVENRPRYTGYSFEKLFP 
jnk1b  241 EMVRGSVLFPGTDHIDQWNKVIEQLGTPSQEFMMKLNQSVRTYVENRPRYAGYSFEKLFP 
 
jnk1a  301 DVLFPADSEHSKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPAEVEAPSPL 
jnk1b  301 DVLFPADSDHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEVEAPPPA 
 
jnk1a  361 ITDKQLDEREHTVEEWKELIYKEVLDWEERMKNGVIRGQPSPLGAAVINGSPQPS-SSSS 
jnk1b  361 ITDKQLDEREHSVEEWKELIYKEVLEWEERTKNGVIRGQPASLGAAVSSDSHEPSTSSSS 
 
jnk1a  420 INDVSSMSTEPTVASDTDSSLEASAGPLSCCR* 
jnk1b  421 INDVSSMSTEVTLTSDTDSSQETSNGALHCCR* 
  APPENDICES 
247 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
A 
 
 
>jnk1a MO seq 
5’ – CTCTCGCTTATTTTTGTTCATGGTG – 3’ 
3’ – GTGGTACTTGTTTTTATTCGCTCTC – 5’ 
 
 
>jnk1a exon 2 
1   gtttgtaacagtctgctttgtctggatgcttacacatcga 
 
  3’ – GTGGTACTTGTTTTTATTCGCTCTC – 5’ 
       ||||||||||||||||||||||||| 
41  cttcaccATGAACAAAAATAAGCGAGAGAAAGAATTCTACAGTGTAGATGTGGGGGATTC 
 
 
101 GACATTCACAGTGTTGAAGCGCTATCAGAATCTAAGACCCATTGGCTCGGGTGCTCAGGG 
 
 
161 AATAGTCTG 
 
 
 
 
B 
 
>jnk1b MO seq 
5’ – CTTTCTCGCGCTTATTCCTGTTCAT – 3’ 
3’ – TACTTGTCCTTATTCGCGCTCTTTC – 5’ 
 
 
>jnk1b exon 2 
1   atttttgaaggtgaagctcttcttgaatgcccaggata 
 
    3’ – TACTTGTCCTTATTCGCGCTCTTTC – 5’ 
                        ||||||||||||||||||||||||| 
41  cagtcagtacggttttcatcATGAACAGGAATAAGCGCGAGAAAGAATATTACA 
 
 
101 GCATAGATGTAGGAGATTCGACGTTCACCGTTTTGAAGCGCTATCAGAATTTAA 
 
 
161 GACCAATCGGGTCCGGAGCACAAGGCATCGTCTG 
 
Figure 62 The binding sites of the jnk1 morpholinos.  
Both jnk1 morpholinos hybridize in a 3’ to 5’ direction with the target 
sequence in exon 2 of A) the jnk1a or B) jnk1b genes. The nucleotide 
sequences in black are those of exon 2 jnk1a and jnk1b respectively. The 
sequences in red represent the morpholino sequences. Verticle lines 
represent the binding sites of the morpholinos to their target.  
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Figure 63 The binding sites of our translation blocking and the Seo et al. 
splice-variant morpholinos.  
Schematic representation of the jnk1a (A) and jnk1b (B) genes where boxes 
represent exons and black lines represent intronic sequence. The pink 
annotation shows the approximate location of the binding sites of the 
morpholino oligonucleotides used by our lab and those published in the paper 
by Seo et al. (Seo et al., 2010) . Text boxes show the MO sequence (in 3’ to 5’  
order) as well as 35bp of the jnk1a or jnk1b genes where the MO binds. In the 
jnk1 gene sequence uppercase represents exonic sequence whereas lowercase 
represents intronic sequence.  
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7.1.1 Abbreviations 
ANOVA analysis of variance 
AP anteroposterior 
ASK MAPKK kinase 5 
ATP adenosine triphosphate 
BMP bone morphogenetic protein 
BP basepair 
BSK basket / drosophila JNK 
cDNA complementary DNA 
CDS coding sequence 
CE convergent extension 
CHD congenital heart defects 
CMO control morpholino 
CNS central nervous system 
CRISPR clustered regularly interspaces short palindromic repeats 
dATP deoxyadenosine triphosphate 
DEPC diethylpyrocarbonate 
DGO diego 
DHARMA bozozok 
DNA deoxyribonucleic acid 
dNTPs deoxyribonucleotide triphosphate 
DS daschsous 
DSH dishevelled 
DTT dithiothreitol 
EDTA ethylenediaminetetraacetic acid 
ELFA1 elongation factor 1-alpha 
EMBL european molecular biology laboratory 
ERK extracellular signal-related kinase 
E-YSL external yolk syncytical layer 
FJ four-jointed 
FMI flamingo 
FT fat 
FZ frizzled 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GDF1 growth/differentiation factor 1 
GFP green fluorescent protein 
GL ganglion layer 
GTP guanosine triphosphate 
HBV hindbrain ventricle 
HPF hours post fertilisation 
INL inner nuclear layer 
IPL inner plexiform layer 
I-YSL internal yolk syncytical layer 
JNK c-jun n-terminal kinase 
kDA kilo daltons 
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LPM lateral plate mesoderm 
L-R left-right 
LRD left-right dynein 
MAP mitogen activated protein 
MAP3K MAPKK kinase 
MAP4K MAPKKK kinase 
MAPK mitogen activated protein kinase 
MAPKAPK MAPK activated protein kinase 
MAPKK MAPK kinase 
MAPKKK MAPKK kinase 
MEK MAPK kinase 
MeOH methanol 
MGT mid-blastula transition 
MKK MAPK kinase 
ML mediolateral 
MO morpholino oligonucleotide 
NCBI national centre for biotechnology information 
NOTO floating head 
OPL outer plexiform layer 
ORF open reading frame 
PCP planar cell polarity 
PCR polymerase chain reaction 
PK prickle 
PL photoreceptor layer 
PTU 1-phenyl 2-thiourea 
PVDF polyvinylidene fluoride 
qPCR quantitative real time PCR 
RACE rapid amplification of cDNA ends 
RNA ribonucleic acid 
ROCK rho kinase 
RPM revolutions per minute 
RT-PCR reverse transcription PCR 
SEM standard error of the mean 
SER serine 
SPAW southpaw / zebrafish nodal 
STAN starry night 
STBM strabismus 
TA no tail 
TAE tris-acetate EDTA buffer 
TAK MAPKK kinase 7 
TBS tris buffered saline 
TBS-T TBS tween 20 
TGFβ transforming growth factor beta 
THR threonine 
TYR tyrosine 
UTR untranslated region 
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UV ultraviolet 
VANG van gogh 
WNT Wingless-related MMTV integration site 
YSL yolk syncytical layer 
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